This is the multi-page printable view of this section. Click here to print.
Gene Ontology (GO)
The Gene Ontology (GO) provides a framework and set of concepts for describing the functions of gene products from all organisms.
- 1: ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)glycogenin => poly{(1,4)-alpha-glucosyl} glycogenin + alpha-D-glucose [GO_0004135]
- 2: (1->3)-beta-D-glucan binding [GO_0001872]
- 3: (1->3)-beta-D-glucan immune receptor activity [GO_0001874]
- 4: (2'-deoxy)adenosine + ATP => (d)AMP + ADP (ADK) [GO_0004001]
- 5: (3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO_0019171]
- 6: (d)ADP + ADP <=> (d)AMP + ATP (AK1) [GO_0004017]
- 7: (d)CDP or UDP + ADP <=> (d)CMP or UMP + ATP (CMPK1) [GO_0050145]
- 8: (d)GMP + ATP <=> (d)GDP + ADP (GUK1) [GO_0004385]
- 9: (d)NTP + ADP <=> (d)NDP + ATP (NME1,2,3) [GO_0004550]
- 10: (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity [GO_0070626]
- 11: (S)-2-hydroxy-acid oxidase activity [GO_0003973]
- 12: [acyl-carrier-protein] S-malonyltransferase activity [GO_0004314]
- 13: [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO_0008467]
- 14: [heparan sulfate]-glucosamine N-sulfotransferase activity [GO_0015016]
- 15: [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO_0004741]
- 16: 1-acyl LPE is acylated to PE by LPEAT [GO_0003841]
- 17: 1-acyl LPE is hydrolyzed to GPETA by PLA2G4C [GO_0004622]
- 18: 1-acylglycerophosphocholine O-acyltransferase activity [GO_0047184]
- 19: 1-palmitoylglycerone phosphate + hexadecanol => O-hexadecylglycerone phosphate + palmitate [GO_0008609]
- 20: 1-phosphatidylinositol 4-kinase activator activity [GO_0098744]
- 21: 1-phosphatidylinositol binding [GO_0005545]
- 22: 1-phosphatidylinositol-3-kinase regulator activity [GO_0046935]
- 23: 1-phosphatidylinositol-5-kinase activity [GO_0052810]
- 24: 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO_0016309]
- 25: 1-PP-IP5 is phosphorylated to 1,5-(PP)2-IP4 by IP6K1/3 in the cytosol [GO_0000829]
- 26: 1,2-diacyl-glycerol + acyl-CoA => triacylglycerol + CoASH [DGAT2] [GO_0004144]
- 27: 1,4-alpha-glucan branching enzyme activity [GO_0003844]
- 28: 1,4-alpha-oligoglucan phosphorylase activity [GO_0004645]
- 29: 1/3 PP-IP5 is dephosphorylated to IP6 by NUDT(1) in the cytosol [GO_0052842]
- 30: 14-3-3 protein binding [GO_0071889]
- 31: 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO_0044594]
- 32: 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO_0072582]
- 33: 17-beta-ketosteroid reductase activity [GO_0072555]
- 34: 2 H2O2 => O2 + 2 H2O [GO_0004096]
- 35: 2 iron, 2 sulfur cluster binding [GO_0051537]
- 36: 2-(3-amino-3-carboxypropyl)histidine synthase activity [GO_0090560]
- 37: 2-hydroxy-3-methylhexadecanoyl-CoA lyase activity [GO_0106360]
- 38: 2-hydroxyacyl-CoA lyase activity [GO_0106359]
- 39: 2-hydroxyglutarate dehydrogenase activity [GO_0047545]
- 40: 2-hydroxyglutarate dehydrogenase activity, forward reaction [GO_0061758]
- 41: 2-hydroxyphytanoyl-CoA => pristanal + formyl-CoA [GO_0016830]
- 42: 2-iminobutanoate deaminase activity [GO_0120242]
- 43: 2-iminobutanoate/2-iminopropanoate deaminase [GO_0120241]
- 44: 2-LTR formation due to circularization of viral DNA [GO_0003909]
- 45: 2-MAG and DAG are transacylated to TAG by PNPLA2/3 [GO_0016411]
- 46: 2-oxoglutarate + NADPH + H+ => (R)-2-hydroxyglutarate + NADP+ [mutant IDH1] [GO_0051990]
- 47: 2-oxoglutarate-dependent dioxygenase activity [GO_0016706]
- 48: 2-Phospho-D-glycerate <=> 3-Phospho-D-glycerate [GO_0004619]
- 49: 2-Phospho-D-glycerate <=> Phosphoenolpyruvate + H2O [GO_0004634]
- 50: 2'-deoxyribonucleotide biosynthetic process [GO_0009265]
- 51: 2'-deoxyribonucleotide metabolic process [GO_0009394]
- 52: 2',3'-cyclic GMP-AMP binding [GO_0061507]
- 53: 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO_0052907]
- 54: 2xENPP1 hydrolyzes FAD to FMN [GO_0004551]
- 55: 2xPDKX:2xZn2+ phosphorylates PDX [GO_0008478]
- 56: 2xPNPO:2xFMN oxidizes PXAP to PXLP [GO_0004733]
- 57: 2xPPCS ligates PPanK with Cys [GO_0004632]
- 58: 2xTPK1:Mg2+ phosphorylates THMN [GO_0004788]
- 59: 2xTRAP hydrolyzes FMN to RIB [GO_0003993]
- 60: 3 iron, 4 sulfur cluster binding [GO_0051538]
- 61: 3-dehydrosphinganine reductase activity [GO_0047560]
- 62: 3-demethoxyubiquinol 3-hydroxylase activity [GO_0008682]
- 63: 3-hydroxyacyl-CoA dehydratase activity [GO_0018812]
- 64: 3-ketohexacosanoyl-CoA + CoASH => tetracosanoyl-CoA + acetyl-CoA [GO_0003988]
- 65: 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO_0003863]
- 66: 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO_0004315]
- 67: 3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity [GO_0010420]
- 68: 3,4-dihydroxyphenylacetaldehyde synthase activity [GO_0106425]
- 69: 3'-5' DNA/RNA helicase activity [GO_0033679]
- 70: 3'-5' exonuclease activity [GO_0008408]
- 71: 3'-5' RNA helicase activity [GO_0034458]
- 72: 3'-5'-exoribonuclease activity involved in mature miRNA 3'-end processing [GO_0044748]
- 73: 3'-flap endonuclease activity [GO_0048257]
- 74: 3'-nucleotidase activity [GO_0008254]
- 75: 3'-phospho-5'-adenylyl sulfate transmembrane transport [GO_1902559]
- 76: 3'-phosphoadenosine 5'-phosphosulfate transport [GO_0046963]
- 77: 3'-tRNA processing endoribonuclease activity [GO_0042781]
- 78: 3'-tyrosyl-DNA phosphodiesterase activity [GO_0017005]
- 79: 3',2'-cyclic GMP-AMP binding [GO_0140704]
- 80: 3',2'-cyclic GMP-AMP synthase activity [GO_0140700]
- 81: 4 iron, 4 sulfur cluster binding [GO_0051539]
- 82: 4-hydroxybenzoate decaprenyltransferase activity [GO_0002083]
- 83: 4-hydroxyphenylpyruvate dioxygenase activity [GO_0003868]
- 84: 4-methylcholesta-8(9),24-dien-3-one is reduced to 4-methylcholesta-8(9),24-dien-3beta-ol [GO_0000253]
- 85: 4-methylcholesta-8(9),24-dien-3beta-ol is oxidized to 4-carboxycholesta-8(9),24-dien-3beta-ol [GO_0000254]
- 86: 4a-hydroxytetrahydrobiopterin => q-dihydrobiopterin + H2O [GO_0008124]
- 87: 4xPALM-C-p-2S-ABCA1 tetramer transports PL from transport vesicle membrane to plasma membrane [GO_0005548]
- 88: 5-HEDH dehydrogenates 5(S)-Hp-18(R)-HpEPE to 18(R)-RvE2 [GO_0003959]
- 89: 5-hydroxy-L-tryptophan decarboxylase activity [GO_0036467]
- 90: 5-Phosphoribosylamine + Glycine + ATP => GAR + ADP + Pi [GO_0004637]
- 91: 5,10-methylenetetrahydrofolate-dependent methyltransferase activity [GO_0042083]
- 92: 5,6-dihydrothymine + H2O => beta-ureidoisobutyrate [GO_0004157]
- 93: 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO_0140933]
- 94: 5'-3' exodeoxyribonuclease activity [GO_0035312]
- 95: 5'-3' exoribonuclease activity [GO_0004534]
- 96: 5'-3' RNA polymerase activity [GO_0034062]
- 97: 5'-deoxynucleotidase activity [GO_0002953]
- 98: 5'-nucleotidase activity [GO_0008253]
- 99: 5beta-cholestan-7alpha,27-diol-3-one is reduced to 5beta-cholestan-3alpha,7alpha,27-triol [GO_0004033]
- 100: 5S rDNA binding [GO_0080084]
- 101: 5S rRNA binding [GO_0008097]
- 102: 5S rRNA primary transcript binding [GO_0008098]
- 103: 6-phosphofructokinase activity [GO_0003872]
- 104: 6,7-dihydropteridine reductase activity [GO_0004155]
- 105: 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO_0047022]
- 106: 7-methylguanosine cap hypermethylation [GO_0036261]
- 107: 7-methylguanosine mRNA capping [GO_0006370]
- 108: 7-methylguanosine RNA capping [GO_0009452]
- 109: 7alpha-hydroxycholesterol is oxidized and isomerized to 4-cholesten-7alpha-ol-3-one [GO_0003854]
- 110: 7S RNA binding [GO_0008312]
- 111: 7SK snRNA binding [GO_0097322]
- 112: 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO_0034039]
- 113: A-type (transient outward) potassium channel activity [GO_0005250]
- 114: abacavir monophosphate + H2O => carbovir monophosphate + cyclopropylamine [GO_0004000]
- 115: ABC-type 3',5'-cyclic GMP transmembrane transporter activity [GO_1905948]
- 116: ABC-type fatty-acyl-CoA transporter activity [GO_0015607]
- 117: ABC-type guanine transporter activity [GO_0008558]
- 118: ABC-type polyamine transporter activity [GO_0015417]
- 119: ABC-type transporter activity [GO_0140359]
- 120: ABC-type xenobiotic transporter activity [GO_0008559]
- 121: ABC7, mABC1 and mABC2 mediate heme transport [GO_0015439]
- 122: ABCC4 accumulation of dense granule contents [GO_0015662]
- 123: AcCho is hydrolyzed to Cho and acetate by ACHE [GO_0003990]
- 124: ACE hydrolyzes Angiotensin-(1-9) to Angiotensin-(1-7) [GO_0070573]
- 125: ACE2 hydrolyzes Angiotensin-(1-8) to Angiotensin-(1-7) [GO_0004181]
- 126: acetaldehyde dehydrogenase (acetylating) activity [GO_0008774]
- 127: acetate CoA-transferase activity [GO_0008775]
- 128: acetate ester transmembrane transporter activity [GO_1901375]
- 129: acetate ester transport [GO_1901374]
- 130: acetate transmembrane transport [GO_0035433]
- 131: acetate transmembrane transporter activity [GO_0015123]
- 132: acetate transport [GO_0006846]
- 133: acetate-CoA ligase activity [GO_0003987]
- 134: acetoacetyl-CoA reductase activity [GO_0018454]
- 135: acetoacetyl-CoA+acetyl-CoA => HMG-CoA + CoASH [GO_0004421]
- 136: acetyl-CoA + 7 malonyl-CoA + 14 NADHP + 14 H+ => palmitate + 7 CO2 + 14 NADP+ + 8 CoASH + 6 H2O [GO_0004312]
- 137: Acetyl-CoA + H2O + Oxaloacetate => Citrate + CoA [GO_0004108]
- 138: acetyl-CoA binding [GO_1905502]
- 139: acetyl-CoA C-acetyltransferase activity [GO_0003985]
- 140: acetylation-dependent protein binding [GO_0140033]
- 141: acetylcholine binding [GO_0042166]
- 142: acetylcholine receptor activator activity [GO_0030549]
- 143: acetylcholine receptor activity [GO_0015464]
- 144: acetylcholine receptor binding [GO_0033130]
- 145: acetylcholine receptor inhibitor activity [GO_0030550]
- 146: acetylcholine receptor regulator activity [GO_0030548]
- 147: acetylcholine receptor signaling pathway [GO_0095500]
- 148: acetylcholine secretion [GO_0061526]
- 149: acetylcholine secretion, neurotransmission [GO_0014055]
- 150: acetylcholine transport [GO_0015870]
- 151: acetylcholine-gated cation-selective channel activity [GO_0022848]
- 152: acetylesterase activity [GO_0008126]
- 153: acetylpyruvate hydrolase activity [GO_0018773]
- 154: acetyltransferase activator activity [GO_0010698]
- 155: acid secretion [GO_0046717]
- 156: acid sphingomyelin phosphodiesterase activity [GO_0061750]
- 157: acid-amino acid ligase activity [GO_0016881]
- 158: acid-ammonia (or amide) ligase activity [GO_0016880]
- 159: acid-sensing ion channel activity [GO_0044736]
- 160: acid-thiol ligase activity [GO_0016878]
- 161: acidic amino acid transmembrane transporter activity [GO_0015172]
- 162: acidic amino acid transport [GO_0015800]
- 163: Acidification of Tf:TfR1 containing endosome [GO_0015078]
- 164: acinar cell differentiation [GO_0090425]
- 165: acinar cell proliferation [GO_1990863]
- 166: acireductone dioxygenase [iron(II)-requiring] activity [GO_0010309]
- 167: acireductone synthase activity [GO_0043874]
- 168: ACP phosphopantetheine attachment site binding [GO_0044620]
- 169: Acrosin Cleavage [GO_0002020]
- 170: ACSBG1,2 ligates CoA-SH to VLCFA, forming VLCFA-CoA [GO_0031957]
- 171: ACSL3,4 ligates coenzyme A (CoA-SH) to palmitate yielding palmitoyl-coenzyme A in the pancreatic beta cell [GO_0090433]
- 172: actin binding [GO_0003779]
- 173: actin cytoskeleton [GO_0015629]
- 174: actin cytoskeleton organization [GO_0030036]
- 175: actin filament [GO_0005884]
- 176: actin filament binding [GO_0051015]
- 177: actin filament bundle [GO_0032432]
- 178: actin filament bundle assembly [GO_0051017]
- 179: actin filament bundle organization [GO_0061572]
- 180: actin filament organization [GO_0007015]
- 181: actin filament-based movement [GO_0030048]
- 182: actin filament-based process [GO_0030029]
- 183: actin filament-based transport [GO_0099515]
- 184: actin monomer binding [GO_0003785]
- 185: actin-based cell projection [GO_0098858]
- 186: actinin binding [GO_0042805]
- 187: action potential [GO_0001508]
- 188: Activated Adenylyl cyclase synthesizes cyclic AMP [GO_0004016]
- 189: Activated ERK1/2 threonine-phosphorylates FGFR4-associated FRS2. [GO_0004707]
- 190: Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3 [GO_0004708]
- 191: Activated JNK phosphorylates c-JUN [GO_0004705]
- 192: Activated MAP2Ks phosphorylate MAPKs downstream of inactive BRAF mutants [GO_0004712]
- 193: Activated type I receptor phosphorylates R-Smad1/5/8 directly [GO_0004675]
- 194: activation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0006919]
- 195: Activation of highly calcium permeable postsynaptic nicotinic acetylcholine receptors [GO_0015276]
- 196: Activation of NLK [GO_0004674]
- 197: Activation of TWIK-related K+ channel (TREK) [GO_0005267]
- 198: active ion transmembrane transporter activity [GO_0022853]
- 199: Active PKA, CaMK IV do not phosphorylate MECP2 mutants R306C,(R306H) at T308 [GO_0010857]
- 200: Active PLCG1 hydrolyses PIP2 [GO_0004435]
- 201: active transmembrane transporter activity [GO_0022804]
- 202: activin binding [GO_0048185]
- 203: activin receptor activity [GO_0017002]
- 204: activin receptor activity, type I [GO_0016361]
- 205: activin receptor activity, type II [GO_0016362]
- 206: activin receptor binding [GO_0070697]
- 207: activin receptor signaling pathway [GO_0032924]
- 208: actomyosin [GO_0042641]
- 209: actomyosin structure organization [GO_0031032]
- 210: acyl binding [GO_0000035]
- 211: acyl carnitine transmembrane transport [GO_1902616]
- 212: acyl carnitine transmembrane transporter activity [GO_0015227]
- 213: acyl carnitine transport [GO_0006844]
- 214: acyl carrier activity [GO_0000036]
- 215: acyl-CoA binding [GO_0120227]
- 216: acyl-CoA desaturase activity [GO_0016215]
- 217: acyl-CoA hydrolase activity [GO_0047617]
- 218: acyl-CoA N-acyltransferase activity [GO_0019186]
- 219: acylglycerol biosynthetic process [GO_0046463]
- 220: acylglycerol kinase activity [GO_0047620]
- 221: acylglycerol metabolic process [GO_0006639]
- 222: acylphosphatase activity [GO_0003998]
- 223: acyltransferase activity, acyl groups converted into alkyl on transfer [GO_0046912]
- 224: acyltransferase activity, transferring groups other than amino-acyl groups [GO_0016747]
- 225: ADAM10:Zn2+:TSPANs cleaves APP(18-770) [GO_1902945]
- 226: ADAT1 deaminates adenosine-37 in tRNA(Ala) [GO_0008251]
- 227: Addition of a third mannose to the N-glycan precursor by ALG2 [GO_0000009]
- 228: Addition of GlcNAc to the glycan on the A arm [GO_0003827]
- 229: Addition of GlcNAc to the Tn antigen forms a Core 3 glycoprotein [GO_0008499]
- 230: Addition of isopentenyl pyrophosphate to DMAPP [GO_0004161]
- 231: Addition of N-acetyl-D-glucosamine to Dolichyl phosphate [GO_0003975]
- 232: adenine binding [GO_0002055]
- 233: adenine nucleotide transmembrane transporter activity [GO_0000295]
- 234: adenine nucleotide transport [GO_0051503]
- 235: adenosine 3',5'-bisphosphate transmembrane transport [GO_0071106]
- 236: adenosine 3',5'-bisphosphate transmembrane transporter activity [GO_0071077]
- 237: adenosine 5'-monophosphoramidase activity [GO_0043530]
- 238: adenosine-phosphate deaminase activity [GO_0047623]
- 239: adenosylhomocysteinase activity [GO_0004013]
- 240: adenosylmethionine decarboxylase activity [GO_0004014]
- 241: adenyl nucleotide binding [GO_0030554]
- 242: adenyl ribonucleotide binding [GO_0032559]
- 243: adenylate cyclase activator activity [GO_0010856]
- 244: adenylate cyclase binding [GO_0008179]
- 245: adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO_0001640]
- 246: adenylate cyclase inhibitor activity [GO_0010855]
- 247: adenylate cyclase regulator activity [GO_0010854]
- 248: adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO_0007189]
- 249: adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO_0007196]
- 250: adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO_0007193]
- 251: adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO_0007188]
- 252: adenylosuccinate synthase activity [GO_0004019]
- 253: adenylyltransferase activity [GO_0070566]
- 254: ADH5 oxidises S-HMGSH to S-FGSH [GO_0051903]
- 255: adipokinetic hormone binding [GO_0097004]
- 256: adipokinetic hormone receptor activity [GO_0097003]
- 257: adipokinetic hormone receptor binding [GO_0097005]
- 258: adiponectin binding [GO_0055100]
- 259: adipose tissue development [GO_0060612]
- 260: ADP binding [GO_0043531]
- 261: ADP catabolic process [GO_0046032]
- 262: ADP metabolic process [GO_0046031]
- 263: ADP phosphatase activity [GO_0043262]
- 264: ADP transmembrane transporter activity [GO_0015217]
- 265: ADP transport [GO_0015866]
- 266: ADP-ribose diphosphatase activity [GO_0047631]
- 267: ADP-ribosylglutamate hydrolase activity [GO_0140293]
- 268: ADP-ribosylserine hydrolase activity [GO_0140292]
- 269: ADP-specific glucokinase activity [GO_0043843]
- 270: adrenergic receptor activity [GO_0004935]
- 271: adrenergic receptor signaling pathway [GO_0071875]
- 272: adult behavior [GO_0030534]
- 273: adult feeding behavior [GO_0008343]
- 274: adult locomotory behavior [GO_0008344]
- 275: adult walking behavior [GO_0007628]
- 276: aerobic respiration [GO_0009060]
- 277: AFMID hydrolyses NFK to L-KYN [GO_0004061]
- 278: aggressive behavior [GO_0002118]
- 279: aging [GO_0007568]
- 280: ALAD condenses 2 dALAs to form PBG [GO_0004655]
- 281: alanine + tRNA(Ala) + ATP => Ala-tRNA(Ala) + AMP + pyrophosphate [GO_0004813]
- 282: alanine transmembrane transporter activity [GO_0022858]
- 283: alanine transport [GO_0032328]
- 284: alanine-glyoxylate transaminase activity [GO_0008453]
- 285: alanine-oxo-acid transaminase activity [GO_0047635]
- 286: ALAS condenses SUCC-CoA and Gly to form dALA [GO_0003870]
- 287: alcohol binding [GO_0043178]
- 288: alcohol dehydrogenase (NAD+) activity [GO_0004022]
- 289: alcohol dehydrogenase (NADP+) activity [GO_0008106]
- 290: alcohol dehydrogenase [NAD(P)+] activity [GO_0018455]
- 291: alcohol dehydrogenase activity, zinc-dependent [GO_0004024]
- 292: alcohol metabolic process [GO_0006066]
- 293: ALD3A1 oxidises 4HPCP to CXPA [GO_0004030]
- 294: aldehyde biosynthetic process [GO_0046184]
- 295: aldehyde decarbonylase activity [GO_0071771]
- 296: aldehyde dehydrogenase (NAD+) activity [GO_0004029]
- 297: aldehyde dehydrogenase (NAD+) inhibitor activity [GO_0140631]
- 298: aldehyde oxidase activity [GO_0004031]
- 299: aldehyde-lyase activity [GO_0016832]
- 300: ALDH4A1 oxidises L-GluSS to Glu [GO_0003842]
- 301: alditol:NADP+ 1-oxidoreductase activity [GO_0004032]
- 302: aldose 1-epimerase activity [GO_0004034]
- 303: ALG3 transfers Man to N-glycan precursor (GlcNAc)2 (Man)5 (PP-Dol)1 [GO_0000033]
- 304: alkali metal ion binding [GO_0031420]
- 305: alkaloid biosynthetic process [GO_0009821]
- 306: alkaloid catabolic process [GO_0009822]
- 307: alkaloid metabolic process [GO_0009820]
- 308: alkane 1-monooxygenase activity [GO_0018685]
- 309: alkanesulfonate transmembrane transporter activity [GO_0042959]
- 310: alkanesulfonate transport [GO_0042918]
- 311: alkylthioltransferase activity [GO_0050497]
- 312: allantoinase activity [GO_0004038]
- 313: allantois development [GO_1905069]
- 314: allatostatin receptor activity [GO_0008261]
- 315: alpha-(1->6)-fucosyltransferase activity [GO_0046921]
- 316: alpha-1,3-glucosidase activity [GO_0090600]
- 317: alpha-1,4-N-acetylgalactosaminyltransferase activity [GO_0035248]
- 318: alpha-actinin binding [GO_0051393]
- 319: alpha-amino acid biosynthetic process [GO_1901607]
- 320: alpha-amino acid catabolic process [GO_1901606]
- 321: alpha-amino acid metabolic process [GO_1901605]
- 322: alpha-aminoadipate + alpha-ketoglutarate <=> alpha-ketoadipate + glutamate [GO_0047536]
- 323: alpha-catenin binding [GO_0045294]
- 324: alpha-D-glucose 6-phosphate + NADP+ => D-glucono-1,5-lactone 6-phosphate + NADPH + H+ [GO_0004345]
- 325: alpha-galactosidase activity [GO_0004557]
- 326: alpha-glucosidase activity [GO_0090599]
- 327: alpha-ketoglutarate reductase activity [GO_0061759]
- 328: alpha-ketoglutarate transmembrane transporter activity [GO_0015139]
- 329: alpha-ketoglutarate transport [GO_0015742]
- 330: alpha-tubulin binding [GO_0043014]
- 331: alpha,alpha-trehalase activity [GO_0004555]
- 332: alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO_0003825]
- 333: ALPI dimer hydrolyses phosphate monoesters [GO_0004035]
- 334: AMDHD2 hydrolyses GlcNGc-6-P to GlcN6P and CCA [GO_0008448]
- 335: ameboidal-type cell migration [GO_0001667]
- 336: amide binding [GO_0033218]
- 337: amide biosynthetic process [GO_0043604]
- 338: amide transmembrane transporter activity [GO_0042887]
- 339: amide transport [GO_0042886]
- 340: amidine-lyase activity [GO_0016842]
- 341: amidophosphoribosyltransferase activity [GO_0004044]
- 342: amine binding [GO_0043176]
- 343: amine biosynthetic process [GO_0009309]
- 344: amine catabolic process [GO_0009310]
- 345: amine metabolic process [GO_0009308]
- 346: amine transmembrane transporter activity [GO_0005275]
- 347: amine transport [GO_0015837]
- 348: amine-lyase activity [GO_0016843]
- 349: amino acid binding [GO_0016597]
- 350: amino acid homeostasis [GO_0080144]
- 351: amino acid kinase activity [GO_0019202]
- 352: amino acid transmembrane transport [GO_0003333]
- 353: amino acid transport [GO_0006865]
- 354: amino acid:cation symporter activity [GO_0005416]
- 355: amino acid:monoatomic cation antiporter activity [GO_0140848]
- 356: amino acid:sodium symporter activity [GO_0005283]
- 357: amino-acid racemase activity [GO_0047661]
- 358: aminoacyl-tRNA editing activity [GO_0002161]
- 359: aminoacyl-tRNA hydrolase activity [GO_0004045]
- 360: aminoacyl-tRNA ligase activity [GO_0004812]
- 361: aminoacyl-tRNA metabolism involved in translational fidelity [GO_0106074]
- 362: aminoacylase activity [GO_0004046]
- 363: aminoacyltransferase activity [GO_0016755]
- 364: aminoglycan biosynthetic process [GO_0006023]
- 365: aminoglycan catabolic process [GO_0006026]
- 366: aminoglycan metabolic process [GO_0006022]
- 367: ammonia ligase activity [GO_0016211]
- 368: ammonia-lyase activity [GO_0016841]
- 369: ammonium excretion [GO_0140734]
- 370: ammonium homeostasis [GO_0097272]
- 371: ammonium ion binding [GO_0070405]
- 372: ammonium ion metabolic process [GO_0097164]
- 373: ammonium transmembrane transport [GO_0072488]
- 374: ammonium transport [GO_0015696]
- 375: AMP binding [GO_0016208]
- 376: AMP biosynthetic process [GO_0006167]
- 377: AMP deaminase activity [GO_0003876]
- 378: AMP metabolic process [GO_0046033]
- 379: AMP transmembrane transporter activity [GO_0080122]
- 380: AMP transport [GO_0080121]
- 381: AMPylase activity [GO_0070733]
- 382: AMT transfers NH2CH2 from GCSH:SAMDLL to THF [GO_0004047]
- 383: amylase activity [GO_0016160]
- 384: amyloid precursor protein catabolic process [GO_0042987]
- 385: amyloid precursor protein metabolic process [GO_0042982]
- 386: amyloid-beta binding [GO_0001540]
- 387: An unknown carrier transports mitochondrial glyoxylate to the cytosol [GO_0022857]
- 388: An unknown oxidase oxidises D-UBGN to UBN [GO_0016627]
- 389: anaphase-promoting complex binding [GO_0010997]
- 390: anatomical structure development [GO_0048856]
- 391: anatomical structure formation involved in morphogenesis [GO_0048646]
- 392: anatomical structure homeostasis [GO_0060249]
- 393: anatomical structure maturation [GO_0071695]
- 394: anatomical structure morphogenesis [GO_0009653]
- 395: anchoring junction [GO_0070161]
- 396: androgen secretion [GO_0035935]
- 397: anesthesia-resistant memory [GO_0007615]
- 398: angioblast cell differentiation [GO_0035779]
- 399: angiogenesis [GO_0001525]
- 400: angiogenesis involved in coronary vascular morphogenesis [GO_0060978]
- 401: animal organ development [GO_0048513]
- 402: animal organ formation [GO_0048645]
- 403: animal organ maturation [GO_0048799]
- 404: animal organ morphogenesis [GO_0009887]
- 405: anion binding [GO_0043168]
- 406: anion channel activity [GO_0005253]
- 407: anion homeostasis [GO_0055081]
- 408: anion transmembrane transport [GO_0098656]
- 409: anion transmembrane transporter activity [GO_0008509]
- 410: anion transport [GO_0006820]
- 411: anion:cation symporter activity [GO_0015296]
- 412: anion:sodium symporter activity [GO_0015373]
- 413: ankyrin binding [GO_0030506]
- 414: annealing activity [GO_0140666]
- 415: anterior/posterior pattern specification [GO_0009952]
- 416: anterograde trans-synaptic signaling [GO_0098916]
- 417: Anthrax lef cleaves target cell MAP2K7 (MEK7) [GO_0008237]
- 418: antigen binding [GO_0003823]
- 419: antioxidant activity [GO_0016209]
- 420: aorta development [GO_0035904]
- 421: aorta morphogenesis [GO_0035909]
- 422: aorta smooth muscle tissue morphogenesis [GO_0060414]
- 423: aortic smooth muscle cell differentiation [GO_0035887]
- 424: AP-1 adaptor complex binding [GO_0035650]
- 425: AP-2 adaptor complex binding [GO_0035612]
- 426: apical ectodermal ridge formation [GO_1905139]
- 427: apolipoprotein binding [GO_0034185]
- 428: apoptotic chromosome condensation [GO_0030263]
- 429: apoptotic nuclear changes [GO_0030262]
- 430: apoptotic process [GO_0006915]
- 431: apoptotic process involved in blood vessel morphogenesis [GO_1902262]
- 432: apoptotic process involved in development [GO_1902742]
- 433: apoptotic process involved in endocardial cushion morphogenesis [GO_0003277]
- 434: apoptotic process involved in heart morphogenesis [GO_0003278]
- 435: apoptotic process involved in morphogenesis [GO_0060561]
- 436: apoptotic process involved in outflow tract morphogenesis [GO_0003275]
- 437: apoptotic process involved in tube lumen cavitation [GO_0060609]
- 438: apoptotic signaling pathway [GO_0097190]
- 439: appendage development [GO_0048736]
- 440: appendage morphogenesis [GO_0035107]
- 441: arginine + H2O => ornithine + urea [ARG1] [GO_0004053]
- 442: arginine kinase activity [GO_0004054]
- 443: arginine N-methyltransferase activity [GO_0016273]
- 444: arginine-tRNA ligase activity [GO_0004814]
- 445: argininosuccinate lyase activity [GO_0004056]
- 446: argininosuccinate synthase activity [GO_0004055]
- 447: arginyltransferase activity [GO_0004057]
- 448: ARHGAP35 stimulates RHOA GTPase activity [GO_0003924]
- 449: aromatic amino acid family biosynthetic process [GO_0009073]
- 450: aromatic amino acid family biosynthetic process, prephenate pathway [GO_0009095]
- 451: aromatic amino acid metabolic process [GO_0009072]
- 452: aromatic amino acid transmembrane transporter activity [GO_0015173]
- 453: aromatic amino acid transport [GO_0015801]
- 454: aromatic compound biosynthetic process [GO_0019438]
- 455: aromatic compound catabolic process [GO_0019439]
- 456: aromatic-L-amino-acid decarboxylase activity [GO_0004058]
- 457: Arp2/3 complex binding [GO_0071933]
- 458: arterial endothelial cell differentiation [GO_0060842]
- 459: artery development [GO_0060840]
- 460: artery morphogenesis [GO_0048844]
- 461: ARV1 transports CHOL from ER membrane to plasma membrane [GO_0015248]
- 462: arylamine N-acetyltransferase activity [GO_0004060]
- 463: arylesterase activity [GO_0004064]
- 464: ascending aorta development [GO_0035905]
- 465: ascending aorta morphogenesis [GO_0035910]
- 466: asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO_0046988]
- 467: asparagine-tRNA ligase activity [GO_0004816]
- 468: aspartate + glutamine + ATP <=> asparagine + glutamate + AMP + pyrophosphate [ASNS] [GO_0004066]
- 469: aspartate + tRNA(Asp) + ATP => Asp-tRNA(Asp) + AMP + pyrophosphate [GO_0004815]
- 470: aspartate 1-decarboxylase activity [GO_0004068]
- 471: aspartate transmembrane transport [GO_0015810]
- 472: aspartate:glutamate, proton antiporter activity [GO_0000515]
- 473: aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902944]
- 474: aspartic-type endopeptidase inhibitor activity [GO_0019828]
- 475: aspartic-type peptidase activity [GO_0070001]
- 476: ASPG hydrolyses L-Asn to L-Asp [GO_0004067]
- 477: Association of GABA B receptor with G protein beta-gamma subunits [GO_0004965]
- 478: associative learning [GO_0008306]
- 479: asymmetric cell division [GO_0008356]
- 480: asymmetric neuroblast division [GO_0055059]
- 481: asymmetric stem cell division [GO_0098722]
- 482: Atg12 activating enzyme activity [GO_0019778]
- 483: ATG3 transfers LC3 from ATG7 to ATG3 [GO_0019776]
- 484: Atg8 activating enzyme activity [GO_0019779]
- 485: Atg8-specific peptidase activity [GO_0019786]
- 486: ATP + 3-Phospho-D-glycerate <=> ADP + 1,3-bisphospho-D-glycerate [GO_0004618]
- 487: ATP biosynthetic process [GO_0006754]
- 488: ATP citrate synthase activity [GO_0003878]
- 489: ATP generation from ADP [GO_0006757]
- 490: ATP metabolic process [GO_0046034]
- 491: ATP transmembrane transporter activity [GO_0005347]
- 492: ATP transport [GO_0015867]
- 493: ATP-dependent activity [GO_0140657]
- 494: ATP-dependent activity, acting on DNA [GO_0008094]
- 495: ATP-dependent activity, acting on RNA [GO_0008186]
- 496: ATP-dependent chromatin remodeler activity [GO_0140658]
- 497: ATP-dependent DNA (cytosine-5-)-methyltransferase activity [GO_0120328]
- 498: ATP-dependent DNA damage sensor activity [GO_0140664]
- 499: ATP-dependent DNA/DNA annealing activity [GO_0036310]
- 500: ATP-dependent FeS chaperone activity [GO_0140663]
- 501: ATP-dependent H2AZ histone chaperone activity [GO_0140849]
- 502: ATP-dependent histone chaperone activity [GO_0140674]
- 503: ATP-dependent NAD(P)H-hydrate dehydratase activity [GO_0047453]
- 504: ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO_0046404]
- 505: ATP-dependent polynucleotide 5'-hydroxyl-kinase activity [GO_0051734]
- 506: ATP-dependent protein binding [GO_0043008]
- 507: ATP-dependent protein folding chaperone [GO_0140662]
- 508: ATP:ADP antiporter activity [GO_0005471]
- 509: ATP2C1/2:Mg2+ transport cytosolic Ca2+ to Golgi lumen [GO_0005388]
- 510: ATP7A transports cytosolic Cu2+ to phagosomal lumen [GO_0043682]
- 511: ATPase activator activity [GO_0001671]
- 512: ATPase activity, coupled to transmembrane movement of ions, rotational mechanism [GO_0044769]
- 513: ATPase binding [GO_0051117]
- 514: ATPase coupled ion transmembrane transporter activity involved in regulation of postsynaptic membrane potential [GO_0099581]
- 515: ATPase inhibitor activity [GO_0042030]
- 516: ATPase regulator activity [GO_0060590]
- 517: ATPase-coupled cation transmembrane transporter activity [GO_0019829]
- 518: ATPase-coupled inorganic anion transmembrane transporter activity [GO_0043225]
- 519: ATPase-coupled ion transmembrane transporter activity [GO_0042625]
- 520: ATPase-coupled lipid transmembrane transporter activity [GO_0034040]
- 521: atrial cardiac muscle tissue development [GO_0003228]
- 522: atrial cardiac muscle tissue morphogenesis [GO_0055009]
- 523: atrial septum development [GO_0003283]
- 524: atrial septum morphogenesis [GO_0060413]
- 525: atrioventricular node cell development [GO_0060928]
- 526: atrioventricular node cell differentiation [GO_0060922]
- 527: atrioventricular node development [GO_0003162]
- 528: Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 [GO_0008349]
- 529: Autoglucosylation of GYG1 complexed with GYS1-a [GO_0008466]
- 530: autonomic nervous system development [GO_0048483]
- 531: Autophosphorylation of LYN kinase [GO_0004713]
- 532: AV node cell action potential [GO_0086016]
- 533: AV node cell to bundle of His cell communication [GO_0086067]
- 534: AV node cell to bundle of His cell signaling [GO_0086027]
- 535: axial mesoderm development [GO_0048318]
- 536: axial mesoderm formation [GO_0048320]
- 537: axial mesoderm morphogenesis [GO_0048319]
- 538: axis specification [GO_0009798]
- 539: axo-dendritic protein transport [GO_0099640]
- 540: axo-dendritic transport [GO_0008088]
- 541: axon [GO_0030424]
- 542: axon cytoplasm [GO_1904115]
- 543: axon development [GO_0061564]
- 544: axon guidance [GO_0007411]
- 545: axon guidance receptor activity [GO_0008046]
- 546: axonal dopamine secretion [GO_0099124]
- 547: axonemal microtubule [GO_0005879]
- 548: axonemal microtubule depolymerization [GO_0060404]
- 549: axoneme [GO_0005930]
- 550: axoneme assembly [GO_0035082]
- 551: axonogenesis [GO_0007409]
- 552: azole transmembrane transport [GO_0045117]
- 553: azole transmembrane transporter activity [GO_1901474]
- 554: B3GALT6 transfers Gal to the tetrasaccharide linker [GO_0047220]
- 555: B3GALTL transfers glucose to O-fucosyl-proteins [GO_0016757]
- 556: B4GALNT2 transfers GalNAc to Type 2 MSGG to form Sda [GO_0008376]
- 557: B4GALT7 transfers Gal group to xylosyl-unit of the tetrasaccharide linker [GO_0046525]
- 558: backward locomotion [GO_0043057]
- 559: Bacterial GUSB hydrolyses BDG to BIL [GO_0004553]
- 560: banded collagen fibril [GO_0098643]
- 561: basal RNA polymerase II transcription machinery binding [GO_0001099]
- 562: basal transcription machinery binding [GO_0001098]
- 563: basement membrane [GO_0005604]
- 564: basement membrane assembly [GO_0070831]
- 565: basement membrane collagen trimer [GO_0098651]
- 566: basement membrane disassembly [GO_0034769]
- 567: basement membrane organization [GO_0071711]
- 568: basic amino acid transmembrane transport [GO_1990822]
- 569: basic amino acid transport [GO_0015802]
- 570: BBOX1:AscH-:Fe2+ dimer dioxygenates TEABT and 2OG to form CAR and SUCCA [GO_0008336]
- 571: BCAP Signalosome phosphorylates PI(4,5)P2 forming PI(3,4,5)P3 [GO_0035004]
- 572: behavior [GO_0007610]
- 573: behavioral response to nutrient [GO_0051780]
- 574: behavioral response to pain [GO_0048266]
- 575: behavioral response to starvation [GO_0042595]
- 576: bent DNA binding [GO_0003681]
- 577: benzene-containing compound metabolic process [GO_0042537]
- 578: beta-1,3-galactosyltransferase activity [GO_0048531]
- 579: beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity [GO_0046981]
- 580: beta-1,4-mannosyltransferase activity [GO_0019187]
- 581: beta-1,4-N-acetylgalactosaminyltransferase activity [GO_0033207]
- 582: beta-alanine transmembrane transporter activity [GO_0001761]
- 583: beta-alanine transport [GO_0001762]
- 584: beta-alanyl amine synthase activity [GO_0003833]
- 585: beta-alanyl-dopamine hydrolase activity [GO_0003832]
- 586: beta-alanyl-histamine hydrolase activity [GO_0031964]
- 587: beta-aspartyl-peptidase activity [GO_0008798]
- 588: beta-carotene 15,15'-dioxygenase activity [GO_0003834]
- 589: beta-catenin binding [GO_0008013]
- 590: beta-catenin destruction complex binding [GO_1904713]
- 591: beta-galactosidase activity [GO_0004565]
- 592: beta-glucosidase activity [GO_0008422]
- 593: beta-hydroxyisobutyryl-CoA + H2O => beta-hydroxyisobutyrate + CoA [GO_0003860]
- 594: beta-mannosidase activity [GO_0004567]
- 595: beta-methylcrotonyl-CoA + ATP + CO2 <=> beta-methylglutaconyl-CoA + ADP + orthophosphate + H2O [MCCA] [GO_0004485]
- 596: beta-N-acetylglucosaminidase activity [GO_0016231]
- 597: beta-tubulin binding [GO_0048487]
- 598: beta-ureidoisobutyrate + H2O => 3-aminoisobutyrate + NH4+ + CO2 [GO_0003837]
- 599: BH domain binding [GO_0051400]
- 600: bHLH transcription factor binding [GO_0043425]
- 601: bicarbonate transmembrane transporter activity [GO_0015106]
- 602: bicarbonate transport [GO_0015701]
- 603: bidentate ribonuclease III activity [GO_0016443]
- 604: bile acid and bile salt transport [GO_0015721]
- 605: bile acid biosynthetic process [GO_0006699]
- 606: bile acid catabolic process [GO_0030573]
- 607: bile acid metabolic process [GO_0008206]
- 608: bile acid secretion [GO_0032782]
- 609: bilirubin transmembrane transporter activity [GO_0015127]
- 610: bilirubin transport [GO_0015723]
- 611: biliverdin reductase (NAD(P)+) activity [GO_0004074]
- 612: binding [GO_0005488]
- 613: biological adhesion [GO_0022610]
- 614: biological phase [GO_0044848]
- 615: biological process involved in interspecies interaction between organisms [GO_0044419]
- 616: biological regulation [GO_0065007]
- 617: biological_process [GO_0008150]
- 618: biosynthetic process [GO_0009058]
- 619: biotin-[acetyl-CoA-carboxylase] ligase activity [GO_0004077]
- 620: BIR domain binding [GO_1990525]
- 621: bis(5'-adenosyl)-hexaphosphatase activity [GO_0034431]
- 622: bis(5'-adenosyl)-pentaphosphatase activity [GO_0034432]
- 623: bis(5'-adenosyl)-triphosphatase activity [GO_0047710]
- 624: bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO_0004081]
- 625: bis(5'-nucleosyl)-tetraphosphatase activity [GO_0008796]
- 626: bisphosphoglycerate 3-phosphatase activity [GO_0034417]
- 627: bisphosphoglycerate phosphatase activity [GO_0034416]
- 628: bitter taste receptor activity [GO_0033038]
- 629: blastocyst development [GO_0001824]
- 630: blastocyst formation [GO_0001825]
- 631: blastocyst growth [GO_0001832]
- 632: bleb [GO_0032059]
- 633: bleb assembly [GO_0032060]
- 634: blood circulation [GO_0008015]
- 635: blood vessel development [GO_0001568]
- 636: blood vessel endothelial cell differentiation [GO_0060837]
- 637: blood vessel maturation [GO_0001955]
- 638: blood vessel morphogenesis [GO_0048514]
- 639: blue light photoreceptor activity [GO_0009882]
- 640: blue light signaling pathway [GO_0009785]
- 641: BMP binding [GO_0036122]
- 642: BMP receptor activity [GO_0098821]
- 643: BMP receptor binding [GO_0070700]
- 644: BMP signaling pathway [GO_0030509]
- 645: body fluid secretion [GO_0007589]
- 646: body morphogenesis [GO_0010171]
- 647: bone cell development [GO_0098751]
- 648: bone development [GO_0060348]
- 649: bone growth [GO_0098868]
- 650: bone marrow development [GO_0048539]
- 651: bone maturation [GO_0070977]
- 652: bone morphogenesis [GO_0060349]
- 653: boss receptor activity [GO_0008288]
- 654: bounding membrane of organelle [GO_0098588]
- 655: box C/D RNA binding [GO_0034512]
- 656: box H/ACA snoRNA binding [GO_0034513]
- 657: brain development [GO_0007420]
- 658: brain morphogenesis [GO_0048854]
- 659: brainstem development [GO_0003360]
- 660: branched-chain amino acid transmembrane transporter activity [GO_0015658]
- 661: branched-chain amino acid transport [GO_0015803]
- 662: branched-chain-amino-acid transaminase activity [GO_0004084]
- 663: branching involved in blood vessel morphogenesis [GO_0001569]
- 664: branching involved in labyrinthine layer morphogenesis [GO_0060670]
- 665: branching involved in pancreas morphogenesis [GO_0061114]
- 666: branching morphogenesis of a nerve [GO_0048755]
- 667: branching morphogenesis of an epithelial tube [GO_0048754]
- 668: bronchiole development [GO_0060435]
- 669: bronchiole morphogenesis [GO_0060436]
- 670: bronchus cartilage development [GO_0060532]
- 671: bronchus cartilage morphogenesis [GO_0060533]
- 672: bronchus development [GO_0060433]
- 673: bronchus morphogenesis [GO_0060434]
- 674: Btn-ACACA:2Mn2+ polymer carboxylates Ac-CoA to form Mal-CoA [GO_0003989]
- 675: butyryl-CoA dehydrogenase activity [GO_0004085]
- 676: Butyrylcholinesterase hydrolyzes acyl Ghrelin [GO_0016788]
- 677: C-5 methylation of cytosine [GO_0090116]
- 678: C-acetyltransferase activity [GO_0016453]
- 679: C-acyltransferase activity [GO_0016408]
- 680: C-methyltransferase activity [GO_0008169]
- 681: C-palmitoyltransferase activity [GO_0016454]
- 682: C2H2 zinc finger domain binding [GO_0070742]
- 683: C4-dicarboxylate transmembrane transporter activity [GO_0015556]
- 684: C4-dicarboxylate transport [GO_0015740]
- 685: Ca2+ influx into the post-synaptic cell [GO_0005231]
- 686: CAAX-protein geranylgeranyltransferase activity [GO_0004662]
- 687: CAD hexamer transforms CAP to N-carb-L-Asp [GO_0004070]
- 688: cadherin binding [GO_0045296]
- 689: cadherin binding involved in cell-cell adhesion [GO_0098641]
- 690: cadmium ion transmembrane transport [GO_0070574]
- 691: cadmium ion transmembrane transporter activity [GO_0015086]
- 692: cadmium ion transport [GO_0015691]
- 693: CAIR + Aspartate + ATP => SAICAR + ADP + Pi [GO_0004639]
- 694: calcitonin binding [GO_0032841]
- 695: calcitonin family binding [GO_0097644]
- 696: calcitonin family receptor activity [GO_0097642]
- 697: calcitonin receptor activity [GO_0004948]
- 698: calcium activated cation channel activity [GO_0005227]
- 699: calcium channel inhibitor activity [GO_0019855]
- 700: calcium channel regulator activity [GO_0005246]
- 701: Calcium Influx through Voltage-gated Calcium Channels [GO_0005245]
- 702: calcium ion binding [GO_0005509]
- 703: calcium ion homeostasis [GO_0055074]
- 704: calcium ion sequestering activity [GO_0140314]
- 705: calcium ion transmembrane import into cytosol [GO_0097553]
- 706: calcium ion transmembrane transport [GO_0070588]
- 707: calcium ion transmembrane transporter activity [GO_0015085]
- 708: calcium ion transport [GO_0006816]
- 709: calcium sensitive guanylate cyclase activator activity [GO_0008048]
- 710: calcium- and calmodulin-responsive adenylate cyclase activity [GO_0008294]
- 711: calcium-activated potassium channel activity [GO_0015269]
- 712: calcium-dependent ATPase activity [GO_0030899]
- 713: calcium-dependent phospholipase A2 activity [GO_0047498]
- 714: calcium-dependent phospholipid binding [GO_0005544]
- 715: calcium-dependent protein binding [GO_0048306]
- 716: calcium-dependent protein kinase inhibitor activity [GO_0008427]
- 717: calcium-dependent protein kinase regulator activity [GO_0010858]
- 718: calcium-dependent protein serine/threonine kinase activity [GO_0009931]
- 719: calcium-dependent protein serine/threonine phosphatase activity [GO_0004723]
- 720: calcium-dependent protein serine/threonine phosphatase regulator activity [GO_0008597]
- 721: calcium-induced calcium release activity [GO_0048763]
- 722: calcium-mediated signaling [GO_0019722]
- 723: calcium-release channel activity [GO_0015278]
- 724: calmodulin binding [GO_0005516]
- 725: calmodulin dependent kinase signaling pathway [GO_0099004]
- 726: calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO_0048101]
- 727: calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO_0004117]
- 728: calmodulin-dependent protein phosphatase activity [GO_0033192]
- 729: Calpain cleaves p35 to p25 [GO_0004198]
- 730: camera-type eye development [GO_0043010]
- 731: camera-type eye morphogenesis [GO_0048593]
- 732: camera-type eye photoreceptor cell differentiation [GO_0060219]
- 733: CaMKK phosphorylates CAMK4 [GO_0004683]
- 734: cAMP binding [GO_0030552]
- 735: cAMP response element binding [GO_0035497]
- 736: cAMP response element binding protein binding [GO_0008140]
- 737: cAMP-dependent protein kinase activity [GO_0004691]
- 738: cAMP-dependent protein kinase regulator activity [GO_0008603]
- 739: cAMP-mediated signaling [GO_0019933]
- 740: canonical NF-kappaB signal transduction [GO_0007249]
- 741: Cap-bound mRNA is activated by helicases [GO_0003724]
- 742: carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO_0004088]
- 743: carbohydrate binding [GO_0030246]
- 744: carbohydrate biosynthetic process [GO_0016051]
- 745: carbohydrate catabolic process [GO_0016052]
- 746: carbohydrate derivative binding [GO_0097367]
- 747: carbohydrate derivative biosynthetic process [GO_1901137]
- 748: carbohydrate derivative catabolic process [GO_1901136]
- 749: carbohydrate derivative metabolic process [GO_1901135]
- 750: carbohydrate derivative transmembrane transporter activity [GO_1901505]
- 751: carbohydrate derivative transport [GO_1901264]
- 752: carbohydrate homeostasis [GO_0033500]
- 753: carbohydrate kinase activity [GO_0019200]
- 754: carbohydrate metabolic process [GO_0005975]
- 755: carbohydrate phosphorylation [GO_0046835]
- 756: carbohydrate transmembrane transport [GO_0034219]
- 757: carbohydrate transmembrane transporter activity [GO_0015144]
- 758: carbohydrate transport [GO_0008643]
- 759: carbohydrate:cation symporter activity [GO_0005402]
- 760: carbohydrate:proton symporter activity [GO_0005351]
- 761: carbon monoxide binding [GO_0070025]
- 762: carbon-halide lyase activity [GO_0016848]
- 763: carbon-nitrogen ligase activity, with glutamine as amido-N-donor [GO_0016884]
- 764: carbon-nitrogen lyase activity [GO_0016840]
- 765: carbon-oxygen lyase activity [GO_0016835]
- 766: carbon-oxygen lyase activity, acting on phosphates [GO_0016838]
- 767: carbon-sulfur lyase activity [GO_0016846]
- 768: Carbonic anhydrase dehydrates bicarbonate (cytosol) [GO_0004089]
- 769: carbonyl reductase (NADPH) activity [GO_0004090]
- 770: carboxyl- or carbamoyltransferase activity [GO_0016743]
- 771: carboxyl-O-methyltransferase activity [GO_0010340]
- 772: carboxylic acid binding [GO_0031406]
- 773: carboxylic acid biosynthetic process [GO_0046394]
- 774: carboxylic acid catabolic process [GO_0046395]
- 775: carboxylic acid metabolic process [GO_0019752]
- 776: carboxylic acid transmembrane transport [GO_1905039]
- 777: carboxylic acid transmembrane transporter activity [GO_0046943]
- 778: carboxylic acid transport [GO_0046942]
- 779: carcinine transmembrane transporter activity [GO_1905131]
- 780: CARD domain binding [GO_0050700]
- 781: cardiac atrium development [GO_0003230]
- 782: cardiac atrium formation [GO_0003210]
- 783: cardiac atrium morphogenesis [GO_0003209]
- 784: cardiac blood vessel endothelial cell differentiation [GO_0060946]
- 785: cardiac cell development [GO_0055006]
- 786: cardiac chamber development [GO_0003205]
- 787: cardiac chamber formation [GO_0003207]
- 788: cardiac chamber morphogenesis [GO_0003206]
- 789: cardiac conduction [GO_0061337]
- 790: cardiac conduction system development [GO_0003161]
- 791: cardiac endothelial cell differentiation [GO_0003348]
- 792: cardiac fibroblast cell development [GO_0060936]
- 793: cardiac fibroblast cell differentiation [GO_0060935]
- 794: cardiac glial cell development [GO_0060952]
- 795: cardiac glial cell differentiation [GO_0060950]
- 796: cardiac left atrium formation [GO_0003216]
- 797: cardiac left atrium morphogenesis [GO_0003212]
- 798: cardiac left ventricle formation [GO_0003218]
- 799: cardiac left ventricle morphogenesis [GO_0003214]
- 800: cardiac muscle adaptation [GO_0014887]
- 801: cardiac muscle cell action potential [GO_0086001]
- 802: cardiac muscle cell apoptotic process [GO_0010659]
- 803: cardiac muscle cell development [GO_0055013]
- 804: cardiac muscle cell differentiation [GO_0055007]
- 805: cardiac muscle cell myoblast differentiation [GO_0060379]
- 806: cardiac muscle cell proliferation [GO_0060038]
- 807: cardiac muscle contraction [GO_0060048]
- 808: cardiac muscle hypertrophy [GO_0003300]
- 809: cardiac muscle myoblast proliferation [GO_0110021]
- 810: cardiac muscle tissue development [GO_0048738]
- 811: cardiac muscle tissue growth [GO_0055017]
- 812: cardiac muscle tissue growth involved in heart morphogenesis [GO_0003245]
- 813: cardiac muscle tissue morphogenesis [GO_0055008]
- 814: cardiac myofibril [GO_0097512]
- 815: cardiac myofibril assembly [GO_0055003]
- 816: cardiac neural crest cell development involved in heart development [GO_0061308]
- 817: cardiac neural crest cell development involved in outflow tract morphogenesis [GO_0061309]
- 818: cardiac neural crest cell differentiation involved in heart development [GO_0061307]
- 819: cardiac neuron development [GO_0060959]
- 820: cardiac neuron differentiation [GO_0060945]
- 821: cardiac pacemaker cell development [GO_0060926]
- 822: cardiac pacemaker cell differentiation [GO_0060920]
- 823: cardiac right atrium formation [GO_0003217]
- 824: cardiac right atrium morphogenesis [GO_0003213]
- 825: cardiac right ventricle formation [GO_0003219]
- 826: cardiac right ventricle morphogenesis [GO_0003215]
- 827: cardiac septum cell differentiation [GO_0003292]
- 828: cardiac septum development [GO_0003279]
- 829: cardiac septum morphogenesis [GO_0060411]
- 830: cardiac skeleton development [GO_0003204]
- 831: cardiac ventricle development [GO_0003231]
- 832: cardiac ventricle formation [GO_0003211]
- 833: cardiac ventricle morphogenesis [GO_0003208]
- 834: cardioblast differentiation [GO_0010002]
- 835: cardiocyte differentiation [GO_0035051]
- 836: cardiogenic plate morphogenesis [GO_0003142]
- 837: cardiolipin synthase (CMP-forming) [GO_0043337]
- 838: cargo adaptor activity [GO_0140312]
- 839: carnitine O-acetyltransferase activity [GO_0004092]
- 840: carnitine O-acyltransferase activity [GO_0016406]
- 841: carnitine O-octanoyltransferase activity [GO_0008458]
- 842: CARNMT1 methylates CARN to Anserine [GO_0030735]
- 843: carotenoid dioxygenase activity [GO_0010436]
- 844: carotenoid isomerooxygenase activity [GO_0106422]
- 845: cartilage development [GO_0051216]
- 846: cartilage development involved in endochondral bone morphogenesis [GO_0060351]
- 847: cartilage morphogenesis [GO_0060536]
- 848: caspase binding [GO_0089720]
- 849: catabolic process [GO_0009056]
- 850: catalytic activity [GO_0003824]
- 851: catalytic activity, acting on a glycoprotein [GO_0140103]
- 852: catalytic activity, acting on a nucleic acid [GO_0140640]
- 853: catalytic activity, acting on a protein [GO_0140096]
- 854: catalytic activity, acting on a rRNA [GO_0140102]
- 855: catalytic activity, acting on a tRNA [GO_0140101]
- 856: catalytic activity, acting on DNA [GO_0140097]
- 857: catalytic activity, acting on RNA [GO_0140098]
- 858: catalytic complex [GO_1902494]
- 859: catechol oxidase activity [GO_0004097]
- 860: catechol-containing compound biosynthetic process [GO_0009713]
- 861: catechol-containing compound catabolic process [GO_0019614]
- 862: catechol-containing compound metabolic process [GO_0009712]
- 863: catecholamine binding [GO_1901338]
- 864: catecholamine biosynthetic process [GO_0042423]
- 865: catecholamine catabolic process [GO_0042424]
- 866: catecholamine metabolic process [GO_0006584]
- 867: catecholamine secretion [GO_0050432]
- 868: catecholamine secretion, neurotransmission [GO_0160043]
- 869: catecholamine transport [GO_0051937]
- 870: catecholamine uptake [GO_0090493]
- 871: cation binding [GO_0043169]
- 872: cation efflux transmembrane transporter activity [GO_0046583]
- 873: cation homeostasis [GO_0055080]
- 874: cation transmembrane transport [GO_0098655]
- 875: cation transmembrane transporter activity [GO_0008324]
- 876: cation transport [GO_0006812]
- 877: cation:chloride symporter activity [GO_0015377]
- 878: CCR4-NOT complex binding [GO_1905762]
- 879: CD27 receptor binding [GO_0005175]
- 880: CD320 transports extracellular TCII:Cbl to endosome [GO_0038024]
- 881: CD38 hydrolyses NAD+ to NAM and ADP-ribose [GO_0003953]
- 882: CD4 biosynthetic process [GO_0045222]
- 883: CDK12 phosphorylates RNA Pol II CTD at DNA repair genes [GO_0004693]
- 884: CDKAL1:4Fe-4S methylthiolates N6-threonylcarbamoyladenosine-37 in tRNA yielding 2-methylthio-N6-threonylcarbamoyladenosine-37 [GO_0035598]
- 885: CDP-alcohol phosphatidyltransferase activity [GO_0017169]
- 886: CDP-choline pathway [GO_0006657]
- 887: CDP-DAG is converted to PGP by PGS1 [GO_0008444]
- 888: CDP-DAG is converted to PI by CDIPT [GO_0003881]
- 889: cell adhesion [GO_0007155]
- 890: cell adhesion involved in heart morphogenesis [GO_0061343]
- 891: cell adhesion mediator activity [GO_0098631]
- 892: cell adhesion molecule binding [GO_0050839]
- 893: cell adhesion receptor activity [GO_0004895]
- 894: cell body [GO_0044297]
- 895: cell chemotaxis [GO_0060326]
- 896: cell communication [GO_0007154]
- 897: cell communication involved in cardiac conduction [GO_0086065]
- 898: cell cortex [GO_0005938]
- 899: cell cortex region [GO_0099738]
- 900: cell cycle [GO_0007049]
- 901: cell cycle DNA replication [GO_0044786]
- 902: cell cycle DNA replication DNA ligation [GO_1902291]
- 903: cell cycle DNA replication DNA unwinding [GO_1902297]
- 904: cell cycle phase [GO_0022403]
- 905: cell cycle process [GO_0022402]
- 906: cell death [GO_0008219]
- 907: cell development [GO_0048468]
- 908: cell differentiation [GO_0030154]
- 909: cell differentiation in hindbrain [GO_0021533]
- 910: cell differentiation in spinal cord [GO_0021515]
- 911: cell differentiation involved in embryonic placenta development [GO_0060706]
- 912: cell division [GO_0051301]
- 913: cell fate commitment [GO_0045165]
- 914: cell fate commitment involved in formation of primary germ layer [GO_0060795]
- 915: cell fate commitment involved in pattern specification [GO_0060581]
- 916: cell growth [GO_0016049]
- 917: cell growth involved in cardiac muscle cell development [GO_0061049]
- 918: cell junction [GO_0030054]
- 919: cell junction assembly [GO_0034329]
- 920: cell junction disassembly [GO_0150146]
- 921: cell junction maintenance [GO_0034331]
- 922: cell junction organization [GO_0034330]
- 923: cell leading edge [GO_0031252]
- 924: cell leading edge cell cortex [GO_1904269]
- 925: cell maturation [GO_0048469]
- 926: cell migration [GO_0016477]
- 927: cell migration in hindbrain [GO_0021535]
- 928: cell migration involved in coronary angiogenesis [GO_0060981]
- 929: cell migration involved in coronary vasculogenesis [GO_0060980]
- 930: cell migration involved in endocardial cushion formation [GO_0003273]
- 931: cell migration involved in gastrulation [GO_0042074]
- 932: cell migration involved in heart development [GO_0060973]
- 933: cell migration involved in heart formation [GO_0060974]
- 934: cell migration involved in vasculogenesis [GO_0035441]
- 935: cell morphogenesis [GO_0000902]
- 936: cell morphogenesis involved in differentiation [GO_0000904]
- 937: cell morphogenesis involved in neuron differentiation [GO_0048667]
- 938: cell motility [GO_0048870]
- 939: cell motility involved in camera-type eye morphogenesis [GO_0003411]
- 940: cell part morphogenesis [GO_0032990]
- 941: cell periphery [GO_0071944]
- 942: cell population proliferation [GO_0008283]
- 943: cell projection [GO_0042995]
- 944: cell projection assembly [GO_0030031]
- 945: cell projection membrane [GO_0031253]
- 946: cell projection morphogenesis [GO_0048858]
- 947: cell projection organization [GO_0030030]
- 948: cell proliferation in hindbrain [GO_0021534]
- 949: cell proliferation in midbrain [GO_0033278]
- 950: cell proliferation involved in compound eye morphogenesis [GO_0035736]
- 951: cell proliferation involved in embryonic placenta development [GO_0060722]
- 952: cell proliferation involved in endocardial cushion morphogenesis [GO_1905315]
- 953: cell proliferation involved in heart morphogenesis [GO_0061323]
- 954: cell proliferation involved in outflow tract morphogenesis [GO_0061325]
- 955: cell surface receptor signaling pathway [GO_0007166]
- 956: cell surface receptor signaling pathway involved in cell-cell signaling [GO_1905114]
- 957: cell-cell adhesion [GO_0098609]
- 958: cell-cell adhesion in response to extracellular stimulus [GO_0140039]
- 959: cell-cell adhesion mediator activity [GO_0098632]
- 960: cell-cell fusion [GO_0140253]
- 961: cell-cell junction [GO_0005911]
- 962: cell-cell junction assembly [GO_0007043]
- 963: cell-cell junction disassembly [GO_0150147]
- 964: cell-cell junction organization [GO_0045216]
- 965: cell-cell signaling [GO_0007267]
- 966: cell-cell signaling by wnt [GO_0198738]
- 967: cell-cell signaling involved in cardiac conduction [GO_0086019]
- 968: cell-cell signaling involved in cell fate commitment [GO_0045168]
- 969: cell-cell signaling involved in lung development [GO_0060495]
- 970: cell-cell signaling involved in placenta development [GO_0060673]
- 971: cell-cell signaling via exosome [GO_0099156]
- 972: cellular aldehyde metabolic process [GO_0006081]
- 973: cellular amide metabolic process [GO_0043603]
- 974: cellular amine metabolic process [GO_0044106]
- 975: cellular amino acid biosynthetic process [GO_0008652]
- 976: cellular amino acid catabolic process [GO_0009063]
- 977: cellular amino acid metabolic process [GO_0006520]
- 978: cellular ammonium homeostasis [GO_0097275]
- 979: cellular anatomical entity [GO_0110165]
- 980: cellular anion homeostasis [GO_0030002]
- 981: cellular aromatic compound metabolic process [GO_0006725]
- 982: cellular biogenic amine biosynthetic process [GO_0042401]
- 983: cellular biogenic amine catabolic process [GO_0042402]
- 984: cellular biogenic amine metabolic process [GO_0006576]
- 985: cellular biosynthetic process [GO_0044249]
- 986: cellular calcium ion homeostasis [GO_0006874]
- 987: cellular carbohydrate biosynthetic process [GO_0034637]
- 988: cellular carbohydrate catabolic process [GO_0044275]
- 989: cellular carbohydrate metabolic process [GO_0044262]
- 990: cellular catabolic process [GO_0044248]
- 991: cellular cation homeostasis [GO_0030003]
- 992: cellular chemical homeostasis [GO_0055082]
- 993: cellular component assembly [GO_0022607]
- 994: cellular component assembly involved in morphogenesis [GO_0010927]
- 995: cellular component biogenesis [GO_0044085]
- 996: cellular component disassembly [GO_0022411]
- 997: cellular component disassembly involved in execution phase of apoptosis [GO_0006921]
- 998: cellular component maintenance [GO_0043954]
- 999: cellular component morphogenesis [GO_0032989]
- 1000: cellular component organization [GO_0016043]
- 1001: cellular component organization or biogenesis [GO_0071840]
- 1002: cellular detoxification [GO_1990748]
- 1003: cellular developmental process [GO_0048869]
- 1004: cellular divalent inorganic anion homeostasis [GO_0072501]
- 1005: cellular divalent inorganic cation homeostasis [GO_0072503]
- 1006: cellular glucan metabolic process [GO_0006073]
- 1007: cellular glucose homeostasis [GO_0001678]
- 1008: cellular homeostasis [GO_0019725]
- 1009: cellular ion homeostasis [GO_0006873]
- 1010: cellular ketone metabolic process [GO_0042180]
- 1011: cellular lipid metabolic process [GO_0044255]
- 1012: cellular localization [GO_0051641]
- 1013: cellular macromolecule biosynthetic process [GO_0034645]
- 1014: cellular macromolecule catabolic process [GO_0044265]
- 1015: cellular macromolecule localization [GO_0070727]
- 1016: cellular macromolecule metabolic process [GO_0044260]
- 1017: cellular metabolic process [GO_0044237]
- 1018: cellular metal ion homeostasis [GO_0006875]
- 1019: cellular modified amino acid biosynthetic process [GO_0042398]
- 1020: cellular modified amino acid metabolic process [GO_0006575]
- 1021: cellular monovalent inorganic anion homeostasis [GO_0030320]
- 1022: cellular monovalent inorganic cation homeostasis [GO_0030004]
- 1023: cellular nitrogen compound biosynthetic process [GO_0044271]
- 1024: cellular nitrogen compound catabolic process [GO_0044270]
- 1025: cellular nitrogen compound metabolic process [GO_0034641]
- 1026: cellular oxidant detoxification [GO_0098869]
- 1027: cellular phosphate ion homeostasis [GO_0030643]
- 1028: cellular pigmentation [GO_0033059]
- 1029: cellular polysaccharide biosynthetic process [GO_0033692]
- 1030: cellular polysaccharide catabolic process [GO_0044247]
- 1031: cellular polysaccharide metabolic process [GO_0044264]
- 1032: cellular process [GO_0009987]
- 1033: cellular process involved in reproduction in multicellular organism [GO_0022412]
- 1034: cellular protein localization [GO_0034613]
- 1035: cellular protein metabolic process [GO_0044267]
- 1036: cellular protein modification process [GO_0006464]
- 1037: cellular respiration [GO_0045333]
- 1038: cellular response to abiotic stimulus [GO_0071214]
- 1039: cellular response to acetylcholine [GO_1905145]
- 1040: cellular response to alcohol [GO_0097306]
- 1041: cellular response to alkaloid [GO_0071312]
- 1042: cellular response to antibiotic [GO_0071236]
- 1043: cellular response to biotic stimulus [GO_0071216]
- 1044: cellular response to blue light [GO_0071483]
- 1045: cellular response to BMP stimulus [GO_0071773]
- 1046: cellular response to caffeine [GO_0071313]
- 1047: cellular response to catecholamine stimulus [GO_0071870]
- 1048: cellular response to chemical stimulus [GO_0070887]
- 1049: cellular response to chemical stress [GO_0062197]
- 1050: cellular response to cytokine stimulus [GO_0071345]
- 1051: cellular response to DNA damage stimulus [GO_0006974]
- 1052: cellular response to dopamine [GO_1903351]
- 1053: cellular response to drug [GO_0035690]
- 1054: cellular response to endogenous stimulus [GO_0071495]
- 1055: cellular response to environmental stimulus [GO_0104004]
- 1056: cellular response to farnesol [GO_0097308]
- 1057: cellular response to fibroblast growth factor stimulus [GO_0044344]
- 1058: cellular response to growth factor stimulus [GO_0071363]
- 1059: cellular response to hormone stimulus [GO_0032870]
- 1060: cellular response to insulin stimulus [GO_0032869]
- 1061: cellular response to light stimulus [GO_0071482]
- 1062: cellular response to lipid [GO_0071396]
- 1063: cellular response to lipopolysaccharide [GO_0071222]
- 1064: cellular response to molecule of bacterial origin [GO_0071219]
- 1065: cellular response to monoamine stimulus [GO_0071868]
- 1066: cellular response to nitrogen compound [GO_1901699]
- 1067: cellular response to organic cyclic compound [GO_0071407]
- 1068: cellular response to organic substance [GO_0071310]
- 1069: cellular response to organonitrogen compound [GO_0071417]
- 1070: cellular response to oxidative stress [GO_0034599]
- 1071: cellular response to oxygen radical [GO_0071450]
- 1072: cellular response to oxygen-containing compound [GO_1901701]
- 1073: cellular response to peptide [GO_1901653]
- 1074: cellular response to peptide hormone stimulus [GO_0071375]
- 1075: cellular response to purine-containing compound [GO_0071415]
- 1076: cellular response to radiation [GO_0071478]
- 1077: cellular response to reactive oxygen species [GO_0034614]
- 1078: cellular response to salt [GO_1902075]
- 1079: cellular response to steroid hormone stimulus [GO_0071383]
- 1080: cellular response to stimulus [GO_0051716]
- 1081: cellular response to stress [GO_0033554]
- 1082: cellular response to superoxide [GO_0071451]
- 1083: cellular response to toxic substance [GO_0097237]
- 1084: cellular response to tumor necrosis factor [GO_0071356]
- 1085: cellular response to xenobiotic stimulus [GO_0071466]
- 1086: cellular sodium ion homeostasis [GO_0006883]
- 1087: cellular sulfate ion homeostasis [GO_0030642]
- 1088: cellular trivalent inorganic anion homeostasis [GO_0072502]
- 1089: cellular_component [GO_0005575]
- 1090: central nervous system development [GO_0007417]
- 1091: central nervous system formation [GO_0021556]
- 1092: central nervous system maturation [GO_0021626]
- 1093: central nervous system morphogenesis [GO_0021551]
- 1094: central nervous system neuron development [GO_0021954]
- 1095: central nervous system neuron differentiation [GO_0021953]
- 1096: central nervous system vasculogenesis [GO_0022009]
- 1097: ceramide + H2O <=> stearate + sphingosine [endoplasmic reticulum] [GO_0017040]
- 1098: ceramide 1-phosphate binding [GO_1902387]
- 1099: ceramide 1-phosphate transfer activity [GO_1902388]
- 1100: ceramide 1-phosphate transport [GO_1902389]
- 1101: ceramide binding [GO_0097001]
- 1102: ceramide cholinephosphotransferase activity [GO_0047493]
- 1103: Ceramide glucosyltransferase (UGCG) catalyses the transfer of glucose to ceramide [GO_0008120]
- 1104: ceramide phosphoethanolamine synthase activity [GO_0002950]
- 1105: ceramide transfer activity [GO_0120017]
- 1106: ceramide transport [GO_0035627]
- 1107: CERK phosphorylates CERA to form C1P [GO_0001729]
- 1108: CES1trimer hydrolyses ACEI pro-drugs to ACEIs [GO_0052689]
- 1109: CES2 hydrolyzes ASA- [GO_0106435]
- 1110: CFTR F508del is degraded by the 26S proteasome [GO_0004175]
- 1111: cGAS produces cyclic GMP-AMP [GO_0061501]
- 1112: cGMP binding [GO_0030553]
- 1113: cGMP biosynthetic process [GO_0006182]
- 1114: cGMP metabolic process [GO_0046068]
- 1115: cGMP:CNG transports Na+ and Ca2+ into the rod outer segment [GO_0005221]
- 1116: channel activator activity [GO_0099103]
- 1117: channel inhibitor activity [GO_0016248]
- 1118: channel regulator activity [GO_0016247]
- 1119: chaperone binding [GO_0051087]
- 1120: charged-tRNA amino acid modification [GO_0019988]
- 1121: chemical homeostasis [GO_0048878]
- 1122: chemical homeostasis within a tissue [GO_0048875]
- 1123: chemical synaptic transmission [GO_0007268]
- 1124: chemical synaptic transmission, postsynaptic [GO_0099565]
- 1125: chemoattractant activity [GO_0042056]
- 1126: chemoattractant activity involved in axon guidance [GO_1902379]
- 1127: chemoattraction of axon [GO_0061642]
- 1128: chemokine activity [GO_0008009]
- 1129: chemokine receptor binding [GO_0042379]
- 1130: chemorepellent activity [GO_0045499]
- 1131: chemorepulsion of axon [GO_0061643]
- 1132: chemosensory behavior [GO_0007635]
- 1133: chemotaxis [GO_0006935]
- 1134: chitin binding [GO_0008061]
- 1135: chitin deacetylase activity [GO_0004099]
- 1136: chitin synthase activity [GO_0004100]
- 1137: chitinase activity [GO_0004568]
- 1138: chloride channel inhibitor activity [GO_0019869]
- 1139: chloride transmembrane transport [GO_1902476]
- 1140: chloride transport [GO_0006821]
- 1141: chlorophyllide a oxygenase [overall] activity [GO_0010277]
- 1142: Cho is acetylated to AcCho by CHAT [GO_0004102]
- 1143: Cho is phosphorylated to PCho by CHK dimer [GO_0004103]
- 1144: cholangiocyte apoptotic process [GO_1902488]
- 1145: cholangiocyte proliferation [GO_1990705]
- 1146: cholesterol binding [GO_0015485]
- 1147: cholesterol dehydrogenase activity [GO_0102294]
- 1148: cholesterol O-acyltransferase activity [GO_0034736]
- 1149: cholesterol transfer activity [GO_0120020]
- 1150: cholesterol-protein transferase activity [GO_0140853]
- 1151: choline transport [GO_0015871]
- 1152: choline:sodium symporter activity [GO_0005307]
- 1153: cholinesterase activity [GO_0004104]
- 1154: chondroblast differentiation [GO_0060591]
- 1155: chondrocyte development [GO_0002063]
- 1156: chondrocyte development involved in endochondral bone morphogenesis [GO_0003433]
- 1157: chondrocyte differentiation [GO_0002062]
- 1158: chondrocyte differentiation involved in endochondral bone morphogenesis [GO_0003413]
- 1159: chondrocyte morphogenesis [GO_0090171]
- 1160: chondrocyte morphogenesis involved in endochondral bone morphogenesis [GO_0003414]
- 1161: chordate embryonic development [GO_0043009]
- 1162: chorion development [GO_0060717]
- 1163: chorionic trophoblast cell development [GO_0060719]
- 1164: chorionic trophoblast cell differentiation [GO_0060718]
- 1165: chorionic trophoblast cell proliferation [GO_0097360]
- 1166: chromatin [GO_0000785]
- 1167: chromatin assembly [GO_0031497]
- 1168: chromatin assembly or disassembly [GO_0006333]
- 1169: chromatin binding [GO_0003682]
- 1170: chromatin disassembly [GO_0031498]
- 1171: chromatin DNA binding [GO_0031490]
- 1172: chromatin insulator sequence binding [GO_0043035]
- 1173: chromatin loop anchoring activity [GO_0140587]
- 1174: chromatin organization [GO_0006325]
- 1175: chromatin remodeling [GO_0006338]
- 1176: chromatin silencing complex [GO_0005677]
- 1177: chromatin-protein adaptor activity [GO_0140463]
- 1178: chromo shadow domain binding [GO_0070087]
- 1179: chromosome [GO_0005694]
- 1180: chromosome condensation [GO_0030261]
- 1181: chromosome localization [GO_0050000]
- 1182: chromosome organization [GO_0051276]
- 1183: chromosome organization involved in meiotic cell cycle [GO_0070192]
- 1184: chromosome segregation [GO_0007059]
- 1185: Chymase hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-8) [GO_0008236]
- 1186: ciliary basal body-plasma membrane docking [GO_0097711]
- 1187: ciliary body morphogenesis [GO_0061073]
- 1188: ciliary membrane [GO_0060170]
- 1189: ciliary plasm [GO_0097014]
- 1190: ciliary transition zone [GO_0035869]
- 1191: ciliary transition zone assembly [GO_1905349]
- 1192: cilium [GO_0005929]
- 1193: cilium assembly [GO_0060271]
- 1194: cilium disassembly [GO_0061523]
- 1195: cilium organization [GO_0044782]
- 1196: circadian behavior [GO_0048512]
- 1197: circadian mating behavior [GO_0035648]
- 1198: circadian rhythm [GO_0007623]
- 1199: circadian sleep/wake cycle [GO_0042745]
- 1200: circadian sleep/wake cycle process [GO_0022410]
- 1201: circadian sleep/wake cycle, sleep [GO_0050802]
- 1202: circulatory system development [GO_0072359]
- 1203: circulatory system process [GO_0003013]
- 1204: cis-regulatory region sequence-specific DNA binding [GO_0000987]
- 1205: cis-trans isomerase activity [GO_0016859]
- 1206: citrate <=> isocitrate [GO_0003994]
- 1207: citrate secondary active transmembrane transporter activity [GO_0071913]
- 1208: citrate synthase activity [GO_0036440]
- 1209: citrate transmembrane transporter activity [GO_0015137]
- 1210: citrate transport [GO_0015746]
- 1211: class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO_0140078]
- 1212: class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO_0052720]
- 1213: clathrin adaptor activity [GO_0035615]
- 1214: clathrin binding [GO_0030276]
- 1215: clathrin heavy chain binding [GO_0032050]
- 1216: clathrin light chain binding [GO_0032051]
- 1217: CLCN4/5/6 exchange Cl- for H+ [GO_0015297]
- 1218: cleavage involved in rRNA processing [GO_0000469]
- 1219: Cleavage of 5-hydroxyluracil by UNG glycosylase [GO_0004844]
- 1220: Cleavage of formamidopyrimidine (FapyA) by NTHL1 glycosylase [GO_0008534]
- 1221: Cleavage of S protein into S1:S2 [GO_0004252]
- 1222: cloaca development [GO_0035844]
- 1223: cloacal gland development [GO_1904484]
- 1224: club cell differentiation [GO_0060486]
- 1225: CMP biosynthetic process [GO_0009224]
- 1226: CMP metabolic process [GO_0046035]
- 1227: CNDP2:2Mn2+ dimer hydrolyses CysGly [GO_0004180]
- 1228: co-receptor binding [GO_0039706]
- 1229: co-SMAD binding [GO_0070410]
- 1230: CoA carboxylase activity [GO_0016421]
- 1231: CoA hydrolase activity [GO_0016289]
- 1232: CoA-ligase activity [GO_0016405]
- 1233: CoA-transferase activity [GO_0008410]
- 1234: COASY transfers an adenylyl group from ATP to PPANT [GO_0004595]
- 1235: cobalamin binding [GO_0031419]
- 1236: cocaine binding [GO_0019811]
- 1237: coenzyme A transmembrane transport [GO_0035349]
- 1238: coenzyme A transmembrane transporter activity [GO_0015228]
- 1239: coenzyme A transport [GO_0015880]
- 1240: cognition [GO_0050890]
- 1241: cohesin loader activity [GO_0061775]
- 1242: cohesin unloader activity [GO_0140670]
- 1243: collagen binding [GO_0005518]
- 1244: collagen biosynthetic process [GO_0032964]
- 1245: collagen catabolic process [GO_0030574]
- 1246: collagen fibril binding [GO_0098633]
- 1247: collagen fibril organization [GO_0030199]
- 1248: collagen metabolic process [GO_0032963]
- 1249: collagen network [GO_0098645]
- 1250: collagen receptor activity [GO_0038064]
- 1251: collagen trimer [GO_0005581]
- 1252: collagen type II trimer [GO_0005585]
- 1253: collagen type IV trimer [GO_0005587]
- 1254: collagen-activated signaling pathway [GO_0038065]
- 1255: collagen-activated tyrosine kinase receptor signaling pathway [GO_0038063]
- 1256: collagen-containing extracellular matrix [GO_0062023]
- 1257: colon smooth muscle contraction [GO_1990765]
- 1258: columnar/cuboidal epithelial cell development [GO_0002066]
- 1259: columnar/cuboidal epithelial cell differentiation [GO_0002065]
- 1260: columnar/cuboidal epithelial cell maturation [GO_0002069]
- 1261: common bile duct development [GO_0061009]
- 1262: Complex I oxidises NADH to NAD+, reduces CoQ to QH2 [GO_0008137]
- 1263: complex of collagen trimers [GO_0098644]
- 1264: compound eye development [GO_0048749]
- 1265: compound eye morphogenesis [GO_0001745]
- 1266: compound eye photoreceptor cell differentiation [GO_0001751]
- 1267: compound eye retinal cell apoptotic process [GO_1990010]
- 1268: compound eye retinal cell programmed cell death [GO_0046667]
- 1269: COMT transfers Met to DOPAC to form HVA [GO_0008168]
- 1270: Concentrative transport (import) of a nucleoside and two sodium ions by solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 [GO_0005415]
- 1271: connective tissue development [GO_0061448]
- 1272: contractile fiber [GO_0043292]
- 1273: conus arteriosus development [GO_0003238]
- 1274: conus arteriosus formation [GO_0003240]
- 1275: conus arteriosus morphogenesis [GO_0003239]
- 1276: conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO_0071951]
- 1277: COP9 signalosome deneddylates nuclear CRL4 E3 ubiquitin ligase complex [GO_0019784]
- 1278: COPII receptor activity [GO_0097020]
- 1279: copper chaperone activity [GO_0016531]
- 1280: copper ion binding [GO_0005507]
- 1281: copper ion transmembrane transport [GO_0035434]
- 1282: copper ion transmembrane transporter activity [GO_0005375]
- 1283: copper ion transport [GO_0006825]
- 1284: COPRS:CCND1:CDK4:PRMT5:pT5-WDR77 methylates arginine-4 of histone H4 (H4R3) [GO_0008469]
- 1285: copulation [GO_0007620]
- 1286: corazonin receptor activity [GO_0035237]
- 1287: corazonin receptor binding [GO_0071858]
- 1288: Core MLL complex methylates H3K4Me2-Nucleosome at the GP1BA gene promoter [GO_0042800]
- 1289: Core MLL complex, SMYD3, PRDM9 methylate dimethyl-lysine-5 of histone H3 (H3K4) [GO_0018024]
- 1290: core promoter sequence-specific DNA binding [GO_0001046]
- 1291: coreceptor activity [GO_0015026]
- 1292: coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060724]
- 1293: coreceptor activity involved in Wnt signaling pathway [GO_0071936]
- 1294: cornea development in camera-type eye [GO_0061303]
- 1295: coronary vasculature development [GO_0060976]
- 1296: coronary vasculature morphogenesis [GO_0060977]
- 1297: coronary vein morphogenesis [GO_0003169]
- 1298: corticotropin-releasing hormone binding [GO_0051424]
- 1299: courtship behavior [GO_0007619]
- 1300: CP2 mannose-ethanolamine phosphotransferase activity [GO_0051267]
- 1301: CPO transforms COPRO3 to PPGEN9 [GO_0004109]
- 1302: CPT1A,B transfers PALM to CAR [GO_0004095]
- 1303: cranial ganglion development [GO_0061550]
- 1304: cranial ganglion formation [GO_0061560]
- 1305: cranial ganglion maturation [GO_0061558]
- 1306: cranial ganglion morphogenesis [GO_0061559]
- 1307: cranial nerve development [GO_0021545]
- 1308: cranial nerve formation [GO_0021603]
- 1309: cranial nerve maturation [GO_0021605]
- 1310: cranial nerve morphogenesis [GO_0021602]
- 1311: cranial skeletal system development [GO_1904888]
- 1312: CRD domain binding [GO_0071906]
- 1313: creatine + ATP => phosphocreatine + ADP [CK octamer] [GO_0004111]
- 1314: crossover junction DNA endonuclease activity [GO_0008821]
- 1315: Crotonoyl-CoA+H2O<=>(S)-3-Hydroxybutanoyl-CoA [GO_0004300]
- 1316: CRYL1 dimer dehydrogenates L-gulonate to 3-dehydro-L-gulonate [GO_0050104]
- 1317: CS is cleaved from its proteoglycan [GO_0016798]
- 1318: CTU1:CTU2:URM1 thiolates uridine-34 in tRNAs [GO_0016783]
- 1319: cullin family protein binding [GO_0097602]
- 1320: CYB5Rs reduce MetHb to HbA [GO_0004128]
- 1321: CYBRD1:Heme reduces Fe3+ to Fe2+ [GO_0016722]
- 1322: cyclase activator activity [GO_0010853]
- 1323: cyclase activity [GO_0009975]
- 1324: cyclase inhibitor activity [GO_0010852]
- 1325: cyclase regulator activity [GO_0010851]
- 1326: cyclic GMP-AMP binding [GO_0140702]
- 1327: cyclic GMP-AMP synthase activity [GO_0140699]
- 1328: cyclic nucleotide binding [GO_0030551]
- 1329: cyclic nucleotide biosynthetic process [GO_0009190]
- 1330: cyclic nucleotide metabolic process [GO_0009187]
- 1331: cyclic nucleotide-dependent protein kinase activity [GO_0004690]
- 1332: cyclic nucleotide-gated ion channel activity [GO_0043855]
- 1333: cyclic purine nucleotide metabolic process [GO_0052652]
- 1334: cyclic pyranopterin monophosphate synthase activity [GO_0061799]
- 1335: cyclic-di-GMP binding [GO_0035438]
- 1336: cyclic-di-GMP transmembrane transporter activity [GO_0140927]
- 1337: cyclic-nucleotide phosphodiesterase activity [GO_0004112]
- 1338: cyclic-nucleotide-mediated signaling [GO_0019935]
- 1339: cyclin binding [GO_0030332]
- 1340: cyclin-dependent protein kinase activity [GO_0097472]
- 1341: cyclin-dependent protein serine/threonine kinase activator activity [GO_0061575]
- 1342: cyclin-dependent protein serine/threonine kinase inhibitor activity [GO_0004861]
- 1343: cyclin-dependent protein serine/threonine kinase regulator activity [GO_0016538]
- 1344: Cyclisation of GTP to precursor Z [GO_1904047]
- 1345: cyclo-ligase activity [GO_0016882]
- 1346: cyclohydrolase activity [GO_0019238]
- 1347: cyclosporin A binding [GO_0016018]
- 1348: CYP24A1 24-hydroxylates CTL [GO_0030342]
- 1349: CYP2D6 4-hydroxylates debrisoquine [GO_0016712]
- 1350: CYP4F8 19-hydroxylates PGH2 [GO_0004497]
- 1351: cysteine biosynthetic process [GO_0019344]
- 1352: cysteine dioxygenase activity [GO_0017172]
- 1353: cysteine metabolic process [GO_0006534]
- 1354: cysteine synthase activity [GO_0004124]
- 1355: cysteine-S-conjugate beta-lyase activity [GO_0047804]
- 1356: cysteine-tRNA ligase activity [GO_0004817]
- 1357: cysteine-type deNEDDylase activity [GO_0140757]
- 1358: cysteine-type endopeptidase activator activity [GO_0140608]
- 1359: cysteine-type endopeptidase activator activity involved in apoptotic process [GO_0008656]
- 1360: cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO_0097199]
- 1361: cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_0097200]
- 1362: cysteine-type endopeptidase inhibitor activity [GO_0004869]
- 1363: cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO_0043027]
- 1364: cysteine-type endopeptidase regulator activity involved in apoptotic process [GO_0043028]
- 1365: cystic duct development [GO_0035628]
- 1366: cytidine catabolic process [GO_0006216]
- 1367: cytidine deaminase activity [GO_0004126]
- 1368: cytidine deamination [GO_0009972]
- 1369: cytidine kinase activity [GO_0043771]
- 1370: cytidine metabolic process [GO_0046087]
- 1371: cytidylate kinase activity [GO_0004127]
- 1372: cytidylyltransferase activity [GO_0070567]
- 1373: cytochrome-c oxidase activity [GO_0004129]
- 1374: cytokine activity [GO_0005125]
- 1375: cytokine binding [GO_0019955]
- 1376: cytokine receptor activity [GO_0004896]
- 1377: cytokine receptor binding [GO_0005126]
- 1378: cytokine-mediated signaling pathway [GO_0019221]
- 1379: cytokinesis [GO_0000910]
- 1380: cytoplasm [GO_0005737]
- 1381: cytoplasm organization [GO_0007028]
- 1382: cytoplasmic microtubule [GO_0005881]
- 1383: cytoplasmic microtubule bundle [GO_1905720]
- 1384: cytoplasmic microtubule depolymerization [GO_0010938]
- 1385: cytoplasmic microtubule organization [GO_0031122]
- 1386: cytoplasmic region [GO_0099568]
- 1387: cytoplasmic vesicle [GO_0031410]
- 1388: cytoplasmic vesicle membrane [GO_0030659]
- 1389: cytoskeletal anchor activity [GO_0008093]
- 1390: cytoskeletal motor activator activity [GO_0140660]
- 1391: cytoskeletal motor activity [GO_0003774]
- 1392: cytoskeletal motor inhibitor activity [GO_0140661]
- 1393: cytoskeletal motor regulator activity [GO_0140659]
- 1394: cytoskeletal protein binding [GO_0008092]
- 1395: cytoskeletal protein-membrane anchor activity [GO_0106006]
- 1396: cytoskeletal regulatory protein binding [GO_0005519]
- 1397: cytoskeleton [GO_0005856]
- 1398: cytoskeleton organization [GO_0007010]
- 1399: cytoskeleton-dependent intracellular transport [GO_0030705]
- 1400: Cytosolic chenodeoxycholoyl-CoA or choloyl-CoA are conjugated with glycine or taurine [GO_0016746]
- 1401: Cytosolic PHD2,3 hydroxylates proline residues on HIF1A [GO_0031545]
- 1402: D-amino acid transmembrane transporter activity [GO_0042943]
- 1403: D-amino acid transport [GO_0042940]
- 1404: D-amino-acid oxidase activity [GO_0003884]
- 1405: D-aminoacyl-tRNA deacylase activity [GO_0051499]
- 1406: D-arabinose 1-dehydrogenase [NAD(P)+] activity [GO_0045290]
- 1407: D-fructose 1,6-bisphosphate + H2O => D-fructose 6-phosphate + orthophosphate [GO_0042132]
- 1408: D-fructose 6-phosphate + ATP => D-fructose 2,6-bisphosphate + ADP [GO_0003873]
- 1409: D-fructose 6-phosphate <=> alpha-D-Glucose 6-phosphate [GO_0004347]
- 1410: D-glucono-1,5-lactone 6-phosphate + H2O => 6-phospho-D-gluconate [GO_0017057]
- 1411: D-glyceraldehyde 3-phosphate + orthophosphate + NAD+ <=> 1,3-bisphospho-D-glycerate + NADH + H+ [GO_0004365]
- 1412: D-loop dissociation and strand annealing [GO_0003678]
- 1413: D-ribulokinase activity [GO_0019150]
- 1414: D-ribulose 5-phosphate <=> ribose 5-phosphate [GO_0004751]
- 1415: D-tyrosyl-tRNA(Tyr) deacylase activity [GO_0051500]
- 1416: D-xylose 1-dehydrogenase (NADP+) activity [GO_0047837]
- 1417: D5 dopamine receptor binding [GO_0031752]
- 1418: dA, dG, or dI + ATP => dAMP, dGMP, or dIMP + ADP (DGUOK) [GO_0019136]
- 1419: damaged DNA binding [GO_0003684]
- 1420: dAMP biosynthetic process [GO_0006170]
- 1421: dAMP metabolic process [GO_0046053]
- 1422: DARPP-32 phosphorylated on T34 binds to PP1, inhibiting its function [GO_0019888]
- 1423: DARPP-32 phosphorylated on Thr75 binds to PKA, inhibiting its function [GO_0004862]
- 1424: DCLRE1C (ARTEMIS) processes DNA DSB ends [GO_0004519]
- 1425: dCMP deaminase activity [GO_0004132]
- 1426: DCXR tetramer reduces L-xylulose to xylitol [GO_0050038]
- 1427: DDAH1,2 hydrolyses ADMA to DMA and L-Cit [GO_0016403]
- 1428: DDHD1,2 hydrolyse PA [GO_0004620]
- 1429: DDT-dehydrochlorinase activity [GO_0018833]
- 1430: deacetylase activity [GO_0019213]
- 1431: DEAD/H-box RNA helicase binding [GO_0017151]
- 1432: deaminated base DNA N-glycosylase activity [GO_0097506]
- 1433: death domain binding [GO_0070513]
- 1434: death receptor activity [GO_0005035]
- 1435: death receptor agonist activity [GO_0038177]
- 1436: death receptor binding [GO_0005123]
- 1437: decarboxylation-driven active transmembrane transporter activity [GO_0015451]
- 1438: defecation [GO_0030421]
- 1439: Defective ABCC9 (in KCNJ11:ABCC9) does not transport K+ from extracellular region to cytosol [GO_0005242]
- 1440: Defective ALG9 does not add the last mannose to the N-glycan precursor [GO_0000026]
- 1441: Defective APRT does not convert adenine to AMP [GO_0003999]
- 1442: Defective B3GAT3 does not transfer GlcA to tetrasaccharide linker [GO_0015018]
- 1443: Defective CFTR does not transport Cl- from cytosol to extracellular region [GO_0015108]
- 1444: Defective CHSY1 does not transfer GalNAc to chondroitin [GO_0047238]
- 1445: Defective CYP11B2 does not oxidise CORST [GO_0008395]
- 1446: Defective DPM3 does not transfer mannose to DOLP to form DOLPman [GO_0004582]
- 1447: Defective EXT1 (in EXT1:EXT2) does not transfer GlcNAc to the heparan chain [GO_0050508]
- 1448: Defective EXT2 (in EXT1:EXT2) does not transfer GlcA to heparan [GO_0050509]
- 1449: Defective FMO3 does not N-oxidise TMA [GO_0004499]
- 1450: Defective G6PC3 does not hydrolyze glucose 6-phosphate [GO_0004346]
- 1451: Defective GALK1 does not phosphorylate Gal [GO_0004335]
- 1452: Defective GALT does not transfer UMP to Gal1P [GO_0008108]
- 1453: Defective GCK does not phosphorylate Glc to form G6P [GO_0004340]
- 1454: Defective GCLC does not ligate L-Glu to L-Cys [GO_0004357]
- 1455: Defective GFPT1 does not transfer an amino group from L-Gln to F6P to form GlcN6P [GO_0004360]
- 1456: Defective GGT1 does not hydrolyse glutamate from AFXBO-SG, AFNBO-SG [GO_0036374]
- 1457: Defective GNS does not hydrolyse 6-sulfate from GlcNAc6S [GO_0008449]
- 1458: Defective GSS does not synthesize GSH [GO_0004363]
- 1459: Defective HEXA does not cleave the terminal GalNAc from keratan sulfate [GO_0004563]
- 1460: Defective IDUA does not hydrolyse Heparan sulfate chain(1) [GO_0003940]
- 1461: Defective KHK does not phosphorylate beta-D-fructose [GO_0004454]
- 1462: Defective MAN1B1 does not hydrolyse 1,2-linked mannose (a branch) [GO_0004571]
- 1463: Defective MAOA does not oxidatively deaminate 5HT [GO_0008131]
- 1464: Defective MAT1A does not transfer Ado from ATP to L-Met [GO_0004478]
- 1465: Defective MGAT2 does not transfer GlcNAc to N-glycans [GO_0008455]
- 1466: Defective OPLAH does not hydrolyse OPRO [GO_0017168]
- 1467: Defective PAH does not hydroxylate L-Phe to L-Tyr [GO_0004505]
- 1468: Defective RDH12 does not reduce atRAL to atROL [GO_0052650]
- 1469: Defective RHAG does not transport NH4+ from cytosol to extracellular region (rbc) [GO_0008519]
- 1470: Defective SGSH does not hydrolyse Heparan sulfate chain(2) [GO_0016250]
- 1471: Defective SLC11A2 does not cotransport Fe2+, H+ from extracellular region to cytosol [GO_0005381]
- 1472: Defective SLC12A6 does not cotransport K+, Cl- from cytosol to extracellular region [GO_0015379]
- 1473: Defective SLC20A2 does not cotransport Pi, Na+ from extracellular region to cytosol [GO_0005436]
- 1474: Defective SLC22A18 does not exchange extracellular organic cations for cytosolic H+ [GO_0015299]
- 1475: Defective SLC24A4 does not exchange extracellular 4Na+ for cytosolic Ca2+, K+ [GO_0008273]
- 1476: Defective SLC26A2 does not cotransport extracellular SO4(2-), H+ to cytosol [GO_0015116]
- 1477: Defective SLC37A4 does not exchange G6P and Pi across the ER membrane [GO_0061513]
- 1478: Defective SLC4A1 does not exchange Cl- for HCO3- (in erythrocytes) [GO_0005452]
- 1479: Defective SLC5A7 does not cotransport Cho, Cl-, Na+ from extracellular region to cytosol [GO_0015220]
- 1480: Defective UGT1A1 does not transfer GlcA from UDP-GlcA to BMG [GO_0015020]
- 1481: Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins [GO_0000224]
- 1482: Dehydration of methylthio-ribulose-P [GO_0046570]
- 1483: dehydroascorbic acid transport [GO_0070837]
- 1484: dehydrodolichyl diphosphate synthase activity [GO_0045547]
- 1485: delayed rectifier potassium channel activity [GO_0005251]
- 1486: delta(3,5)-delta(2,4)-dienoyl-CoA isomerase activity [GO_0051750]
- 1487: demethylase activity [GO_0032451]
- 1488: denatured protein binding [GO_0031249]
- 1489: dendrite [GO_0030425]
- 1490: dendrite cytoplasm [GO_0032839]
- 1491: dendritic tree [GO_0097447]
- 1492: deoxyadenosine kinase activity [GO_0004136]
- 1493: deoxycytidine kinase activity [GO_0004137]
- 1494: deoxycytidyl transferase activity [GO_0017125]
- 1495: deoxyguanosine kinase activity [GO_0004138]
- 1496: deoxyhypusine monooxygenase activity [GO_0019135]
- 1497: deoxyribodipyrimidine photo-lyase activity [GO_0003904]
- 1498: deoxyribonuclease I activity [GO_0004530]
- 1499: deoxyribonuclease II activity [GO_0004531]
- 1500: deoxyribonucleoside monophosphate biosynthetic process [GO_0009157]
- 1501: deoxyribonucleoside monophosphate metabolic process [GO_0009162]
- 1502: deoxyribonucleotide biosynthetic process [GO_0009263]
- 1503: deoxyribonucleotide metabolic process [GO_0009262]
- 1504: deoxyribose phosphate biosynthetic process [GO_0046385]
- 1505: deoxyribose phosphate metabolic process [GO_0019692]
- 1506: dephospho-CoA kinase activity [GO_0004140]
- 1507: dephosphorylation [GO_0016311]
- 1508: Dephosphorylation of AKT by PP2A [GO_0008195]
- 1509: Dephosphorylation of CD3-zeta by PD-1 bound phosphatases [GO_0004725]
- 1510: Dephosphorylation of phospho-Cdh1 [GO_0004721]
- 1511: DERA cleaves dR5P to GA3P and CH3CHO [GO_0004139]
- 1512: dermal bone morphogenesis [GO_0061972]
- 1513: dermatome development [GO_0061054]
- 1514: descending aorta development [GO_0035906]
- 1515: descending aorta morphogenesis [GO_0035911]
- 1516: deSUMOylase activity [GO_0016929]
- 1517: detection of abiotic stimulus [GO_0009582]
- 1518: detection of biotic stimulus [GO_0009595]
- 1519: detection of calcium ion [GO_0005513]
- 1520: detection of carbon dioxide [GO_0003031]
- 1521: detection of chemical stimulus [GO_0009593]
- 1522: detection of chemical stimulus involved in sensory perception [GO_0050907]
- 1523: detection of chemical stimulus involved in sensory perception of bitter taste [GO_0001580]
- 1524: detection of chemical stimulus involved in sensory perception of pain [GO_0050968]
- 1525: detection of chemical stimulus involved in sensory perception of salty taste [GO_0001583]
- 1526: detection of chemical stimulus involved in sensory perception of smell [GO_0050911]
- 1527: detection of chemical stimulus involved in sensory perception of sour taste [GO_0001581]
- 1528: detection of chemical stimulus involved in sensory perception of sweet taste [GO_0001582]
- 1529: detection of chemical stimulus involved in sensory perception of taste [GO_0050912]
- 1530: detection of chemical stimulus involved in sensory perception of umami taste [GO_0046535]
- 1531: detection of cold stimulus involved in thermoception [GO_0120169]
- 1532: detection of external biotic stimulus [GO_0098581]
- 1533: detection of external stimulus [GO_0009581]
- 1534: detection of high humidity [GO_0098516]
- 1535: detection of high humidity stimulus involved in sensory perception [GO_0098514]
- 1536: detection of hot stimulus involved in thermoception [GO_0120168]
- 1537: detection of humidity [GO_0098513]
- 1538: detection of humidity stimulus involved in sensory perception [GO_0098512]
- 1539: detection of hydrogen ion [GO_0003030]
- 1540: detection of light stimulus [GO_0009583]
- 1541: detection of light stimulus involved in sensory perception [GO_0050962]
- 1542: detection of light stimulus involved in visual perception [GO_0050908]
- 1543: detection of low humidity [GO_0098517]
- 1544: detection of low humidity stimulus involved in sensory perception [GO_0098515]
- 1545: detection of mechanical stimulus [GO_0050982]
- 1546: detection of mechanical stimulus involved in equilibrioception [GO_0050973]
- 1547: detection of mechanical stimulus involved in sensory perception [GO_0050974]
- 1548: detection of mechanical stimulus involved in sensory perception of pain [GO_0050966]
- 1549: detection of mechanical stimulus involved in sensory perception of sound [GO_0050910]
- 1550: detection of mechanical stimulus involved in sensory perception of touch [GO_0050976]
- 1551: detection of mechanical stimulus involved in sensory perception of wind [GO_0071066]
- 1552: detection of molecule of fungal origin [GO_0032491]
- 1553: detection of osmotic stimulus [GO_0043575]
- 1554: detection of pH by chemoreceptor signaling [GO_0003022]
- 1555: detection of pheromone [GO_0043695]
- 1556: detection of stimulus [GO_0051606]
- 1557: detection of stimulus involved in sensory perception [GO_0050906]
- 1558: detection of stimulus involved in sensory perception of pain [GO_0062149]
- 1559: detection of temperature stimulus [GO_0016048]
- 1560: detection of temperature stimulus involved in sensory perception [GO_0050961]
- 1561: detection of temperature stimulus involved in sensory perception of pain [GO_0050965]
- 1562: detection of temperature stimulus involved in thermoception [GO_0050960]
- 1563: detection of visible light [GO_0009584]
- 1564: detoxification [GO_0098754]
- 1565: detoxification of inorganic compound [GO_0061687]
- 1566: detoxification of nitrogen compound [GO_0051410]
- 1567: deubiquitinase activator activity [GO_0035800]
- 1568: deubiquitinase activity [GO_0101005]
- 1569: deUFMylase activity [GO_0071567]
- 1570: development of primary female sexual characteristics [GO_0046545]
- 1571: development of primary sexual characteristics [GO_0045137]
- 1572: developmental cell growth [GO_0048588]
- 1573: developmental growth [GO_0048589]
- 1574: developmental growth involved in morphogenesis [GO_0060560]
- 1575: developmental induction [GO_0031128]
- 1576: developmental maturation [GO_0021700]
- 1577: developmental pigmentation [GO_0048066]
- 1578: developmental process [GO_0032502]
- 1579: developmental process involved in reproduction [GO_0003006]
- 1580: dGTPase activity [GO_0008832]
- 1581: DHAP is converted to 1-acyl GO3P by GNPAT [GO_0016287]
- 1582: DHDDS:NUS1 elongates E,E-FPP with (n)IPPP to form pPPP [GO_0016765]
- 1583: DHPS tetramer synthesizes EIF5A and spermidine from Dhp-K50-EIF5A [GO_0034038]
- 1584: diacylglycerol binding [GO_0019992]
- 1585: diacylglycerol cholinephosphotransferase activity [GO_0004142]
- 1586: diacylglycerol diphosphate phosphatase activity [GO_0000810]
- 1587: diacylglycerol kinase activity [GO_0004143]
- 1588: diaphragm development [GO_0060539]
- 1589: diaphragm morphogenesis [GO_0060540]
- 1590: dibutyl phthalate binding [GO_0035275]
- 1591: dicarboxylic acid biosynthetic process [GO_0043650]
- 1592: dicarboxylic acid catabolic process [GO_0043649]
- 1593: dicarboxylic acid metabolic process [GO_0043648]
- 1594: dicarboxylic acid transport [GO_0006835]
- 1595: digestion [GO_0007586]
- 1596: Digestion of 1-6 linkages of limit dextrins to yield maltose, maltotriose, longer maltosides, and glucose [GO_0004558]
- 1597: Digestion of linear starch (amylose) by extracellular amylase [GO_0004556]
- 1598: Digestion of triacylglycerols by extracellular PTL:colipase [GO_0047372]
- 1599: digestive system development [GO_0055123]
- 1600: digestive system process [GO_0022600]
- 1601: digestive tract development [GO_0048565]
- 1602: digestive tract morphogenesis [GO_0048546]
- 1603: dihydrofolate reductase activity [GO_0004146]
- 1604: dihydrolipoyllysine-residue acetyltransferase activity [GO_0004742]
- 1605: dihydrolipoyllysine-residue succinyltransferase activity [GO_0004149]
- 1606: dihydroorotase activity [GO_0004151]
- 1607: dihydroorotate dehydrogenase activity [GO_0004152]
- 1608: dihydropterin deaminase activity [GO_0004153]
- 1609: dihydropyrimidine dehydrogenase (NADP+) activity [GO_0017113]
- 1610: dihydroxyacetone phosphate <=> D-glyceraldehyde 3-phosphate [GO_0004807]
- 1611: DIMT1 dimethylates adenosine-1850,1851 of 18S rRNA yielding 6-dimethyladenosine-1850,1851 [GO_0000179]
- 1612: dioxygenase activity [GO_0051213]
- 1613: dipeptidase activity [GO_0016805]
- 1614: dipeptide transmembrane transport [GO_0035442]
- 1615: dipeptide transmembrane transporter activity [GO_0071916]
- 1616: dipeptide transport [GO_0042938]
- 1617: dipeptidyl-peptidase activity [GO_0008239]
- 1618: diphenyl phthalate binding [GO_0035274]
- 1619: diphosphoinositol-pentakisphosphate kinase activity [GO_0033857]
- 1620: diphosphoinositol-polyphosphate diphosphatase activity [GO_0008486]
- 1621: diphosphoric monoester hydrolase activity [GO_0016794]
- 1622: diphosphotransferase activity [GO_0016778]
- 1623: diphthine methylesterase activity [GO_0061685]
- 1624: direct ossification [GO_0036072]
- 1625: directional locomotion [GO_0033058]
- 1626: disaccharide metabolic process [GO_0005984]
- 1627: disaccharide transmembrane transporter activity [GO_0015154]
- 1628: disaccharide transport [GO_0015766]
- 1629: disordered domain specific binding [GO_0097718]
- 1630: Dissociation of cytosolic HSF1:HSP90:HDAC6:PTGES3 upon sensing protein aggregates [GO_0051787]
- 1631: disulfide oxidoreductase activity [GO_0015036]
- 1632: diterpenoid metabolic process [GO_0016101]
- 1633: diuretic hormone activity [GO_0008613]
- 1634: diuretic hormone receptor activity [GO_0008036]
- 1635: divalent inorganic anion homeostasis [GO_0072505]
- 1636: divalent inorganic cation homeostasis [GO_0072507]
- 1637: DNA (cytosine-5-)-methyltransferase activity [GO_0003886]
- 1638: DNA 5'-adenosine monophosphate hydrolase activity [GO_0033699]
- 1639: DNA alkylation [GO_0006305]
- 1640: DNA bending complex [GO_1990104]
- 1641: DNA binding [GO_0003677]
- 1642: DNA binding, bending [GO_0008301]
- 1643: DNA biosynthetic process [GO_0071897]
- 1644: DNA clamp unloader activity [GO_0061860]
- 1645: DNA clamp unloading [GO_0090618]
- 1646: DNA conformation change [GO_0071103]
- 1647: DNA damage sensor activity [GO_0140612]
- 1648: DNA demethylase activity [GO_0035514]
- 1649: DNA duplex unwinding [GO_0032508]
- 1650: DNA endonuclease activity, producing 3'-phosphomonoesters [GO_0016889]
- 1651: DNA geometric change [GO_0032392]
- 1652: DNA ligase (ATP) activity [GO_0003910]
- 1653: DNA ligation [GO_0006266]
- 1654: DNA ligation involved in DNA recombination [GO_0051102]
- 1655: DNA metabolic process [GO_0006259]
- 1656: DNA methylation [GO_0006306]
- 1657: DNA methylation on cytosine [GO_0032776]
- 1658: DNA modification [GO_0006304]
- 1659: DNA packaging [GO_0006323]
- 1660: DNA packaging complex [GO_0044815]
- 1661: DNA photolyase activity [GO_0003913]
- 1662: DNA polymerase activity [GO_0034061]
- 1663: DNA polymerase binding [GO_0070182]
- 1664: DNA polymerase processivity factor activity [GO_0030337]
- 1665: DNA primase activity [GO_0003896]
- 1666: DNA recombination [GO_0006310]
- 1667: DNA repair [GO_0006281]
- 1668: DNA replication [GO_0006260]
- 1669: DNA replication origin binding [GO_0003688]
- 1670: DNA replication, synthesis of RNA primer [GO_0006269]
- 1671: DNA secondary structure binding [GO_0000217]
- 1672: DNA synthesis involved in DNA replication [GO_0090592]
- 1673: DNA synthesis involved in mitochondrial DNA replication [GO_0110166]
- 1674: DNA synthesis involved in mitotic DNA replication [GO_1904860]
- 1675: DNA topoisomerase activity [GO_0003916]
- 1676: DNA topoisomerase binding [GO_0044547]
- 1677: DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO_0003917]
- 1678: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO_0072587]
- 1679: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO_0003918]
- 1680: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) inhibitor activity [GO_0008657]
- 1681: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) regulator activity [GO_0072586]
- 1682: DNA translocase activity [GO_0015616]
- 1683: DNA transport [GO_0051027]
- 1684: DNA unwinding involved in DNA replication [GO_0006268]
- 1685: DNA-binding transcription activator activity [GO_0001216]
- 1686: DNA-binding transcription activator activity, RNA polymerase II-specific [GO_0001228]
- 1687: DNA-binding transcription factor activity [GO_0003700]
- 1688: DNA-binding transcription factor activity, RNA polymerase II-specific [GO_0000981]
- 1689: DNA-binding transcription factor binding [GO_0140297]
- 1690: DNA-binding transcription repressor activity [GO_0001217]
- 1691: DNA-binding transcription repressor activity, RNA polymerase II-specific [GO_0001227]
- 1692: DNA-binding transcription repressor activity, RNA polymerase III-specific [GO_0106250]
- 1693: DNA-dependent DNA replication DNA ligation [GO_0051104]
- 1694: DNA-DNA tethering activity [GO_0106260]
- 1695: DNA-methyltransferase activity [GO_0009008]
- 1696: DNA-templated DNA replication [GO_0006261]
- 1697: DNA-templated transcription [GO_0006351]
- 1698: DNA-templated transcription initiation [GO_0006352]
- 1699: DNA-templated transcription termination [GO_0006353]
- 1700: DNA/DNA annealing activity [GO_1990814]
- 1701: DNA/RNA helicase activity [GO_0033677]
- 1702: DNA/RNA hybrid binding [GO_0071667]
- 1703: dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO_0052925]
- 1704: dolichol kinase activity [GO_0004168]
- 1705: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO_0042283]
- 1706: dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO_0106073]
- 1707: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO_0042281]
- 1708: dolichyl-phosphate beta-glucosyltransferase activity [GO_0004581]
- 1709: dopachrome isomerase activity [GO_0004167]
- 1710: dopamine beta-monooxygenase activity [GO_0004500]
- 1711: dopamine binding [GO_0035240]
- 1712: dopamine neurotransmitter receptor activity [GO_0004952]
- 1713: dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO_0001591]
- 1714: dopamine neurotransmitter receptor activity, coupled via Gs [GO_0001588]
- 1715: dopamine receptor binding [GO_0050780]
- 1716: dopamine receptor signaling pathway [GO_0007212]
- 1717: dopamine secretion [GO_0014046]
- 1718: dopamine secretion, neurotransmission [GO_0061527]
- 1719: dopamine transport [GO_0015872]
- 1720: dopamine uptake [GO_0090494]
- 1721: dopamine:sodium symporter activity [GO_0005330]
- 1722: dopaminechrome tautomerase activity [GO_0106417]
- 1723: dormancy process [GO_0022611]
- 1724: dorsal aorta development [GO_0035907]
- 1725: dorsal aorta morphogenesis [GO_0035912]
- 1726: dorsal/ventral axis specification [GO_0009950]
- 1727: dorsal/ventral pattern formation [GO_0009953]
- 1728: double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO_0008311]
- 1729: double-stranded DNA binding [GO_0003690]
- 1730: double-stranded DNA exodeoxyribonuclease activity [GO_0008309]
- 1731: double-stranded DNA helicase activity [GO_0036121]
- 1732: double-stranded RNA adenosine deaminase activity [GO_0003726]
- 1733: double-stranded RNA binding [GO_0003725]
- 1734: double-stranded RNA-specific ribonuclease activity [GO_0032296]
- 1735: double-stranded telomeric DNA binding [GO_0003691]
- 1736: DPH5 transfers four methyl groups from AdoMet to aminocarboxypropyl EEF2 [GO_0004164]
- 1737: DPH6 ligates ammonium to diphthine-EEF2 [GO_0017178]
- 1738: DPH7 hydrolyzes a methyl group on Me-diphthine EEF2 [GO_0051723]
- 1739: drug transport [GO_0015893]
- 1740: DUS2:EPRS reduces uridine to dihydrouridine in tRNAs [GO_0017150]
- 1741: dUTP diphosphatase activity [GO_0004170]
- 1742: dynactin binding [GO_0034452]
- 1743: dynein complex binding [GO_0070840]
- 1744: dynein heavy chain binding [GO_0045504]
- 1745: dynein intermediate chain binding [GO_0045505]
- 1746: dynein light chain binding [GO_0045503]
- 1747: dynein light intermediate chain binding [GO_0051959]
- 1748: E-box binding [GO_0070888]
- 1749: ecdysis-triggering hormone activity [GO_0008255]
- 1750: ecdysis-triggering hormone receptor activity [GO_0042654]
- 1751: ecdysone 20-monooxygenase activity [GO_0004501]
- 1752: ecdysone binding [GO_0035100]
- 1753: ecdysone oxidase activity [GO_0047875]
- 1754: ecdysteroid 2-hydroxylase activity [GO_0042768]
- 1755: ecdysteroid 22-hydroxylase activity [GO_0042767]
- 1756: ecdysteroid 25-hydroxylase activity [GO_0035302]
- 1757: ecdysteroid-phosphate phosphatase activity [GO_0102531]
- 1758: ECI2 isomerizes 3Z-enoyl-CoA to 2E-enoyl-CoA [GO_0004165]
- 1759: eclosion [GO_0007562]
- 1760: eclosion rhythm [GO_0008062]
- 1761: ectoderm development [GO_0007398]
- 1762: ectoderm formation [GO_0001705]
- 1763: ectodermal cell differentiation [GO_0010668]
- 1764: ectodermal digestive tract development [GO_0007439]
- 1765: ectodermal placode development [GO_0071696]
- 1766: ectodermal placode formation [GO_0060788]
- 1767: ectodermal placode morphogenesis [GO_0071697]
- 1768: Ectonucleotide pyrophosphatase/phosphodiesterase 7 (ENPP7) hydrolyses sphingomyelin [GO_0004767]
- 1769: ectopic germ cell programmed cell death [GO_0035234]
- 1770: eEF1A complexes with GTP [GO_0019001]
- 1771: efflux transmembrane transporter activity [GO_0015562]
- 1772: EGF-domain serine glucosyltransferase activity [GO_0140561]
- 1773: EGF-domain serine xylosyltransferase activity [GO_0140562]
- 1774: egg chorion [GO_0042600]
- 1775: egg coat [GO_0035805]
- 1776: eIF2 activation [GO_0003743]
- 1777: ELAC2 cleaves the 3' end of pre-tRNA [GO_0004549]
- 1778: elastic fiber [GO_0071953]
- 1779: elastic fiber assembly [GO_0048251]
- 1780: electron transfer activity [GO_0009055]
- 1781: Electron transfer from ubiquinol to cytochrome c of complex III [GO_0008121]
- 1782: electron transport chain [GO_0022900]
- 1783: electron-transferring-flavoprotein dehydrogenase activity [GO_0004174]
- 1784: elongation factor-2 kinase activity [GO_0004686]
- 1785: Elongation of gamma-lenolenoyl-CoA to dihomo-gamma-lenolenoyl-CoA [GO_0009922]
- 1786: Elongation Of The Telomeric Chromosome End [GO_0003720]
- 1787: embryo development [GO_0009790]
- 1788: embryo development ending in birth or egg hatching [GO_0009792]
- 1789: embryonic camera-type eye development [GO_0031076]
- 1790: embryonic camera-type eye formation [GO_0060900]
- 1791: embryonic camera-type eye morphogenesis [GO_0048596]
- 1792: embryonic cleavage [GO_0040016]
- 1793: embryonic development via the syncytial blastoderm [GO_0001700]
- 1794: embryonic epithelial tube formation [GO_0001838]
- 1795: embryonic eye morphogenesis [GO_0048048]
- 1796: embryonic heart tube development [GO_0035050]
- 1797: embryonic heart tube formation [GO_0003144]
- 1798: embryonic heart tube formation via epithelial folding [GO_0003145]
- 1799: embryonic heart tube morphogenesis [GO_0003143]
- 1800: embryonic morphogenesis [GO_0048598]
- 1801: embryonic organ development [GO_0048568]
- 1802: embryonic organ morphogenesis [GO_0048562]
- 1803: embryonic placenta development [GO_0001892]
- 1804: embryonic placenta morphogenesis [GO_0060669]
- 1805: embryonic process involved in female pregnancy [GO_0060136]
- 1806: endocardial cell development [GO_0060958]
- 1807: endocardial cell differentiation [GO_0060956]
- 1808: endocardial cushion development [GO_0003197]
- 1809: endocardial cushion formation [GO_0003272]
- 1810: endocardial cushion morphogenesis [GO_0003203]
- 1811: endocardial endothelium development [GO_0061147]
- 1812: endocardium development [GO_0003157]
- 1813: endocardium formation [GO_0060214]
- 1814: endocardium morphogenesis [GO_0003160]
- 1815: endochondral bone growth [GO_0003416]
- 1816: endochondral bone morphogenesis [GO_0060350]
- 1817: endocrine hormone secretion [GO_0060986]
- 1818: endocrine pancreas development [GO_0031018]
- 1819: endocrine process [GO_0050886]
- 1820: endocrine system development [GO_0035270]
- 1821: endocytosis [GO_0006897]
- 1822: endodeoxyribonuclease activator activity [GO_0140656]
- 1823: endodeoxyribonuclease activity [GO_0004520]
- 1824: endoderm development [GO_0007492]
- 1825: endoderm formation [GO_0001706]
- 1826: endodermal cell differentiation [GO_0035987]
- 1827: endodermal-mesodermal cell signaling [GO_0003133]
- 1828: endomembrane system [GO_0012505]
- 1829: endomembrane system organization [GO_0010256]
- 1830: endomitotic cell cycle [GO_0007113]
- 1831: endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters [GO_0016894]
- 1832: endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters [GO_0016893]
- 1833: endonucleolytic cleavage involved in rRNA processing [GO_0000478]
- 1834: endonucleolytic cleavage involved in tRNA processing [GO_1905267]
- 1835: endopeptidase activator activity [GO_0061133]
- 1836: endopeptidase inhibitor activity [GO_0004866]
- 1837: endopeptidase regulator activity [GO_0061135]
- 1838: endoplasmic reticulum signal peptide binding [GO_0030942]
- 1839: endopolyphosphatase activity [GO_0000298]
- 1840: endoribonuclease activity, cleaving miRNA-paired mRNA [GO_0090624]
- 1841: endoribonuclease activity, cleaving siRNA-paired mRNA [GO_0070551]
- 1842: endoribonuclease activity, producing 5'-phosphomonoesters [GO_0016891]
- 1843: endoribonuclease inhibitor activity [GO_0060698]
- 1844: endothelial cell apoptotic process [GO_0072577]
- 1845: endothelial cell development [GO_0001885]
- 1846: endothelial cell differentiation [GO_0045446]
- 1847: endothelial cell morphogenesis [GO_0001886]
- 1848: endothelial cell proliferation [GO_0001935]
- 1849: endothelial tube formation [GO_0120331]
- 1850: endothelial tube morphogenesis [GO_0061154]
- 1851: endothelium development [GO_0003158]
- 1852: energy derivation by oxidation of organic compounds [GO_0015980]
- 1853: energy reserve metabolic process [GO_0006112]
- 1854: energy taxis [GO_0009453]
- 1855: eNoSC dimethylates histone H3 at lysine-9 [GO_0046974]
- 1856: enteric smooth muscle cell differentiation [GO_0035645]
- 1857: enteroendocrine cell differentiation [GO_0035883]
- 1858: entrainment of circadian clock [GO_0009649]
- 1859: entrainment of circadian clock by photoperiod [GO_0043153]
- 1860: entry into diapause [GO_0055115]
- 1861: entry into reproductive diapause [GO_0055116]
- 1862: enucleate erythrocyte development [GO_0048822]
- 1863: enucleate erythrocyte differentiation [GO_0043353]
- 1864: enucleate erythrocyte maturation [GO_0043354]
- 1865: envelope [GO_0031975]
- 1866: Envoplakin, periplakin, involucrin, SPR binding mediated by TGM1 crosslinking [GO_0003810]
- 1867: enzyme activator activity [GO_0008047]
- 1868: enzyme binding [GO_0019899]
- 1869: enzyme inhibitor activity [GO_0004857]
- 1870: enzyme regulator activity [GO_0030234]
- 1871: enzyme-linked receptor protein signaling pathway [GO_0007167]
- 1872: enzyme-substrate adaptor activity [GO_0140767]
- 1873: EP300,CREBBP acetylate FOXO4 [GO_0061733]
- 1874: ephrin receptor activity [GO_0005003]
- 1875: ephrin receptor binding [GO_0046875]
- 1876: ephrin receptor signaling pathway [GO_0048013]
- 1877: epicardium morphogenesis [GO_1905223]
- 1878: epidermal cell differentiation [GO_0009913]
- 1879: epidermal cell division [GO_0010481]
- 1880: epidermal growth factor binding [GO_0048408]
- 1881: epidermal growth factor receptor activity [GO_0005006]
- 1882: epidermal growth factor receptor binding [GO_0005154]
- 1883: epidermal growth factor receptor signaling pathway [GO_0007173]
- 1884: epidermal stem cell homeostasis [GO_0036334]
- 1885: epidermis development [GO_0008544]
- 1886: epidermis morphogenesis [GO_0048730]
- 1887: epigenetic maintenance of chromatin in transcription-competent conformation [GO_0045815]
- 1888: epithelial cell apoptotic process [GO_1904019]
- 1889: epithelial cell development [GO_0002064]
- 1890: epithelial cell differentiation [GO_0030855]
- 1891: epithelial cell differentiation involved in embryonic placenta development [GO_0060671]
- 1892: epithelial cell maturation [GO_0002070]
- 1893: epithelial cell morphogenesis [GO_0003382]
- 1894: epithelial cell morphogenesis involved in gastrulation [GO_0003381]
- 1895: epithelial cell proliferation [GO_0050673]
- 1896: epithelial cell proliferation involved in liver morphogenesis [GO_0072575]
- 1897: epithelial cell proliferation involved in lung morphogenesis [GO_0060502]
- 1898: epithelial to mesenchymal transition [GO_0001837]
- 1899: epithelial tube branching involved in lung morphogenesis [GO_0060441]
- 1900: epithelial tube formation [GO_0072175]
- 1901: epithelial tube morphogenesis [GO_0060562]
- 1902: epithelium development [GO_0060429]
- 1903: EPM2A dimer dephosphorylates phosphoglycogen-GYG2 [GO_0019203]
- 1904: Equilibrative transport (export) of nucleosides and free bases by solute carrier family 29 (nucleoside transporters), member 1 [GO_0005337]
- 1905: equilibrioception [GO_0050957]
- 1906: ER retention sequence binding [GO_0046923]
- 1907: ERBB signaling pathway [GO_0038127]
- 1908: ERCC2-facilitated RNA Pol II backtracking in TC-NER [GO_0043139]
- 1909: erythrocyte apoptotic process [GO_1902217]
- 1910: erythrocyte development [GO_0048821]
- 1911: erythrocyte differentiation [GO_0030218]
- 1912: erythrocyte homeostasis [GO_0034101]
- 1913: erythrocyte maturation [GO_0043249]
- 1914: erythrose 4-phosphate/phosphoenolpyruvate family amino acid biosynthetic process [GO_1902223]
- 1915: erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process [GO_1902221]
- 1916: ESD dimer hydrolyses S-FGSH to GSH [GO_0018738]
- 1917: esophagus development [GO_1903702]
- 1918: establishment of cell polarity [GO_0030010]
- 1919: establishment of cell polarity involved in ameboidal cell migration [GO_0003365]
- 1920: establishment of cell polarity involved in gastrulation cell migration [GO_0003379]
- 1921: establishment of chromosome localization [GO_0051303]
- 1922: establishment of epithelial cell polarity [GO_0090162]
- 1923: establishment of Golgi localization [GO_0051683]
- 1924: establishment of localization [GO_0051234]
- 1925: establishment of localization in cell [GO_0051649]
- 1926: establishment of neuroblast polarity [GO_0045200]
- 1927: establishment of organelle localization [GO_0051656]
- 1928: establishment of pigment granule localization [GO_0051905]
- 1929: establishment of planar polarity [GO_0001736]
- 1930: establishment of protein localization [GO_0045184]
- 1931: establishment of protein localization to chromatin [GO_0071169]
- 1932: establishment of protein localization to chromosome [GO_0070199]
- 1933: establishment of protein localization to extracellular region [GO_0035592]
- 1934: establishment of protein localization to membrane [GO_0090150]
- 1935: establishment of protein localization to organelle [GO_0072594]
- 1936: establishment of protein localization to plasma membrane [GO_0061951]
- 1937: establishment of protein localization to vacuole [GO_0072666]
- 1938: establishment of RNA localization [GO_0051236]
- 1939: establishment of tissue polarity [GO_0007164]
- 1940: establishment of vesicle localization [GO_0051650]
- 1941: establishment or maintenance of cell polarity [GO_0007163]
- 1942: establishment or maintenance of cytoskeleton polarity [GO_0030952]
- 1943: establishment or maintenance of cytoskeleton polarity involved in ameboidal cell migration [GO_0003371]
- 1944: establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO_0003380]
- 1945: establishment or maintenance of microtubule cytoskeleton polarity [GO_0030951]
- 1946: establishment or maintenance of neuroblast polarity [GO_0045196]
- 1947: establishment or maintenance of transmembrane electrochemical gradient [GO_0010248]
- 1948: estrogen response element binding [GO_0034056]
- 1949: ETA is phosphorylated to PETA by CHK/ETNK [GO_0004305]
- 1950: ethanolamine-phosphate phospho-lyase activity [GO_0050459]
- 1951: ethanolaminephosphotransferase activity [GO_0004307]
- 1952: euchromatin binding [GO_1990188]
- 1953: eukaryotic initiation factor 4E binding [GO_0008190]
- 1954: eukaryotic initiation factor 4G binding [GO_0031370]
- 1955: eukaryotic initiation factor eIF2 binding [GO_0071074]
- 1956: eukaryotic translation initiation factor 2alpha kinase activity [GO_0004694]
- 1957: Exchange of oxygen with sulfur in MoCo [GO_0008265]
- 1958: excitatory chemical synaptic transmission [GO_0098976]
- 1959: excitatory postsynaptic potential [GO_0060079]
- 1960: excretion [GO_0007588]
- 1961: execution phase of apoptosis [GO_0097194]
- 1962: EXO1 interacting with MSH2:MSH6 excises single strand DNA containing a mismatch [GO_0008409]
- 1963: exocrine pancreas development [GO_0031017]
- 1964: exocrine system development [GO_0035272]
- 1965: exocytic process [GO_0140029]
- 1966: exocytic vesicle [GO_0070382]
- 1967: exocytic vesicle membrane [GO_0099501]
- 1968: exocytosis [GO_0006887]
- 1969: exodeoxyribonuclease activity [GO_0004529]
- 1970: exodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO_0016895]
- 1971: exon-exon junction complex binding [GO_1990448]
- 1972: exonuclease activity [GO_0004527]
- 1973: exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters [GO_0016796]
- 1974: exonucleolytic trimming involved in rRNA processing [GO_0000459]
- 1975: exopeptidase activity [GO_0008238]
- 1976: exopolyphosphatase activity [GO_0004309]
- 1977: exoribonuclease activator activity [GO_0044692]
- 1978: exoribonuclease activity [GO_0004532]
- 1979: exoribonuclease activity, producing 5'-phosphomonoesters [GO_0016896]
- 1980: exosomal secretion [GO_1990182]
- 1981: export from cell [GO_0140352]
- 1982: Exportin-5 recognizes 3' overhang of pre-miRNA [GO_0003723]
- 1983: external encapsulating structure [GO_0030312]
- 1984: external encapsulating structure organization [GO_0045229]
- 1985: external genitalia morphogenesis [GO_0035261]
- 1986: extracellular amino acid transport [GO_0006860]
- 1987: extracellular ammonia-gated monoatomic ion channel activity [GO_0036081]
- 1988: extracellular carbohydrate transport [GO_0006859]
- 1989: extracellular exosome [GO_0070062]
- 1990: extracellular exosome assembly [GO_0071971]
- 1991: extracellular exosome biogenesis [GO_0097734]
- 1992: extracellular ligand-gated ion channel activity [GO_0005230]
- 1993: extracellular matrix [GO_0031012]
- 1994: extracellular matrix assembly [GO_0085029]
- 1995: extracellular matrix binding [GO_0050840]
- 1996: extracellular matrix constituent conferring elasticity [GO_0030023]
- 1997: extracellular matrix disassembly [GO_0022617]
- 1998: extracellular matrix organization [GO_0030198]
- 1999: extracellular matrix organization involved in endocardium development [GO_0061148]
- 2000: extracellular matrix protein binding [GO_1990430]
- 2001: extracellular matrix structural constituent [GO_0005201]
- 2002: extracellular matrix structural constituent conferring tensile strength [GO_0030020]
- 2003: extracellular membrane-bounded organelle [GO_0065010]
- 2004: extracellular negative regulation of signal transduction [GO_1900116]
- 2005: extracellular non-membrane-bounded organelle [GO_0043264]
- 2006: extracellular organelle [GO_0043230]
- 2007: extracellular phenylacetaldehyde-gated monoatomic ion channel activity [GO_0036082]
- 2008: extracellular region [GO_0005576]
- 2009: extracellular regulation of signal transduction [GO_1900115]
- 2010: extracellular space [GO_0005615]
- 2011: extracellular structure organization [GO_0043062]
- 2012: extracellular transport [GO_0006858]
- 2013: extracellular vesicle [GO_1903561]
- 2014: extracellular vesicle biogenesis [GO_0140112]
- 2015: extracellularly glutamate-gated chloride channel activity [GO_0008068]
- 2016: extracellularly glutamate-gated ion channel activity [GO_0005234]
- 2017: extraembryonic membrane development [GO_1903867]
- 2018: eye development [GO_0001654]
- 2019: eye morphogenesis [GO_0048592]
- 2020: eye photoreceptor cell development [GO_0042462]
- 2021: eye photoreceptor cell differentiation [GO_0001754]
- 2022: face development [GO_0060324]
- 2023: face morphogenesis [GO_0060325]
- 2024: FAD binding [GO_0071949]
- 2025: FAD transmembrane transport [GO_0035350]
- 2026: FAD transmembrane transporter activity [GO_0015230]
- 2027: FAD transport [GO_0015883]
- 2028: FAD-dependent H3K4me/H3K4me3 demethylase activity [GO_0140682]
- 2029: FANCD2 deubiquitination by USP1:WDR48 [GO_0004843]
- 2030: farnesoic acid O-methyltransferase activity [GO_0019010]
- 2031: farnesyltranstransferase activity [GO_0004311]
- 2032: fat cell apoptotic process [GO_1904606]
- 2033: fat cell differentiation [GO_0045444]
- 2034: fat cell proliferation [GO_0070341]
- 2035: fatty acid alpha-hydroxylase activity [GO_0080132]
- 2036: fatty acid amide hydrolase activity [GO_0017064]
- 2037: fatty acid binding [GO_0005504]
- 2038: fatty acid biosynthetic process [GO_0006633]
- 2039: fatty acid derivative binding [GO_1901567]
- 2040: fatty acid ligase activity [GO_0015645]
- 2041: fatty acid metabolic process [GO_0006631]
- 2042: fatty acid omega-hydroxylase activity [GO_0120250]
- 2043: fatty acid transport [GO_0015908]
- 2044: fatty-acyl-CoA binding [GO_0000062]
- 2045: fatty-acyl-CoA reductase (alcohol-forming) activity [GO_0080019]
- 2046: fatty-acyl-CoA transport [GO_0015916]
- 2047: FECH binds Fe2+ to PRIN9 to form heme [GO_0004325]
- 2048: feeding behavior [GO_0007631]
- 2049: female gamete generation [GO_0007292]
- 2050: female germ cell nucleus [GO_0001674]
- 2051: female germ-line stem cell asymmetric division [GO_0048132]
- 2052: female gonad development [GO_0008585]
- 2053: female gonad morphogenesis [GO_0061040]
- 2054: female mating behavior [GO_0060180]
- 2055: female meiosis chromosome segregation [GO_0016321]
- 2056: female meiotic nuclear division [GO_0007143]
- 2057: female pregnancy [GO_0007565]
- 2058: female sex differentiation [GO_0046660]
- 2059: ferric iron binding [GO_0008199]
- 2060: ferrous iron binding [GO_0008198]
- 2061: ferrous iron transmembrane transporter activity [GO_0015093]
- 2062: fertilization [GO_0009566]
- 2063: FFAT motif binding [GO_0033149]
- 2064: FGAR + L-Glutamine + ATP + H2O => FGAM + L-Glutamate + ADP + Pi [GO_0004642]
- 2065: Fgd1 reactivates F420 [GO_0016614]
- 2066: FGFR1-associated PI3K phosphorylates PIP2 to PIP3 [GO_0046934]
- 2067: fibrillar collagen trimer [GO_0005583]
- 2068: fibrin multimer, crosslinked:tissue plasminogen activator (one-chain) + plasminogen activator inhibitor 1 -> fibrin multimer, crosslinked:tissue plasminogen activator (one-chain):plasminogen activator inhibitor 1 [GO_0004867]
- 2069: fibrinogen binding [GO_0070051]
- 2070: fibrinogen complex [GO_0005577]
- 2071: fibroblast apoptotic process [GO_0044346]
- 2072: fibroblast growth factor binding [GO_0017134]
- 2073: fibroblast growth factor receptor activity [GO_0005007]
- 2074: fibroblast growth factor receptor binding [GO_0005104]
- 2075: fibroblast growth factor receptor signaling pathway [GO_0008543]
- 2076: fibroblast proliferation [GO_0048144]
- 2077: fibroblast proliferation involved in heart morphogenesis [GO_0061385]
- 2078: filamin binding [GO_0031005]
- 2079: first spliceosomal transesterification activity [GO_0000384]
- 2080: FK506 binding [GO_0005528]
- 2081: flap endonuclease activity [GO_0048256]
- 2082: flavin adenine dinucleotide binding [GO_0050660]
- 2083: flavin-linked sulfhydryl oxidase activity [GO_0016971]
- 2084: flight [GO_0060361]
- 2085: flippase activity [GO_0140327]
- 2086: fluid transport [GO_0042044]
- 2087: FMN adenylyltransferase activity [GO_0003919]
- 2088: FMN binding [GO_0010181]
- 2089: FMN transmembrane transporter activity [GO_0044610]
- 2090: FN3KRP phosphorylates PsiAm, RibAm [GO_0016301]
- 2091: folic acid transport [GO_0015884]
- 2092: folic acid-containing compound biosynthetic process [GO_0009396]
- 2093: folic acid-containing compound metabolic process [GO_0006760]
- 2094: foregut morphogenesis [GO_0007440]
- 2095: formaldehyde dehydrogenase activity [GO_0018467]
- 2096: formate transmembrane transporter activity [GO_0015499]
- 2097: formate transport [GO_0015724]
- 2098: formate-tetrahydrofolate ligase activity [GO_0004329]
- 2099: formation of anatomical boundary [GO_0048859]
- 2100: formation of animal organ boundary [GO_0010160]
- 2101: Formation of meiotic heteroduplex [GO_0000150]
- 2102: formation of primary germ layer [GO_0001704]
- 2103: formation of translation initiation ternary complex [GO_0001677]
- 2104: formyltetrahydrofolate dehydrogenase activity [GO_0016155]
- 2105: forward locomotion [GO_0043056]
- 2106: four-way junction DNA binding [GO_0000400]
- 2107: four-way junction helicase activity [GO_0009378]
- 2108: FPGS-2 transforms THF to THFPG [GO_0004326]
- 2109: frizzled binding [GO_0005109]
- 2110: fructokinase activity [GO_0008865]
- 2111: fructose transmembrane transport [GO_0015755]
- 2112: fructose-6-phosphate binding [GO_0070095]
- 2113: fructose-bisphosphate aldolase activity [GO_0004332]
- 2114: FTMT 24mer oxidises 4Fe2+ to 4Fe(3+)O(OH) [GO_0004322]
- 2115: FUCA1 hydrolyses NGP:1,6-GlcNAc [GO_0004560]
- 2116: fucose binding [GO_0042806]
- 2117: fucosidase activity [GO_0015928]
- 2118: fucosylation [GO_0036065]
- 2119: fucosyltransferase activity [GO_0008417]
- 2120: Fumarate + H2O <=> (S)-Malate [GO_0004333]
- 2121: fumarylacetoacetate => fumarate + acetoacetate [GO_0004334]
- 2122: FUOM isomerises alpha-Fuc to beta-Fuc [GO_0016857]
- 2123: FUT4,5,9,(10,11) transfer Fuc to Type 2 chains to form LeX [GO_0046920]
- 2124: FXN:NFS1:ISD11:ISCU assembles 2Fe-2S iron-sulfur cluster [GO_0031071]
- 2125: G protein activity [GO_0003925]
- 2126: G protein-coupled acetylcholine receptor activity [GO_0016907]
- 2127: G protein-coupled acetylcholine receptor signaling pathway [GO_0007213]
- 2128: G protein-coupled acetylcholine receptor signaling pathway involved in positive regulation of acetylcholine secretion, neurotransmission [GO_1904065]
- 2129: G protein-coupled adenosine receptor activity [GO_0001609]
- 2130: G protein-coupled adenosine receptor signaling pathway [GO_0001973]
- 2131: G protein-coupled amine receptor activity [GO_0008227]
- 2132: G protein-coupled glutamate receptor activity [GO_0098988]
- 2133: G protein-coupled glutamate receptor binding [GO_0035256]
- 2134: G protein-coupled glutamate receptor signaling pathway [GO_0007216]
- 2135: G protein-coupled neurotransmitter receptor activity [GO_0099528]
- 2136: G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO_0099579]
- 2137: G protein-coupled peptide receptor activity [GO_0008528]
- 2138: G protein-coupled photoreceptor activity [GO_0008020]
- 2139: G protein-coupled purinergic receptor signaling pathway [GO_0035588]
- 2140: G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO_0099530]
- 2141: G protein-coupled receptor binding [GO_0001664]
- 2142: G protein-coupled receptor kinase activity [GO_0004703]
- 2143: G protein-coupled receptor signaling pathway [GO_0007186]
- 2144: G protein-coupled serotonin receptor activity [GO_0004993]
- 2145: G protein-coupled serotonin receptor signaling pathway [GO_0098664]
- 2146: G-protein alpha-subunit binding [GO_0001965]
- 2147: G-protein beta-subunit binding [GO_0031681]
- 2148: G-protein beta/gamma-subunit complex binding [GO_0031683]
- 2149: G-protein coupled receptor activity [GO_0004930]
- 2150: G-quadruplex DNA binding [GO_0051880]
- 2151: G-quadruplex RNA binding [GO_0002151]
- 2152: G/U mismatch-specific uracil-DNA glycosylase activity [GO_0043739]
- 2153: GABA receptor activity [GO_0016917]
- 2154: GABA receptor binding [GO_0050811]
- 2155: GABA-A receptor activity [GO_0004890]
- 2156: GABA-gated chloride ion channel activity [GO_0022851]
- 2157: galactose binding [GO_0005534]
- 2158: galactosidase activity [GO_0015925]
- 2159: galactoside binding [GO_0016936]
- 2160: galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO_0046989]
- 2161: Galactosylation of collagen propeptide hydroxylysines by PLOD3 [GO_0050211]
- 2162: galactosyltransferase activity [GO_0008378]
- 2163: GALE:NAD+ dimer reversibly epimerises UDP-Gal to UDP-Glc [GO_0003978]
- 2164: gall bladder development [GO_0061010]
- 2165: gamete generation [GO_0007276]
- 2166: gamma-aminobutyric acid secretion [GO_0014051]
- 2167: gamma-aminobutyric acid secretion, neurotransmission [GO_0061534]
- 2168: gamma-aminobutyric acid transmembrane transporter activity [GO_0015185]
- 2169: gamma-aminobutyric acid transport [GO_0015812]
- 2170: gamma-aminobutyric acid:sodium:chloride symporter activity [GO_0005332]
- 2171: gamma-glutamyl-peptidase activity [GO_0034722]
- 2172: gamma-glutamylaminecyclotransferase activity [GO_0061929]
- 2173: gamma-glutamylcyclotransferase activity [GO_0003839]
- 2174: gamma-tubulin binding [GO_0043015]
- 2175: gamma-tubulin complex binding [GO_0140496]
- 2176: ganglion development [GO_0061548]
- 2177: ganglion formation [GO_0061554]
- 2178: ganglion maturation [GO_0061553]
- 2179: ganglion morphogenesis [GO_0061552]
- 2180: gap junction channel activity [GO_0005243]
- 2181: gap junction hemi-channel activity [GO_0055077]
- 2182: gas homeostasis [GO_0033483]
- 2183: gas transport [GO_0015669]
- 2184: gastric acid secretion [GO_0001696]
- 2185: gastric mucosal blood circulation [GO_1990768]
- 2186: gastro-intestinal system smooth muscle contraction [GO_0014831]
- 2187: gastrulation [GO_0007369]
- 2188: gated channel activity [GO_0022836]
- 2189: GCH1 reduces GTP to dihydroneopterin triphosphate [GO_0003934]
- 2190: GDP binding [GO_0019003]
- 2191: GDP metabolic process [GO_0046710]
- 2192: GDP phosphatase activity [GO_0004382]
- 2193: GDP-D-glucose phosphorylase activity [GO_0080048]
- 2194: GDP-dissociation inhibitor activity [GO_0005092]
- 2195: GDP-fucose transmembrane transport [GO_0015783]
- 2196: GDP-L-fucose biosynthetic process [GO_0042350]
- 2197: GDP-L-fucose metabolic process [GO_0046368]
- 2198: GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO_0004377]
- 2199: gene expression [GO_0010467]
- 2200: gene expression involved in extracellular matrix organization [GO_1901148]
- 2201: general transcription initiation factor activity [GO_0140223]
- 2202: general transcription initiation factor binding [GO_0140296]
- 2203: generation of neurons [GO_0048699]
- 2204: generation of precursor metabolites and energy [GO_0006091]
- 2205: genitalia development [GO_0048806]
- 2206: genitalia morphogenesis [GO_0035112]
- 2207: geranyltranstransferase activity [GO_0004337]
- 2208: germ cell development [GO_0007281]
- 2209: germ cell nucleus [GO_0043073]
- 2210: germ cell proliferation [GO_0036093]
- 2211: germ-line stem cell division [GO_0042078]
- 2212: germarium-derived egg chamber formation [GO_0007293]
- 2213: germline stem cell asymmetric division [GO_0098728]
- 2214: GGCX gamma-carboxylates F7(21-466) (pro-factor VII) [GO_0008488]
- 2215: GGT transfers GSH to 16S,17S-epoxy-DHA to form PCTR1 [GO_0004364]
- 2216: Gi/o-coupled serotonin receptor activity [GO_0001586]
- 2217: gland development [GO_0048732]
- 2218: gland morphogenesis [GO_0022612]
- 2219: glandular epithelial cell development [GO_0002068]
- 2220: glandular epithelial cell differentiation [GO_0002067]
- 2221: glandular epithelial cell maturation [GO_0002071]
- 2222: Glc6P is isomerised to I3P by ISYNA1 in the cytosol [GO_0004512]
- 2223: GlcNAc1P is dephosphorylated to UDP-N-acetyl-glucosamine [GO_0003977]
- 2224: glial cell apoptotic process [GO_0034349]
- 2225: glial cell development [GO_0021782]
- 2226: glial cell differentiation [GO_0010001]
- 2227: glial cell growth [GO_0042065]
- 2228: glial cell projection [GO_0097386]
- 2229: glial cell proliferation [GO_0014009]
- 2230: glial cell-neuron signaling [GO_0150098]
- 2231: glioblast division [GO_0048860]
- 2232: gliogenesis [GO_0042063]
- 2233: glucagon secretion [GO_0070091]
- 2234: glucan biosynthetic process [GO_0009250]
- 2235: glucan catabolic process [GO_0009251]
- 2236: glucan metabolic process [GO_0044042]
- 2237: gluconeogenesis [GO_0006094]
- 2238: gluconolactonase activity [GO_0004341]
- 2239: glucosamine 6-phosphate N-acetyltransferase activity [GO_0004343]
- 2240: glucosamine-6-phosphate deaminase activity [GO_0004342]
- 2241: glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO_0032216]
- 2242: glucose 6-phosphate metabolic process [GO_0051156]
- 2243: glucose binding [GO_0005536]
- 2244: glucose catabolic process [GO_0006007]
- 2245: glucose homeostasis [GO_0042593]
- 2246: glucose metabolic process [GO_0006006]
- 2247: glucose transmembrane transport [GO_1904659]
- 2248: glucose-6-phosphate 1-epimerase activity [GO_0047938]
- 2249: glucose-6-phosphate transmembrane transporter activity [GO_0015152]
- 2250: glucose-6-phosphate transport [GO_0015760]
- 2251: glucosidase activity [GO_0015926]
- 2252: Glucosylation of collagen propeptide hydroxylysines [GO_0033823]
- 2253: Glucosylceramidase cleaves the glucosidic bond of glucocerebroside to form ceramide [GO_0004348]
- 2254: glucosyltransferase activity [GO_0046527]
- 2255: glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO_0001888]
- 2256: GLUT1 (SLC2A1) tetramer transports Glc from extracellular region to cytosol [GO_0055056]
- 2257: glutamate + tRNA(Glu) + ATP => Glu-tRNA(Glu) + AMP + pyrophosphate [GO_0004818]
- 2258: glutamate 5-kinase activity [GO_0004349]
- 2259: glutamate binding [GO_0016595]
- 2260: glutamate dehydrogenase (NAD+) activity [GO_0004352]
- 2261: glutamate dehydrogenase [NAD(P)+] activity [GO_0004353]
- 2262: glutamate receptor activity [GO_0008066]
- 2263: glutamate receptor binding [GO_0035254]
- 2264: glutamate receptor signaling pathway [GO_0007215]
- 2265: glutamate secretion [GO_0014047]
- 2266: glutamate secretion, neurotransmission [GO_0061535]
- 2267: glutamate synthase (NADH) activity [GO_0016040]
- 2268: glutamate synthase activity [GO_0015930]
- 2269: glutamate synthase activity, NAD(P)H as acceptor [GO_0045181]
- 2270: glutamate-5-semialdehyde dehydrogenase activity [GO_0004350]
- 2271: glutamate-ammonia ligase activity [GO_0004356]
- 2272: glutamate-cysteine ligase catalytic subunit binding [GO_0035226]
- 2273: glutamate-cysteine ligase regulator activity [GO_1990609]
- 2274: glutamate-gated calcium ion channel activity [GO_0022849]
- 2275: glutamate:sodium symporter activity [GO_0015501]
- 2276: glutamine + H2O => glutamate + NH4+ [GLS] [GO_0004359]
- 2277: glutamine + tRNA(Gln) + ATP => Gln-tRNA(Gln) + AMP + pyrophosphate [GO_0004819]
- 2278: glutaminyl-peptide cyclotransferase activity [GO_0016603]
- 2279: glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO_0050567]
- 2280: glutaryl-CoA + FAD => crotonyl-CoA + FADH2 + CO2 [GO_0004361]
- 2281: glutathione binding [GO_0043295]
- 2282: glutathione biosynthetic process [GO_0006750]
- 2283: glutathione disulfide oxidoreductase activity [GO_0015038]
- 2284: Glutathione is taken up by the bacterium [GO_1904680]
- 2285: glutathione metabolic process [GO_0006749]
- 2286: glutathione oxidoreductase activity [GO_0097573]
- 2287: glutathione specific gamma-glutamylcyclotransferase activity [GO_0061928]
- 2288: Gly-tRNA(Ala) hydrolase activity [GO_0106026]
- 2289: glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity [GO_0043891]
- 2290: glycerate dehydrogenase activity [GO_0008465]
- 2291: glycerol kinase activity [GO_0004370]
- 2292: glycerol-3-phosphate dehydrogenase (quinone) activity [GO_0004368]
- 2293: glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO_0047952]
- 2294: glycerol-3-phosphate O-acyltransferase activity [GO_0004366]
- 2295: glycerolipid biosynthetic process [GO_0045017]
- 2296: glycerolipid metabolic process [GO_0046486]
- 2297: glycerophosphocholine phosphodiesterase activity [GO_0047389]
- 2298: glycerophosphodiester phosphodiesterase activity [GO_0008889]
- 2299: glycerophospholipid biosynthetic process [GO_0046474]
- 2300: glycerophospholipid metabolic process [GO_0006650]
- 2301: glycine binding [GO_0016594]
- 2302: glycine dehydrogenase (decarboxylating) activity [GO_0004375]
- 2303: glycine N-acyltransferase activity [GO_0047961]
- 2304: glycine secretion [GO_0061536]
- 2305: glycine secretion, neurotransmission [GO_0061537]
- 2306: glycine transmembrane transporter activity [GO_0015187]
- 2307: glycine transport [GO_0015816]
- 2308: glycine-gated chloride ion channel activity [GO_0022852]
- 2309: glycine-tRNA ligase activity [GO_0004820]
- 2310: glycine:sodium symporter activity [GO_0015375]
- 2311: glycogen binding [GO_2001069]
- 2312: glycogen biosynthetic process [GO_0005978]
- 2313: glycogen catabolic process [GO_0005980]
- 2314: glycogen metabolic process [GO_0005977]
- 2315: glycogen phosphorylase (PYGM) dimer b + 2 ATP => glycogen phosphorylase (PYGM) dimer a + 2 ADP [GO_0004689]
- 2316: glycolipid binding [GO_0051861]
- 2317: glycolipid mannosyltransferase activity [GO_0004376]
- 2318: glycolytic process [GO_0006096]
- 2319: glycolytic process through fructose-6-phosphate [GO_0061615]
- 2320: glycoprotein 3-alpha-L-fucosyltransferase activity [GO_0018392]
- 2321: glycoprotein biosynthetic process [GO_0009101]
- 2322: glycoprotein catabolic process [GO_0006516]
- 2323: glycoprotein metabolic process [GO_0009100]
- 2324: glycoprotein transport [GO_0034436]
- 2325: glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO_0016263]
- 2326: glycosaminoglycan binding [GO_0005539]
- 2327: glycosaminoglycan biosynthetic process [GO_0006024]
- 2328: glycosaminoglycan catabolic process [GO_0006027]
- 2329: glycosaminoglycan metabolic process [GO_0030203]
- 2330: glycosphingolipid binding [GO_0043208]
- 2331: glycosyl compound catabolic process [GO_1901658]
- 2332: glycosyl compound metabolic process [GO_1901657]
- 2333: glycosylated region protein binding [GO_0140081]
- 2334: glycosylation [GO_0070085]
- 2335: Glycosylation of Pre-NOTCH by FRINGE [GO_0033829]
- 2336: glycosylation-dependent protein binding [GO_0140032]
- 2337: GLYCTK phosphorylates DGA to 3PDGA [GO_0008887]
- 2338: glycylpeptide N-tetradecanoyltransferase activity [GO_0004379]
- 2339: glyoxylate reductase (NADP+) activity [GO_0030267]
- 2340: glyoxylate reductase activity [GO_0106345]
- 2341: GMDS dehydrates GDP-Man to GDP-DHDMan [GO_0008446]
- 2342: GMP biosynthetic process [GO_0006177]
- 2343: GMP metabolic process [GO_0046037]
- 2344: GMP synthase activity [GO_0003921]
- 2345: GNMT tetramer transfers methyl group from AdoMet to Gly to form AdoHyc and SARC [GO_0017174]
- 2346: GO_0000004 [GO_0000004]
- 2347: GO_0004872 [GO_0004872]
- 2348: GO_0005904 [GO_0005904]
- 2349: GO_0006724 [GO_0006724]
- 2350: GO_0006819 [GO_0006819]
- 2351: GO_0006822 [GO_0006822]
- 2352: GO_0006841 [GO_0006841]
- 2353: GO_0006866 [GO_0006866]
- 2354: GO_0007582 [GO_0007582]
- 2355: GO_0008151 [GO_0008151]
- 2356: GO_0008372 [GO_0008372]
- 2357: GO_0009586 [GO_0009586]
- 2358: GO_0009592 [GO_0009592]
- 2359: GO_0010554 [GO_0010554]
- 2360: GO_0015457 [GO_0015457]
- 2361: GO_0015460 [GO_0015460]
- 2362: GO_0015674 [GO_0015674]
- 2363: GO_0015873 [GO_0015873]
- 2364: GO_0019952 [GO_0019952]
- 2365: GO_0023033 [GO_0023033]
- 2366: GO_0023046 [GO_0023046]
- 2367: GO_0048062 [GO_0048062]
- 2368: GO_0048063 [GO_0048063]
- 2369: GO_0050791 [GO_0050791]
- 2370: GO_0050874 [GO_0050874]
- 2371: GO_0050875 [GO_0050875]
- 2372: GO_0050876 [GO_0050876]
- 2373: GO_0050895 [GO_0050895]
- 2374: GO_0051244 [GO_0051244]
- 2375: GO_0051706 [GO_0051706]
- 2376: GO_0051869 [GO_0051869]
- 2377: GO_0055128 [GO_0055128]
- 2378: Golgi apparatus [GO_0005794]
- 2379: Golgi disassembly [GO_0090166]
- 2380: Golgi inheritance [GO_0048313]
- 2381: Golgi localization [GO_0051645]
- 2382: Golgi membrane [GO_0000139]
- 2383: Golgi membrane fusion [GO_0036504]
- 2384: Golgi organization [GO_0007030]
- 2385: Golgi reassembly [GO_0090168]
- 2386: Golgi to plasma membrane protein transport [GO_0043001]
- 2387: Golgi to plasma membrane transport [GO_0006893]
- 2388: Golgi to secretory granule transport [GO_0055107]
- 2389: Golgi to transport vesicle transport [GO_0055108]
- 2390: Golgi to vacuole transport [GO_0006896]
- 2391: Golgi transport complex binding [GO_0140164]
- 2392: Golgi vesicle transport [GO_0048193]
- 2393: Golgi-associated vesicle [GO_0005798]
- 2394: Golgi-associated vesicle membrane [GO_0030660]
- 2395: gonad development [GO_0008406]
- 2396: gonad morphogenesis [GO_0035262]
- 2397: gonadal mesoderm development [GO_0007506]
- 2398: GPI anchor binding [GO_0034235]
- 2399: GPX5,6 reduce H2O2 to H2O [GO_0004602]
- 2400: Gq/11-coupled serotonin receptor activity [GO_0001587]
- 2401: gravitaxis [GO_0042332]
- 2402: GRK1,4,7 phosphorylate MII to p-MII [GO_0050254]
- 2403: grooming behavior [GO_0007625]
- 2404: Group 3 - Selective Cl- transport [GO_0005254]
- 2405: group II metabotropic glutamate receptor activity [GO_0001641]
- 2406: Growing HA is extruded from the cell by ABCC5 [GO_0008514]
- 2407: growth [GO_0040007]
- 2408: growth factor activity [GO_0008083]
- 2409: growth factor binding [GO_0019838]
- 2410: growth factor receptor binding [GO_0070851]
- 2411: growth involved in heart morphogenesis [GO_0003241]
- 2412: GSTO dimers reduce DeHA to AscH- [GO_0045174]
- 2413: GTP 3',8'-cyclase activity [GO_0061798]
- 2414: GTP cyclohydrolase activity [GO_0003933]
- 2415: GTP cyclohydrolase binding [GO_0044549]
- 2416: GTP cyclohydrolase I regulator activity [GO_0060308]
- 2417: GTP-dependent protein binding [GO_0030742]
- 2418: GTPase activating protein binding [GO_0032794]
- 2419: GTPase binding [GO_0051020]
- 2420: GTPase inhibitor activity [GO_0005095]
- 2421: GTPase regulator activity [GO_0030695]
- 2422: GU repeat RNA binding [GO_1990605]
- 2423: guanine deaminase activity [GO_0008892]
- 2424: guanine nucleotide transmembrane transport [GO_1903790]
- 2425: guanine nucleotide transmembrane transporter activity [GO_0001409]
- 2426: guanine nucleotide transport [GO_0001408]
- 2427: guanine transmembrane transport [GO_1903716]
- 2428: guanine transmembrane transporter activity [GO_0015208]
- 2429: guanine transport [GO_0015854]
- 2430: guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO_0008893]
- 2431: guanyl nucleotide exchange factor inhibitor activity [GO_1990624]
- 2432: guanyl ribonucleotide binding [GO_0032561]
- 2433: guanyl-nucleotide exchange factor activity [GO_0005085]
- 2434: guanyl-nucleotide exchange factor adaptor activity [GO_0005091]
- 2435: guanylate cyclase activator activity [GO_0030250]
- 2436: guanylate cyclase activity [GO_0004383]
- 2437: guanylate cyclase inhibitor activity [GO_0030251]
- 2438: guanylate cyclase regulator activity [GO_0030249]
- 2439: guanylyltransferase activity [GO_0070568]
- 2440: GUSB tetramer hydrolyses GlcA-1,3-GlcNAc [GO_0004566]
- 2441: H2O2 diffuses from the mitochondrial matrix to the cytosol [GO_0015267]
- 2442: HAGH hydrolyses (R)-S-LGSH to GSH and LACT [GO_0004416]
- 2443: hatching [GO_0035188]
- 2444: hatching behavior [GO_0035187]
- 2445: HCO3- transport through ion channel [GO_0017081]
- 2446: HDAC4 deacetylates RUNX3 [GO_0033558]
- 2447: head development [GO_0060322]
- 2448: head morphogenesis [GO_0060323]
- 2449: heart capillary growth [GO_0003248]
- 2450: heart contraction [GO_0060047]
- 2451: heart development [GO_0007507]
- 2452: heart formation [GO_0060914]
- 2453: heart growth [GO_0060419]
- 2454: heart morphogenesis [GO_0003007]
- 2455: heart process [GO_0003015]
- 2456: heart rudiment development [GO_0003313]
- 2457: heart rudiment formation [GO_0003315]
- 2458: heart rudiment morphogenesis [GO_0003314]
- 2459: heat shock protein binding [GO_0031072]
- 2460: hedgehog family protein binding [GO_0097108]
- 2461: hedgehog receptor activity [GO_0008158]
- 2462: hematopoietic or lymphoid organ development [GO_0048534]
- 2463: hematopoietic progenitor cell differentiation [GO_0002244]
- 2464: hematopoietic stem cell differentiation [GO_0060218]
- 2465: hematopoietic stem cell homeostasis [GO_0061484]
- 2466: hematopoietic stem cell proliferation [GO_0071425]
- 2467: heme binding [GO_0020037]
- 2468: heme transmembrane transport [GO_0035351]
- 2469: heme transport [GO_0015886]
- 2470: hemopoiesis [GO_0030097]
- 2471: heparan sulfate 2-O-sulfotransferase activity [GO_0004394]
- 2472: heparan sulfate N-deacetylase activity [GO_0102140]
- 2473: heparan sulfate proteoglycan binding [GO_0043395]
- 2474: heparan sulfate sulfotransferase activity [GO_0034483]
- 2475: heparin binding [GO_0008201]
- 2476: heparosan-N-sulfate-glucuronate 5-epimerase activity [GO_0047464]
- 2477: hepatic duct development [GO_0061011]
- 2478: hepatic immune response [GO_0002384]
- 2479: hepaticobiliary system development [GO_0061008]
- 2480: hepaticobiliary system process [GO_0061007]
- 2481: hepatoblast apoptotic process [GO_1902489]
- 2482: hepatoblast differentiation [GO_0061017]
- 2483: hepatocyte apoptotic process [GO_0097284]
- 2484: hepatocyte differentiation [GO_0070365]
- 2485: hepatocyte homeostasis [GO_0036333]
- 2486: heterochromatin [GO_0000792]
- 2487: heterochromatin assembly [GO_0031507]
- 2488: heterochromatin boundary formation [GO_0033696]
- 2489: heterochromatin organization [GO_0070828]
- 2490: heterocycle biosynthetic process [GO_0018130]
- 2491: heterocycle catabolic process [GO_0046700]
- 2492: heterocycle metabolic process [GO_0046483]
- 2493: heterocyclic compound binding [GO_1901363]
- 2494: heterotrimeric G-protein binding [GO_0032795]
- 2495: hexacosanoyl-CoA + O2 => trans-2,3-dehydrohexacosanoyl-CoA + H2O2 [GO_0003997]
- 2496: hexokinase activity [GO_0004396]
- 2497: hexosaminidase activity [GO_0015929]
- 2498: hexose biosynthetic process [GO_0019319]
- 2499: hexose catabolic process [GO_0019320]
- 2500: hexose metabolic process [GO_0019318]
- 2501: hexose phosphate transmembrane transporter activity [GO_0015119]
- 2502: hexose phosphate transport [GO_0015712]
- 2503: hexose transmembrane transport [GO_0008645]
- 2504: hexose-phosphate:inorganic phosphate antiporter activity [GO_0015526]
- 2505: hexosyltransferase activity [GO_0016758]
- 2506: HHAT palmitoylates Hh N-terminal fragment [GO_0008374]
- 2507: high mobility group box 1 binding [GO_0070379]
- 2508: high voltage-gated calcium channel activity [GO_0008331]
- 2509: high-affinity basic amino acid transmembrane transporter activity [GO_0005287]
- 2510: high-affinity L-arginine transmembrane transporter activity [GO_0005289]
- 2511: hindbrain development [GO_0030902]
- 2512: hindbrain formation [GO_0021576]
- 2513: hindbrain maturation [GO_0021578]
- 2514: hindbrain morphogenesis [GO_0021575]
- 2515: hindbrain-spinal cord boundary formation [GO_0021906]
- 2516: hindgut contraction [GO_0043133]
- 2517: hindgut development [GO_0061525]
- 2518: hindgut morphogenesis [GO_0007442]
- 2519: His-Purkinje system cell development [GO_0060933]
- 2520: His-Purkinje system cell differentiation [GO_0060932]
- 2521: His-Purkinje system development [GO_0003164]
- 2522: histamine secretion [GO_0001821]
- 2523: histamine secretion, neurotransmission [GO_0061538]
- 2524: histamine transport [GO_0051608]
- 2525: histamine-gated chloride channel activity [GO_0019182]
- 2526: histidine + tRNA(His) + ATP => His-tRNA(His) + AMP + pyrophosphate [GO_0004821]
- 2527: Histidine is decarboxylated to histamine [GO_0004398]
- 2528: histone acetyltransferase binding [GO_0035035]
- 2529: histone acetyltransferase regulator activity [GO_0035034]
- 2530: histone binding [GO_0042393]
- 2531: histone chaperone activity [GO_0140713]
- 2532: histone deacetylase binding [GO_0042826]
- 2533: histone deacetylase inhibitor activity [GO_0046811]
- 2534: histone deacetylase regulator activity [GO_0035033]
- 2535: histone deacetylation [GO_0016575]
- 2536: histone glutamine N-methyltransferase activity [GO_1990259]
- 2537: histone H2A acetyltransferase activity [GO_0043998]
- 2538: histone H2A kinase activity [GO_0140995]
- 2539: histone H2A methyltransferase activity [GO_0140940]
- 2540: histone H2AT120 kinase activity [GO_1990244]
- 2541: histone H2B ubiquitin ligase activity [GO_0141054]
- 2542: histone H3 acetyltransferase activity [GO_0010484]
- 2543: histone H3 demethylase activity [GO_0141052]
- 2544: histone H3 kinase activity [GO_0140996]
- 2545: histone H3 methyltransferase activity [GO_0140938]
- 2546: histone H3K deacetylase activity [GO_0141050]
- 2547: histone H3K14 acetyltransferase activity [GO_0036408]
- 2548: histone H3K18 acetyltransferase activity [GO_0043993]
- 2549: histone H3K23 acetyltransferase activity [GO_0043994]
- 2550: histone H3K27 acetyltransferase activity [GO_0044017]
- 2551: histone H3K27 dimethyltransferase activity [GO_0140952]
- 2552: histone H3K27 monomethyltransferase activity [GO_0140953]
- 2553: histone H3K27 trimethyltransferase activity [GO_0140951]
- 2554: histone H3K27me2/H3K27me3 demethylase activity [GO_0071558]
- 2555: histone H3K36 demethylase activity [GO_0051864]
- 2556: histone H3K36 dimethyltransferase activity [GO_0140954]
- 2557: histone H3K36 methyltransferase activity [GO_0046975]
- 2558: histone H3K36 trimethyltransferase activity [GO_0140955]
- 2559: histone H3K36me2/H3K36me3 demethylase activity [GO_0140681]
- 2560: histone H3K4 demethylase activity [GO_0032453]
- 2561: histone H3K4 dimethyltransferase activity [GO_0140946]
- 2562: histone H3K4 monomethyltransferase activity [GO_0140945]
- 2563: histone H3K4 trimethyltransferase activity [GO_0140999]
- 2564: histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO_0034647]
- 2565: histone H3K56me2/H3K56me3 demethylase activity [GO_0140760]
- 2566: histone H3K79 methyltransferase activity [GO_0031151]
- 2567: histone H3K9 deacetylase activity [GO_0032129]
- 2568: histone H3K9 dimethyltransferase activity [GO_0140942]
- 2569: histone H3K9 monomethyltransferase activity [GO_0140948]
- 2570: histone H3K9 trimethyltransferase activity [GO_0140949]
- 2571: histone H3K9me/H3K9me2 demethylase activity [GO_0140683]
- 2572: histone H3K9me2 methyltransferase activity [GO_0140947]
- 2573: histone H3K9me2/H3K9me3 demethylase activity [GO_0140684]
- 2574: histone H3R17 methyltransferase activity [GO_0035642]
- 2575: histone H3R2 methyltransferase activity [GO_0070611]
- 2576: histone H3R3 demethylase activity [GO_0033749]
- 2577: histone H3S10 kinase activity [GO_0035175]
- 2578: histone H3T11 kinase activity [GO_0035402]
- 2579: histone H3T3 kinase activity [GO_0072354]
- 2580: histone H4 acetyltransferase activity [GO_0010485]
- 2581: histone H4 demethylase activity [GO_0141058]
- 2582: histone H4 methyltransferase activity [GO_0140939]
- 2583: histone H4K16 acetyltransferase activity [GO_0046972]
- 2584: histone H4K20 methyltransferase activity [GO_0042799]
- 2585: histone H4K20 monomethyltransferase activity [GO_0140944]
- 2586: histone H4K20 trimethyltransferase activity [GO_0140943]
- 2587: histone H4K20me methyltransferase activity [GO_0140941]
- 2588: histone H4R3 methyltransferase activity [GO_0044020]
- 2589: histone kinase activity [GO_0035173]
- 2590: histone methyltransferase activity [GO_0042054]
- 2591: histone methyltransferase binding [GO_1990226]
- 2592: histone modification [GO_0016570]
- 2593: histone modifying activity [GO_0140993]
- 2594: histone octamer slider activity [GO_0140751]
- 2595: histone pre-mRNA DCP binding [GO_0071208]
- 2596: histone pre-mRNA stem-loop binding [GO_0071207]
- 2597: histone reader activity [GO_0140566]
- 2598: histone serine kinase activity [GO_0035174]
- 2599: histone threonine kinase activity [GO_0035184]
- 2600: histone ubiquitin ligase activity [GO_0140852]
- 2601: HLCS biotinylates PC:Mn2+ [GO_0018271]
- 2602: HMG box domain binding [GO_0071837]
- 2603: HMGCR dimer reduces bHMG-CoA to MVA [GO_0004420]
- 2604: HMOX1 dimer, HMOX2 cleave heme [GO_0004392]
- 2605: holo-[acyl-carrier-protein] synthase activity [GO_0008897]
- 2606: holocytochrome-c synthase activity [GO_0004408]
- 2607: homeostasis of number of cells [GO_0048872]
- 2608: homeostasis of number of cells within a tissue [GO_0048873]
- 2609: homeostatic process [GO_0042592]
- 2610: homogentisate 1,2-dioxygenase activity [GO_0004411]
- 2611: hormone activity [GO_0005179]
- 2612: hormone binding [GO_0042562]
- 2613: hormone metabolic process [GO_0042445]
- 2614: hormone receptor binding [GO_0051427]
- 2615: hormone secretion [GO_0046879]
- 2616: hormone transport [GO_0009914]
- 2617: hormone-mediated signaling pathway [GO_0009755]
- 2618: HPRT1 catalyzes the conversion of guanine or hypoxanthine to GMP or IMP [GO_0106130]
- 2619: HRSP12 deaminates 2AA to 2OBUTA [GO_0019239]
- 2620: HS6STs sulfate GlcN at C6 in heparan sulfate/heparin [GO_0017095]
- 2621: HSD17B2 oxidises estradiol (E2) to estrone (E1) [GO_0004303]
- 2622: HSD17B4 dehydrogenates 3-hydroxyhexacosanoyl-CoA [GO_0003857]
- 2623: HSF1 acetylation at Lys80 [GO_0034212]
- 2624: HSP110s exchange ATP for ADP on HSP70s:ADP [GO_0000774]
- 2625: Hsp70 protein binding [GO_0030544]
- 2626: Hsp90 protein binding [GO_0051879]
- 2627: Hv1 Mediated H+ Permeability [GO_0022843]
- 2628: hyaluronan biosynthetic process [GO_0030213]
- 2629: hyaluronan catabolic process [GO_0030214]
- 2630: hyaluronan metabolic process [GO_0030212]
- 2631: hyaluronic acid binding [GO_0005540]
- 2632: hydro-lyase activity [GO_0016836]
- 2633: hydrolase activity, acting on acid anhydrides [GO_0016817]
- 2634: hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO_0016818]
- 2635: hydrolase activity, acting on acid carbon-carbon bonds [GO_0016822]
- 2636: hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances [GO_0016823]
- 2637: hydrolase activity, acting on acid phosphorus-nitrogen bonds [GO_0016825]
- 2638: hydrolase activity, acting on acid sulfur-nitrogen bonds [GO_0016826]
- 2639: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO_0016812]
- 2640: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines [GO_0016814]
- 2641: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO_0016811]
- 2642: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO_0016813]
- 2643: hydrolase activity, acting on carbon-sulfur bonds [GO_0046508]
- 2644: hydrolase activity, acting on ether bonds [GO_0016801]
- 2645: hydrolase activity, hydrolyzing N-glycosyl compounds [GO_0016799]
- 2646: Hydroperoxy reductase reduces 4(S)-Hp-17(S)-HDHA to RvD6 [GO_0016491]
- 2647: hydroxyisourate hydrolase activity [GO_0033971]
- 2648: hydroxylysine kinase activity [GO_0047992]
- 2649: hydroxymethyl-, formyl- and related transferase activity [GO_0016742]
- 2650: hydroxymethylbilane synthase activity [GO_0004418]
- 2651: hydroxymethylglutaryl-CoA lyase activity [GO_0004419]
- 2652: hydroxypyruvate isomerase activity [GO_0008903]
- 2653: hydroxypyruvate reductase activity [GO_0016618]
- 2654: I-kappaB phosphorylation [GO_0007252]
- 2655: I-SMAD binding [GO_0070411]
- 2656: I(1,3,4,5,6)P5 is phosphorylated to 5-PP-IP4 by IP6K1/2 in the nucleus [GO_0000827]
- 2657: I(1,4,5)P3 is phosphorylated to I(1,3,4,5)P4 by IPMK in the nucleus [GO_0008440]
- 2658: I(1,4)P2 is dephosphorylated to I4P by INPP1 in the cytosol [GO_0004441]
- 2659: I1P is dephosphorylated to Ins by IMPA1/2 in the cytosol [GO_0008934]
- 2660: identical protein binding [GO_0042802]
- 2661: IDS hydrolyses dermatan sulfate (Chebi:63517 chain) [GO_0004423]
- 2662: IFNL1:IFNLR1:p-JAK1:IL10RB:p-TYK2 phosphorylates IFNLR1 [GO_0004714]
- 2663: IkappaB kinase activity [GO_0008384]
- 2664: IkappaB kinase complex binding [GO_0106137]
- 2665: IL12B dimerizes [GO_0003756]
- 2666: IL4R, IL2RG, JAK1 in IL4-bound IL4R1:JAK1 are phosphorylated [GO_0004715]
- 2667: imaginal disc growth factor receptor binding [GO_0008084]
- 2668: immune effector process [GO_0002252]
- 2669: immune receptor activity [GO_0140375]
- 2670: immune response [GO_0006955]
- 2671: immune system development [GO_0002520]
- 2672: immune system process [GO_0002376]
- 2673: IMP cyclohydrolase activity [GO_0003937]
- 2674: IMP dehydrogenase activity [GO_0003938]
- 2675: IMPAD1 hydrolyses PAP to AMP [GO_0008441]
- 2676: import into cell [GO_0098657]
- 2677: import into nucleus [GO_0051170]
- 2678: Importin-8 imports AGO2:miRNA into the nucleus [GO_0017056]
- 2679: in utero embryonic development [GO_0001701]
- 2680: indolalkylamine biosynthetic process [GO_0046219]
- 2681: indolalkylamine metabolic process [GO_0006586]
- 2682: indole alkaloid biosynthetic process [GO_0035835]
- 2683: indole alkaloid metabolic process [GO_0035834]
- 2684: indole-containing compound biosynthetic process [GO_0042435]
- 2685: indole-containing compound catabolic process [GO_0042436]
- 2686: indole-containing compound metabolic process [GO_0042430]
- 2687: inhibition of neuroepithelial cell differentiation [GO_0002085]
- 2688: inner cell mass cell differentiation [GO_0001826]
- 2689: inner cell mass cell proliferation [GO_0001833]
- 2690: inorganic anion transmembrane transport [GO_0098661]
- 2691: inorganic anion transmembrane transporter activity [GO_0015103]
- 2692: inorganic anion transport [GO_0015698]
- 2693: inorganic cation transmembrane transport [GO_0098662]
- 2694: inorganic cation transmembrane transporter activity [GO_0022890]
- 2695: inorganic ion homeostasis [GO_0098771]
- 2696: inorganic ion transmembrane transport [GO_0098660]
- 2697: inorganic molecular entity transmembrane transporter activity [GO_0015318]
- 2698: inorganic phosphate transmembrane transporter activity [GO_0005315]
- 2699: inositol 1,4,5 trisphosphate binding [GO_0070679]
- 2700: inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0005220]
- 2701: inositol bisphosphate phosphatase activity [GO_0016312]
- 2702: inositol hexakisphosphate 5-kinase activity [GO_0000832]
- 2703: inositol hexakisphosphate binding [GO_0000822]
- 2704: inositol monophosphate phosphatase activity [GO_0052834]
- 2705: inositol pentakisphosphate 2-kinase activity [GO_0035299]
- 2706: inositol phosphate kinase activity [GO_0180030]
- 2707: inositol phosphate phosphatase activity [GO_0052745]
- 2708: inositol phosphate-mediated signaling [GO_0048016]
- 2709: inositol tetrakisphosphate 5-kinase activity [GO_0047326]
- 2710: inositol tetrakisphosphate kinase activity [GO_0051765]
- 2711: inositol tetrakisphosphate phosphatase activity [GO_0052743]
- 2712: inositol trisphosphate kinase activity [GO_0051766]
- 2713: inositol trisphosphate phosphatase activity [GO_0046030]
- 2714: inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO_0051717]
- 2715: inositol-1,4,5-trisphosphate 6-kinase activity [GO_0000823]
- 2716: inositol-polyphosphate 5-phosphatase activity [GO_0004445]
- 2717: insemination [GO_0007320]
- 2718: insulin binding [GO_0043559]
- 2719: insulin catabolic process [GO_1901143]
- 2720: insulin metabolic process [GO_1901142]
- 2721: insulin receptor activity [GO_0005009]
- 2722: insulin receptor binding [GO_0005158]
- 2723: insulin receptor signaling pathway [GO_0008286]
- 2724: insulin receptor substrate binding [GO_0043560]
- 2725: insulin secretion [GO_0030073]
- 2726: Insulin secretory granule docks at the plasma membrane [GO_0000149]
- 2727: insulin-like growth factor binding [GO_0005520]
- 2728: insulin-like growth factor receptor binding [GO_0005159]
- 2729: integral component of Golgi membrane [GO_0030173]
- 2730: integral component of membrane [GO_0016021]
- 2731: integral component of muscle cell projection membrane [GO_0061455]
- 2732: integral component of nuclear outer membrane [GO_0031309]
- 2733: integral component of organelle membrane [GO_0031301]
- 2734: integral component of pigment granule membrane [GO_0090740]
- 2735: integral component of plasma membrane [GO_0005887]
- 2736: integral component of synaptic membrane [GO_0099699]
- 2737: integral component of vacuolar membrane [GO_0031166]
- 2738: integrin binding [GO_0005178]
- 2739: intercellular transport [GO_0010496]
- 2740: intermediate mesoderm development [GO_0048389]
- 2741: intermediate mesoderm formation [GO_0048391]
- 2742: intermediate mesoderm morphogenesis [GO_0048390]
- 2743: intermembrane lipid transfer [GO_0120009]
- 2744: internal genitalia morphogenesis [GO_0035260]
- 2745: Internal Methylation of mRNA [GO_0001734]
- 2746: interphase [GO_0051325]
- 2747: interstitial cell of Cajal differentiation [GO_0061453]
- 2748: intestinal absorption [GO_0050892]
- 2749: intestinal epithelial cell development [GO_0060576]
- 2750: intestinal epithelial cell differentiation [GO_0060575]
- 2751: intestinal epithelial cell maturation [GO_0060574]
- 2752: intestinal lipid catabolic process [GO_0044258]
- 2753: intestine smooth muscle contraction [GO_0014827]
- 2754: intracellular anatomical structure [GO_0005622]
- 2755: intracellular calcium activated chloride channel activity [GO_0005229]
- 2756: intracellular cAMP-activated cation channel activity [GO_0005222]
- 2757: intracellular cGMP-activated cation channel activity [GO_0005223]
- 2758: intracellular chloride channel activity [GO_0061778]
- 2759: intracellular ligand-gated ion channel activity [GO_0005217]
- 2760: intracellular lipid transport [GO_0032365]
- 2761: intracellular membrane-bounded organelle [GO_0043231]
- 2762: intracellular non-membrane-bounded organelle [GO_0043232]
- 2763: intracellular nucleoside transport [GO_0015859]
- 2764: intracellular organelle [GO_0043229]
- 2765: intracellular organelle lumen [GO_0070013]
- 2766: intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO_0097682]
- 2767: intracellular protein transmembrane transport [GO_0065002]
- 2768: intracellular protein transport [GO_0006886]
- 2769: intracellular receptor signaling pathway [GO_0030522]
- 2770: intracellular signal transduction [GO_0035556]
- 2771: intracellular signal transduction involved in positive regulation of cell growth [GO_1905427]
- 2772: intracellular signaling cassette [GO_0141124]
- 2773: intracellular sodium activated potassium channel activity [GO_0005228]
- 2774: intracellular sterol transport [GO_0032366]
- 2775: intracellular transport [GO_0046907]
- 2776: intracellular vesicle [GO_0097708]
- 2777: intracellularly calcium-gated channel activity [GO_0141147]
- 2778: intraciliary transport [GO_0042073]
- 2779: intraciliary transport involved in cilium assembly [GO_0035735]
- 2780: intraciliary transport particle [GO_0030990]
- 2781: intraciliary transport particle B binding [GO_0120170]
- 2782: intrahepatic bile duct development [GO_0035622]
- 2783: intramembrane lipid transporter activity [GO_0140303]
- 2784: intramembranous bone growth [GO_0098867]
- 2785: intramembranous bone morphogenesis [GO_1904770]
- 2786: intramembranous ossification [GO_0001957]
- 2787: intramolecular lyase activity [GO_0016872]
- 2788: intramolecular oxidoreductase activity, interconverting aldoses and ketoses [GO_0016861]
- 2789: intramolecular oxidoreductase activity, transposing C=C bonds [GO_0016863]
- 2790: intramolecular oxidoreductase activity, transposing S-S bonds [GO_0016864]
- 2791: intramolecular transferase activity [GO_0016866]
- 2792: intramolecular transferase activity, phosphotransferases [GO_0016868]
- 2793: intrinsic component of Golgi membrane [GO_0031228]
- 2794: intrinsic component of membrane [GO_0031224]
- 2795: intrinsic component of nuclear outer membrane [GO_0031308]
- 2796: intrinsic component of organelle membrane [GO_0031300]
- 2797: intrinsic component of plasma membrane [GO_0031226]
- 2798: intrinsic component of synaptic membrane [GO_0099240]
- 2799: intrinsic component of vacuolar membrane [GO_0031310]
- 2800: inward rectifier potassium channel inhibitor activity [GO_0070320]
- 2801: iodotyrosine deiodinase activity [GO_0140616]
- 2802: ion binding [GO_0043167]
- 2803: ion channel activity [GO_0005216]
- 2804: ion channel inhibitor activity [GO_0008200]
- 2805: ion channel modulating, G protein-coupled receptor signaling pathway [GO_0099105]
- 2806: ion channel regulator activity [GO_0099106]
- 2807: ion channel regulator activity involved in G protein-coupled receptor signaling pathway [GO_0099107]
- 2808: ion gated channel activity [GO_0022839]
- 2809: ion homeostasis [GO_0050801]
- 2810: ion transmembrane transport [GO_0034220]
- 2811: ion transmembrane transporter activity [GO_0015075]
- 2812: ion transport [GO_0006811]
- 2813: ionotropic glutamate receptor activity [GO_0004970]
- 2814: ionotropic glutamate receptor binding [GO_0035255]
- 2815: ionotropic glutamate receptor signaling pathway [GO_0035235]
- 2816: ionotropic olfactory receptor activity [GO_0170020]
- 2817: ionotropic taste receptor activity [GO_0170021]
- 2818: IP3R tetramer:I(1,4,5)P3:4xCa2+ transports Ca2+ from platelet dense tubular system to cytosol [GO_0005262]
- 2819: IP6 is phosphorylated to 5-PP-IP5 by IP6K1/3 in the cytosol [GO_0000828]
- 2820: IRAK1 phosphorylates Pellino upon TLR7/8 or 9 activation [GO_0004672]
- 2821: IRE1alpha hydrolyzes Xbp1 mRNA and Xbp1 mRNA is spliced [GO_0004521]
- 2822: iRHOM2 transports ADAM17:Zn2+ from Golgi to the plasma membrane [GO_0140318]
- 2823: iris morphogenesis [GO_0061072]
- 2824: iron chaperone activity [GO_0034986]
- 2825: iron coordination entity transport [GO_1901678]
- 2826: iron ion binding [GO_0005506]
- 2827: iron ion sequestering activity [GO_0140315]
- 2828: iron ion transmembrane transport [GO_0034755]
- 2829: iron ion transmembrane transporter inhibitor activity [GO_0097690]
- 2830: iron ion transport [GO_0006826]
- 2831: iron-responsive element binding [GO_0030350]
- 2832: iron-sulfur cluster binding [GO_0051536]
- 2833: isocitrate + NADP+ => 2-oxoglutarate + CO2 + NADPH + H+ [GO_0004450]
- 2834: isocitrate dehydrogenase (NAD+) activity [GO_0004449]
- 2835: isocitrate dehydrogenase [NAD(P)+] activity [GO_0004448]
- 2836: isoleucine + tRNA(Ile) + ATP => Ile-tRNA(Ile) + AMP + pyrophosphate [GO_0004822]
- 2837: Isomerization of (2R)-pristanoyl-CoA to (2S)-pristanoyl-CoA [GO_0008111]
- 2838: Isomerization of 3-trans-decenoyl-CoA to form trans-dec-2-enoyl-CoA [GO_0016860]
- 2839: Isomerization of GlcNAc6P to GlcNAc1P [GO_0004610]
- 2840: Isopentenyl pyrophosphate rearranges to dimethylallyl pyrophosphate [GO_0004452]
- 2841: isoprenoid binding [GO_0019840]
- 2842: isoprenoid metabolic process [GO_0006720]
- 2843: isovaleryl-CoA dehydrogenase activity [GO_0008470]
- 2844: JAK3 in IL7:p-Y449-IL7R:JAK1:IL2RG:JAK3 is phosphorylated [GO_0019199]
- 2845: JMJD1C demethylates H3K9 mono- and di-methylation [GO_0032454]
- 2846: JNK cascade [GO_0007254]
- 2847: jump response [GO_0007630]
- 2848: JUN kinase binding [GO_0008432]
- 2849: JUN kinase kinase kinase activity [GO_0004706]
- 2850: JUN kinase kinase kinase kinase activity [GO_0042656]
- 2851: JUN kinase phosphatase activity [GO_0008579]
- 2852: juvenile hormone acid methyltransferase activity [GO_0035049]
- 2853: juvenile hormone binding [GO_0005500]
- 2854: juvenile hormone epoxide hydrolase activity [GO_0008096]
- 2855: juvenile hormone response element binding [GO_0070594]
- 2856: juvenile-hormone esterase activity [GO_0004453]
- 2857: K+-independent Li+/Ca2+ exchanger transport [GO_0015368]
- 2858: K11-linked polyubiquitin modification-dependent protein binding [GO_0071795]
- 2859: K48-linked polyubiquitin modification-dependent protein binding [GO_0036435]
- 2860: K63-linked polyubiquitin modification-dependent protein binding [GO_0070530]
- 2861: kainate selective glutamate receptor activity [GO_0015277]
- 2862: KAMKMT transfers 3xCH3 groups from 3xAdoMet to CALM1 [GO_0018025]
- 2863: karyogamy [GO_0000741]
- 2864: KAT5 acetylates ATM at DNA DSBs [GO_0016407]
- 2865: KAT7-containing ING4/5 complexes acetylate Me3K-histone H3 [GO_0004402]
- 2866: KBTBD7:CUL3:RBX1 ubiquitinates NF1 [GO_0061630]
- 2867: KCNJ11 tetramer:ABCC8 tetramer binds 4xATP, closing the channel [GO_0005524]
- 2868: KDEL sequence binding [GO_0005046]
- 2869: KDM2A, KDM2B, KDM4A demethylate MeK37-histone H3 [GO_0032452]
- 2870: ketone biosynthetic process [GO_0042181]
- 2871: ketone catabolic process [GO_0042182]
- 2872: kinase activator activity [GO_0019209]
- 2873: kinase binding [GO_0019900]
- 2874: kinase inhibitor activity [GO_0019210]
- 2875: kinase regulator activity [GO_0019207]
- 2876: kinesin binding [GO_0019894]
- 2877: kinetochore adaptor activity [GO_0140483]
- 2878: kinetochore binding [GO_0043515]
- 2879: kynurenine 3-monooxygenase activity [GO_0004502]
- 2880: kynurenine aminotransferase activity [GO_0036137]
- 2881: kynurenine metabolic process [GO_0070189]
- 2882: kynurenine-oxoglutarate transaminase activity [GO_0016212]
- 2883: L-alanine transmembrane transporter activity [GO_0015180]
- 2884: L-alanine transport [GO_0015808]
- 2885: L-allo-threonine aldolase activity [GO_0008732]
- 2886: L-alpha-amino acid transmembrane transport [GO_1902475]
- 2887: L-amino acid biosynthetic process [GO_0170034]
- 2888: L-amino acid metabolic process [GO_0170033]
- 2889: L-amino acid transmembrane transporter activity [GO_0015179]
- 2890: L-amino acid transport [GO_0015807]
- 2891: L-arginine transmembrane transport [GO_1903826]
- 2892: L-arginine transmembrane transporter activity [GO_0061459]
- 2893: L-ascorbate oxidase activity [GO_0008447]
- 2894: L-ascorbic acid binding [GO_0031418]
- 2895: L-aspartate transmembrane transport [GO_0070778]
- 2896: L-aspartate transmembrane transporter activity [GO_0015183]
- 2897: L-aspartate:2-oxoglutarate aminotransferase activity [GO_0004069]
- 2898: L-cystine transmembrane transporter activity [GO_0015184]
- 2899: L-cystine transport [GO_0015811]
- 2900: L-dopa decarboxylase activator activity [GO_0036478]
- 2901: L-dopa decarboxylase activity [GO_0036468]
- 2902: L-galactose dehydrogenase activity [GO_0010349]
- 2903: L-glutamate import [GO_0051938]
- 2904: L-glutamate transmembrane transport [GO_0015813]
- 2905: L-glutamate transmembrane transporter activity [GO_0005313]
- 2906: L-glutamine aminotransferase activity [GO_0070548]
- 2907: L-histidine transmembrane transport [GO_0089709]
- 2908: L-histidine transmembrane transporter activity [GO_0005290]
- 2909: L-iditol 2-dehydrogenase activity [GO_0003939]
- 2910: L-isoleucine transaminase activity [GO_0052656]
- 2911: L-kynurenine metabolic process [GO_0097052]
- 2912: L-lactate dehydrogenase activity [GO_0004459]
- 2913: L-leucine transaminase activity [GO_0052654]
- 2914: L-leucine transmembrane transporter activity [GO_0015190]
- 2915: L-lysine transmembrane transport [GO_1903401]
- 2916: L-lysine transmembrane transporter activity [GO_0015189]
- 2917: L-lysine transport [GO_1902022]
- 2918: L-methionine-(S)-S-oxide reductase activity [GO_0036456]
- 2919: L-methionine:thioredoxin-disulfide S-oxidoreductase activity [GO_0033744]
- 2920: L-ornithine transmembrane transport [GO_1903352]
- 2921: L-phosphoserine phosphatase activity [GO_0036424]
- 2922: L-serine ammonia-lyase activity [GO_0003941]
- 2923: L-serine transmembrane transporter activity [GO_0015194]
- 2924: L-serine transport [GO_0015825]
- 2925: L-serine-phosphatidylcholine phosphatidyltransferase activity [GO_0106258]
- 2926: L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO_0106245]
- 2927: L-threonine ammonia-lyase activity [GO_0004794]
- 2928: L-tryptophan transmembrane transporter activity [GO_0015196]
- 2929: L-tyrosine aminotransferase activity [GO_0070547]
- 2930: L-valine transaminase activity [GO_0052655]
- 2931: labyrinthine layer blood vessel development [GO_0060716]
- 2932: labyrinthine layer development [GO_0060711]
- 2933: labyrinthine layer formation [GO_0060714]
- 2934: labyrinthine layer morphogenesis [GO_0060713]
- 2935: lactate dehydrogenase activity [GO_0004457]
- 2936: lactoylglutathione lyase activity [GO_0004462]
- 2937: lamin binding [GO_0005521]
- 2938: laminin binding [GO_0043236]
- 2939: laminin receptor activity [GO_0005055]
- 2940: large conductance calcium-activated potassium channel activity [GO_0060072]
- 2941: large ribosomal subunit rRNA binding [GO_0070180]
- 2942: larval behavior [GO_0030537]
- 2943: larval locomotory behavior [GO_0008345]
- 2944: larval turning behavior [GO_0035179]
- 2945: lateral mesoderm development [GO_0048368]
- 2946: lateral mesoderm formation [GO_0048370]
- 2947: lateral mesoderm morphogenesis [GO_0048369]
- 2948: latrotoxin receptor activity [GO_0016524]
- 2949: LCMT2 methylates yW-72 yielding yW-58 at nucleotide 37 of tRNA(Phe) [GO_0008175]
- 2950: leading edge membrane [GO_0031256]
- 2951: leak channel activity [GO_0022840]
- 2952: learning [GO_0007612]
- 2953: learning or memory [GO_0007611]
- 2954: left lung development [GO_0060459]
- 2955: left lung morphogenesis [GO_0060460]
- 2956: left ventricular cardiac muscle tissue morphogenesis [GO_0003220]
- 2957: lens development in camera-type eye [GO_0002088]
- 2958: lens morphogenesis in camera-type eye [GO_0002089]
- 2959: lens placode formation [GO_0001743]
- 2960: leucine binding [GO_0070728]
- 2961: leucine-tRNA ligase activity [GO_0004823]
- 2962: leucokinin receptor activity [GO_0042071]
- 2963: leukocyte apoptotic process [GO_0071887]
- 2964: leukocyte differentiation [GO_0002521]
- 2965: leukocyte homeostasis [GO_0001776]
- 2966: leukocyte mediated immunity [GO_0002443]
- 2967: leukocyte proliferation [GO_0070661]
- 2968: LIAS:2(4Fe-4S) transforms octanoyl-K107-GCSH to lipoyl-K107-GCSH [GO_0016992]
- 2969: ligand-activated transcription factor activity [GO_0098531]
- 2970: ligand-gated anion channel activity [GO_0099095]
- 2971: ligand-gated calcium channel activity [GO_0099604]
- 2972: ligand-gated cation channel activity [GO_0099094]
- 2973: ligand-gated channel activity [GO_0022834]
- 2974: ligand-gated ion channel signaling pathway [GO_1990806]
- 2975: ligase activity [GO_0016874]
- 2976: ligase activity, forming carbon-carbon bonds [GO_0016885]
- 2977: ligase activity, forming carbon-nitrogen bonds [GO_0016879]
- 2978: ligase activity, forming carbon-oxygen bonds [GO_0016875]
- 2979: ligase activity, forming carbon-sulfur bonds [GO_0016877]
- 2980: ligase activity, forming phosphoric ester bonds [GO_0016886]
- 2981: ligase regulator activity [GO_0055103]
- 2982: light-activated ion channel activity [GO_0010461]
- 2983: LIM domain binding [GO_0030274]
- 2984: limb development [GO_0060173]
- 2985: limit dextrin-glycogenin => ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl) glycogenin [GO_0004134]
- 2986: linear polyubiquitin binding [GO_1990450]
- 2987: lipase activator activity [GO_0060229]
- 2988: lipase activity [GO_0016298]
- 2989: LIPG dimer hydrolyzes HDL-associated TAG to DAG and LCFA [GO_0004465]
- 2990: lipid antigen binding [GO_0030882]
- 2991: lipid binding [GO_0008289]
- 2992: lipid biosynthetic process [GO_0008610]
- 2993: lipid catabolic process [GO_0016042]
- 2994: lipid digestion [GO_0044241]
- 2995: lipid export from cell [GO_0140353]
- 2996: lipid homeostasis [GO_0055088]
- 2997: lipid import into cell [GO_0140354]
- 2998: lipid kinase activity [GO_0001727]
- 2999: lipid localization [GO_0010876]
- 3000: lipid metabolic process [GO_0006629]
- 3001: lipid modification [GO_0030258]
- 3002: lipid phosphatase activity [GO_0042577]
- 3003: lipid phosphorylation [GO_0046834]
- 3004: lipid storage [GO_0019915]
- 3005: lipid transfer activity [GO_0120013]
- 3006: lipid translocation [GO_0034204]
- 3007: lipid transmembrane transporter activity [GO_0170055]
- 3008: lipid transport [GO_0006869]
- 3009: lipid transport involved in lipid storage [GO_0010877]
- 3010: lipo-PDH decarboxylates PYR to Ac-CoA [GO_0004738]
- 3011: lipoate biosynthetic process [GO_0009107]
- 3012: lipoate metabolic process [GO_0009106]
- 3013: lipoic acid binding [GO_0031405]
- 3014: lipopolysaccharide binding [GO_0001530]
- 3015: lipopolysaccharide immune receptor activity [GO_0001875]
- 3016: lipopolysaccharide-mediated signaling pathway [GO_0031663]
- 3017: lipoprotein lipase activator activity [GO_0060230]
- 3018: lipoprotein particle binding [GO_0071813]
- 3019: lipoprotein particle receptor activity [GO_0030228]
- 3020: lipoprotein particle receptor binding [GO_0070325]
- 3021: lipoteichoic acid binding [GO_0070891]
- 3022: lipoyl(octanoyl) transferase activity [GO_0033819]
- 3023: lipoyltransferase activity [GO_0017118]
- 3024: liver development [GO_0001889]
- 3025: liver morphogenesis [GO_0072576]
- 3026: lncRNA binding [GO_0106222]
- 3027: Loading of acetylcholine in synaptic vesicles [GO_0005277]
- 3028: Loading of PCNA - Sliding Clamp Formation on the C-strand of the telomere [GO_0003689]
- 3029: loading of Serotonin in synaptic vesicles [GO_0008504]
- 3030: localization [GO_0051179]
- 3031: localization of cell [GO_0051674]
- 3032: localization within membrane [GO_0051668]
- 3033: locomotion [GO_0040011]
- 3034: locomotion involved in locomotory behavior [GO_0031987]
- 3035: locomotor rhythm [GO_0045475]
- 3036: locomotory behavior [GO_0007626]
- 3037: locus ceruleus development [GO_0021703]
- 3038: locus ceruleus formation [GO_0021705]
- 3039: locus ceruleus maturation [GO_0021706]
- 3040: locus ceruleus morphogenesis [GO_0021704]
- 3041: long-chain fatty acid metabolic process [GO_0001676]
- 3042: long-chain fatty acid transport [GO_0015909]
- 3043: long-chain fatty acid transporter activity [GO_0005324]
- 3044: long-chain fatty acid-CoA ligase activity [GO_0004467]
- 3045: long-chain fatty acyl-CoA binding [GO_0036042]
- 3046: long-chain fatty acyl-CoA hydrolase activity [GO_0052816]
- 3047: long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO_0016509]
- 3048: long-chain-acyl-CoA dehydrogenase activity [GO_0004466]
- 3049: long-chain-fatty-acyl-CoA reductase activity [GO_0050062]
- 3050: Long-range resection of DNA DSBs by EXO1 or DNA2 [GO_0004536]
- 3051: long-term memory [GO_0007616]
- 3052: low voltage-gated calcium channel activity [GO_0008332]
- 3053: low-density lipoprotein particle binding [GO_0030169]
- 3054: low-density lipoprotein particle receptor activity [GO_0005041]
- 3055: low-density lipoprotein particle receptor binding [GO_0050750]
- 3056: lpdC dimer reactivates dlaT [GO_0004148]
- 3057: LRAT esterifies RBP1:atROL and FACYLs to atREs [GO_0016416]
- 3058: LTA4H:Zn2+ hydrolyses 16S,17S-epoxy-DHA to (N)PD1 [GO_0004301]
- 3059: lung cell differentiation [GO_0060479]
- 3060: lung ciliated cell differentiation [GO_0061141]
- 3061: lung connective tissue development [GO_0060427]
- 3062: lung development [GO_0030324]
- 3063: lung epithelial cell differentiation [GO_0060487]
- 3064: lung epithelium development [GO_0060428]
- 3065: lung growth [GO_0060437]
- 3066: lung morphogenesis [GO_0060425]
- 3067: lung neuroendocrine cell differentiation [GO_0061100]
- 3068: lung secretory cell differentiation [GO_0061140]
- 3069: lung vasculature development [GO_0060426]
- 3070: luteinization [GO_0001553]
- 3071: LYPLA2 hydrolyses PALM-C3,4-GAP43 [GO_0008474]
- 3072: Lys48-specific deubiquitinase activity [GO_1990380]
- 3073: lysine + tRNA(Lys) + ATP => Lys-tRNA(Lys) + AMP + pyrophosphate [GO_0004824]
- 3074: lysine-acetylated histone binding [GO_0070577]
- 3075: lysophosphatidic acid acyltransferase activity [GO_0042171]
- 3076: lysophosphatidic acid phosphatase activity [GO_0052642]
- 3077: lysophospholipid acyltransferase activity [GO_0071617]
- 3078: LYZ hydrolyzes peptidoglycans in the bacterial cell wall [GO_0003796]
- 3079: M phase [GO_0000279]
- 3080: m7G(5')pppN diphosphatase activator activity [GO_1990521]
- 3081: m7G(5')pppN diphosphatase activity [GO_0050072]
- 3082: macrolide binding [GO_0005527]
- 3083: macromolecule biosynthetic process [GO_0009059]
- 3084: macromolecule catabolic process [GO_0009057]
- 3085: macromolecule deacylation [GO_0098732]
- 3086: macromolecule depalmitoylation [GO_0098734]
- 3087: macromolecule glycosylation [GO_0043413]
- 3088: macromolecule localization [GO_0033036]
- 3089: macromolecule metabolic process [GO_0043170]
- 3090: macromolecule methylation [GO_0043414]
- 3091: macromolecule modification [GO_0043412]
- 3092: macromolecule transmembrane transporter activity [GO_0022884]
- 3093: magnesium ion binding [GO_0000287]
- 3094: magnesium ion transmembrane transport [GO_1903830]
- 3095: magnesium ion transport [GO_0015693]
- 3096: maintenance of location [GO_0051235]
- 3097: maintenance of location in cell [GO_0051651]
- 3098: maintenance of presynaptic active zone structure [GO_0048790]
- 3099: maintenance of synapse structure [GO_0099558]
- 3100: malate + NAD+ <=> oxaloacetate + NADH + H+ [GO_0030060]
- 3101: malate dehydrogenase (decarboxylating) (NAD+) activity [GO_0004471]
- 3102: malate dehydrogenase activity [GO_0016615]
- 3103: malate transmembrane transport [GO_0071423]
- 3104: malate transmembrane transporter activity [GO_0015140]
- 3105: malate transport [GO_0015743]
- 3106: male courtship behavior [GO_0008049]
- 3107: male courtship behavior, veined wing extension [GO_0048065]
- 3108: male courtship behavior, veined wing generated song production [GO_0045433]
- 3109: male courtship behavior, veined wing vibration [GO_0016545]
- 3110: male mating behavior [GO_0060179]
- 3111: maleylacetoacetate isomerase activity [GO_0016034]
- 3112: malic enzyme activity [GO_0004470]
- 3113: malonate-semialdehyde dehydrogenase (acetylating) activity [GO_0018478]
- 3114: malonyltransferase activity [GO_0016420]
- 3115: maltose alpha-glucosidase activity [GO_0032450]
- 3116: maltose metabolic process [GO_0000023]
- 3117: MAN2B1 hydrolyses GlcNAc (Man)5 to GlcNAc (Man)3 [GO_0004559]
- 3118: manganese ion binding [GO_0030145]
- 3119: manganese ion transmembrane transport [GO_0071421]
- 3120: manganese ion transmembrane transporter activity [GO_0005384]
- 3121: manganese ion transport [GO_0006828]
- 3122: mannokinase activity [GO_0019158]
- 3123: mannose binding [GO_0005537]
- 3124: mannose-1-phosphate guanylyltransferase (GTP) activity [GO_0004475]
- 3125: mannose-6-phosphate isomerase activity [GO_0004476]
- 3126: mannose(a1-4)glucosaminyl-acyl-PI + phosphatidylethanolamine -> (ethanolamineP) mannose(al1-4)glucosaminyl-acyl-PI + diacylglycerol [GO_0051377]
- 3127: mannosidase activity [GO_0015923]
- 3128: mannosyl-oligosaccharide 1,6-alpha-mannosidase activity [GO_0052767]
- 3129: mannosyl-oligosaccharide mannosidase activity [GO_0015924]
- 3130: mannosylation [GO_0097502]
- 3131: mannosyltransferase activity [GO_0000030]
- 3132: MAP kinase phosphatase activity [GO_0033549]
- 3133: MAP kinase tyrosine phosphatase activity [GO_0033550]
- 3134: MAP kinase tyrosine/serine/threonine phosphatase activity [GO_0017017]
- 3135: MAP-kinase scaffold activity [GO_0005078]
- 3136: MAPK cascade [GO_0000165]
- 3137: mastication [GO_0071626]
- 3138: mating [GO_0007618]
- 3139: mating behavior [GO_0007617]
- 3140: MCM complex binding [GO_1904931]
- 3141: MCM8 mediated fork unwinding [GO_0004386]
- 3142: MDMQ10H2 is methylated to DMQ10H2 by COQ5 [GO_0008425]
- 3143: ME1:Mg2+ tetramer oxidatively decarboxylates MAL to PYR [GO_0004473]
- 3144: mechanoreceptor activity [GO_0140897]
- 3145: mechanosensitive cation channel activity [GO_0140135]
- 3146: mechanosensitive ion channel activity [GO_0008381]
- 3147: mechanosensitive voltage-gated sodium channel activity [GO_0101013]
- 3148: MECR dimer reduces tdec2-CoA to DEC-CoA [GO_0019166]
- 3149: medium-chain fatty acid omega-hydroxylase activity [GO_0140981]
- 3150: medium-chain fatty acid-CoA ligase activity [GO_0031956]
- 3151: medium-chain-acyl-CoA dehydrogenase activity [GO_0070991]
- 3152: medium-term memory [GO_0072375]
- 3153: medulla oblongata development [GO_0021550]
- 3154: medulla oblongata formation [GO_0021580]
- 3155: medulla oblongata maturation [GO_0021582]
- 3156: medulla oblongata morphogenesis [GO_0021579]
- 3157: megakaryocyte development [GO_0035855]
- 3158: megakaryocyte differentiation [GO_0030219]
- 3159: meiotic cell cycle [GO_0051321]
- 3160: meiotic cell cycle phase [GO_0098762]
- 3161: meiotic cell cycle process [GO_1903046]
- 3162: meiotic cell cycle process involved in oocyte maturation [GO_1903537]
- 3163: meiotic chromosome condensation [GO_0010032]
- 3164: meiotic chromosome segregation [GO_0045132]
- 3165: meiotic interphase [GO_0051328]
- 3166: meiotic M phase [GO_0051327]
- 3167: meiotic nuclear division [GO_0140013]
- 3168: meiotic nuclear membrane disassembly [GO_0051078]
- 3169: membrane [GO_0016020]
- 3170: membrane assembly [GO_0071709]
- 3171: membrane biogenesis [GO_0044091]
- 3172: membrane bone morphogenesis [GO_0061973]
- 3173: membrane disassembly [GO_0030397]
- 3174: membrane docking [GO_0022406]
- 3175: membrane fission [GO_0090148]
- 3176: membrane fusion [GO_0061025]
- 3177: membrane invagination [GO_0010324]
- 3178: membrane organization [GO_0061024]
- 3179: membrane protein complex [GO_0098796]
- 3180: membrane-bounded organelle [GO_0043227]
- 3181: membrane-enclosed lumen [GO_0031974]
- 3182: membranous septum morphogenesis [GO_0003149]
- 3183: memory [GO_0007613]
- 3184: mesenchymal cell apoptotic process [GO_0097152]
- 3185: mesenchymal cell development [GO_0014031]
- 3186: mesenchymal cell differentiation [GO_0048762]
- 3187: mesenchymal cell differentiation involved in bone development [GO_1901706]
- 3188: mesenchymal cell differentiation involved in lung development [GO_0060915]
- 3189: mesenchymal cell differentiation involved in renal system development [GO_2001012]
- 3190: mesenchymal cell proliferation [GO_0010463]
- 3191: mesenchymal cell proliferation involved in lung development [GO_0060916]
- 3192: mesenchymal to epithelial transition [GO_0060231]
- 3193: mesenchyme development [GO_0060485]
- 3194: mesenchyme morphogenesis [GO_0072132]
- 3195: mesoderm development [GO_0007498]
- 3196: mesoderm formation [GO_0001707]
- 3197: mesoderm morphogenesis [GO_0048332]
- 3198: mesodermal cell differentiation [GO_0048333]
- 3199: Met1-linked polyubiquitin deubiquitinase activity [GO_0061815]
- 3200: metabolic process [GO_0008152]
- 3201: metal cation:monoatomic cation antiporter activity [GO_0140828]
- 3202: metal cluster binding [GO_0051540]
- 3203: metal ion binding [GO_0046872]
- 3204: metal ion homeostasis [GO_0055065]
- 3205: metal ion sensor activity [GO_0140784]
- 3206: metal ion sequestering activity [GO_0140487]
- 3207: metal ion transmembrane transporter activity [GO_0046873]
- 3208: metal ion transport [GO_0030001]
- 3209: metal-dependent deNEDDylase activity [GO_0140758]
- 3210: metal-dependent deubiquitinase activity [GO_0140492]
- 3211: metalloaminopeptidase activity [GO_0070006]
- 3212: metallochaperone activity [GO_0016530]
- 3213: metalloendopeptidase inhibitor activity [GO_0008191]
- 3214: metalloexopeptidase activity [GO_0008235]
- 3215: metencephalon development [GO_0022037]
- 3216: methionine + tRNA(Met) + ATP => Met-tRNA(Met) + AMP + pyrophosphate [GO_0004825]
- 3217: methionine adenosyltransferase regulator activity [GO_0048270]
- 3218: methionyl-tRNA formyltransferase activity [GO_0004479]
- 3219: methyl transfer-driven active transmembrane transporter activity [GO_0015452]
- 3220: methyl-CpG binding [GO_0008327]
- 3221: methylated histone binding [GO_0035064]
- 3222: methylation [GO_0032259]
- 3223: Methylation of N-acetyl-5-HT to form melatonin [GO_0008172]
- 3224: methylation-dependent protein binding [GO_0140034]
- 3225: methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO_0004487]
- 3226: methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO_0004488]
- 3227: methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO_0004486]
- 3228: methylmalonate semialdehyde + NAD+ + CoA => propionyl-CoA + CO2 + NADH + H+ [GO_0004491]
- 3229: methylmalonyl semialdehyde + NADH + H+ <=> beta-hydroxyisobutyrate + NAD+ [GO_0008442]
- 3230: Methylthio-ribulose-P = Methylthio-ribose-P [GO_0046523]
- 3231: methylthiotransferase activity [GO_0035596]
- 3232: METTL1:WDR4 methylates guanosine-46 of tRNA(Phe) yielding 7-methylguanosine-46 [GO_0008176]
- 3233: Mevalonate is phosphorylated to mevalonate-5-phosphate [GO_0004496]
- 3234: Mevalonate-5-phosphate is further phosphorylated. [GO_0004631]
- 3235: MGMT/hAGT mediated DNA Damage Reversal [GO_0003908]
- 3236: MHC protein binding [GO_0042287]
- 3237: MIA40:ERV1 (CHCHD4:GFER) oxidizes cysteine residues to cystine disulfide bonds [GO_0015035]
- 3238: microfilament motor activity [GO_0000146]
- 3239: microtubule [GO_0005874]
- 3240: microtubule bundle [GO_0097427]
- 3241: microtubule bundle formation [GO_0001578]
- 3242: microtubule cytoskeleton [GO_0015630]
- 3243: microtubule cytoskeleton organization [GO_0000226]
- 3244: microtubule cytoskeleton organization involved in mitosis [GO_1902850]
- 3245: microtubule depolymerization [GO_0007019]
- 3246: microtubule minus-end binding [GO_0051011]
- 3247: microtubule motor activity [GO_0003777]
- 3248: microtubule nucleation [GO_0007020]
- 3249: microtubule plus end polymerase [GO_0061863]
- 3250: microtubule plus-end binding [GO_0051010]
- 3251: microtubule polymerization [GO_0046785]
- 3252: microtubule polymerization based movement [GO_0099098]
- 3253: microtubule polymerization based protein transport [GO_0099112]
- 3254: microtubule polymerization or depolymerization [GO_0031109]
- 3255: microtubule stabilizing activity [GO_0140778]
- 3256: microtubule-based movement [GO_0007018]
- 3257: microtubule-based process [GO_0007017]
- 3258: microtubule-based protein transport [GO_0099118]
- 3259: microtubule-based transport [GO_0099111]
- 3260: microvillus [GO_0005902]
- 3261: microvillus assembly [GO_0030033]
- 3262: microvillus organization [GO_0032528]
- 3263: midbrain development [GO_0030901]
- 3264: midbrain morphogenesis [GO_1904693]
- 3265: midbrain-hindbrain boundary development [GO_0030917]
- 3266: midbrain-hindbrain boundary initiation [GO_0021547]
- 3267: midbrain-hindbrain boundary maturation [GO_0021732]
- 3268: midbrain-hindbrain boundary morphogenesis [GO_0021555]
- 3269: midgut development [GO_0007494]
- 3270: minor groove of adenine-thymine-rich DNA binding [GO_0003680]
- 3271: minus-end-directed microtubule motor activity [GO_0008569]
- 3272: MIOX oxidises Ins to GlcA [GO_0050113]
- 3273: miRNA binding [GO_0035198]
- 3274: miRNA processing [GO_0035196]
- 3275: miRNA-mediated gene silencing [GO_0035195]
- 3276: miRNA-mediated gene silencing by mRNA destabilization [GO_0035279]
- 3277: mismatch base pair DNA N-glycosylase activity [GO_0000700]
- 3278: mismatched DNA binding [GO_0030983]
- 3279: Mitochondrial BTD hydrolyses BCTN [GO_0047708]
- 3280: mitochondrial calcium ion homeostasis [GO_0051560]
- 3281: mitochondrial chromosome [GO_0000262]
- 3282: mitochondrial chromosome packaging [GO_0090139]
- 3283: mitochondrial DNA metabolic process [GO_0032042]
- 3284: mitochondrial DNA replication [GO_0006264]
- 3285: mitochondrial envelope [GO_0005740]
- 3286: mitochondrial gene expression [GO_0140053]
- 3287: mitochondrial genome maintenance [GO_0000002]
- 3288: mitochondrial matrix [GO_0005759]
- 3289: mitochondrial membrane [GO_0031966]
- 3290: mitochondrial membrane organization [GO_0007006]
- 3291: mitochondrial mRNA catabolic process [GO_0000958]
- 3292: mitochondrial mRNA modification [GO_0080156]
- 3293: mitochondrial mRNA processing [GO_0090615]
- 3294: mitochondrial nucleoid [GO_0042645]
- 3295: mitochondrial promoter sequence-specific DNA binding [GO_0001018]
- 3296: mitochondrial protein catabolic process [GO_0035694]
- 3297: mitochondrial protein-containing complex [GO_0098798]
- 3298: mitochondrial protein-transporting ATPase activity [GO_0008566]
- 3299: mitochondrial ribosome [GO_0005761]
- 3300: mitochondrial ribosome binding [GO_0097177]
- 3301: mitochondrial RNA 3'-end processing [GO_0000965]
- 3302: mitochondrial RNA 5'-end processing [GO_0000964]
- 3303: mitochondrial RNA catabolic process [GO_0000957]
- 3304: mitochondrial RNA metabolic process [GO_0000959]
- 3305: mitochondrial RNA modification [GO_1900864]
- 3306: mitochondrial RNA processing [GO_0000963]
- 3307: mitochondrial single-subunit type RNA polymerase binding [GO_0001001]
- 3308: Mitochondrial tetrahydrofolate export across the inner mitochondrial membrane [GO_0008517]
- 3309: mitochondrial transcription [GO_0006390]
- 3310: mitochondrial transcription factor activity [GO_0034246]
- 3311: mitochondrial translation [GO_0032543]
- 3312: mitochondrial translational elongation [GO_0070125]
- 3313: mitochondrial translational initiation [GO_0070124]
- 3314: mitochondrial translational termination [GO_0070126]
- 3315: mitochondrial tRNA 3'-end processing [GO_1990180]
- 3316: mitochondrial tRNA methylation [GO_0070901]
- 3317: mitochondrial tRNA modification [GO_0070900]
- 3318: mitochondrial tRNA processing [GO_0090646]
- 3319: mitochondrion [GO_0005739]
- 3320: mitochondrion DNA recombination [GO_1905951]
- 3321: mitochondrion organization [GO_0007005]
- 3322: mitochondrion targeting sequence binding [GO_0030943]
- 3323: mitogen-activated protein kinase binding [GO_0051019]
- 3324: mitogen-activated protein kinase kinase binding [GO_0031434]
- 3325: mitogen-activated protein kinase kinase kinase binding [GO_0031435]
- 3326: mitotic cell cycle [GO_0000278]
- 3327: mitotic cell cycle phase [GO_0098763]
- 3328: mitotic cell cycle process [GO_1903047]
- 3329: mitotic cell cycle, embryonic [GO_0045448]
- 3330: mitotic chromosome condensation [GO_0007076]
- 3331: mitotic DNA replication [GO_1902969]
- 3332: mitotic DNA replication DNA duplex unwinding [GO_1902971]
- 3333: mitotic DNA replication DNA ligation [GO_1902973]
- 3334: mitotic interphase [GO_0051329]
- 3335: mitotic M phase [GO_0000087]
- 3336: mitotic nuclear division [GO_0140014]
- 3337: mitotic nuclear membrane disassembly [GO_0007077]
- 3338: mitotic nuclear membrane organization [GO_0101024]
- 3339: mitotic sister chromatid segregation [GO_0000070]
- 3340: modification-dependent macromolecule catabolic process [GO_0043632]
- 3341: modification-dependent protein binding [GO_0140030]
- 3342: modification-dependent protein catabolic process [GO_0019941]
- 3343: modified amino acid binding [GO_0072341]
- 3344: modified amino acid transmembrane transporter activity [GO_0072349]
- 3345: modified amino acid transport [GO_0072337]
- 3346: modulation of chemical synaptic transmission [GO_0050804]
- 3347: modulation of excitatory postsynaptic potential [GO_0098815]
- 3348: molecular adaptor activity [GO_0060090]
- 3349: molecular carrier activity [GO_0140104]
- 3350: molecular condensate scaffold activity [GO_0140693]
- 3351: molecular function activator activity [GO_0140677]
- 3352: molecular function inhibitor activity [GO_0140678]
- 3353: molecular function regulator [GO_0098772]
- 3354: molecular tag activity [GO_0141047]
- 3355: molecular transducer activity [GO_0060089]
- 3356: molecular_function [GO_0003674]
- 3357: molybdenum ion binding [GO_0030151]
- 3358: molybdopterin cofactor binding [GO_0043546]
- 3359: molybdopterin molybdotransferase activity [GO_0061599]
- 3360: monoamine transport [GO_0015844]
- 3361: monocarboxylate:sodium symporter activity [GO_0140161]
- 3362: monocarboxylic acid binding [GO_0033293]
- 3363: monocarboxylic acid biosynthetic process [GO_0072330]
- 3364: monocarboxylic acid catabolic process [GO_0072329]
- 3365: monocarboxylic acid metabolic process [GO_0032787]
- 3366: monocarboxylic acid transport [GO_0015718]
- 3367: mononuclear cell differentiation [GO_1903131]
- 3368: mononuclear cell proliferation [GO_0032943]
- 3369: monosaccharide binding [GO_0048029]
- 3370: monosaccharide biosynthetic process [GO_0046364]
- 3371: monosaccharide catabolic process [GO_0046365]
- 3372: monosaccharide metabolic process [GO_0005996]
- 3373: monosaccharide transmembrane transport [GO_0015749]
- 3374: monosaccharide transmembrane transporter activity [GO_0015145]
- 3375: monovalent cation:proton antiporter activity [GO_0005451]
- 3376: monovalent inorganic anion homeostasis [GO_0055083]
- 3377: monovalent inorganic cation homeostasis [GO_0055067]
- 3378: monovalent inorganic cation transport [GO_0015672]
- 3379: morphogen activity [GO_0016015]
- 3380: morphogenesis of a branching epithelium [GO_0061138]
- 3381: morphogenesis of a branching structure [GO_0001763]
- 3382: morphogenesis of a polarized epithelium [GO_0001738]
- 3383: morphogenesis of an endothelium [GO_0003159]
- 3384: morphogenesis of an epithelial bud [GO_0060572]
- 3385: morphogenesis of an epithelial fold [GO_0060571]
- 3386: morphogenesis of an epithelial fold involved in embryonic heart tube formation [GO_0003152]
- 3387: morphogenesis of an epithelial sheet [GO_0002011]
- 3388: morphogenesis of an epithelium [GO_0002009]
- 3389: morphogenesis of embryonic epithelium [GO_0016331]
- 3390: motor neuron apoptotic process [GO_0097049]
- 3391: movement of cell or subcellular component [GO_0006928]
- 3392: MPC1:MPC2 cotransports PYR, H+ from cytosol to mitochondrial matrix [GO_0050833]
- 3393: MRN:CtIP exonucleolytically hydrolyzes DNA 3' to SPO11 and SPO11:double-strand break dissociates to SPO11:oligonucleotide and resected 5' end [GO_0008296]
- 3394: mRNA (nucleoside-2'-O-)-methyltransferase activity [GO_0004483]
- 3395: mRNA 3'-UTR AU-rich region binding [GO_0035925]
- 3396: mRNA 3'-UTR binding [GO_0003730]
- 3397: mRNA 5'-cap (guanine-N7-)-methyltransferase activity [GO_0004482]
- 3398: mRNA 5'-diphosphatase activity [GO_0034353]
- 3399: mRNA 5'-phosphatase activity [GO_0140818]
- 3400: mRNA 5'-UTR binding [GO_0048027]
- 3401: mRNA base-pairing translational repressor activity [GO_1903231]
- 3402: mRNA binding [GO_0003729]
- 3403: mRNA cap binding complex binding [GO_0140262]
- 3404: mRNA catabolic process [GO_0006402]
- 3405: mRNA destabilization [GO_0061157]
- 3406: mRNA metabolic process [GO_0016071]
- 3407: mRNA methylation [GO_0080009]
- 3408: mRNA methyltransferase activity [GO_0008174]
- 3409: mRNA modification [GO_0016556]
- 3410: mRNA polyadenylation [GO_0004652]
- 3411: mRNA processing [GO_0006397]
- 3412: mRNA regulatory element binding translation repressor activity [GO_0000900]
- 3413: MRSBs reduce L-methyl-(R)-S-oxide to L-methionine [GO_0033743]
- 3414: MscR reduces nitrosomycothiol to ammonia [GO_0016620]
- 3415: MsrA/B reduces peptide-methionine S/R-sulfoxides [GO_0008113]
- 3416: MTA2-NuRD complex deacetylates TP53 [GO_0004407]
- 3417: MTHFD2, D2L oxidise 5,10-methylene-THF to 5,10-methenyl-THF [GO_0004477]
- 3418: MTHFR dimer reduces 5,10-methylene-THFPG to 5-methyl-THFPG [GO_0004489]
- 3419: MTHFS transforms 5-formyl-THFPG to 5,10-methenyl-THFPG [GO_0030272]
- 3420: mucopolysaccharide metabolic process [GO_1903510]
- 3421: mucus secretion [GO_0070254]
- 3422: multi-ciliated epithelial cell differentiation [GO_1903251]
- 3423: multi-multicellular organism process [GO_0044706]
- 3424: multi-organism process [GO_0051704]
- 3425: multi-organism reproductive process [GO_0044703]
- 3426: multicellular organism development [GO_0007275]
- 3427: multicellular organism growth [GO_0035264]
- 3428: multicellular organism metabolic process [GO_0044236]
- 3429: multicellular organism reproduction [GO_0032504]
- 3430: multicellular organismal catabolic process [GO_0044243]
- 3431: multicellular organismal homeostasis [GO_0048871]
- 3432: multicellular organismal lipid catabolic process [GO_0044240]
- 3433: multicellular organismal movement [GO_0050879]
- 3434: multicellular organismal process [GO_0032501]
- 3435: multicellular organismal reproductive process [GO_0048609]
- 3436: multicellular organismal response to stress [GO_0033555]
- 3437: multicellular organismal signaling [GO_0035637]
- 3438: muramoyltetrapeptide carboxypeptidase activity [GO_0106415]
- 3439: muramyl dipeptide binding [GO_0032500]
- 3440: muscle adaptation [GO_0043500]
- 3441: muscle alpha-actinin binding [GO_0051371]
- 3442: muscle cell apoptotic process [GO_0010657]
- 3443: muscle cell cellular homeostasis [GO_0046716]
- 3444: muscle cell development [GO_0055001]
- 3445: muscle cell differentiation [GO_0042692]
- 3446: muscle cell projection [GO_0036194]
- 3447: muscle cell projection membrane [GO_0036195]
- 3448: muscle cell proliferation [GO_0033002]
- 3449: muscle contraction [GO_0006936]
- 3450: muscle hypertrophy [GO_0014896]
- 3451: muscle organ development [GO_0007517]
- 3452: muscle organ morphogenesis [GO_0048644]
- 3453: muscle structure development [GO_0061061]
- 3454: muscle system process [GO_0003012]
- 3455: muscle tissue development [GO_0060537]
- 3456: muscle tissue morphogenesis [GO_0060415]
- 3457: muscular septum morphogenesis [GO_0003150]
- 3458: musculoskeletal movement [GO_0050881]
- 3459: MVD decarboxylates MVA5PP to IPPP [GO_0004163]
- 3460: myeloid cell apoptotic process [GO_0033028]
- 3461: myeloid cell development [GO_0061515]
- 3462: myeloid cell differentiation [GO_0030099]
- 3463: myeloid cell homeostasis [GO_0002262]
- 3464: myeloid leukocyte differentiation [GO_0002573]
- 3465: myeloid leukocyte mediated immunity [GO_0002444]
- 3466: myeloid progenitor cell differentiation [GO_0002318]
- 3467: myoblast development [GO_0048627]
- 3468: myoblast differentiation [GO_0045445]
- 3469: myoblast division [GO_0014872]
- 3470: myoblast maturation [GO_0048628]
- 3471: myoblast proliferation [GO_0051450]
- 3472: myofibril [GO_0030016]
- 3473: myofibril assembly [GO_0030239]
- 3474: myoinhibitory hormone activity [GO_0016085]
- 3475: myosin binding [GO_0017022]
- 3476: myosin head/neck binding [GO_0032028]
- 3477: myosin heavy chain binding [GO_0032036]
- 3478: myosin II binding [GO_0045159]
- 3479: myosin II heavy chain binding [GO_0032038]
- 3480: myosin II light chain binding [GO_0032033]
- 3481: myosin III binding [GO_0031473]
- 3482: myosin light chain binding [GO_0032027]
- 3483: myosin light chain kinase activity [GO_0004687]
- 3484: myosin phosphatase activity [GO_0017018]
- 3485: myosin phosphatase regulator activity [GO_0017020]
- 3486: myosin V binding [GO_0031489]
- 3487: myosin VI binding [GO_0070853]
- 3488: myosin VI head/neck binding [GO_0070855]
- 3489: myosin VI heavy chain binding [GO_0070854]
- 3490: myosin VI light chain binding [GO_0070856]
- 3491: myostimulatory hormone activity [GO_0016084]
- 3492: myosuppressin receptor activity [GO_0035013]
- 3493: myotome development [GO_0061055]
- 3494: myotube cell development [GO_0014904]
- 3495: myotube differentiation [GO_0014902]
- 3496: myristoyl-CoA+FAD<=>trans-Tetradec-2-enoyl-CoA+FADH2 [GO_0003995]
- 3497: myristoyltransferase activity [GO_0019107]
- 3498: N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [GO_0033842]
- 3499: N-acetylation of serotonin [GO_0004059]
- 3500: N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO_0050510]
- 3501: N-acetylglucosamine 6-O-sulfotransferase activity [GO_0001517]
- 3502: N-acetylglucosamine kinase activity [GO_0045127]
- 3503: N-acetylglucosaminyl-PI + H2O -> glucosaminyl-PI + acetate [GO_0000225]
- 3504: N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO_0004577]
- 3505: N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO_0046987]
- 3506: N-acylneuraminate cytidylyltransferase activity [GO_0008781]
- 3507: N-acylneuraminate-9-phosphatase activity [GO_0050124]
- 3508: N-acylneuraminate-9-phosphate synthase activity [GO_0047444]
- 3509: N-acyltransferase activity [GO_0016410]
- 3510: N-glycan trimming of Spike [GO_0033919]
- 3511: N-hydroxy-2-acetylaminofluorene + PAPS => 2-acetylaminofluorene-N-sulfate + PAP [GO_0008146]
- 3512: N-methyltransferase activity [GO_0008170]
- 3513: N-succinyltransferase activity [GO_0016749]
- 3514: N-terminal protein N-methyltransferase activity [GO_0071885]
- 3515: N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO_0003948]
- 3516: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO_0004018]
- 3517: N6-isopentenyladenosine methylthiotransferase activity [GO_0035597]
- 3518: N6-methyladenosine-containing RNA binding [GO_1990247]
- 3519: NAAA hydrolyses NAEs to FAs and ethanolamine [GO_0016810]
- 3520: NAADP-sensitive calcium-release channel activity [GO_0072345]
- 3521: NAD binding [GO_0051287]
- 3522: NAD transmembrane transport [GO_0035352]
- 3523: NAD transmembrane transporter activity [GO_0051724]
- 3524: NAD transport [GO_0043132]
- 3525: NAD-dependent histone deacetylase activity [GO_0017136]
- 3526: NAD-dependent histone H3K18 deacetylase activity [GO_0097372]
- 3527: NAD-independent histone deacetylase activity [GO_0045129]
- 3528: NAD(P)H dehydrogenase (quinone) activity [GO_0003955]
- 3529: NAD(P)H oxidase H2O2-forming activity [GO_0016174]
- 3530: NAD+ binding [GO_0070403]
- 3531: NAD+ kinase activity [GO_0003951]
- 3532: NAD+-protein ADP-ribosyltransferase activity [GO_1990404]
- 3533: NAD+-protein-serine ADP-ribosyltransferase activity [GO_0140805]
- 3534: NADH binding [GO_0070404]
- 3535: NADH dehydrogenase (quinone) activity [GO_0050136]
- 3536: NADH dehydrogenase activity [GO_0003954]
- 3537: NADHX epimerase activity [GO_0052856]
- 3538: NADP binding [GO_0050661]
- 3539: NADP phosphatase activity [GO_0019178]
- 3540: NADPH binding [GO_0070402]
- 3541: NADPH phosphatase activity [GO_0102757]
- 3542: NADPH-adrenodoxin reductase activity [GO_0015039]
- 3543: NADSYN1 hexamer amidates NAAD to NAD+ [GO_0003952]
- 3544: narrow pore channel activity [GO_0022842]
- 3545: NAT10 acetylates cytidine-1337 and cytidine-1842 of 18S rRNA yielding 4-acetylcytidine-1377 and 4-acetylcytidine-1842 [GO_0008080]
- 3546: NatC acetylates ARFFRP1 [GO_0004596]
- 3547: NCEH1 hydrolyzes cholesterol esters [GO_0004771]
- 3548: ncRNA 5'-end processing [GO_0034471]
- 3549: ncRNA metabolic process [GO_0034660]
- 3550: ncRNA processing [GO_0034470]
- 3551: NEDD8 activating enzyme activity [GO_0019781]
- 3552: NEDD8 conjugating enzyme activity [GO_0061654]
- 3553: NEDD8 ligase activity [GO_0061663]
- 3554: NEDD8 transferase activity [GO_0019788]
- 3555: negative chemotaxis [GO_0050919]
- 3556: negative energy taxis [GO_0052129]
- 3557: negative gravitaxis [GO_0048060]
- 3558: negative phototaxis [GO_0046957]
- 3559: negative regulation of 1-phosphatidylinositol 4-kinase activity [GO_0043127]
- 3560: negative regulation of 1-phosphatidylinositol-3-kinase activity [GO_0061902]
- 3561: negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO_0090217]
- 3562: negative regulation of acetylcholine secretion, neurotransmission [GO_0014058]
- 3563: negative regulation of acetylcholine-gated cation channel activity [GO_1903049]
- 3564: negative regulation of acid-sensing ion channel activity [GO_1901586]
- 3565: negative regulation of acinar cell proliferation [GO_1904698]
- 3566: negative regulation of aconitate hydratase activity [GO_1904233]
- 3567: negative regulation of actin binding [GO_1904617]
- 3568: negative regulation of actin filament binding [GO_1904530]
- 3569: negative regulation of actin filament bundle assembly [GO_0032232]
- 3570: negative regulation of action potential [GO_0045759]
- 3571: negative regulation of activin receptor signaling pathway [GO_0032926]
- 3572: negative regulation of adenosine receptor signaling pathway [GO_0060169]
- 3573: negative regulation of adenylate cyclase activity [GO_0007194]
- 3574: negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO_0106072]
- 3575: negative regulation of adipose tissue development [GO_1904178]
- 3576: negative regulation of alkaline phosphatase activity [GO_0010693]
- 3577: negative regulation of alpha-(1->3)-fucosyltransferase activity [GO_1905620]
- 3578: negative regulation of amine transport [GO_0051953]
- 3579: negative regulation of amino acid transport [GO_0051956]
- 3580: negative regulation of aminoacyl-tRNA ligase activity [GO_1903631]
- 3581: negative regulation of amyloid precursor protein catabolic process [GO_1902992]
- 3582: negative regulation of androgen secretion [GO_2000835]
- 3583: negative regulation of angiogenesis [GO_0016525]
- 3584: negative regulation of animal organ morphogenesis [GO_0110111]
- 3585: negative regulation of anion channel activity [GO_0010360]
- 3586: negative regulation of anion transmembrane transport [GO_1903960]
- 3587: negative regulation of anion transport [GO_1903792]
- 3588: negative regulation of aorta morphogenesis [GO_1903848]
- 3589: negative regulation of aortic smooth muscle cell differentiation [GO_1904830]
- 3590: negative regulation of apical ectodermal ridge formation [GO_1905141]
- 3591: negative regulation of apolipoprotein binding [GO_2000657]
- 3592: negative regulation of apoptotic process [GO_0043066]
- 3593: negative regulation of apoptotic process involved in development [GO_1904746]
- 3594: negative regulation of apoptotic process involved in morphogenesis [GO_1902338]
- 3595: negative regulation of apoptotic process involved in outflow tract morphogenesis [GO_1902257]
- 3596: negative regulation of apoptotic signaling pathway [GO_2001234]
- 3597: negative regulation of arginase activity [GO_0150071]
- 3598: negative regulation of artery morphogenesis [GO_1905652]
- 3599: negative regulation of aspartic endopeptidase activity, intramembrane cleaving [GO_0120288]
- 3600: negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902960]
- 3601: negative regulation of aspartic-type peptidase activity [GO_1905246]
- 3602: negative regulation of asymmetric cell division [GO_0045769]
- 3603: negative regulation of ATP biosynthetic process [GO_2001170]
- 3604: negative regulation of ATP citrate synthase activity [GO_2000984]
- 3605: negative regulation of ATP metabolic process [GO_1903579]
- 3606: negative regulation of ATP-dependent activity [GO_0032780]
- 3607: negative regulation of ATP:ADP antiporter activity [GO_0070927]
- 3608: negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO_1901895]
- 3609: negative regulation of AV node cell action potential [GO_1903950]
- 3610: negative regulation of axo-dendritic protein transport [GO_1905127]
- 3611: negative regulation of axon guidance [GO_1902668]
- 3612: negative regulation of axonemal microtubule depolymerization [GO_0007027]
- 3613: negative regulation of axonogenesis [GO_0050771]
- 3614: negative regulation of backward locomotion [GO_1905851]
- 3615: negative regulation of behavior [GO_0048521]
- 3616: negative regulation of beta-galactosidase activity [GO_1903770]
- 3617: negative regulation of bile acid biosynthetic process [GO_0070858]
- 3618: negative regulation of bile acid metabolic process [GO_1904252]
- 3619: negative regulation of bile acid secretion [GO_0120190]
- 3620: negative regulation of binding [GO_0051100]
- 3621: negative regulation of biological process [GO_0048519]
- 3622: negative regulation of biosynthetic process [GO_0009890]
- 3623: negative regulation of bleb assembly [GO_1904171]
- 3624: negative regulation of blood circulation [GO_1903523]
- 3625: negative regulation of blood vessel endothelial cell differentiation [GO_0110059]
- 3626: negative regulation of blood vessel morphogenesis [GO_2000181]
- 3627: negative regulation of BMP signaling pathway [GO_0030514]
- 3628: negative regulation of bone development [GO_1903011]
- 3629: negative regulation of branching involved in lung morphogenesis [GO_0061048]
- 3630: negative regulation of branching morphogenesis of a nerve [GO_2000173]
- 3631: negative regulation of calcium ion binding [GO_1901877]
- 3632: negative regulation of calcium ion transmembrane transport [GO_1903170]
- 3633: negative regulation of calcium ion transmembrane transporter activity [GO_1901020]
- 3634: negative regulation of calcium ion transport [GO_0051926]
- 3635: negative regulation of calcium-dependent ATPase activity [GO_1903611]
- 3636: negative regulation of calcium-mediated signaling [GO_0050849]
- 3637: negative regulation of calcium:sodium antiporter activity [GO_1903280]
- 3638: negative regulation of cAMP-dependent protein kinase activity [GO_2000480]
- 3639: negative regulation of cAMP-mediated signaling [GO_0043951]
- 3640: negative regulation of canonical NF-kappaB signal transduction [GO_0043124]
- 3641: negative regulation of carbohydrate metabolic process [GO_0045912]
- 3642: negative regulation of cardiac chamber formation [GO_1901211]
- 3643: negative regulation of cardiac chamber morphogenesis [GO_1901220]
- 3644: negative regulation of cardiac conduction [GO_1903780]
- 3645: negative regulation of cardiac muscle adaptation [GO_0010616]
- 3646: negative regulation of cardiac muscle cell apoptotic process [GO_0010667]
- 3647: negative regulation of cardiac muscle cell differentiation [GO_2000726]
- 3648: negative regulation of cardiac muscle cell myoblast differentiation [GO_2000691]
- 3649: negative regulation of cardiac muscle cell proliferation [GO_0060044]
- 3650: negative regulation of cardiac muscle contraction [GO_0055118]
- 3651: negative regulation of cardiac muscle fiber development [GO_0055019]
- 3652: negative regulation of cardiac muscle hypertrophy [GO_0010614]
- 3653: negative regulation of cardiac muscle myoblast proliferation [GO_0110023]
- 3654: negative regulation of cardiac muscle tissue development [GO_0055026]
- 3655: negative regulation of cardiac muscle tissue growth [GO_0055022]
- 3656: negative regulation of cardiac myofibril assembly [GO_1905305]
- 3657: negative regulation of cardiac ventricle development [GO_1904413]
- 3658: negative regulation of cardiac ventricle formation [GO_1904943]
- 3659: negative regulation of cardioblast differentiation [GO_0051892]
- 3660: negative regulation of cardiocyte differentiation [GO_1905208]
- 3661: negative regulation of cartilage development [GO_0061037]
- 3662: negative regulation of catabolic process [GO_0009895]
- 3663: negative regulation of catalase activity [GO_1902552]
- 3664: negative regulation of catalytic activity [GO_0043086]
- 3665: negative regulation of catecholamine metabolic process [GO_0045914]
- 3666: negative regulation of catecholamine secretion [GO_0033604]
- 3667: negative regulation of cation channel activity [GO_2001258]
- 3668: negative regulation of cation transmembrane transport [GO_1904063]
- 3669: negative regulation of CD4 production [GO_0045225]
- 3670: negative regulation of cell adhesion [GO_0007162]
- 3671: negative regulation of cell communication [GO_0010648]
- 3672: negative regulation of cell cycle [GO_0045786]
- 3673: negative regulation of cell cycle process [GO_0010948]
- 3674: negative regulation of cell death [GO_0060548]
- 3675: negative regulation of cell development [GO_0010721]
- 3676: negative regulation of cell differentiation [GO_0045596]
- 3677: negative regulation of cell differentiation involved in embryonic placenta development [GO_0060806]
- 3678: negative regulation of cell division [GO_0051782]
- 3679: negative regulation of cell fate commitment [GO_0010454]
- 3680: negative regulation of cell growth [GO_0030308]
- 3681: negative regulation of cell growth involved in cardiac muscle cell development [GO_0061052]
- 3682: negative regulation of cell junction assembly [GO_1901889]
- 3683: negative regulation of cell maturation [GO_1903430]
- 3684: negative regulation of cell migration [GO_0030336]
- 3685: negative regulation of cell morphogenesis involved in differentiation [GO_0010771]
- 3686: negative regulation of cell motility [GO_2000146]
- 3687: negative regulation of cell population proliferation [GO_0008285]
- 3688: negative regulation of cell projection organization [GO_0031345]
- 3689: negative regulation of cell proliferation in midbrain [GO_1904934]
- 3690: negative regulation of cell proliferation involved in compound eye morphogenesis [GO_2000496]
- 3691: negative regulation of cell proliferation involved in heart morphogenesis [GO_2000137]
- 3692: negative regulation of cell-cell adhesion [GO_0022408]
- 3693: negative regulation of cellular amide metabolic process [GO_0034249]
- 3694: negative regulation of cellular amine catabolic process [GO_0033242]
- 3695: negative regulation of cellular amine metabolic process [GO_0033239]
- 3696: negative regulation of cellular amino acid biosynthetic process [GO_2000283]
- 3697: negative regulation of cellular amino acid metabolic process [GO_0045763]
- 3698: negative regulation of cellular biosynthetic process [GO_0031327]
- 3699: negative regulation of cellular carbohydrate metabolic process [GO_0010677]
- 3700: negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated [GO_0010678]
- 3701: negative regulation of cellular catabolic process [GO_0031330]
- 3702: negative regulation of cellular component movement [GO_0051271]
- 3703: negative regulation of cellular component organization [GO_0051129]
- 3704: negative regulation of cellular macromolecule biosynthetic process [GO_2000113]
- 3705: negative regulation of cellular metabolic process [GO_0031324]
- 3706: negative regulation of cellular process [GO_0048523]
- 3707: negative regulation of cellular protein metabolic process [GO_0032269]
- 3708: negative regulation of cellular respiration [GO_1901856]
- 3709: negative regulation of cellular response to alcohol [GO_1905958]
- 3710: negative regulation of cellular response to caffeine [GO_1901181]
- 3711: negative regulation of cellular response to drug [GO_2001039]
- 3712: negative regulation of cellular response to growth factor stimulus [GO_0090288]
- 3713: negative regulation of cellular response to insulin stimulus [GO_1900077]
- 3714: negative regulation of cellular response to oxidative stress [GO_1900408]
- 3715: negative regulation of chemokine activity [GO_1900137]
- 3716: negative regulation of chemorepellent activity [GO_1903668]
- 3717: negative regulation of chemotaxis [GO_0050922]
- 3718: negative regulation of chloride transport [GO_2001226]
- 3719: negative regulation of cholangiocyte apoptotic process [GO_1904193]
- 3720: negative regulation of cholangiocyte proliferation [GO_1904055]
- 3721: negative regulation of cholesterol transporter activity [GO_0060695]
- 3722: negative regulation of choline O-acetyltransferase activity [GO_1902770]
- 3723: negative regulation of chondrocyte development [GO_0061182]
- 3724: negative regulation of chondrocyte differentiation [GO_0032331]
- 3725: negative regulation of chorionic trophoblast cell proliferation [GO_1901383]
- 3726: negative regulation of chromatin assembly or disassembly [GO_0045798]
- 3727: negative regulation of chromatin binding [GO_0035562]
- 3728: negative regulation of chromatin organization [GO_1905268]
- 3729: negative regulation of chromosome condensation [GO_1902340]
- 3730: negative regulation of chromosome organization [GO_2001251]
- 3731: negative regulation of chromosome segregation [GO_0051985]
- 3732: negative regulation of cilium assembly [GO_1902018]
- 3733: negative regulation of circadian rhythm [GO_0042754]
- 3734: negative regulation of circadian sleep/wake cycle, sleep [GO_0042321]
- 3735: negative regulation of CoA-transferase activity [GO_1905919]
- 3736: negative regulation of collagen binding [GO_0033342]
- 3737: negative regulation of collagen biosynthetic process [GO_0032966]
- 3738: negative regulation of collagen catabolic process [GO_0010711]
- 3739: negative regulation of collagen fibril organization [GO_1904027]
- 3740: negative regulation of collagen metabolic process [GO_0010713]
- 3741: negative regulation of colon smooth muscle contraction [GO_1904342]
- 3742: negative regulation of compound eye photoreceptor cell differentiation [GO_0110118]
- 3743: negative regulation of compound eye retinal cell apoptotic process [GO_1901693]
- 3744: negative regulation of compound eye retinal cell programmed cell death [GO_0046673]
- 3745: negative regulation of copper ion transmembrane transport [GO_1902312]
- 3746: negative regulation of core promoter binding [GO_1904797]
- 3747: negative regulation of coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060728]
- 3748: negative regulation of cyclase activity [GO_0031280]
- 3749: negative regulation of cyclic nucleotide-gated ion channel activity [GO_1902160]
- 3750: negative regulation of cyclic-nucleotide phosphodiesterase activity [GO_0051344]
- 3751: negative regulation of cyclin-dependent protein kinase activity [GO_1904030]
- 3752: negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO_0045736]
- 3753: negative regulation of cystathionine beta-synthase activity [GO_1904042]
- 3754: negative regulation of cysteine metabolic process [GO_1901495]
- 3755: negative regulation of cysteine-type endopeptidase activity [GO_2000117]
- 3756: negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0043154]
- 3757: negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO_2001268]
- 3758: negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_2001271]
- 3759: negative regulation of cytochrome-c oxidase activity [GO_1905376]
- 3760: negative regulation of cytokine activity [GO_0060302]
- 3761: negative regulation of cytokine-mediated signaling pathway [GO_0001960]
- 3762: negative regulation of cytokinesis [GO_0032466]
- 3763: negative regulation of cytoskeleton organization [GO_0051494]
- 3764: negative regulation of D-amino-acid oxidase activity [GO_1900758]
- 3765: negative regulation of deacetylase activity [GO_0150066]
- 3766: negative regulation of defecation [GO_2000293]
- 3767: negative regulation of delayed rectifier potassium channel activity [GO_1902260]
- 3768: negative regulation of deoxyribonuclease activity [GO_0032076]
- 3769: negative regulation of dephosphorylation [GO_0035305]
- 3770: negative regulation of dermatome development [GO_0061185]
- 3771: negative regulation of detection of mechanical stimulus involved in sensory perception of touch [GO_1905788]
- 3772: negative regulation of developmental growth [GO_0048640]
- 3773: negative regulation of developmental pigmentation [GO_0048086]
- 3774: negative regulation of developmental process [GO_0051093]
- 3775: negative regulation of diacylglycerol kinase activity [GO_1905688]
- 3776: negative regulation of digestive system process [GO_0060457]
- 3777: negative regulation of dipeptide transmembrane transport [GO_2001149]
- 3778: negative regulation of dipeptide transport [GO_2000879]
- 3779: negative regulation of DNA binding [GO_0043392]
- 3780: negative regulation of DNA biosynthetic process [GO_2000279]
- 3781: negative regulation of DNA duplex unwinding [GO_1905463]
- 3782: negative regulation of DNA helicase activity [GO_1905775]
- 3783: negative regulation of DNA ligase activity [GO_1904876]
- 3784: negative regulation of DNA ligation [GO_0051107]
- 3785: negative regulation of DNA metabolic process [GO_0051053]
- 3786: negative regulation of DNA methylation [GO_1905642]
- 3787: negative regulation of DNA N-glycosylase activity [GO_1902545]
- 3788: negative regulation of DNA primase activity [GO_1903933]
- 3789: negative regulation of DNA recombination [GO_0045910]
- 3790: negative regulation of DNA repair [GO_0045738]
- 3791: negative regulation of DNA replication [GO_0008156]
- 3792: negative regulation of DNA replication origin binding [GO_1902596]
- 3793: negative regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO_2000372]
- 3794: negative regulation of DNA-binding transcription factor activity [GO_0043433]
- 3795: negative regulation of DNA-directed DNA polymerase activity [GO_1900263]
- 3796: negative regulation of DNA-templated DNA replication [GO_2000104]
- 3797: negative regulation of DNA-templated transcription [GO_0045892]
- 3798: negative regulation of DNA-templated transcription initiation [GO_2000143]
- 3799: negative regulation of dopamine receptor signaling pathway [GO_0060160]
- 3800: negative regulation of dopamine secretion [GO_0033602]
- 3801: negative regulation of double-stranded telomeric DNA binding [GO_1905768]
- 3802: negative regulation of dUTP diphosphatase activity [GO_1903628]
- 3803: negative regulation of eclosion [GO_0045804]
- 3804: negative regulation of ectoderm development [GO_2000384]
- 3805: negative regulation of electron transfer activity [GO_1904733]
- 3806: negative regulation of embryonic camera-type eye development [GO_1902864]
- 3807: negative regulation of embryonic development [GO_0045992]
- 3808: negative regulation of endocytosis [GO_0045806]
- 3809: negative regulation of endodeoxyribonuclease activity [GO_0032078]
- 3810: negative regulation of endodermal cell differentiation [GO_1903225]
- 3811: negative regulation of endopeptidase activity [GO_0010951]
- 3812: negative regulation of endoribonuclease activity [GO_0060702]
- 3813: negative regulation of endothelial cell apoptotic process [GO_2000352]
- 3814: negative regulation of endothelial cell development [GO_1901551]
- 3815: negative regulation of endothelial cell differentiation [GO_0045602]
- 3816: negative regulation of endothelial cell proliferation [GO_0001937]
- 3817: negative regulation of endothelial tube morphogenesis [GO_1905955]
- 3818: negative regulation of entry into reproductive diapause [GO_0061964]
- 3819: negative regulation of ephrin receptor signaling pathway [GO_1901188]
- 3820: negative regulation of epidermal cell differentiation [GO_0045605]
- 3821: negative regulation of epidermal growth factor receptor signaling pathway [GO_0042059]
- 3822: negative regulation of epidermal growth factor-activated receptor activity [GO_0007175]
- 3823: negative regulation of epidermis development [GO_0045683]
- 3824: negative regulation of epithelial cell apoptotic process [GO_1904036]
- 3825: negative regulation of epithelial cell differentiation [GO_0030857]
- 3826: negative regulation of epithelial cell proliferation [GO_0050680]
- 3827: negative regulation of epithelial cell proliferation involved in lung morphogenesis [GO_2000795]
- 3828: negative regulation of epithelial to mesenchymal transition [GO_0010719]
- 3829: negative regulation of epithelial tube formation [GO_1905277]
- 3830: negative regulation of ERBB signaling pathway [GO_1901185]
- 3831: negative regulation of erythrocyte apoptotic process [GO_1902251]
- 3832: negative regulation of erythrocyte differentiation [GO_0045647]
- 3833: negative regulation of establishment of protein localization [GO_1904950]
- 3834: negative regulation of establishment or maintenance of neuroblast polarity [GO_2000248]
- 3835: negative regulation of euchromatin binding [GO_1904794]
- 3836: negative regulation of excitatory postsynaptic potential [GO_0090394]
- 3837: negative regulation of execution phase of apoptosis [GO_1900118]
- 3838: negative regulation of exocytosis [GO_0045920]
- 3839: negative regulation of exodeoxyribonuclease activity [GO_1902393]
- 3840: negative regulation of exonuclease activity [GO_1905778]
- 3841: negative regulation of exoribonuclease activity [GO_1901918]
- 3842: negative regulation of exosomal secretion [GO_1903542]
- 3843: negative regulation of extracellular exosome assembly [GO_1903552]
- 3844: negative regulation of extracellular matrix assembly [GO_1901202]
- 3845: negative regulation of extracellular matrix disassembly [GO_0010716]
- 3846: negative regulation of extracellular matrix organization [GO_1903054]
- 3847: negative regulation of eye photoreceptor cell development [GO_0042480]
- 3848: negative regulation of fat cell apoptotic process [GO_1904650]
- 3849: negative regulation of fat cell differentiation [GO_0045599]
- 3850: negative regulation of fat cell proliferation [GO_0070345]
- 3851: negative regulation of fatty acid biosynthetic process [GO_0045717]
- 3852: negative regulation of fatty acid metabolic process [GO_0045922]
- 3853: negative regulation of fatty acid transport [GO_2000192]
- 3854: negative regulation of feeding behavior [GO_2000252]
- 3855: negative regulation of female gonad development [GO_2000195]
- 3856: negative regulation of ferrous iron binding [GO_1904433]
- 3857: negative regulation of fertilization [GO_0060467]
- 3858: negative regulation of fibroblast apoptotic process [GO_2000270]
- 3859: negative regulation of fibroblast growth factor receptor signaling pathway [GO_0040037]
- 3860: negative regulation of fibroblast proliferation [GO_0048147]
- 3861: negative regulation of formation of translation initiation ternary complex [GO_1901191]
- 3862: negative regulation of forward locomotion [GO_1905849]
- 3863: negative regulation of G protein-coupled receptor signaling pathway [GO_0045744]
- 3864: negative regulation of G-quadruplex DNA binding [GO_1905494]
- 3865: negative regulation of GABA-A receptor activity [GO_0106042]
- 3866: negative regulation of gamma-aminobutyric acid secretion [GO_0014053]
- 3867: negative regulation of gastric acid secretion [GO_0060455]
- 3868: negative regulation of gastric mucosal blood circulation [GO_1904345]
- 3869: negative regulation of gastro-intestinal system smooth muscle contraction [GO_1904305]
- 3870: negative regulation of gastrulation [GO_2000542]
- 3871: negative regulation of gene expression [GO_0010629]
- 3872: negative regulation of gene expression, epigenetic [GO_0045814]
- 3873: negative regulation of gene silencing by RNA [GO_0060967]
- 3874: negative regulation of germ cell proliferation [GO_1905937]
- 3875: negative regulation of glial cell apoptotic process [GO_0034351]
- 3876: negative regulation of glial cell differentiation [GO_0045686]
- 3877: negative regulation of glial cell proliferation [GO_0060253]
- 3878: negative regulation of gliogenesis [GO_0014014]
- 3879: negative regulation of glucagon secretion [GO_0070093]
- 3880: negative regulation of glucokinase activity [GO_0033132]
- 3881: negative regulation of gluconeogenesis [GO_0045721]
- 3882: negative regulation of glucose transmembrane transport [GO_0010829]
- 3883: negative regulation of glucosylceramidase activity [GO_1905124]
- 3884: negative regulation of glucuronosyltransferase activity [GO_1904224]
- 3885: negative regulation of glutamate receptor signaling pathway [GO_1900450]
- 3886: negative regulation of glutamate secretion [GO_0014050]
- 3887: negative regulation of glutamate secretion, neurotransmission [GO_1903295]
- 3888: negative regulation of glutamate-ammonia ligase activity [GO_1905479]
- 3889: negative regulation of glutamate-cysteine ligase activity [GO_0035228]
- 3890: negative regulation of glutathione biosynthetic process [GO_1903787]
- 3891: negative regulation of glutathione peroxidase activity [GO_1903283]
- 3892: negative regulation of glycine secretion, neurotransmission [GO_1904625]
- 3893: negative regulation of glycogen (starch) synthase activity [GO_2000466]
- 3894: negative regulation of glycogen biosynthetic process [GO_0045719]
- 3895: negative regulation of glycogen catabolic process [GO_0045818]
- 3896: negative regulation of glycogen metabolic process [GO_0070874]
- 3897: negative regulation of glycolytic process [GO_0045820]
- 3898: negative regulation of glycolytic process through fructose-6-phosphate [GO_1904539]
- 3899: negative regulation of glycoprotein biosynthetic process [GO_0010561]
- 3900: negative regulation of glycoprotein metabolic process [GO_1903019]
- 3901: negative regulation of Golgi to plasma membrane protein transport [GO_0042997]
- 3902: negative regulation of gonad development [GO_1905940]
- 3903: negative regulation of growth [GO_0045926]
- 3904: negative regulation of GTP binding [GO_1904425]
- 3905: negative regulation of GTP cyclohydrolase I activity [GO_0043105]
- 3906: negative regulation of GTPase activity [GO_0034260]
- 3907: negative regulation of guanyl-nucleotide exchange factor activity [GO_1905098]
- 3908: negative regulation of guanylate cyclase activity [GO_0031283]
- 3909: negative regulation of heart contraction [GO_0045822]
- 3910: negative regulation of heart growth [GO_0061117]
- 3911: negative regulation of helicase activity [GO_0051097]
- 3912: negative regulation of hematopoietic progenitor cell differentiation [GO_1901533]
- 3913: negative regulation of hematopoietic stem cell differentiation [GO_1902037]
- 3914: negative regulation of hematopoietic stem cell proliferation [GO_1902034]
- 3915: negative regulation of heme oxygenase activity [GO_0061962]
- 3916: negative regulation of hemopoiesis [GO_1903707]
- 3917: negative regulation of heparan sulfate proteoglycan binding [GO_1905859]
- 3918: negative regulation of hepatocyte apoptotic process [GO_1903944]
- 3919: negative regulation of hepatocyte differentiation [GO_0070367]
- 3920: negative regulation of heterochromatin assembly [GO_0031452]
- 3921: negative regulation of heterochromatin organization [GO_0120262]
- 3922: negative regulation of hexokinase activity [GO_1903300]
- 3923: negative regulation of high voltage-gated calcium channel activity [GO_1901842]
- 3924: negative regulation of hindgut contraction [GO_0060451]
- 3925: negative regulation of histone deacetylase activity [GO_1901726]
- 3926: negative regulation of histone deacetylation [GO_0031064]
- 3927: negative regulation of histone demethylase activity (H3-K4 specific) [GO_1904174]
- 3928: negative regulation of histone modification [GO_0031057]
- 3929: negative regulation of hormone metabolic process [GO_0032351]
- 3930: negative regulation of hormone secretion [GO_0046888]
- 3931: negative regulation of hyaluronan biosynthetic process [GO_1900126]
- 3932: negative regulation of hydrolase activity [GO_0051346]
- 3933: negative regulation of I-kappaB phosphorylation [GO_1903720]
- 3934: negative regulation of immune effector process [GO_0002698]
- 3935: negative regulation of immune response [GO_0050777]
- 3936: negative regulation of immune system process [GO_0002683]
- 3937: negative regulation of inorganic anion transmembrane transport [GO_1903796]
- 3938: negative regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0031586]
- 3939: negative regulation of insulin receptor signaling pathway [GO_0046627]
- 3940: negative regulation of insulin secretion [GO_0046676]
- 3941: negative regulation of intestinal absorption [GO_1904479]
- 3942: negative regulation of intestinal epithelial cell development [GO_1905299]
- 3943: negative regulation of intracellular calcium activated chloride channel activity [GO_1902939]
- 3944: negative regulation of intracellular lipid transport [GO_0032378]
- 3945: negative regulation of intracellular protein transport [GO_0090317]
- 3946: negative regulation of intracellular signal transduction [GO_1902532]
- 3947: negative regulation of intracellular sterol transport [GO_0032381]
- 3948: negative regulation of intracellular transport [GO_0032387]
- 3949: negative regulation of inward rectifier potassium channel activity [GO_1903609]
- 3950: negative regulation of ion transmembrane transport [GO_0034766]
- 3951: negative regulation of ion transmembrane transporter activity [GO_0032413]
- 3952: negative regulation of ion transport [GO_0043271]
- 3953: negative regulation of iron ion transmembrane transport [GO_0034760]
- 3954: negative regulation of iron ion transmembrane transporter activity [GO_1904255]
- 3955: negative regulation of iron ion transport [GO_0034757]
- 3956: negative regulation of isoleucine-tRNA ligase activity [GO_1905016]
- 3957: negative regulation of isoprenoid metabolic process [GO_0045827]
- 3958: negative regulation of JNK cascade [GO_0046329]
- 3959: negative regulation of JUN kinase activity [GO_0043508]
- 3960: negative regulation of kinase activity [GO_0033673]
- 3961: negative regulation of L-dopa decarboxylase activity [GO_1903199]
- 3962: negative regulation of large conductance calcium-activated potassium channel activity [GO_1902607]
- 3963: negative regulation of leucine-tRNA ligase activity [GO_1903634]
- 3964: negative regulation of leukocyte apoptotic process [GO_2000107]
- 3965: negative regulation of leukocyte differentiation [GO_1902106]
- 3966: negative regulation of leukocyte mediated immunity [GO_0002704]
- 3967: negative regulation of leukocyte proliferation [GO_0070664]
- 3968: negative regulation of ligase activity [GO_0051352]
- 3969: negative regulation of light-activated channel activity [GO_0045831]
- 3970: negative regulation of lipase activity [GO_0060192]
- 3971: negative regulation of lipid binding [GO_1900131]
- 3972: negative regulation of lipid biosynthetic process [GO_0051055]
- 3973: negative regulation of lipid catabolic process [GO_0050995]
- 3974: negative regulation of lipid kinase activity [GO_0090219]
- 3975: negative regulation of lipid localization [GO_1905953]
- 3976: negative regulation of lipid metabolic process [GO_0045833]
- 3977: negative regulation of lipid storage [GO_0010888]
- 3978: negative regulation of lipid transport [GO_0032369]
- 3979: negative regulation of lipid transporter activity [GO_0110114]
- 3980: negative regulation of lipopolysaccharide-mediated signaling pathway [GO_0031665]
- 3981: negative regulation of lipoprotein lipase activity [GO_0051005]
- 3982: negative regulation of locomotion [GO_0040013]
- 3983: negative regulation of locomotion involved in locomotory behavior [GO_0090327]
- 3984: negative regulation of locomotor rhythm [GO_1904060]
- 3985: negative regulation of low-density lipoprotein particle receptor binding [GO_1905596]
- 3986: negative regulation of low-density lipoprotein receptor activity [GO_1905598]
- 3987: negative regulation of lung ciliated cell differentiation [GO_1901247]
- 3988: negative regulation of lyase activity [GO_0051350]
- 3989: negative regulation of lysozyme activity [GO_1903591]
- 3990: negative regulation of macromolecule biosynthetic process [GO_0010558]
- 3991: negative regulation of macromolecule metabolic process [GO_0010605]
- 3992: negative regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO_1903219]
- 3993: negative regulation of male mating behavior [GO_1902436]
- 3994: negative regulation of MAP kinase activity [GO_0043407]
- 3995: negative regulation of MAPK cascade [GO_0043409]
- 3996: negative regulation of megakaryocyte differentiation [GO_0045653]
- 3997: negative regulation of meiotic cell cycle [GO_0051447]
- 3998: negative regulation of meiotic cell cycle process involved in oocyte maturation [GO_1904145]
- 3999: negative regulation of meiotic nuclear division [GO_0045835]
- 4000: negative regulation of membrane invagination [GO_1905154]
- 4001: negative regulation of mesenchymal cell apoptotic process [GO_2001054]
- 4002: negative regulation of mesenchymal cell proliferation [GO_0072201]
- 4003: negative regulation of mesenchymal cell proliferation involved in lung development [GO_2000791]
- 4004: negative regulation of mesoderm development [GO_2000381]
- 4005: negative regulation of mesoderm formation [GO_1905903]
- 4006: negative regulation of mesodermal cell differentiation [GO_1905771]
- 4007: negative regulation of metabolic process [GO_0009892]
- 4008: negative regulation of metalloendopeptidase activity [GO_1904684]
- 4009: negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902963]
- 4010: negative regulation of metallopeptidase activity [GO_1905049]
- 4011: negative regulation of methionine-tRNA ligase activity [GO_1905019]
- 4012: negative regulation of methylenetetrahydrofolate reductase (NAD(P)H) activity [GO_1903869]
- 4013: negative regulation of microtubule binding [GO_1904527]
- 4014: negative regulation of microtubule depolymerization [GO_0007026]
- 4015: negative regulation of microtubule nucleation [GO_1905833]
- 4016: negative regulation of microtubule plus-end binding [GO_1903032]
- 4017: negative regulation of microtubule polymerization [GO_0031115]
- 4018: negative regulation of microtubule polymerization or depolymerization [GO_0031111]
- 4019: negative regulation of microvillus assembly [GO_1903697]
- 4020: negative regulation of miRNA processing [GO_1903799]
- 4021: negative regulation of miRNA-mediated gene silencing [GO_0060965]
- 4022: negative regulation of mitochondrial ATP synthesis coupled proton transport [GO_1905707]
- 4023: negative regulation of mitochondrial DNA metabolic process [GO_1901859]
- 4024: negative regulation of mitochondrial DNA replication [GO_0090298]
- 4025: negative regulation of mitochondrial mRNA catabolic process [GO_1905638]
- 4026: negative regulation of mitochondrial RNA catabolic process [GO_0000961]
- 4027: negative regulation of mitochondrial translation [GO_0070130]
- 4028: negative regulation of mitochondrial translational elongation [GO_1905083]
- 4029: negative regulation of mitochondrial translational initiation [GO_0070133]
- 4030: negative regulation of mitochondrion organization [GO_0010823]
- 4031: negative regulation of mitotic cell cycle [GO_0045930]
- 4032: negative regulation of mitotic cell cycle DNA replication [GO_1903464]
- 4033: negative regulation of mitotic cell cycle, embryonic [GO_0045976]
- 4034: negative regulation of mitotic chromosome condensation [GO_1905213]
- 4035: negative regulation of mitotic nuclear division [GO_0045839]
- 4036: negative regulation of mitotic nuclear envelope disassembly [GO_1905558]
- 4037: negative regulation of mitotic sister chromatid segregation [GO_0033048]
- 4038: negative regulation of molecular function [GO_0044092]
- 4039: negative regulation of mononuclear cell proliferation [GO_0032945]
- 4040: negative regulation of monooxygenase activity [GO_0032769]
- 4041: negative regulation of morphogenesis of an epithelium [GO_1905331]
- 4042: negative regulation of motor neuron apoptotic process [GO_2000672]
- 4043: negative regulation of mRNA 3'-UTR binding [GO_1903838]
- 4044: negative regulation of mRNA binding [GO_1904572]
- 4045: negative regulation of mRNA catabolic process [GO_1902373]
- 4046: negative regulation of mRNA metabolic process [GO_1903312]
- 4047: negative regulation of mRNA modification [GO_0090367]
- 4048: negative regulation of mRNA processing [GO_0050686]
- 4049: negative regulation of mucus secretion [GO_0070256]
- 4050: negative regulation of multicellular organism growth [GO_0040015]
- 4051: negative regulation of multicellular organismal process [GO_0051241]
- 4052: negative regulation of muscle adaptation [GO_0014745]
- 4053: negative regulation of muscle cell apoptotic process [GO_0010656]
- 4054: negative regulation of muscle cell differentiation [GO_0051148]
- 4055: negative regulation of muscle contraction [GO_0045932]
- 4056: negative regulation of muscle hypertrophy [GO_0014741]
- 4057: negative regulation of muscle organ development [GO_0048635]
- 4058: negative regulation of muscle tissue development [GO_1901862]
- 4059: negative regulation of myeloid cell apoptotic process [GO_0033033]
- 4060: negative regulation of myeloid cell differentiation [GO_0045638]
- 4061: negative regulation of myeloid leukocyte differentiation [GO_0002762]
- 4062: negative regulation of myeloid leukocyte mediated immunity [GO_0002887]
- 4063: negative regulation of myeloid progenitor cell differentiation [GO_1905454]
- 4064: negative regulation of myoblast differentiation [GO_0045662]
- 4065: negative regulation of myoblast proliferation [GO_2000818]
- 4066: negative regulation of myosin light chain kinase activity [GO_0035506]
- 4067: negative regulation of myotube differentiation [GO_0010832]
- 4068: negative regulation of NAD(P)H oxidase activity [GO_0033861]
- 4069: negative regulation of NAD+ ADP-ribosyltransferase activity [GO_1901665]
- 4070: negative regulation of NAD+ kinase activity [GO_0033671]
- 4071: negative regulation of negative chemotaxis [GO_0050925]
- 4072: negative regulation of nervous system development [GO_0051961]
- 4073: negative regulation of nervous system process [GO_0031645]
- 4074: negative regulation of netrin-activated signaling pathway [GO_1902842]
- 4075: negative regulation of neural crest cell differentiation [GO_1905293]
- 4076: negative regulation of neural crest formation [GO_0090301]
- 4077: negative regulation of neural precursor cell proliferation [GO_2000178]
- 4078: negative regulation of neural retina development [GO_0061076]
- 4079: negative regulation of neuroblast proliferation [GO_0007406]
- 4080: negative regulation of neurogenesis [GO_0050768]
- 4081: negative regulation of neuromuscular junction development [GO_1904397]
- 4082: negative regulation of neuron apoptotic process [GO_0043524]
- 4083: negative regulation of neuron death [GO_1901215]
- 4084: negative regulation of neuron differentiation [GO_0045665]
- 4085: negative regulation of neuron maturation [GO_0014043]
- 4086: negative regulation of neuron projection development [GO_0010977]
- 4087: negative regulation of neuronal action potential [GO_1904456]
- 4088: negative regulation of neurotransmitter secretion [GO_0046929]
- 4089: negative regulation of neurotransmitter transport [GO_0051589]
- 4090: negative regulation of neurotransmitter uptake [GO_0051581]
- 4091: negative regulation of nitric-oxide synthase activity [GO_0051001]
- 4092: negative regulation of nitrogen compound metabolic process [GO_0051172]
- 4093: negative regulation of NMDA glutamate receptor activity [GO_1904782]
- 4094: negative regulation of non-membrane spanning protein tyrosine kinase activity [GO_1903996]
- 4095: negative regulation of norepinephrine secretion [GO_0010700]
- 4096: negative regulation of norepinephrine uptake [GO_0051622]
- 4097: negative regulation of nuclear cell cycle DNA replication [GO_1902576]
- 4098: negative regulation of nuclear division [GO_0051784]
- 4099: negative regulation of nuclear migration along microtubule [GO_1902839]
- 4100: negative regulation of nuclease activity [GO_0032074]
- 4101: negative regulation of nucleic acid-templated transcription [GO_1903507]
- 4102: negative regulation of nucleobase-containing compound metabolic process [GO_0045934]
- 4103: negative regulation of nucleobase-containing compound transport [GO_0032240]
- 4104: negative regulation of nucleocytoplasmic transport [GO_0046823]
- 4105: negative regulation of nucleoside metabolic process [GO_0045978]
- 4106: negative regulation of nucleoside transport [GO_0032243]
- 4107: negative regulation of nucleotide biosynthetic process [GO_0030809]
- 4108: negative regulation of nucleotide catabolic process [GO_0030812]
- 4109: negative regulation of nucleotide metabolic process [GO_0045980]
- 4110: negative regulation of oligopeptide transport [GO_2000877]
- 4111: negative regulation of oocyte development [GO_0060283]
- 4112: negative regulation of oocyte maturation [GO_1900194]
- 4113: negative regulation of oogenesis [GO_1905880]
- 4114: negative regulation of opsin-mediated signaling pathway [GO_0016059]
- 4115: negative regulation of organ growth [GO_0046621]
- 4116: negative regulation of organelle assembly [GO_1902116]
- 4117: negative regulation of organelle organization [GO_0010639]
- 4118: negative regulation of organic acid transport [GO_0032891]
- 4119: negative regulation of ossification [GO_0030279]
- 4120: negative regulation of oviposition [GO_1901045]
- 4121: negative regulation of oxidative phosphorylation [GO_0090324]
- 4122: negative regulation of oxidoreductase activity [GO_0051354]
- 4123: negative regulation of oxygen metabolic process [GO_2000375]
- 4124: negative regulation of P-type sodium:potassium-exchanging transporter activity [GO_1903407]
- 4125: negative regulation of pancreatic A cell differentiation [GO_2000227]
- 4126: negative regulation of peptidase activity [GO_0010466]
- 4127: negative regulation of peptide hormone secretion [GO_0090278]
- 4128: negative regulation of peptide secretion [GO_0002792]
- 4129: negative regulation of peptidyl-tyrosine phosphorylation [GO_0050732]
- 4130: negative regulation of peroxidase activity [GO_2000469]
- 4131: negative regulation of pharynx morphogenesis [GO_0110042]
- 4132: negative regulation of phosphatase activity [GO_0010923]
- 4133: negative regulation of phosphate metabolic process [GO_0045936]
- 4134: negative regulation of phosphate transmembrane transport [GO_2000186]
- 4135: negative regulation of phosphatidate phosphatase activity [GO_1903741]
- 4136: negative regulation of phosphatidylcholine biosynthetic process [GO_2001246]
- 4137: negative regulation of phosphatidylcholine metabolic process [GO_0150174]
- 4138: negative regulation of phosphatidylinositol 3-kinase activity [GO_0043553]
- 4139: negative regulation of phosphatidylinositol biosynthetic process [GO_0010512]
- 4140: negative regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO_0120140]
- 4141: negative regulation of phospholipase A2 activity [GO_1900138]
- 4142: negative regulation of phospholipase activity [GO_0010519]
- 4143: negative regulation of phospholipase C activity [GO_1900275]
- 4144: negative regulation of phospholipase D activity [GO_1904006]
- 4145: negative regulation of phospholipid biosynthetic process [GO_0071072]
- 4146: negative regulation of phospholipid metabolic process [GO_1903726]
- 4147: negative regulation of phospholipid scramblase activity [GO_1900162]
- 4148: negative regulation of phospholipid translocation [GO_0061093]
- 4149: negative regulation of phospholipid transport [GO_2001139]
- 4150: negative regulation of phosphoprotein phosphatase activity [GO_0032515]
- 4151: negative regulation of phosphorus metabolic process [GO_0010563]
- 4152: negative regulation of phosphorylation [GO_0042326]
- 4153: negative regulation of photoreceptor cell differentiation [GO_0046533]
- 4154: negative regulation of pigment cell differentiation [GO_0050941]
- 4155: negative regulation of placenta blood vessel development [GO_0110081]
- 4156: negative regulation of plasma membrane bounded cell projection assembly [GO_0120033]
- 4157: negative regulation of poly(A)-specific ribonuclease activity [GO_0106247]
- 4158: negative regulation of polyamine transmembrane transport [GO_1902268]
- 4159: negative regulation of polynucleotide adenylyltransferase activity [GO_1904246]
- 4160: negative regulation of polysome binding [GO_1905697]
- 4161: negative regulation of positive chemotaxis [GO_0050928]
- 4162: negative regulation of post-embryonic development [GO_0048581]
- 4163: negative regulation of post-transcriptional gene silencing [GO_0060149]
- 4164: negative regulation of post-transcriptional gene silencing by RNA [GO_1900369]
- 4165: negative regulation of post-translational protein modification [GO_1901874]
- 4166: negative regulation of potassium ion transmembrane transport [GO_1901380]
- 4167: negative regulation of potassium ion transmembrane transporter activity [GO_1901017]
- 4168: negative regulation of potassium ion transport [GO_0043267]
- 4169: negative regulation of pre-miRNA processing [GO_2000632]
- 4170: negative regulation of presynapse assembly [GO_1905607]
- 4171: negative regulation of primary amine oxidase activity [GO_1902283]
- 4172: negative regulation of programmed cell death [GO_0043069]
- 4173: negative regulation of prostaglandin-E synthase activity [GO_2000362]
- 4174: negative regulation of proteasomal protein catabolic process [GO_1901799]
- 4175: negative regulation of protein ADP-ribosylation [GO_0010836]
- 4176: negative regulation of protein binding [GO_0032091]
- 4177: negative regulation of protein catabolic process [GO_0042177]
- 4178: negative regulation of protein catabolic process in the vacuole [GO_1904351]
- 4179: negative regulation of protein dephosphorylation [GO_0035308]
- 4180: negative regulation of protein depolymerization [GO_1901880]
- 4181: negative regulation of protein deubiquitination [GO_0090086]
- 4182: negative regulation of protein folding [GO_1903333]
- 4183: negative regulation of protein glycosylation [GO_0060051]
- 4184: negative regulation of protein homodimerization activity [GO_0090074]
- 4185: negative regulation of protein K48-linked deubiquitination [GO_1903094]
- 4186: negative regulation of protein K63-linked deubiquitination [GO_1903005]
- 4187: negative regulation of protein kinase activity [GO_0006469]
- 4188: negative regulation of protein localization [GO_1903828]
- 4189: negative regulation of protein localization to cell cortex [GO_1904777]
- 4190: negative regulation of protein localization to cell leading edge [GO_1905872]
- 4191: negative regulation of protein localization to cell periphery [GO_1904376]
- 4192: negative regulation of protein localization to cell-cell junction [GO_0150119]
- 4193: negative regulation of protein localization to chromatin [GO_0120186]
- 4194: negative regulation of protein localization to ciliary membrane [GO_1903568]
- 4195: negative regulation of protein localization to cilium [GO_1903565]
- 4196: negative regulation of protein localization to membrane [GO_1905476]
- 4197: negative regulation of protein localization to microtubule [GO_1902817]
- 4198: negative regulation of protein localization to nucleolus [GO_1904750]
- 4199: negative regulation of protein localization to nucleus [GO_1900181]
- 4200: negative regulation of protein localization to plasma membrane [GO_1903077]
- 4201: negative regulation of protein localization to presynapse [GO_1905385]
- 4202: negative regulation of protein maturation [GO_1903318]
- 4203: negative regulation of protein metabolic process [GO_0051248]
- 4204: negative regulation of protein modification by small protein conjugation or removal [GO_1903321]
- 4205: negative regulation of protein modification process [GO_0031400]
- 4206: negative regulation of protein O-linked glycosylation [GO_1904099]
- 4207: negative regulation of protein phosphorylation [GO_0001933]
- 4208: negative regulation of protein polymerization [GO_0032272]
- 4209: negative regulation of protein secretion [GO_0050709]
- 4210: negative regulation of protein serine/threonine kinase activity [GO_0071901]
- 4211: negative regulation of protein serine/threonine phosphatase activity [GO_1905183]
- 4212: negative regulation of protein sumoylation [GO_0033234]
- 4213: negative regulation of protein transport [GO_0051224]
- 4214: negative regulation of protein tyrosine kinase activity [GO_0061099]
- 4215: negative regulation of protein tyrosine phosphatase activity [GO_1903614]
- 4216: negative regulation of protein ubiquitination [GO_0031397]
- 4217: negative regulation of protein-containing complex assembly [GO_0031333]
- 4218: negative regulation of protein-containing complex disassembly [GO_0043242]
- 4219: negative regulation of protein-glutamine gamma-glutamyltransferase activity [GO_0150075]
- 4220: negative regulation of proteolysis [GO_0045861]
- 4221: negative regulation of proteolysis involved in protein catabolic process [GO_1903051]
- 4222: negative regulation of proton-transporting ATP synthase activity, rotational mechanism [GO_1905272]
- 4223: negative regulation of purine nucleotide biosynthetic process [GO_1900372]
- 4224: negative regulation of purine nucleotide catabolic process [GO_0033122]
- 4225: negative regulation of purine nucleotide metabolic process [GO_1900543]
- 4226: negative regulation of pyrimidine nucleotide biosynthetic process [GO_1900398]
- 4227: negative regulation of pyruvate dehydrogenase activity [GO_1904183]
- 4228: negative regulation of pyruvate kinase activity [GO_1903303]
- 4229: negative regulation of reactive oxygen species metabolic process [GO_2000378]
- 4230: negative regulation of receptor binding [GO_1900121]
- 4231: negative regulation of receptor-mediated endocytosis [GO_0048261]
- 4232: negative regulation of release of sequestered calcium ion into cytosol [GO_0051280]
- 4233: negative regulation of removal of superoxide radicals [GO_1904832]
- 4234: negative regulation of reproductive process [GO_2000242]
- 4235: negative regulation of respiratory gaseous exchange [GO_1903941]
- 4236: negative regulation of response to alcohol [GO_1901420]
- 4237: negative regulation of response to biotic stimulus [GO_0002832]
- 4238: negative regulation of response to calcium ion [GO_1905946]
- 4239: negative regulation of response to cytokine stimulus [GO_0060761]
- 4240: negative regulation of response to DNA damage stimulus [GO_2001021]
- 4241: negative regulation of response to drug [GO_2001024]
- 4242: negative regulation of response to external stimulus [GO_0032102]
- 4243: negative regulation of response to extracellular stimulus [GO_0032105]
- 4244: negative regulation of response to nutrient levels [GO_0032108]
- 4245: negative regulation of response to oxidative stress [GO_1902883]
- 4246: negative regulation of response to reactive oxygen species [GO_1901032]
- 4247: negative regulation of response to stimulus [GO_0048585]
- 4248: negative regulation of response to wounding [GO_1903035]
- 4249: negative regulation of retina development in camera-type eye [GO_1902867]
- 4250: negative regulation of retinal cell programmed cell death [GO_0046671]
- 4251: negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO_1905433]
- 4252: negative regulation of Rho-dependent protein serine/threonine kinase activity [GO_2000299]
- 4253: negative regulation of ribonuclease activity [GO_0060701]
- 4254: negative regulation of ribosome biogenesis [GO_0090071]
- 4255: negative regulation of RNA binding [GO_1905215]
- 4256: negative regulation of RNA biosynthetic process [GO_1902679]
- 4257: negative regulation of RNA catabolic process [GO_1902369]
- 4258: negative regulation of RNA helicase activity [GO_1902281]
- 4259: negative regulation of RNA metabolic process [GO_0051253]
- 4260: negative regulation of RNA polymerase I regulatory region sequence-specific DNA binding [GO_1901840]
- 4261: negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO_1903026]
- 4262: negative regulation of RNA polymerase III activity [GO_1903623]
- 4263: negative regulation of RNA splicing [GO_0033119]
- 4264: negative regulation of rRNA processing [GO_2000233]
- 4265: negative regulation of ryanodine-sensitive calcium-release channel activity [GO_0060315]
- 4266: negative regulation of saliva secretion [GO_1905747]
- 4267: negative regulation of sarcomere organization [GO_0060299]
- 4268: negative regulation of secondary metabolite biosynthetic process [GO_1900377]
- 4269: negative regulation of secretion [GO_0051048]
- 4270: negative regulation of secretion by cell [GO_1903531]
- 4271: negative regulation of secretory granule organization [GO_1904410]
- 4272: negative regulation of selenocysteine insertion sequence binding [GO_1904574]
- 4273: negative regulation of semaphorin-plexin signaling pathway [GO_2001261]
- 4274: negative regulation of sensory perception of bitter taste [GO_1904661]
- 4275: negative regulation of sensory perception of pain [GO_1904057]
- 4276: negative regulation of sensory perception of sweet taste [GO_1904657]
- 4277: negative regulation of sequestering of calcium ion [GO_0051283]
- 4278: negative regulation of serine C-palmitoyltransferase activity [GO_1904221]
- 4279: negative regulation of serine-type endopeptidase activity [GO_1900004]
- 4280: negative regulation of serine-type peptidase activity [GO_1902572]
- 4281: negative regulation of serotonin biosynthetic process [GO_1905628]
- 4282: negative regulation of serotonin secretion [GO_0014063]
- 4283: negative regulation of serotonin uptake [GO_0051612]
- 4284: negative regulation of signal transduction [GO_0009968]
- 4285: negative regulation of signaling [GO_0023057]
- 4286: negative regulation of signaling receptor activity [GO_2000272]
- 4287: negative regulation of sister chromatid segregation [GO_0033046]
- 4288: negative regulation of skeletal muscle cell differentiation [GO_2001015]
- 4289: negative regulation of skeletal muscle cell proliferation [GO_0014859]
- 4290: negative regulation of skeletal muscle fiber development [GO_0048744]
- 4291: negative regulation of skeletal muscle fiber differentiation [GO_1902810]
- 4292: negative regulation of skeletal muscle hypertrophy [GO_1904205]
- 4293: negative regulation of skeletal muscle tissue development [GO_0048642]
- 4294: negative regulation of skeletal muscle tissue growth [GO_0048632]
- 4295: negative regulation of small GTPase binding [GO_1904476]
- 4296: negative regulation of small intestine smooth muscle contraction [GO_1904348]
- 4297: negative regulation of small molecule metabolic process [GO_0062014]
- 4298: negative regulation of smooth muscle cell apoptotic process [GO_0034392]
- 4299: negative regulation of smooth muscle cell differentiation [GO_0051151]
- 4300: negative regulation of smooth muscle cell proliferation [GO_0048662]
- 4301: negative regulation of smooth muscle contraction [GO_0045986]
- 4302: negative regulation of smooth muscle hypertrophy [GO_1905148]
- 4303: negative regulation of smooth muscle tissue development [GO_1905900]
- 4304: negative regulation of sodium ion transmembrane transport [GO_1902306]
- 4305: negative regulation of sodium ion transmembrane transporter activity [GO_2000650]
- 4306: negative regulation of sodium ion transport [GO_0010766]
- 4307: negative regulation of sodium:proton antiporter activity [GO_0032416]
- 4308: negative regulation of somatic stem cell division [GO_1904676]
- 4309: negative regulation of somatostatin secretion [GO_0090275]
- 4310: negative regulation of stem cell differentiation [GO_2000737]
- 4311: negative regulation of stem cell proliferation [GO_2000647]
- 4312: negative regulation of steroid biosynthetic process [GO_0010894]
- 4313: negative regulation of steroid hormone secretion [GO_2000832]
- 4314: negative regulation of steroid metabolic process [GO_0045939]
- 4315: negative regulation of sterol transport [GO_0032372]
- 4316: negative regulation of stomach neuroendocrine cell differentiation [GO_0061106]
- 4317: negative regulation of store-operated calcium channel activity [GO_1901340]
- 4318: negative regulation of stress-activated MAPK cascade [GO_0032873]
- 4319: negative regulation of stress-activated protein kinase signaling cascade [GO_0070303]
- 4320: negative regulation of striated muscle cell apoptotic process [GO_0010664]
- 4321: negative regulation of striated muscle cell differentiation [GO_0051154]
- 4322: negative regulation of striated muscle contraction [GO_0045988]
- 4323: negative regulation of striated muscle tissue development [GO_0045843]
- 4324: negative regulation of succinate dehydrogenase activity [GO_1904230]
- 4325: negative regulation of sulfur amino acid metabolic process [GO_0031336]
- 4326: negative regulation of sulfur metabolic process [GO_0051175]
- 4327: negative regulation of SUMO transferase activity [GO_1903183]
- 4328: negative regulation of superoxide dismutase activity [GO_1901670]
- 4329: negative regulation of supramolecular fiber organization [GO_1902904]
- 4330: negative regulation of synapse assembly [GO_0051964]
- 4331: negative regulation of synapse organization [GO_1905809]
- 4332: negative regulation of synapse pruning [GO_1905807]
- 4333: negative regulation of synaptic transmission [GO_0050805]
- 4334: negative regulation of synaptic transmission, cholinergic [GO_0032223]
- 4335: negative regulation of synaptic transmission, dopaminergic [GO_0032227]
- 4336: negative regulation of synaptic transmission, GABAergic [GO_0032229]
- 4337: negative regulation of synaptic transmission, glutamatergic [GO_0051967]
- 4338: negative regulation of synaptic transmission, glycinergic [GO_0060093]
- 4339: negative regulation of syncytium formation by plasma membrane fusion [GO_0034242]
- 4340: negative regulation of tau-protein kinase activity [GO_1902948]
- 4341: negative regulation of telomerase activity [GO_0051974]
- 4342: negative regulation of telomeric DNA binding [GO_1904743]
- 4343: negative regulation of termination of DNA-templated transcription [GO_0060567]
- 4344: negative regulation of tetrapyrrole biosynthetic process [GO_1901464]
- 4345: negative regulation of tetrapyrrole catabolic process [GO_1901405]
- 4346: negative regulation of tetrapyrrole metabolic process [GO_1901402]
- 4347: negative regulation of thioredoxin peroxidase activity [GO_1903124]
- 4348: negative regulation of threonine-tRNA ligase activity [GO_1905022]
- 4349: negative regulation of transcription by RNA polymerase I [GO_0016479]
- 4350: negative regulation of transcription by RNA polymerase II [GO_0000122]
- 4351: negative regulation of transcription by RNA polymerase III [GO_0016480]
- 4352: negative regulation of transcription regulatory region DNA binding [GO_2000678]
- 4353: negative regulation of transferase activity [GO_0051348]
- 4354: negative regulation of translation [GO_0017148]
- 4355: negative regulation of translation in response to oxidative stress [GO_0032938]
- 4356: negative regulation of translation in response to stress [GO_0032055]
- 4357: negative regulation of translational elongation [GO_0045900]
- 4358: negative regulation of translational initiation [GO_0045947]
- 4359: negative regulation of translational initiation in response to stress [GO_0032057]
- 4360: negative regulation of translational termination [GO_0045904]
- 4361: negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO_0090101]
- 4362: negative regulation of transmembrane transport [GO_0034763]
- 4363: negative regulation of transmission of nerve impulse [GO_0051970]
- 4364: negative regulation of transport [GO_0051051]
- 4365: negative regulation of transporter activity [GO_0032410]
- 4366: negative regulation of triglyceride biosynthetic process [GO_0010868]
- 4367: negative regulation of triglyceride metabolic process [GO_0090209]
- 4368: negative regulation of tRNA metabolic process [GO_1903327]
- 4369: negative regulation of tRNA processing [GO_2000236]
- 4370: negative regulation of trophectodermal cell proliferation [GO_1904074]
- 4371: negative regulation of tube lumen cavitation [GO_1903133]
- 4372: negative regulation of tumor necrosis factor-mediated signaling pathway [GO_0010804]
- 4373: negative regulation of turning behavior involved in mating [GO_0061096]
- 4374: negative regulation of type B pancreatic cell apoptotic process [GO_2000675]
- 4375: negative regulation of type B pancreatic cell development [GO_2000077]
- 4376: negative regulation of type B pancreatic cell proliferation [GO_1904691]
- 4377: negative regulation of tyrosinase activity [GO_0032772]
- 4378: negative regulation of tyrosine 3-monooxygenase activity [GO_1903177]
- 4379: negative regulation of ubiquinone biosynthetic process [GO_1904774]
- 4380: negative regulation of ubiquitin protein ligase activity [GO_1904667]
- 4381: negative regulation of ubiquitin-dependent protein catabolic process [GO_2000059]
- 4382: negative regulation of ubiquitin-protein transferase activity [GO_0051444]
- 4383: negative regulation of ubiquitin-specific protease activity [GO_2000157]
- 4384: negative regulation of vacuolar transport [GO_1903336]
- 4385: negative regulation of vascular associated smooth muscle cell apoptotic process [GO_1905460]
- 4386: negative regulation of vascular associated smooth muscle cell differentiation [GO_1905064]
- 4387: negative regulation of vascular associated smooth muscle cell proliferation [GO_1904706]
- 4388: negative regulation of vascular endothelial cell proliferation [GO_1905563]
- 4389: negative regulation of vasculature development [GO_1901343]
- 4390: negative regulation of vasculogenesis [GO_2001213]
- 4391: negative regulation of vesicle fusion [GO_0031339]
- 4392: negative regulation of vesicle fusion with Golgi apparatus [GO_0106215]
- 4393: negative regulation of vesicle transport along microtubule [GO_1901609]
- 4394: negative regulation of vessel branching [GO_1905554]
- 4395: negative regulation of vitamin metabolic process [GO_0046137]
- 4396: negative regulation of voltage-gated calcium channel activity [GO_1901386]
- 4397: negative regulation of voltage-gated chloride channel activity [GO_1902942]
- 4398: negative regulation of voltage-gated potassium channel activity [GO_1903817]
- 4399: negative regulation of voltage-gated sodium channel activity [GO_1905151]
- 4400: negative regulation of water channel activity [GO_1902428]
- 4401: negative regulation of Wnt signaling pathway [GO_0030178]
- 4402: negative regulation of wound healing [GO_0061045]
- 4403: negative regulation of zinc ion transmembrane transport [GO_0071583]
- 4404: negative regulation of zinc ion transport [GO_0071582]
- 4405: NEIL1,NEIL2 incises DNA strand 5' to the AP site [GO_0003906]
- 4406: NEIL3 cleaves 5-guanidinohydantoin [GO_0019104]
- 4407: nephrocyte filtration [GO_0097206]
- 4408: nerve development [GO_0021675]
- 4409: nerve maturation [GO_0021682]
- 4410: nervous system development [GO_0007399]
- 4411: nervous system process [GO_0050877]
- 4412: netrin receptor activity [GO_0005042]
- 4413: netrin receptor activity involved in chemoattraction [GO_0038006]
- 4414: netrin receptor activity involved in chemorepulsion [GO_0005043]
- 4415: netrin-activated signaling pathway [GO_0038007]
- 4416: network-forming collagen trimer [GO_0098642]
- 4417: neural crest cell development [GO_0014032]
- 4418: neural crest cell differentiation [GO_0014033]
- 4419: neural crest formation [GO_0014029]
- 4420: neural fold formation [GO_0001842]
- 4421: neural keel formation [GO_0014025]
- 4422: neural nucleus development [GO_0048857]
- 4423: neural plate anterior/posterior regionalization [GO_0021999]
- 4424: neural plate development [GO_0001840]
- 4425: neural plate formation [GO_0021990]
- 4426: neural plate morphogenesis [GO_0001839]
- 4427: neural plate pattern specification [GO_0060896]
- 4428: neural plate regionalization [GO_0060897]
- 4429: neural precursor cell proliferation [GO_0061351]
- 4430: neural retina development [GO_0003407]
- 4431: neural rod cavitation [GO_0014024]
- 4432: neural rod formation [GO_0014023]
- 4433: neural tube development [GO_0021915]
- 4434: neural tube formation [GO_0001841]
- 4435: neural tube patterning [GO_0021532]
- 4436: neurexin family protein binding [GO_0042043]
- 4437: neuroblast development [GO_0014019]
- 4438: neuroblast differentiation [GO_0014016]
- 4439: neuroblast division [GO_0055057]
- 4440: neuroblast proliferation [GO_0007405]
- 4441: neuroendocrine cell differentiation [GO_0061101]
- 4442: neuroepithelial cell differentiation [GO_0060563]
- 4443: neurogenesis [GO_0022008]
- 4444: neuroligin family protein binding [GO_0097109]
- 4445: neuromedin U binding [GO_0042924]
- 4446: neuromedin U receptor activity [GO_0001607]
- 4447: neuromuscular junction [GO_0031594]
- 4448: neuromuscular junction development [GO_0007528]
- 4449: neuromuscular junction of myotube [GO_0098523]
- 4450: neuromuscular process [GO_0050905]
- 4451: neuromuscular process controlling balance [GO_0050885]
- 4452: neuromuscular process controlling posture [GO_0050884]
- 4453: neuron apoptotic process [GO_0051402]
- 4454: neuron cellular homeostasis [GO_0070050]
- 4455: neuron death [GO_0070997]
- 4456: neuron development [GO_0048666]
- 4457: neuron differentiation [GO_0030182]
- 4458: neuron maturation [GO_0042551]
- 4459: neuron projection [GO_0043005]
- 4460: neuron projection cytoplasm [GO_0120111]
- 4461: neuron projection development [GO_0031175]
- 4462: neuron projection guidance [GO_0097485]
- 4463: neuron projection membrane [GO_0032589]
- 4464: neuron projection morphogenesis [GO_0048812]
- 4465: neuron projection organization [GO_0106027]
- 4466: neuron-glial cell signaling [GO_0150099]
- 4467: neuron-neuron synaptic transmission [GO_0007270]
- 4468: neuronal action potential [GO_0019228]
- 4469: neuronal cell body [GO_0043025]
- 4470: neuropeptide activity [GO_0160041]
- 4471: neuropeptide binding [GO_0042923]
- 4472: neuropeptide F receptor activity [GO_0042263]
- 4473: neuropeptide F receptor binding [GO_0071859]
- 4474: neuropeptide hormone activity [GO_0005184]
- 4475: neuropeptide receptor activity [GO_0008188]
- 4476: neuropeptide receptor binding [GO_0071855]
- 4477: neuropeptide signaling pathway [GO_0007218]
- 4478: neuropeptide Y receptor activity [GO_0004983]
- 4479: neurotransmitter binding [GO_0042165]
- 4480: neurotransmitter receptor activity [GO_0030594]
- 4481: neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO_0099529]
- 4482: neurotransmitter receptor regulator activity [GO_0099602]
- 4483: neurotransmitter reuptake [GO_0098810]
- 4484: neurotransmitter secretion [GO_0007269]
- 4485: neurotransmitter transport [GO_0006836]
- 4486: neurotransmitter uptake [GO_0001504]
- 4487: neurotransmitter:sodium symporter activity [GO_0005328]
- 4488: neurotrophin binding [GO_0043121]
- 4489: neurotrophin receptor activity [GO_0005030]
- 4490: neurotrophin signaling pathway [GO_0038179]
- 4491: neutral amino acid transmembrane transporter activity [GO_0015175]
- 4492: neutral amino acid transport [GO_0015804]
- 4493: neutral L-amino acid:sodium symporter activity [GO_0005295]
- 4494: neutral lipid biosynthetic process [GO_0046460]
- 4495: neutral lipid metabolic process [GO_0006638]
- 4496: NF-kappaB binding [GO_0051059]
- 4497: nicotinamidase activity [GO_0008936]
- 4498: nicotinamide nucleotide metabolic process [GO_0046496]
- 4499: nicotinate phosphoribosyltransferase activity [GO_0004516]
- 4500: nitric oxide binding [GO_0070026]
- 4501: nitric-oxide synthase activity [GO_0004517]
- 4502: nitric-oxide synthase binding [GO_0050998]
- 4503: nitric-oxide synthase inhibitor activity [GO_0036487]
- 4504: nitric-oxide synthase regulator activity [GO_0030235]
- 4505: nitrite reductase (NO-forming) activity [GO_0050421]
- 4506: nitrite reductase activity [GO_0098809]
- 4507: nitrogen compound metabolic process [GO_0006807]
- 4508: nitrogen compound transport [GO_0071705]
- 4509: NMDA glutamate receptor activity [GO_0004972]
- 4510: NMNAT1 transfers an adenylyl group from ATP to NAMN to yield NAAD [GO_0004515]
- 4511: NMNAT2 transfers an adenylyl group from ATP to NMN to yield NAD+ [GO_0000309]
- 4512: NMRK2 phosphorylates NR to yield NMN [GO_0050262]
- 4513: non-membrane spanning protein tyrosine phosphatase activity [GO_0004726]
- 4514: non-membrane-bounded organelle [GO_0043228]
- 4515: non-membrane-bounded organelle assembly [GO_0140694]
- 4516: non-proteinogenic amino acid metabolic process [GO_0170041]
- 4517: non-ribosomal peptide synthetase activity [GO_1904091]
- 4518: nonribosomal peptide biosynthetic process [GO_0019184]
- 4519: NOP2 (NSUN1) methylates cytidine-4447 of 28S rRNA yielding 5-methylcytidine-4447 [GO_0009383]
- 4520: Noradrenaline clearance from the synaptic cleft [GO_0005326]
- 4521: norepinephrine binding [GO_0051380]
- 4522: norepinephrine biosynthetic process [GO_0042421]
- 4523: norepinephrine catabolic process [GO_0042422]
- 4524: norepinephrine metabolic process [GO_0042415]
- 4525: norepinephrine secretion [GO_0048243]
- 4526: norepinephrine transport [GO_0015874]
- 4527: norepinephrine uptake [GO_0051620]
- 4528: Notch binding [GO_0005112]
- 4529: notochord development [GO_0030903]
- 4530: notochord formation [GO_0014028]
- 4531: notochord morphogenesis [GO_0048570]
- 4532: NOX3 complex:RAC1:GTP generates superoxide from oxygen [GO_0016175]
- 4533: NRAMP1 transports divalent metal ions across phagosomal membranes of macrophages [GO_0051139]
- 4534: NSF-dependent ATP hydrolysis disassembles the cis-SNARE at the TGN [GO_0016887]
- 4535: nsp12 transfers guanylyl onto SARS-CoV-2 plus strand subgenomic RNAs [GO_0004484]
- 4536: nsp13 helicase melts secondary structures in SARS-CoV-2 genomic RNA template [GO_0032574]
- 4537: nsp14 acts as a 3'-to-5' exonuclease to remove misincorporated nucleotides from nascent RNA [GO_0000175]
- 4538: nsp3-4 cleaves itself [GO_0004197]
- 4539: NSUN2 methylates cytidine-34, cytidine-48 of unspliced tRNA(Leu)(CAA) [GO_0016428]
- 4540: NTPDase2 hydrolyzes nucleoside triphosphates [GO_0017111]
- 4541: nuclear chromosome [GO_0000228]
- 4542: nuclear chromosome segregation [GO_0098813]
- 4543: nuclear division [GO_0000280]
- 4544: nuclear DNA replication [GO_0033260]
- 4545: nuclear DNA replication DNA duplex unwinding [GO_1902320]
- 4546: nuclear DNA replication DNA ligation [GO_1902333]
- 4547: Nuclear DUSPs dephosphorylate MAPKs [GO_0008138]
- 4548: nuclear envelope [GO_0005635]
- 4549: nuclear envelope organization [GO_0006998]
- 4550: nuclear export [GO_0051168]
- 4551: nuclear export signal receptor activity [GO_0005049]
- 4552: nuclear fragmentation involved in apoptotic nuclear change [GO_0030264]
- 4553: nuclear glucocorticoid receptor binding [GO_0035259]
- 4554: nuclear import signal receptor activity [GO_0061608]
- 4555: nuclear localization sequence binding [GO_0008139]
- 4556: nuclear lumen [GO_0031981]
- 4557: nuclear membrane [GO_0031965]
- 4558: nuclear membrane biogenesis [GO_0101025]
- 4559: nuclear membrane disassembly [GO_0051081]
- 4560: nuclear membrane fusion [GO_0000740]
- 4561: nuclear membrane fusion involved in karyogamy [GO_0048288]
- 4562: nuclear membrane organization [GO_0071763]
- 4563: nuclear microtubule [GO_0005880]
- 4564: nuclear migration [GO_0007097]
- 4565: nuclear migration along microfilament [GO_0031022]
- 4566: nuclear migration along microtubule [GO_0030473]
- 4567: nuclear outer membrane [GO_0005640]
- 4568: nuclear outer membrane organization [GO_0071764]
- 4569: nuclear outer membrane-endoplasmic reticulum membrane network [GO_0042175]
- 4570: nuclear pore [GO_0005643]
- 4571: nuclear protein-containing complex [GO_0140513]
- 4572: nuclear receptor activity [GO_0004879]
- 4573: nuclear receptor binding [GO_0016922]
- 4574: nuclear receptor coactivator activity [GO_0030374]
- 4575: nuclear receptor corepressor activity [GO_0140536]
- 4576: nuclear steroid receptor activity [GO_0003707]
- 4577: nuclear transport [GO_0051169]
- 4578: nuclease activator activity [GO_0170053]
- 4579: nuclease activity [GO_0004518]
- 4580: nuclease inhibitor activity [GO_0140721]
- 4581: nucleate erythrocyte development [GO_0048823]
- 4582: nucleate erythrocyte differentiation [GO_0043363]
- 4583: nucleate erythrocyte maturation [GO_0043362]
- 4584: nucleic acid binding [GO_0003676]
- 4585: nucleic acid biosynthetic process [GO_0141187]
- 4586: nucleic acid catabolic process [GO_0141188]
- 4587: nucleic acid metabolic process [GO_0090304]
- 4588: nucleic acid phosphodiester bond hydrolysis [GO_0090305]
- 4589: nucleic acid transmembrane transporter activity [GO_0051032]
- 4590: nucleic acid transport [GO_0050657]
- 4591: nucleic acid-templated transcription [GO_0097659]
- 4592: nucleobase binding [GO_0002054]
- 4593: nucleobase biosynthetic process [GO_0046112]
- 4594: nucleobase catabolic process [GO_0046113]
- 4595: nucleobase metabolic process [GO_0009112]
- 4596: nucleobase transmembrane transporter activity [GO_0015205]
- 4597: nucleobase transport [GO_0015851]
- 4598: nucleobase-containing compound biosynthetic process [GO_0034654]
- 4599: nucleobase-containing compound catabolic process [GO_0034655]
- 4600: nucleobase-containing compound kinase activity [GO_0019205]
- 4601: nucleobase-containing compound metabolic process [GO_0006139]
- 4602: nucleobase-containing compound transmembrane transporter activity [GO_0015932]
- 4603: nucleobase-containing compound transport [GO_0015931]
- 4604: nucleobase-containing small molecule catabolic process [GO_0034656]
- 4605: nucleobase-containing small molecule metabolic process [GO_0055086]
- 4606: nucleocytoplasmic carrier activity [GO_0140142]
- 4607: nucleocytoplasmic transport [GO_0006913]
- 4608: nucleoid [GO_0009295]
- 4609: nucleologenesis [GO_0017126]
- 4610: nucleolus [GO_0005730]
- 4611: nucleolus organization [GO_0007000]
- 4612: nucleoside binding [GO_0001882]
- 4613: nucleoside catabolic process [GO_0009164]
- 4614: nucleoside diphosphate catabolic process [GO_0009134]
- 4615: nucleoside diphosphate metabolic process [GO_0009132]
- 4616: nucleoside diphosphate phosphatase activity [GO_0017110]
- 4617: nucleoside diphosphate phosphorylation [GO_0006165]
- 4618: nucleoside kinase activity [GO_0019206]
- 4619: nucleoside metabolic process [GO_0009116]
- 4620: nucleoside monophosphate biosynthetic process [GO_0009124]
- 4621: nucleoside monophosphate metabolic process [GO_0009123]
- 4622: nucleoside monophosphate phosphorylation [GO_0046940]
- 4623: nucleoside phosphate binding [GO_1901265]
- 4624: nucleoside phosphate biosynthetic process [GO_1901293]
- 4625: nucleoside phosphate catabolic process [GO_1901292]
- 4626: nucleoside phosphate metabolic process [GO_0006753]
- 4627: nucleoside transmembrane transport [GO_1901642]
- 4628: nucleoside transport [GO_0015858]
- 4629: nucleoside triphosphate adenylate kinase activity [GO_0046899]
- 4630: nucleoside triphosphate biosynthetic process [GO_0009142]
- 4631: nucleoside triphosphate diphosphatase activity [GO_0047429]
- 4632: nucleoside triphosphate metabolic process [GO_0009141]
- 4633: nucleoside-triphosphatase regulator activity [GO_0060589]
- 4634: nucleosomal DNA binding [GO_0031492]
- 4635: nucleosome [GO_0000786]
- 4636: nucleosome array spacer activity [GO_0140750]
- 4637: nucleosome binding [GO_0031491]
- 4638: nucleotidase activity [GO_0008252]
- 4639: nucleotide binding [GO_0000166]
- 4640: nucleotide biosynthetic process [GO_0009165]
- 4641: nucleotide catabolic process [GO_0009166]
- 4642: nucleotide metabolic process [GO_0009117]
- 4643: nucleotide phosphorylation [GO_0046939]
- 4644: nucleotide transmembrane transport [GO_1901679]
- 4645: nucleotide transmembrane transporter activity [GO_0015215]
- 4646: nucleotide transport [GO_0006862]
- 4647: nucleotide-sugar biosynthetic process [GO_0009226]
- 4648: nucleotide-sugar metabolic process [GO_0009225]
- 4649: nucleotide-sugar transmembrane transport [GO_0015780]
- 4650: nucleotide-sugar transmembrane transporter activity [GO_0005338]
- 4651: nucleus [GO_0005634]
- 4652: nucleus disassembly [GO_1905690]
- 4653: nucleus localization [GO_0051647]
- 4654: nucleus organization [GO_0006997]
- 4655: NUDT12 hydrolyses NADH to NMNH [GO_0035529]
- 4656: NUDT16 hydrolyses IDP to IMP [GO_1990003]
- 4657: NUDT18 hydrolyses 8-oxo-dGDP to 8-oxo-dGMP [GO_0044715]
- 4658: NUDT18 hydrolyses 8-oxo-GDP to 8-oxo-GMP [GO_0044716]
- 4659: nutrient reservoir activity [GO_0045735]
- 4660: O-acetyltransferase activity [GO_0016413]
- 4661: O-glycosylation of 3a is terminated [GO_0008373]
- 4662: O-linoleoyltransferase activity [GO_0032576]
- 4663: O-methyltransferase activity [GO_0008171]
- 4664: O-octanoyltransferase activity [GO_0016414]
- 4665: O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO_0004648]
- 4666: obsolete axon part [GO_0033267]
- 4667: obsolete cell [GO_0005623]
- 4668: obsolete cell part [GO_0044464]
- 4669: obsolete cell projection part [GO_0044463]
- 4670: obsolete membrane part [GO_0044425]
- 4671: obsolete negative regulation of multi-organism process [GO_0043901]
- 4672: obsolete neuron part [GO_0097458]
- 4673: obsolete plasma membrane bounded cell projection part [GO_0120038]
- 4674: obsolete plasma membrane part [GO_0044459]
- 4675: obsolete positive regulation of multi-organism process [GO_0043902]
- 4676: obsolete synapse part [GO_0044456]
- 4677: OCT1 transports organic cations out of hepatic cells [GO_0015101]
- 4678: octanol dehydrogenase activity [GO_0004552]
- 4679: octanoyltransferase activity [GO_0016415]
- 4680: octopamine receptor activity [GO_0004989]
- 4681: octopamine secretion [GO_0061539]
- 4682: octopamine secretion, neurotransmission [GO_0061540]
- 4683: odorant binding [GO_0005549]
- 4684: olefinic compound metabolic process [GO_0120254]
- 4685: olfactory behavior [GO_0042048]
- 4686: olfactory learning [GO_0008355]
- 4687: olfactory receptor activity [GO_0004984]
- 4688: oligopeptidase activity [GO_0070012]
- 4689: oligopeptide binding [GO_1900750]
- 4690: oligopeptide transmembrane transport [GO_0035672]
- 4691: oligopeptide transmembrane transporter activity [GO_0035673]
- 4692: oligopeptide transport [GO_0006857]
- 4693: oligosaccharide binding [GO_0070492]
- 4694: oligosaccharide metabolic process [GO_0009311]
- 4695: oligosaccharide transmembrane transporter activity [GO_0015157]
- 4696: oligosaccharide transport [GO_0015772]
- 4697: oligosaccharide-lipid intermediate biosynthetic process [GO_0006490]
- 4698: oligosaccharyl transferase activity [GO_0004576]
- 4699: OMA1 hydrolyses OPA1 [GO_0004222]
- 4700: omega peptidase activity [GO_0008242]
- 4701: omega-amidase activity [GO_0050152]
- 4702: one-carbon compound transport [GO_0019755]
- 4703: oocyte construction [GO_0007308]
- 4704: oocyte development [GO_0048599]
- 4705: oocyte differentiation [GO_0009994]
- 4706: oocyte growth [GO_0001555]
- 4707: oocyte localization involved in germarium-derived egg chamber formation [GO_0030720]
- 4708: oocyte maturation [GO_0001556]
- 4709: oocyte microtubule cytoskeleton organization [GO_0016325]
- 4710: oocyte morphogenesis [GO_0048601]
- 4711: oogenesis [GO_0048477]
- 4712: ooplasm [GO_1990917]
- 4713: opsin binding [GO_0002046]
- 4714: optic cup morphogenesis involved in camera-type eye development [GO_0002072]
- 4715: optic vesicle formation [GO_0003403]
- 4716: optic vesicle morphogenesis [GO_0003404]
- 4717: optokinetic behavior [GO_0007634]
- 4718: optomotor response [GO_0071632]
- 4719: organ growth [GO_0035265]
- 4720: organ or tissue specific immune response [GO_0002251]
- 4721: organellar ribosome [GO_0000313]
- 4722: organelle [GO_0043226]
- 4723: organelle assembly [GO_0070925]
- 4724: organelle disassembly [GO_1903008]
- 4725: organelle envelope [GO_0031967]
- 4726: organelle fission [GO_0048285]
- 4727: organelle fusion [GO_0048284]
- 4728: organelle inheritance [GO_0048308]
- 4729: organelle localization [GO_0051640]
- 4730: organelle localization by membrane tethering [GO_0140056]
- 4731: organelle lumen [GO_0043233]
- 4732: organelle membrane [GO_0031090]
- 4733: organelle membrane fusion [GO_0090174]
- 4734: organelle organization [GO_0006996]
- 4735: organelle outer membrane [GO_0031968]
- 4736: organelle transport along microtubule [GO_0072384]
- 4737: organic acid binding [GO_0043177]
- 4738: organic acid biosynthetic process [GO_0016053]
- 4739: organic acid catabolic process [GO_0016054]
- 4740: organic acid metabolic process [GO_0006082]
- 4741: organic acid transmembrane transport [GO_1903825]
- 4742: organic acid transmembrane transporter activity [GO_0005342]
- 4743: organic acid transport [GO_0015849]
- 4744: organic anion transport [GO_0015711]
- 4745: organic cation transport [GO_0015695]
- 4746: organic cyclic compound binding [GO_0097159]
- 4747: organic cyclic compound biosynthetic process [GO_1901362]
- 4748: organic cyclic compound catabolic process [GO_1901361]
- 4749: organic cyclic compound metabolic process [GO_1901360]
- 4750: organic hydroxy compound biosynthetic process [GO_1901617]
- 4751: organic hydroxy compound catabolic process [GO_1901616]
- 4752: organic hydroxy compound metabolic process [GO_1901615]
- 4753: organic hydroxy compound transmembrane transporter activity [GO_1901618]
- 4754: organic hydroxy compound transport [GO_0015850]
- 4755: organic substance biosynthetic process [GO_1901576]
- 4756: organic substance catabolic process [GO_1901575]
- 4757: organic substance metabolic process [GO_0071704]
- 4758: organic substance transport [GO_0071702]
- 4759: organism emergence from protective structure [GO_0071684]
- 4760: organonitrogen compound biosynthetic process [GO_1901566]
- 4761: organonitrogen compound catabolic process [GO_1901565]
- 4762: organonitrogen compound metabolic process [GO_1901564]
- 4763: organophosphate biosynthetic process [GO_0090407]
- 4764: organophosphate catabolic process [GO_0046434]
- 4765: organophosphate ester transmembrane transporter activity [GO_0015605]
- 4766: organophosphate ester transport [GO_0015748]
- 4767: organophosphate metabolic process [GO_0019637]
- 4768: organophosphate:inorganic phosphate antiporter activity [GO_0015315]
- 4769: ornithine (cytosolic) + citrulline (mitochondrial) => ornithine (mitochondrial) + citrulline (cytosolic) [GO_0000064]
- 4770: ornithine => putrescine + CO2 [GO_0004586]
- 4771: ornithine decarboxylase activator activity [GO_0042978]
- 4772: ornithine decarboxylase inhibitor activity [GO_0008073]
- 4773: ornithine decarboxylase regulator activity [GO_0042979]
- 4774: ornithine transport [GO_0015822]
- 4775: ornithine-oxo-acid transaminase activity [GO_0004587]
- 4776: orotidine-5'-phosphate decarboxylase activity [GO_0004590]
- 4777: osmosensor activity [GO_0005034]
- 4778: ossification [GO_0001503]
- 4779: ossification involved in bone maturation [GO_0043931]
- 4780: outer membrane [GO_0019867]
- 4781: outflow tract morphogenesis [GO_0003151]
- 4782: outflow tract septum morphogenesis [GO_0003148]
- 4783: outward rectifier potassium channel activity [GO_0015271]
- 4784: outward rectifier potassium channel inhibitor activity [GO_0140628]
- 4785: oviduct development [GO_0060066]
- 4786: oviduct epithelium development [GO_0035846]
- 4787: oviduct morphogenesis [GO_0035848]
- 4788: oviposition [GO_0018991]
- 4789: ovulation cycle [GO_0042698]
- 4790: ovulation cycle process [GO_0022602]
- 4791: oxalate transmembrane transporter activity [GO_0019531]
- 4792: oxalate transport [GO_0019532]
- 4793: oxaloacetate + GTP => phosphoenolpyruvate + GDP + CO2 [cytosol] [GO_0004613]
- 4794: oxaloacetate transmembrane transporter activity [GO_0015131]
- 4795: oxaloacetate transport [GO_0015729]
- 4796: oxaloacetate(2-) transmembrane transport [GO_1902356]
- 4797: oxidative DNA demethylase activity [GO_0035516]
- 4798: oxidative phosphorylation [GO_0006119]
- 4799: oxidized base lesion DNA N-glycosylase activity [GO_0000702]
- 4800: oxidized DNA binding [GO_0032356]
- 4801: oxidized purine DNA binding [GO_0032357]
- 4802: oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO_0000703]
- 4803: oxidoreductase activity, acting on a heme group of donors [GO_0016675]
- 4804: oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO_0016671]
- 4805: oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor [GO_0016668]
- 4806: oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor [GO_0016670]
- 4807: oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor [GO_0016672]
- 4808: oxidoreductase activity, acting on CH or CH2 groups [GO_0016725]
- 4809: oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor [GO_0016728]
- 4810: oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor [GO_0016726]
- 4811: oxidoreductase activity, acting on diphenols and related substances as donors [GO_0016679]
- 4812: oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor [GO_0016682]
- 4813: oxidoreductase activity, acting on iron-sulfur proteins as donors [GO_0016730]
- 4814: oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor [GO_0016731]
- 4815: oxidoreductase activity, acting on metal ions, oxygen as acceptor [GO_0016724]
- 4816: oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO_0016653]
- 4817: oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor [GO_0016657]
- 4818: oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor [GO_0050664]
- 4819: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO_0016655]
- 4820: oxidoreductase activity, acting on other nitrogenous compounds as donors [GO_0016661]
- 4821: oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor [GO_0016662]
- 4822: oxidoreductase activity, acting on other nitrogenous compounds as donors, oxygen as acceptor [GO_0016663]
- 4823: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO_0016705]
- 4824: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO_0016716]
- 4825: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO_0016709]
- 4826: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO_0016715]
- 4827: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen [GO_0016713]
- 4828: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen [GO_0016714]
- 4829: oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO_0016717]
- 4830: oxidoreductase activity, acting on peroxide as acceptor [GO_0016684]
- 4831: oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO_0016701]
- 4832: oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases) [GO_0016703]
- 4833: oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO_0016702]
- 4834: oxidoreductase activity, acting on superoxide radicals as acceptor [GO_0016721]
- 4835: oxidoreductase activity, acting on the aldehyde or oxo group of donors [GO_0016903]
- 4836: oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor [GO_0016624]
- 4837: oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor [GO_0016623]
- 4838: oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor [GO_0016634]
- 4839: oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor [GO_0016635]
- 4840: oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor [GO_0052890]
- 4841: oxidoreductase activity, acting on the CH-NH group of donors [GO_0016645]
- 4842: oxidoreductase activity, acting on the CH-NH group of donors, disulfide as acceptor [GO_0016648]
- 4843: oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor [GO_0046997]
- 4844: oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor [GO_0016646]
- 4845: oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor [GO_0016647]
- 4846: oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor [GO_0016649]
- 4847: oxidoreductase activity, acting on the CH-NH2 group of donors [GO_0016638]
- 4848: oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor [GO_0016642]
- 4849: oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO_0016639]
- 4850: oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor [GO_0016641]
- 4851: oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor [GO_0016899]
- 4852: oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor [GO_0016901]
- 4853: oxidoreductase activity, acting on X-H and Y-H to form an X-Y bond [GO_0046992]
- 4854: oxidoreduction-driven active transmembrane transporter activity [GO_0015453]
- 4855: oxo-acid-lyase activity [GO_0016833]
- 4856: oxoacid metabolic process [GO_0043436]
- 4857: oxoglutarate dehydrogenase (succinyl-transferring) activity [GO_0004591]
- 4858: oxygen binding [GO_0019825]
- 4859: oxygen carrier activity [GO_0005344]
- 4860: oxygen homeostasis [GO_0032364]
- 4861: oxygen metabolic process [GO_0072592]
- 4862: oxygen sensor activity [GO_0019826]
- 4863: oxygen transport [GO_0015671]
- 4864: oxygen-dependent protoporphyrinogen oxidase activity [GO_0004729]
- 4865: p-AMPK phosphorylates TSC1:TSC2 [GO_0004679]
- 4866: P-element binding [GO_0003693]
- 4867: p-hydroxyphenylpyruvate + glutamate <=> tyrosine + alpha-ketoglutarate [GO_0004838]
- 4868: p-S256-Aquaporin-2 passively transports water into cell [GO_0015250]
- 4869: p-S295-PDE3B hydrolyses cAMP to AMP [GO_0004114]
- 4870: p-S400-Cot phosphorylates NIK [GO_0004709]
- 4871: p-S54-PDE4B hydrolyses cAMP [GO_0004115]
- 4872: p-SPHK1 phosphorylates sphingosine to sphingosine 1-phosphate [GO_0017050]
- 4873: P-TEFb complex binding [GO_0106140]
- 4874: P-type ATPases type IV transport internal-facing APLs to external side of the plasma membrane [GO_0140326]
- 4875: P-type manganese transporter activity [GO_0140613]
- 4876: P-type potassium transmembrane transporter activity [GO_0008556]
- 4877: P-type sodium transporter activity [GO_0008554]
- 4878: P-type sodium:potassium-exchanging transporter activity [GO_0005391]
- 4879: P-type transmembrane transporter activity [GO_0140358]
- 4880: p120-RasGAP activates GTP hydrolysis on RAS, inactivating it [GO_0005096]
- 4881: p53 binding [GO_0002039]
- 4882: PA is converted to CDP-DAG by CDS2 [GO_0004605]
- 4883: pagA(197-794):ANTRX2 oligomer transports cya and lef (target cell endosome to cytosol) [GO_0008320]
- 4884: palmitoleoyltransferase activity [GO_1990698]
- 4885: palmitoyl hydrolase activity [GO_0098599]
- 4886: palmitoyl-CoA + serine => 3-ketosphinganine + CoASH + CO2 [GO_0004758]
- 4887: palmitoylation of eNOS [GO_0016409]
- 4888: pancreas development [GO_0031016]
- 4889: pancreas morphogenesis [GO_0061113]
- 4890: pancreatic A cell development [GO_0003322]
- 4891: pancreatic A cell differentiation [GO_0003310]
- 4892: pancreatic bud formation [GO_0061130]
- 4893: pancreatic D cell development [GO_0003324]
- 4894: pancreatic D cell differentiation [GO_0003311]
- 4895: pancreatic PP cell development [GO_0003325]
- 4896: pancreatic PP cell differentiation [GO_0003312]
- 4897: pantothenate kinase activity [GO_0004594]
- 4898: PAPSS1,2 transfer PO4(2-) group from ATP to APS to form PAPS [GO_0004020]
- 4899: paramesonephric duct development [GO_0061205]
- 4900: paraxial mesoderm development [GO_0048339]
- 4901: paraxial mesoderm formation [GO_0048341]
- 4902: paraxial mesoderm morphogenesis [GO_0048340]
- 4903: parietal peritoneum development [GO_1904819]
- 4904: PARN deadenylates mRNA [GO_0004535]
- 4905: PARPs transfer ADP-D-ribose to proteins (poly(ADP-ribosyl)ation) [GO_0003950]
- 4906: Passive I- efflux mediated by SMCT1 [GO_0022803]
- 4907: patched binding [GO_0005113]
- 4908: pattern recognition receptor activity [GO_0038187]
- 4909: pattern specification process [GO_0007389]
- 4910: PC is converted to PS by PTDSS1 [GO_0016740]
- 4911: PC is hydrolyzed to 2-acyl LPC by PLA2G4C [GO_0008970]
- 4912: PC is hydrolyzed to PA and choline by PLD1/2 [GO_0004630]
- 4913: PCho and CTP are condensed to CDP-Cho by PCYT1 dimer [GO_0004105]
- 4914: PCMT1 transfers CH3 from AdoMet to isoAsp to form MetAsp [GO_0004719]
- 4915: PDE6 hydrolyses cGMP to GMP [GO_0047555]
- 4916: PDK isoforms phosphorylate lipo-PDH [GO_0004740]
- 4917: PDPK1 activates PRKCZ [GO_0004676]
- 4918: PDZ domain binding [GO_0030165]
- 4919: Pellino ubiquitinates hp-IRAK1 [GO_0034450]
- 4920: pentosyltransferase activity [GO_0016763]
- 4921: peptidase activator activity [GO_0016504]
- 4922: peptidase activator activity involved in apoptotic process [GO_0016505]
- 4923: peptidase inhibitor activity [GO_0030414]
- 4924: peptidase regulator activity [GO_0061134]
- 4925: peptide binding [GO_0042277]
- 4926: peptide biosynthetic process [GO_0043043]
- 4927: peptide catabolic process [GO_0043171]
- 4928: peptide deformylase activity [GO_0042586]
- 4929: peptide hormone binding [GO_0017046]
- 4930: peptide hormone receptor binding [GO_0051428]
- 4931: peptide hormone secretion [GO_0030072]
- 4932: peptide metabolic process [GO_0006518]
- 4933: peptide receptor activity [GO_0001653]
- 4934: peptide secretion [GO_0002790]
- 4935: peptide transport [GO_0015833]
- 4936: peptide-glutamate-alpha-N-acetyltransferase activity [GO_1990190]
- 4937: peptide-serine-alpha-N-acetyltransferase activity [GO_1990189]
- 4938: peptidoglycan binding [GO_0042834]
- 4939: peptidoglycan immune receptor activity [GO_0016019]
- 4940: peptidoglycan muralytic activity [GO_0061783]
- 4941: peptidoglycan transmembrane transporter activity [GO_0015647]
- 4942: peptidoglycan transport [GO_0015835]
- 4943: peptidyl-amino acid modification [GO_0018193]
- 4944: peptidyl-aspartic acid 3-dioxygenase activity [GO_0062101]
- 4945: peptidyl-cysteine S-nitrosylase activity [GO_0035605]
- 4946: peptidyl-dipeptidase activity [GO_0008241]
- 4947: peptidyl-lysine 5-dioxygenase activity [GO_0070815]
- 4948: peptidyl-lysine desuccinylation [GO_0036049]
- 4949: peptidyl-lysine modification [GO_0018205]
- 4950: peptidyl-proline dioxygenase activity [GO_0031543]
- 4951: peptidyl-proline hydroxylation [GO_0019511]
- 4952: peptidyl-proline modification [GO_0018208]
- 4953: peptidyl-tyrosine modification [GO_0018212]
- 4954: peptidyl-tyrosine phosphorylation [GO_0018108]
- 4955: peptidylamidoglycolate lyase activity [GO_0004598]
- 4956: peptidylglycine monooxygenase activity [GO_0004504]
- 4957: pericardium development [GO_0060039]
- 4958: pericardium morphogenesis [GO_0003344]
- 4959: peripheral nervous system development [GO_0007422]
- 4960: peripheral nervous system neuron development [GO_0048935]
- 4961: peripheral nervous system neuron differentiation [GO_0048934]
- 4962: peristalsis [GO_0030432]
- 4963: peritoneum development [GO_1904820]
- 4964: peroxidase activity [GO_0004601]
- 4965: peroxisome matrix targeting signal-1 binding [GO_0005052]
- 4966: peroxisome matrix targeting signal-2 binding [GO_0005053]
- 4967: peroxisome membrane targeting sequence binding [GO_0033328]
- 4968: peroxisome targeting sequence binding [GO_0000268]
- 4969: Peroxynitrite is reduced by AhpE [GO_0051920]
- 4970: Persulfide sulfur is dioxygenated [GO_0050313]
- 4971: PETA and CTP are condensed to CDP-ETA by PCY2 [GO_0004306]
- 4972: PEX1:PEX6:PEX26:ZFAND6:Ub:PEX5S,L:PEX14:PEX13:PEX2:PEX10:PEX12 dissociates yielding cytosolic Ub:PEX5S,L and membrane PEX14:PEX13:PEX2:PEX10:PEX12 [GO_0042626]
- 4973: PGLYRP2 hydrolyzes bacterial peptidoglycan [GO_0008745]
- 4974: PGM:Mg2+ isomerise G1P to G6P [GO_0004614]
- 4975: PGM2:Mg2+ isomerises dR1P to dR5P [GO_0008973]
- 4976: pH-gated chloride channel activity [GO_0061797]
- 4977: pH-gated monoatomic ion channel activity [GO_0160128]
- 4978: pharyngeal arch artery morphogenesis [GO_0061626]
- 4979: pharyngeal gland morphogenesis [GO_1905905]
- 4980: pharyngeal system development [GO_0060037]
- 4981: pharynx development [GO_0060465]
- 4982: pharynx morphogenesis [GO_0110040]
- 4983: phasic smooth muscle contraction [GO_0014821]
- 4984: phenol-containing compound biosynthetic process [GO_0046189]
- 4985: phenol-containing compound catabolic process [GO_0019336]
- 4986: phenol-containing compound metabolic process [GO_0018958]
- 4987: phenylalanine + tRNA(Phe) + ATP => Phe-tRNA(Phe) + AMP + pyrophosphate [GO_0004826]
- 4988: phenylalkylamine binding [GO_0008145]
- 4989: pheromone binding [GO_0005550]
- 4990: pheromone receptor activity [GO_0016503]
- 4991: PHF8 demethylates histone H4K20me1 [GO_0035575]
- 4992: PHGHD tetramer dehydrogenates 3PG [GO_0004617]
- 4993: phosphatase activator activity [GO_0019211]
- 4994: phosphatase activity [GO_0016791]
- 4995: phosphatase binding [GO_0019902]
- 4996: phosphatase inhibitor activity [GO_0019212]
- 4997: phosphatase regulator activity [GO_0019208]
- 4998: phosphate ion binding [GO_0042301]
- 4999: phosphate ion homeostasis [GO_0055062]
- 5000: phosphate ion transmembrane transport [GO_0035435]
- 5001: phosphate ion transmembrane transporter activity [GO_0015114]
- 5002: phosphate ion transport [GO_0006817]
- 5003: phosphate-containing compound metabolic process [GO_0006796]
- 5004: phosphatidic acid binding [GO_0070300]
- 5005: phosphatidic acid transfer activity [GO_1990050]
- 5006: phosphatidylcholine + ceramide <=> sphingomyelin + diacylglycerol [SGMS2] [GO_0033188]
- 5007: phosphatidylcholine binding [GO_0031210]
- 5008: phosphatidylcholine biosynthetic process [GO_0006656]
- 5009: phosphatidylcholine metabolic process [GO_0046470]
- 5010: phosphatidylcholine transporter activity [GO_0008525]
- 5011: phosphatidylcholine:cardiolipin O-linoleoyltransferase activity [GO_0032577]
- 5012: phosphatidylethanolamine binding [GO_0008429]
- 5013: phosphatidylinositol + UDP-N-acetyl-D-glucosamine -> N-acetylglucosaminyl-PI + UDP [GO_0008194]
- 5014: phosphatidylinositol 3-kinase activator activity [GO_0141038]
- 5015: phosphatidylinositol 3-kinase binding [GO_0043548]
- 5016: phosphatidylinositol 3-kinase catalytic subunit binding [GO_0036313]
- 5017: phosphatidylinositol 3-kinase regulator activity [GO_0035014]
- 5018: phosphatidylinositol binding [GO_0035091]
- 5019: phosphatidylinositol biosynthetic process [GO_0006661]
- 5020: phosphatidylinositol bisphosphate binding [GO_1902936]
- 5021: phosphatidylinositol bisphosphate kinase activity [GO_0052813]
- 5022: phosphatidylinositol bisphosphate phosphatase activity [GO_0034593]
- 5023: phosphatidylinositol deacylase activity [GO_0050185]
- 5024: phosphatidylinositol kinase activity [GO_0052742]
- 5025: phosphatidylinositol metabolic process [GO_0046488]
- 5026: phosphatidylinositol monophosphate phosphatase activity [GO_0052744]
- 5027: phosphatidylinositol N-acetylglucosaminyltransferase activity [GO_0017176]
- 5028: phosphatidylinositol phosphate 5-phosphatase activity [GO_0034595]
- 5029: phosphatidylinositol phosphate binding [GO_1901981]
- 5030: phosphatidylinositol phosphate biosynthetic process [GO_0046854]
- 5031: phosphatidylinositol phosphate kinase activity [GO_0016307]
- 5032: phosphatidylinositol phosphate phosphatase activity [GO_0052866]
- 5033: phosphatidylinositol trisphosphate phosphatase activity [GO_0034594]
- 5034: phosphatidylinositol-3-phosphate binding [GO_0032266]
- 5035: phosphatidylinositol-3-phosphate biosynthetic process [GO_0036092]
- 5036: phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO_0016316]
- 5037: phosphatidylinositol-3,4-bisphosphate binding [GO_0043325]
- 5038: phosphatidylinositol-3,4-bisphosphate phosphatase activity [GO_0106017]
- 5039: phosphatidylinositol-3,4,5-trisphosphate binding [GO_0005547]
- 5040: phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO_0052629]
- 5041: phosphatidylinositol-3,5-bisphosphate binding [GO_0080025]
- 5042: phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO_0106018]
- 5043: phosphatidylinositol-4-phosphate binding [GO_0070273]
- 5044: phosphatidylinositol-4-phosphate phosphatase activity [GO_0043812]
- 5045: phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO_0034597]
- 5046: phosphatidylinositol-4,5-bisphosphate binding [GO_0005546]
- 5047: phosphatidylinositol-4,5-bisphosphate phosphatase activity [GO_0106019]
- 5048: phosphatidylinositol-5-phosphate binding [GO_0010314]
- 5049: phosphatidylserine binding [GO_0001786]
- 5050: phosphatidylserine decarboxylase activity [GO_0004609]
- 5051: phosphatidyltransferase activity [GO_0030572]
- 5052: phosphoenolpyruvate + ADP => pyruvate + ATP [GO_0004743]
- 5053: phosphoenolpyruvate carboxykinase activity [GO_0004611]
- 5054: phosphofructokinase activity [GO_0008443]
- 5055: phosphogluconate dehydrogenase (decarboxylating) activity [GO_0004616]
- 5056: phospholipase A2 activator activity [GO_0016005]
- 5057: phospholipase activator activity [GO_0016004]
- 5058: phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO_0030845]
- 5059: phospholipase D activator activity [GO_1990583]
- 5060: phospholipid binding [GO_0005543]
- 5061: phospholipid biosynthetic process [GO_0008654]
- 5062: phospholipid metabolic process [GO_0006644]
- 5063: phospholipid scramblase activity [GO_0017128]
- 5064: phospholipid transfer activity [GO_0120014]
- 5065: phospholipid translocation [GO_0045332]
- 5066: phospholipid transport [GO_0015914]
- 5067: phosphopantetheine binding [GO_0031177]
- 5068: phosphopantetheine-dependent carrier activity [GO_0140414]
- 5069: phosphopantothenoylcysteine decarboxylase activity [GO_0004633]
- 5070: phosphoprotein binding [GO_0051219]
- 5071: phosphoribosylaminoimidazole carboxylase activity [GO_0004638]
- 5072: phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO_0004643]
- 5073: phosphoribosylformylglycinamidine cyclo-ligase activity [GO_0004641]
- 5074: phosphoribosylglycinamide formyltransferase activity [GO_0004644]
- 5075: phosphoric diester hydrolase activity [GO_0008081]
- 5076: phosphoric ester hydrolase activity [GO_0042578]
- 5077: phosphorus metabolic process [GO_0006793]
- 5078: phosphorus-oxygen lyase activity [GO_0016849]
- 5079: phosphorylase kinase regulator activity [GO_0008607]
- 5080: Phosphorylated GYS1 catalyzes the polyglucosylation of oligoGlc-GYG1 [GO_0004373]
- 5081: phosphorylation [GO_0016310]
- 5082: Phosphorylation of NEFL by the P-TEFb(Cyclin T1:Cdk9) complex [GO_0008353]
- 5083: Phosphorylation of human JNKs by activated MKK4/MKK7 [GO_0008545]
- 5084: Phosphorylation of STAT1 at Ser727 [GO_0004697]
- 5085: phosphoserine residue binding [GO_0050815]
- 5086: phosphotransferase activity, alcohol group as acceptor [GO_0016773]
- 5087: phosphotransferase activity, carboxyl group as acceptor [GO_0016774]
- 5088: phosphotransferase activity, for other substituted phosphate groups [GO_0016780]
- 5089: phosphotransferase activity, nitrogenous group as acceptor [GO_0016775]
- 5090: phosphotransferase activity, paired acceptors [GO_0016781]
- 5091: phosphotransferase activity, phosphate group as acceptor [GO_0016776]
- 5092: phosphotyrosine residue binding [GO_0001784]
- 5093: photoperiodism [GO_0009648]
- 5094: photoreceptor activity [GO_0009881]
- 5095: photoreceptor cell development [GO_0042461]
- 5096: photoreceptor cell differentiation [GO_0046530]
- 5097: photoreceptor cell morphogenesis [GO_0008594]
- 5098: phototaxis [GO_0042331]
- 5099: phototransduction [GO_0007602]
- 5100: phototransduction, visible light [GO_0007603]
- 5101: physiological cardiac muscle hypertrophy [GO_0003301]
- 5102: physiological muscle hypertrophy [GO_0003298]
- 5103: PI is phosphorylated to PI4P by PI4KB at the Golgi membrane [GO_0004430]
- 5104: PI(3,4)P2 is dephosphorylated to PI4P by PTEN at the plasma membrane [GO_0051800]
- 5105: PI(3,5)P2 is dephosphorylated to PI3P by SYNJ at the plasma membrane [GO_0043813]
- 5106: PI(4,5)P2, PI(3,4)P2 and PI(3,4,5)P3 are dephosphorylated to PI5P, PI3P and PI(3,4)P by INPP5F at the endosome membrane [GO_0034596]
- 5107: PI3K-containing complexes phosphorylate PIP2 to PIP3 [GO_0016303]
- 5108: PI3P is dephosphorylated to PI by MTMR9-bound MTMR8 or MTMR6 at the plasma membrane [GO_0004438]
- 5109: PI3P is phosphorylated to PI(3,5)P2 by PIKFYVE at the Golgi membrane [GO_0000285]
- 5110: PI4P is phosphorylated to PI(3,4)P2 by PIK3C2A/G at the Golgi membrane [GO_0035005]
- 5111: PI4P is phosphorylated to PI(4,5)P2 by PIP5K1A-C at the plasma membrane [GO_0016308]
- 5112: pigment binding [GO_0031409]
- 5113: pigment cell development [GO_0070285]
- 5114: pigment cell differentiation [GO_0050931]
- 5115: pigment granule [GO_0048770]
- 5116: pigment granule localization [GO_0051875]
- 5117: pigment granule membrane [GO_0090741]
- 5118: pigment granule organization [GO_0048753]
- 5119: pigment granule transport [GO_0051904]
- 5120: pigmentation [GO_0043473]
- 5121: piRNA binding [GO_0034584]
- 5122: piRNA cluster binding [GO_1990470]
- 5123: PITPNM1,2,3 exchange PI for PA [GO_0008526]
- 5124: PLA2G15 hydrolyses LPC to GPCho and LCFA(-) [GO_0047499]
- 5125: placenta blood vessel development [GO_0060674]
- 5126: placenta development [GO_0001890]
- 5127: plasma membrane [GO_0005886]
- 5128: plasma membrane bounded cell projection [GO_0120025]
- 5129: plasma membrane bounded cell projection assembly [GO_0120031]
- 5130: plasma membrane bounded cell projection cytoplasm [GO_0032838]
- 5131: plasma membrane bounded cell projection morphogenesis [GO_0120039]
- 5132: plasma membrane bounded cell projection organization [GO_0120036]
- 5133: plasma membrane fusion [GO_0045026]
- 5134: plasma membrane organization [GO_0007009]
- 5135: plasma membrane phospholipid scrambling [GO_0017121]
- 5136: plasma membrane protein complex [GO_0098797]
- 5137: plasma membrane region [GO_0098590]
- 5138: PLC gamma 2-mediated PIP2 hydrolysis [GO_0004629]
- 5139: PLD6 dimer hydrolyses cardiolipin to PA and PG [GO_0035755]
- 5140: plus-end directed microfilament motor activity [GO_0060002]
- 5141: plus-end-directed microtubule motor activity [GO_0008574]
- 5142: PMM1,2 isomerise Man6P to Man1P [GO_0004615]
- 5143: PNPLA4 hydrolyzes TAG [GO_0004806]
- 5144: POFUT2 transfers fucose to TSR domain-containing proteins [GO_0046922]
- 5145: POLB incorporates a single nucleotide in place of excised AP residue in NEIL1,NEIL2-mediated AP site resolution [GO_0003887]
- 5146: poly-ADP-D-ribose binding [GO_0072572]
- 5147: poly-purine tract binding [GO_0070717]
- 5148: poly-pyrimidine tract binding [GO_0008187]
- 5149: poly((1,4)-alpha-glycosyl) glycogenin-1 + n orthophosphate => glycogenin-1 + n D-glucose 1-phosphate [PYGM,PYGB] [GO_0008184]
- 5150: poly(A) binding [GO_0008143]
- 5151: poly(ADP-ribose) glycohydrolase activity [GO_0004649]
- 5152: poly(G) binding [GO_0034046]
- 5153: poly(U) RNA binding [GO_0008266]
- 5154: polyamine oxidase activity [GO_0046592]
- 5155: polyamine transmembrane transport [GO_1902047]
- 5156: polyamine transmembrane transporter activity [GO_0015203]
- 5157: polyamine transport [GO_0015846]
- 5158: Polyglutamylase complex (TTLL1) polyglutamylates alpha subunits of tubulin [GO_0070740]
- 5159: polymeric cytoskeletal fiber [GO_0099513]
- 5160: polynucleotide 3'-phosphatase activity [GO_0046403]
- 5161: polynucleotide 5'-hydroxyl-kinase activity [GO_0051731]
- 5162: polynucleotide 5'-phosphatase activity [GO_0004651]
- 5163: polynucleotide adenylyltransferase activator activity [GO_1990749]
- 5164: polypeptide N-acetylgalactosaminyltransferase activity [GO_0004653]
- 5165: polyprenyltransferase activity [GO_0002094]
- 5166: polyribonucleotide nucleotidyltransferase activity [GO_0004654]
- 5167: polysaccharide binding [GO_0030247]
- 5168: polysaccharide biosynthetic process [GO_0000271]
- 5169: polysaccharide catabolic process [GO_0000272]
- 5170: polysaccharide immune receptor activity [GO_0001873]
- 5171: polysaccharide localization [GO_0033037]
- 5172: polysaccharide metabolic process [GO_0005976]
- 5173: polysaccharide transmembrane transporter activity [GO_0015159]
- 5174: polysaccharide transport [GO_0015774]
- 5175: polysome binding [GO_1905538]
- 5176: polyubiquitin modification-dependent protein binding [GO_0031593]
- 5177: POMGNT2 transfers GlcNAc to Man-DAG1 [GO_0008375]
- 5178: POMT1:POMT2 transfers Man from Dol-P-Man to DAG1(30-653) [GO_0004169]
- 5179: pons development [GO_0021548]
- 5180: pons formation [GO_0021584]
- 5181: pons maturation [GO_0021586]
- 5182: pons morphogenesis [GO_0021583]
- 5183: POR reduces CYP450:Fe3+ to CYP450:Fe2+ [GO_0003958]
- 5184: porin activity [GO_0015288]
- 5185: positive chemotaxis [GO_0050918]
- 5186: positive regulation of 1-phosphatidylinositol 4-kinase activity [GO_0043128]
- 5187: positive regulation of 1-phosphatidylinositol-3-kinase activity [GO_0061903]
- 5188: positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO_0090216]
- 5189: positive regulation of acetylcholine secretion, neurotransmission [GO_0014057]
- 5190: positive regulation of acid-sensing ion channel activity [GO_1901587]
- 5191: positive regulation of acinar cell proliferation [GO_1904699]
- 5192: positive regulation of aconitate hydratase activity [GO_1904234]
- 5193: positive regulation of actin binding [GO_1904618]
- 5194: positive regulation of actin filament binding [GO_1904531]
- 5195: positive regulation of actin filament bundle assembly [GO_0032233]
- 5196: positive regulation of actin filament-based movement [GO_1903116]
- 5197: positive regulation of action potential [GO_0045760]
- 5198: positive regulation of activin receptor signaling pathway [GO_0032927]
- 5199: positive regulation of adenosine receptor signaling pathway [GO_0060168]
- 5200: positive regulation of adenylate cyclase activity [GO_0045762]
- 5201: positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO_0071879]
- 5202: positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO_0106071]
- 5203: positive regulation of adipose tissue development [GO_1904179]
- 5204: positive regulation of alkaline phosphatase activity [GO_0010694]
- 5205: positive regulation of alpha-(1->3)-fucosyltransferase activity [GO_1905621]
- 5206: positive regulation of amine transport [GO_0051954]
- 5207: positive regulation of amino acid transport [GO_0051957]
- 5208: positive regulation of aminoacyl-tRNA ligase activity [GO_1903632]
- 5209: positive regulation of amyloid precursor protein catabolic process [GO_1902993]
- 5210: positive regulation of androgen receptor activity [GO_2000825]
- 5211: positive regulation of androgen secretion [GO_2000836]
- 5212: positive regulation of angiogenesis [GO_0045766]
- 5213: positive regulation of animal organ morphogenesis [GO_0110110]
- 5214: positive regulation of anion channel activity [GO_1901529]
- 5215: positive regulation of anion transmembrane transport [GO_1903961]
- 5216: positive regulation of anion transport [GO_1903793]
- 5217: positive regulation of aorta morphogenesis [GO_1903849]
- 5218: positive regulation of aortic smooth muscle cell differentiation [GO_1904831]
- 5219: positive regulation of apical ectodermal ridge formation [GO_1905142]
- 5220: positive regulation of apolipoprotein binding [GO_2000658]
- 5221: positive regulation of apoptotic process [GO_0043065]
- 5222: positive regulation of apoptotic process involved in development [GO_1904747]
- 5223: positive regulation of apoptotic process involved in morphogenesis [GO_1902339]
- 5224: positive regulation of apoptotic process involved in outflow tract morphogenesis [GO_1902258]
- 5225: positive regulation of apoptotic signaling pathway [GO_2001235]
- 5226: positive regulation of arginase activity [GO_0150072]
- 5227: positive regulation of argininosuccinate synthase activity [GO_1905753]
- 5228: positive regulation of artery morphogenesis [GO_1905653]
- 5229: positive regulation of aspartic endopeptidase activity, intramembrane cleaving [GO_0120289]
- 5230: positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902961]
- 5231: positive regulation of aspartic-type peptidase activity [GO_1905247]
- 5232: positive regulation of asymmetric cell division [GO_0045770]
- 5233: positive regulation of ATP biosynthetic process [GO_2001171]
- 5234: positive regulation of ATP citrate synthase activity [GO_2000985]
- 5235: positive regulation of ATP metabolic process [GO_1903580]
- 5236: positive regulation of ATP-dependent activity [GO_0032781]
- 5237: positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO_1901896]
- 5238: positive regulation of AV node cell action potential [GO_1903951]
- 5239: positive regulation of axo-dendritic protein transport [GO_1905128]
- 5240: positive regulation of axon guidance [GO_1902669]
- 5241: positive regulation of axonogenesis [GO_0050772]
- 5242: positive regulation of backward locomotion [GO_1905852]
- 5243: positive regulation of behavior [GO_0048520]
- 5244: positive regulation of beta-galactosidase activity [GO_1903771]
- 5245: positive regulation of bile acid biosynthetic process [GO_0070859]
- 5246: positive regulation of bile acid metabolic process [GO_1904253]
- 5247: positive regulation of bile acid secretion [GO_0120189]
- 5248: positive regulation of binding [GO_0051099]
- 5249: positive regulation of biological process [GO_0048518]
- 5250: positive regulation of biosynthetic process [GO_0009891]
- 5251: positive regulation of bleb assembly [GO_1904172]
- 5252: positive regulation of blood circulation [GO_1903524]
- 5253: positive regulation of blood vessel branching [GO_1905555]
- 5254: positive regulation of blood vessel endothelial cell differentiation [GO_0110058]
- 5255: positive regulation of BMP signaling pathway [GO_0030513]
- 5256: positive regulation of bone development [GO_1903012]
- 5257: positive regulation of branching involved in lung morphogenesis [GO_0061047]
- 5258: positive regulation of branching morphogenesis of a nerve [GO_1905492]
- 5259: positive regulation of calcium ion binding [GO_1901878]
- 5260: positive regulation of calcium ion transmembrane transport [GO_1904427]
- 5261: positive regulation of calcium ion transmembrane transporter activity [GO_1901021]
- 5262: positive regulation of calcium ion transport [GO_0051928]
- 5263: positive regulation of calcium-dependent ATPase activity [GO_1903612]
- 5264: positive regulation of calcium-mediated signaling [GO_0050850]
- 5265: positive regulation of calcium:sodium antiporter activity [GO_1903281]
- 5266: positive regulation of cAMP-dependent protein kinase activity [GO_2000481]
- 5267: positive regulation of cAMP-mediated signaling [GO_0043950]
- 5268: positive regulation of canonical NF-kappaB signal transduction [GO_0043123]
- 5269: positive regulation of carbohydrate metabolic process [GO_0045913]
- 5270: positive regulation of cardiac chamber formation [GO_1901212]
- 5271: positive regulation of cardiac chamber morphogenesis [GO_1901221]
- 5272: positive regulation of cardiac conduction [GO_1903781]
- 5273: positive regulation of cardiac muscle adaptation [GO_0010615]
- 5274: positive regulation of cardiac muscle cell apoptotic process [GO_0010666]
- 5275: positive regulation of cardiac muscle cell differentiation [GO_2000727]
- 5276: positive regulation of cardiac muscle cell myoblast differentiation [GO_2000700]
- 5277: positive regulation of cardiac muscle cell proliferation [GO_0060045]
- 5278: positive regulation of cardiac muscle contraction [GO_0060452]
- 5279: positive regulation of cardiac muscle fiber development [GO_0055020]
- 5280: positive regulation of cardiac muscle hypertrophy [GO_0010613]
- 5281: positive regulation of cardiac muscle myoblast proliferation [GO_0110024]
- 5282: positive regulation of cardiac muscle tissue development [GO_0055025]
- 5283: positive regulation of cardiac muscle tissue growth [GO_0055023]
- 5284: positive regulation of cardiac myofibril assembly [GO_1905306]
- 5285: positive regulation of cardiac ventricle development [GO_1904414]
- 5286: positive regulation of cardiac ventricle formation [GO_1904944]
- 5287: positive regulation of cardioblast differentiation [GO_0051891]
- 5288: positive regulation of cardiocyte differentiation [GO_1905209]
- 5289: positive regulation of cartilage development [GO_0061036]
- 5290: positive regulation of catabolic process [GO_0009896]
- 5291: positive regulation of catalase activity [GO_1902553]
- 5292: positive regulation of catalytic activity [GO_0043085]
- 5293: positive regulation of catecholamine metabolic process [GO_0045915]
- 5294: positive regulation of catecholamine secretion [GO_0033605]
- 5295: positive regulation of cation channel activity [GO_2001259]
- 5296: positive regulation of cation transmembrane transport [GO_1904064]
- 5297: positive regulation of CD4 production [GO_0045224]
- 5298: positive regulation of cell adhesion [GO_0045785]
- 5299: positive regulation of cell communication [GO_0010647]
- 5300: positive regulation of cell cycle [GO_0045787]
- 5301: positive regulation of cell cycle process [GO_0090068]
- 5302: positive regulation of cell death [GO_0010942]
- 5303: positive regulation of cell development [GO_0010720]
- 5304: positive regulation of cell differentiation [GO_0045597]
- 5305: positive regulation of cell division [GO_0051781]
- 5306: positive regulation of cell fate commitment [GO_0010455]
- 5307: positive regulation of cell growth [GO_0030307]
- 5308: positive regulation of cell growth involved in cardiac muscle cell development [GO_0061051]
- 5309: positive regulation of cell junction assembly [GO_1901890]
- 5310: positive regulation of cell maturation [GO_1903431]
- 5311: positive regulation of cell migration [GO_0030335]
- 5312: positive regulation of cell morphogenesis involved in differentiation [GO_0010770]
- 5313: positive regulation of cell motility [GO_2000147]
- 5314: positive regulation of cell population proliferation [GO_0008284]
- 5315: positive regulation of cell projection organization [GO_0031346]
- 5316: positive regulation of cell proliferation in midbrain [GO_1904935]
- 5317: positive regulation of cell proliferation involved in compound eye morphogenesis [GO_2000497]
- 5318: positive regulation of cell proliferation involved in heart morphogenesis [GO_2000138]
- 5319: positive regulation of cell proliferation involved in outflow tract morphogenesis [GO_1901964]
- 5320: positive regulation of cell-cell adhesion [GO_0022409]
- 5321: positive regulation of cellular amide metabolic process [GO_0034250]
- 5322: positive regulation of cellular amine catabolic process [GO_0033243]
- 5323: positive regulation of cellular amine metabolic process [GO_0033240]
- 5324: positive regulation of cellular amino acid biosynthetic process [GO_2000284]
- 5325: positive regulation of cellular amino acid metabolic process [GO_0045764]
- 5326: positive regulation of cellular biosynthetic process [GO_0031328]
- 5327: positive regulation of cellular carbohydrate metabolic process [GO_0010676]
- 5328: positive regulation of cellular catabolic process [GO_0031331]
- 5329: positive regulation of cellular component biogenesis [GO_0044089]
- 5330: positive regulation of cellular component movement [GO_0051272]
- 5331: positive regulation of cellular component organization [GO_0051130]
- 5332: positive regulation of cellular metabolic process [GO_0031325]
- 5333: positive regulation of cellular process [GO_0048522]
- 5334: positive regulation of cellular protein metabolic process [GO_0032270]
- 5335: positive regulation of cellular respiration [GO_1901857]
- 5336: positive regulation of cellular response to alcohol [GO_1905959]
- 5337: positive regulation of cellular response to drug [GO_2001040]
- 5338: positive regulation of cellular response to insulin stimulus [GO_1900078]
- 5339: positive regulation of cellular response to oxidative stress [GO_1900409]
- 5340: positive regulation of chemorepellent activity [GO_1903669]
- 5341: positive regulation of chemotaxis [GO_0050921]
- 5342: positive regulation of cholangiocyte apoptotic process [GO_1904194]
- 5343: positive regulation of cholangiocyte proliferation [GO_1904056]
- 5344: positive regulation of choline O-acetyltransferase activity [GO_1902771]
- 5345: positive regulation of chondrocyte development [GO_1902761]
- 5346: positive regulation of chondrocyte differentiation [GO_0032332]
- 5347: positive regulation of chorionic trophoblast cell proliferation [GO_1901384]
- 5348: positive regulation of chromatin assembly or disassembly [GO_0045799]
- 5349: positive regulation of chromatin binding [GO_0035563]
- 5350: positive regulation of chromatin organization [GO_1905269]
- 5351: positive regulation of chromosome condensation [GO_1905821]
- 5352: positive regulation of chromosome organization [GO_2001252]
- 5353: positive regulation of chromosome segregation [GO_0051984]
- 5354: positive regulation of cilium assembly [GO_0045724]
- 5355: positive regulation of circadian rhythm [GO_0042753]
- 5356: positive regulation of circadian sleep/wake cycle, sleep [GO_0045938]
- 5357: positive regulation of CoA-transferase activity [GO_1905920]
- 5358: positive regulation of collagen binding [GO_0033343]
- 5359: positive regulation of collagen biosynthetic process [GO_0032967]
- 5360: positive regulation of collagen catabolic process [GO_0120158]
- 5361: positive regulation of collagen fibril organization [GO_1904028]
- 5362: positive regulation of collagen metabolic process [GO_0010714]
- 5363: positive regulation of colon smooth muscle contraction [GO_1904343]
- 5364: positive regulation of compound eye photoreceptor cell differentiation [GO_0110117]
- 5365: positive regulation of compound eye retinal cell apoptotic process [GO_1901694]
- 5366: positive regulation of compound eye retinal cell programmed cell death [GO_0046672]
- 5367: positive regulation of copper ion transmembrane transport [GO_1902313]
- 5368: positive regulation of core promoter binding [GO_1904798]
- 5369: positive regulation of coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060727]
- 5370: positive regulation of cyclase activity [GO_0031281]
- 5371: positive regulation of cyclic nucleotide-gated ion channel activity [GO_1902161]
- 5372: positive regulation of cyclic-nucleotide phosphodiesterase activity [GO_0051343]
- 5373: positive regulation of cyclin-dependent protein kinase activity [GO_1904031]
- 5374: positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO_0045737]
- 5375: positive regulation of cystathionine beta-synthase activity [GO_1904043]
- 5376: positive regulation of cysteine metabolic process [GO_1901496]
- 5377: positive regulation of cysteine-type endopeptidase activity [GO_2001056]
- 5378: positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0043280]
- 5379: positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO_2001269]
- 5380: positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_2001272]
- 5381: positive regulation of cytochrome-c oxidase activity [GO_1904960]
- 5382: positive regulation of cytokine activity [GO_0060301]
- 5383: positive regulation of cytokine-mediated signaling pathway [GO_0001961]
- 5384: positive regulation of cytokinesis [GO_0032467]
- 5385: positive regulation of cytoskeleton organization [GO_0051495]
- 5386: positive regulation of D-amino-acid oxidase activity [GO_1900759]
- 5387: positive regulation of D-erythro-sphingosine kinase activity [GO_1900023]
- 5388: positive regulation of deacetylase activity [GO_0090045]
- 5389: positive regulation of defecation [GO_2000294]
- 5390: positive regulation of delayed rectifier potassium channel activity [GO_1902261]
- 5391: positive regulation of deoxyribonuclease activity [GO_0032077]
- 5392: positive regulation of dephosphorylation [GO_0035306]
- 5393: positive regulation of dermatome development [GO_0061184]
- 5394: positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO_1905789]
- 5395: positive regulation of developmental growth [GO_0048639]
- 5396: positive regulation of developmental pigmentation [GO_0048087]
- 5397: positive regulation of developmental process [GO_0051094]
- 5398: positive regulation of diacylglycerol kinase activity [GO_1905689]
- 5399: positive regulation of digestive system process [GO_0060456]
- 5400: positive regulation of dipeptide transmembrane transport [GO_2001150]
- 5401: positive regulation of dipeptide transport [GO_2000880]
- 5402: positive regulation of DNA binding [GO_0043388]
- 5403: positive regulation of DNA biosynthetic process [GO_2000573]
- 5404: positive regulation of DNA duplex unwinding [GO_1905464]
- 5405: positive regulation of DNA helicase activity [GO_1905776]
- 5406: positive regulation of DNA ligase activity [GO_1904877]
- 5407: positive regulation of DNA ligation [GO_0051106]
- 5408: positive regulation of DNA metabolic process [GO_0051054]
- 5409: positive regulation of DNA methylation [GO_1905643]
- 5410: positive regulation of DNA N-glycosylase activity [GO_1902546]
- 5411: positive regulation of DNA primase activity [GO_1903934]
- 5412: positive regulation of DNA recombination [GO_0045911]
- 5413: positive regulation of DNA repair [GO_0045739]
- 5414: positive regulation of DNA replication [GO_0045740]
- 5415: positive regulation of DNA replication origin binding [GO_1902597]
- 5416: positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO_2000373]
- 5417: positive regulation of DNA-binding transcription factor activity [GO_0051091]
- 5418: positive regulation of DNA-directed DNA polymerase activity [GO_1900264]
- 5419: positive regulation of DNA-templated DNA replication [GO_2000105]
- 5420: positive regulation of DNA-templated transcription [GO_0045893]
- 5421: positive regulation of DNA-templated transcription initiation [GO_2000144]
- 5422: positive regulation of dopamine receptor signaling pathway [GO_0060161]
- 5423: positive regulation of dopamine secretion [GO_0033603]
- 5424: positive regulation of double-stranded telomeric DNA binding [GO_1905769]
- 5425: positive regulation of dUTP diphosphatase activity [GO_1903629]
- 5426: positive regulation of eclosion [GO_0045805]
- 5427: positive regulation of ectoderm development [GO_2000385]
- 5428: positive regulation of electron transfer activity [GO_1904734]
- 5429: positive regulation of embryonic camera-type eye development [GO_1902865]
- 5430: positive regulation of embryonic development [GO_0040019]
- 5431: positive regulation of endocytosis [GO_0045807]
- 5432: positive regulation of endodeoxyribonuclease activity [GO_0032079]
- 5433: positive regulation of endodermal cell differentiation [GO_1903226]
- 5434: positive regulation of endopeptidase activity [GO_0010950]
- 5435: positive regulation of endoribonuclease activity [GO_1902380]
- 5436: positive regulation of endothelial cell apoptotic process [GO_2000353]
- 5437: positive regulation of endothelial cell development [GO_1901552]
- 5438: positive regulation of endothelial cell differentiation [GO_0045603]
- 5439: positive regulation of endothelial cell proliferation [GO_0001938]
- 5440: positive regulation of endothelial tube morphogenesis [GO_1905956]
- 5441: positive regulation of entry into reproductive diapause [GO_0061965]
- 5442: positive regulation of ephrin receptor signaling pathway [GO_1901189]
- 5443: positive regulation of epidermal cell differentiation [GO_0045606]
- 5444: positive regulation of epidermal growth factor receptor signaling pathway [GO_0045742]
- 5445: positive regulation of epidermal growth factor-activated receptor activity [GO_0045741]
- 5446: positive regulation of epidermis development [GO_0045684]
- 5447: positive regulation of epithelial cell apoptotic process [GO_1904037]
- 5448: positive regulation of epithelial cell differentiation [GO_0030858]
- 5449: positive regulation of epithelial cell proliferation [GO_0050679]
- 5450: positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO_0060501]
- 5451: positive regulation of epithelial to mesenchymal transition [GO_0010718]
- 5452: positive regulation of epithelial tube formation [GO_1905278]
- 5453: positive regulation of ERBB signaling pathway [GO_1901186]
- 5454: positive regulation of erythrocyte apoptotic process [GO_1902252]
- 5455: positive regulation of erythrocyte differentiation [GO_0045648]
- 5456: positive regulation of establishment of protein localization [GO_1904951]
- 5457: positive regulation of euchromatin binding [GO_1904795]
- 5458: positive regulation of excitatory postsynaptic potential [GO_2000463]
- 5459: positive regulation of execution phase of apoptosis [GO_1900119]
- 5460: positive regulation of exocytosis [GO_0045921]
- 5461: positive regulation of exodeoxyribonuclease activity [GO_1902394]
- 5462: positive regulation of exonuclease activity [GO_1905779]
- 5463: positive regulation of exoribonuclease activity [GO_1901919]
- 5464: positive regulation of exosomal secretion [GO_1903543]
- 5465: positive regulation of extracellular exosome assembly [GO_1903553]
- 5466: positive regulation of extracellular matrix assembly [GO_1901203]
- 5467: positive regulation of extracellular matrix disassembly [GO_0090091]
- 5468: positive regulation of extracellular matrix organization [GO_1903055]
- 5469: positive regulation of eye photoreceptor cell development [GO_0042479]
- 5470: positive regulation of fat cell apoptotic process [GO_1904651]
- 5471: positive regulation of fat cell differentiation [GO_0045600]
- 5472: positive regulation of fat cell proliferation [GO_0070346]
- 5473: positive regulation of fatty acid biosynthetic process [GO_0045723]
- 5474: positive regulation of fatty acid metabolic process [GO_0045923]
- 5475: positive regulation of fatty acid transport [GO_2000193]
- 5476: positive regulation of feeding behavior [GO_2000253]
- 5477: positive regulation of female gonad development [GO_2000196]
- 5478: positive regulation of ferrous iron binding [GO_1904434]
- 5479: positive regulation of fertilization [GO_1905516]
- 5480: positive regulation of fibroblast apoptotic process [GO_2000271]
- 5481: positive regulation of fibroblast growth factor receptor signaling pathway [GO_0045743]
- 5482: positive regulation of fibroblast proliferation [GO_0048146]
- 5483: positive regulation of formation of translation initiation ternary complex [GO_1901192]
- 5484: positive regulation of forward locomotion [GO_1905850]
- 5485: positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity [GO_0060550]
- 5486: positive regulation of G protein-coupled receptor signaling pathway [GO_0045745]
- 5487: positive regulation of G-quadruplex DNA binding [GO_1905495]
- 5488: positive regulation of GABA-A receptor activity [GO_0106041]
- 5489: positive regulation of gamma-aminobutyric acid secretion [GO_0014054]
- 5490: positive regulation of gastric acid secretion [GO_0060454]
- 5491: positive regulation of gastric mucosal blood circulation [GO_1904346]
- 5492: positive regulation of gastro-intestinal system smooth muscle contraction [GO_1904306]
- 5493: positive regulation of gastrulation [GO_2000543]
- 5494: positive regulation of gene expression [GO_0010628]
- 5495: positive regulation of germ cell proliferation [GO_1905938]
- 5496: positive regulation of glial cell apoptotic process [GO_0034352]
- 5497: positive regulation of glial cell differentiation [GO_0045687]
- 5498: positive regulation of glial cell proliferation [GO_0060252]
- 5499: positive regulation of gliogenesis [GO_0014015]
- 5500: positive regulation of glucagon secretion [GO_0070094]
- 5501: positive regulation of glucokinase activity [GO_0033133]
- 5502: positive regulation of gluconeogenesis [GO_0045722]
- 5503: positive regulation of glucose metabolic process [GO_0010907]
- 5504: positive regulation of glucose transmembrane transport [GO_0010828]
- 5505: positive regulation of glucosylceramidase activity [GO_1905125]
- 5506: positive regulation of glucuronosyltransferase activity [GO_1904225]
- 5507: positive regulation of glutamate receptor signaling pathway [GO_1900451]
- 5508: positive regulation of glutamate secretion [GO_0014049]
- 5509: positive regulation of glutamate secretion, neurotransmission [GO_1903296]
- 5510: positive regulation of glutamate-ammonia ligase activity [GO_1905480]
- 5511: positive regulation of glutamate-cysteine ligase activity [GO_0035229]
- 5512: positive regulation of glutathione biosynthetic process [GO_1903788]
- 5513: positive regulation of glutathione peroxidase activity [GO_1903284]
- 5514: positive regulation of glycine hydroxymethyltransferase activity [GO_0080114]
- 5515: positive regulation of glycine secretion, neurotransmission [GO_1904626]
- 5516: positive regulation of glycogen (starch) synthase activity [GO_2000467]
- 5517: positive regulation of glycogen biosynthetic process [GO_0045725]
- 5518: positive regulation of glycogen catabolic process [GO_0045819]
- 5519: positive regulation of glycogen metabolic process [GO_0070875]
- 5520: positive regulation of glycolytic process [GO_0045821]
- 5521: positive regulation of glycolytic process through fructose-6-phosphate [GO_1904540]
- 5522: positive regulation of glycoprotein biosynthetic process [GO_0010560]
- 5523: positive regulation of glycoprotein metabolic process [GO_1903020]
- 5524: positive regulation of Golgi to plasma membrane protein transport [GO_0042998]
- 5525: positive regulation of gonad development [GO_1905941]
- 5526: positive regulation of growth [GO_0045927]
- 5527: positive regulation of GTP binding [GO_1904426]
- 5528: positive regulation of GTP cyclohydrolase I activity [GO_0043104]
- 5529: positive regulation of GTPase activity [GO_0043547]
- 5530: positive regulation of guanyl-nucleotide exchange factor activity [GO_1905099]
- 5531: positive regulation of guanylate cyclase activity [GO_0031284]
- 5532: positive regulation of heart contraction [GO_0045823]
- 5533: positive regulation of heart growth [GO_0060421]
- 5534: positive regulation of helicase activity [GO_0051096]
- 5535: positive regulation of hematopoietic progenitor cell differentiation [GO_1901534]
- 5536: positive regulation of hematopoietic stem cell differentiation [GO_1902038]
- 5537: positive regulation of hematopoietic stem cell proliferation [GO_1902035]
- 5538: positive regulation of heme oxygenase activity [GO_0061961]
- 5539: positive regulation of hemopoiesis [GO_1903708]
- 5540: positive regulation of heparan sulfate proteoglycan binding [GO_1905860]
- 5541: positive regulation of hepatocyte apoptotic process [GO_1903945]
- 5542: positive regulation of hepatocyte differentiation [GO_0070368]
- 5543: positive regulation of heterochromatin assembly [GO_0031453]
- 5544: positive regulation of heterochromatin organization [GO_0120263]
- 5545: positive regulation of hexokinase activity [GO_1903301]
- 5546: positive regulation of high voltage-gated calcium channel activity [GO_1901843]
- 5547: positive regulation of hindgut contraction [GO_0060450]
- 5548: positive regulation of histone deacetylase activity [GO_1901727]
- 5549: positive regulation of histone deacetylation [GO_0031065]
- 5550: positive regulation of histone demethylase activity (H3-K4 specific) [GO_1904175]
- 5551: positive regulation of histone modification [GO_0031058]
- 5552: positive regulation of hormone metabolic process [GO_0032352]
- 5553: positive regulation of hormone secretion [GO_0046887]
- 5554: positive regulation of hyaluronan biosynthetic process [GO_1900127]
- 5555: positive regulation of hydrolase activity [GO_0051345]
- 5556: positive regulation of I-kappaB phosphorylation [GO_1903721]
- 5557: positive regulation of immune effector process [GO_0002699]
- 5558: positive regulation of immune response [GO_0050778]
- 5559: positive regulation of immune system process [GO_0002684]
- 5560: positive regulation of inorganic anion transmembrane transport [GO_1903797]
- 5561: positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0031587]
- 5562: positive regulation of inositol-polyphosphate 5-phosphatase activity [GO_0010925]
- 5563: positive regulation of insulin receptor signaling pathway [GO_0046628]
- 5564: positive regulation of insulin secretion [GO_0032024]
- 5565: positive regulation of intestinal absorption [GO_1904480]
- 5566: positive regulation of intestinal epithelial cell development [GO_1905300]
- 5567: positive regulation of intracellular calcium activated chloride channel activity [GO_1902940]
- 5568: positive regulation of intracellular lipid transport [GO_0032379]
- 5569: positive regulation of intracellular protein transport [GO_0090316]
- 5570: positive regulation of intracellular signal transduction [GO_1902533]
- 5571: positive regulation of intracellular sterol transport [GO_0032382]
- 5572: positive regulation of intracellular transport [GO_0032388]
- 5573: positive regulation of inward rectifier potassium channel activity [GO_1901980]
- 5574: positive regulation of ion transmembrane transport [GO_0034767]
- 5575: positive regulation of ion transmembrane transporter activity [GO_0032414]
- 5576: positive regulation of ion transport [GO_0043270]
- 5577: positive regulation of iron ion transmembrane transport [GO_0034761]
- 5578: positive regulation of iron ion transmembrane transporter activity [GO_1904256]
- 5579: positive regulation of iron ion transport [GO_0034758]
- 5580: positive regulation of isoleucine-tRNA ligase activity [GO_1905017]
- 5581: positive regulation of isomerase activity [GO_0010912]
- 5582: positive regulation of isoprenoid metabolic process [GO_0045828]
- 5583: positive regulation of JNK cascade [GO_0046330]
- 5584: positive regulation of JUN kinase activity [GO_0043507]
- 5585: positive regulation of kinase activity [GO_0033674]
- 5586: positive regulation of L-dopa decarboxylase activity [GO_1903200]
- 5587: positive regulation of large conductance calcium-activated potassium channel activity [GO_1902608]
- 5588: positive regulation of leucine-tRNA ligase activity [GO_1903635]
- 5589: positive regulation of leukocyte apoptotic process [GO_2000108]
- 5590: positive regulation of leukocyte differentiation [GO_1902107]
- 5591: positive regulation of leukocyte mediated immunity [GO_0002705]
- 5592: positive regulation of leukocyte proliferation [GO_0070665]
- 5593: positive regulation of ligase activity [GO_0051351]
- 5594: positive regulation of light-activated channel activity [GO_0045832]
- 5595: positive regulation of lipase activity [GO_0060193]
- 5596: positive regulation of lipid binding [GO_1900132]
- 5597: positive regulation of lipid biosynthetic process [GO_0046889]
- 5598: positive regulation of lipid catabolic process [GO_0050996]
- 5599: positive regulation of lipid kinase activity [GO_0090218]
- 5600: positive regulation of lipid localization [GO_1905954]
- 5601: positive regulation of lipid metabolic process [GO_0045834]
- 5602: positive regulation of lipid storage [GO_0010884]
- 5603: positive regulation of lipid transport [GO_0032370]
- 5604: positive regulation of lipid transporter activity [GO_0110113]
- 5605: positive regulation of lipopolysaccharide-mediated signaling pathway [GO_0031666]
- 5606: positive regulation of lipoprotein lipase activity [GO_0051006]
- 5607: positive regulation of locomotion [GO_0040017]
- 5608: positive regulation of locomotion involved in locomotory behavior [GO_0090326]
- 5609: positive regulation of locomotor rhythm [GO_1904061]
- 5610: positive regulation of low-density lipoprotein particle receptor binding [GO_1905597]
- 5611: positive regulation of low-density lipoprotein receptor activity [GO_1905599]
- 5612: positive regulation of lung ciliated cell differentiation [GO_1901248]
- 5613: positive regulation of lyase activity [GO_0051349]
- 5614: positive regulation of Lys63-specific deubiquitinase activity [GO_1903007]
- 5615: positive regulation of lysozyme activity [GO_1903592]
- 5616: positive regulation of m7G(5')pppN diphosphatase activity [GO_1903399]
- 5617: positive regulation of macromolecule biosynthetic process [GO_0010557]
- 5618: positive regulation of macromolecule metabolic process [GO_0010604]
- 5619: positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO_1903220]
- 5620: positive regulation of male mating behavior [GO_1902437]
- 5621: positive regulation of MAP kinase activity [GO_0043406]
- 5622: positive regulation of MAPK cascade [GO_0043410]
- 5623: positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO_0090080]
- 5624: positive regulation of megakaryocyte differentiation [GO_0045654]
- 5625: positive regulation of meiotic cell cycle [GO_0051446]
- 5626: positive regulation of meiotic cell cycle process involved in oocyte maturation [GO_1904146]
- 5627: positive regulation of meiotic nuclear division [GO_0045836]
- 5628: positive regulation of membrane invagination [GO_1905155]
- 5629: positive regulation of mesenchymal cell apoptotic process [GO_2001055]
- 5630: positive regulation of mesenchymal cell proliferation [GO_0002053]
- 5631: positive regulation of mesenchymal cell proliferation involved in lung development [GO_2000792]
- 5632: positive regulation of mesoderm development [GO_2000382]
- 5633: positive regulation of mesoderm formation [GO_1905904]
- 5634: positive regulation of mesodermal cell differentiation [GO_1905772]
- 5635: positive regulation of metabolic process [GO_0009893]
- 5636: positive regulation of metalloendopeptidase activity [GO_1904685]
- 5637: positive regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902964]
- 5638: positive regulation of metallopeptidase activity [GO_1905050]
- 5639: positive regulation of methionine-tRNA ligase activity [GO_1905020]
- 5640: positive regulation of methylenetetrahydrofolate reductase (NAD(P)H) activity [GO_1903870]
- 5641: positive regulation of microtubule binding [GO_1904528]
- 5642: positive regulation of microtubule depolymerization [GO_0031117]
- 5643: positive regulation of microtubule minus-end binding [GO_1902620]
- 5644: positive regulation of microtubule nucleation [GO_0090063]
- 5645: positive regulation of microtubule plus-end binding [GO_1903033]
- 5646: positive regulation of microtubule polymerization [GO_0031116]
- 5647: positive regulation of microtubule polymerization or depolymerization [GO_0031112]
- 5648: positive regulation of microvillus assembly [GO_1903698]
- 5649: positive regulation of miRNA processing [GO_1903800]
- 5650: positive regulation of miRNA-mediated gene silencing [GO_2000637]
- 5651: positive regulation of mitochondrial DNA metabolic process [GO_1901860]
- 5652: positive regulation of mitochondrial DNA replication [GO_0090297]
- 5653: positive regulation of mitochondrial mRNA catabolic process [GO_1905639]
- 5654: positive regulation of mitochondrial RNA catabolic process [GO_0000962]
- 5655: positive regulation of mitochondrial transcription [GO_1903109]
- 5656: positive regulation of mitochondrial translation [GO_0070131]
- 5657: positive regulation of mitochondrial translation in response to stress [GO_0010892]
- 5658: positive regulation of mitochondrial translational elongation [GO_1905084]
- 5659: positive regulation of mitochondrial translational initiation [GO_0070134]
- 5660: positive regulation of mitochondrion organization [GO_0010822]
- 5661: positive regulation of mitotic cell cycle [GO_0045931]
- 5662: positive regulation of mitotic cell cycle DNA replication [GO_1903465]
- 5663: positive regulation of mitotic cell cycle, embryonic [GO_0045977]
- 5664: positive regulation of mitotic chromosome condensation [GO_1903380]
- 5665: positive regulation of mitotic nuclear division [GO_0045840]
- 5666: positive regulation of mitotic nuclear envelope disassembly [GO_1905559]
- 5667: positive regulation of mitotic sister chromatid segregation [GO_0062033]
- 5668: positive regulation of molecular function [GO_0044093]
- 5669: positive regulation of mononuclear cell proliferation [GO_0032946]
- 5670: positive regulation of monooxygenase activity [GO_0032770]
- 5671: positive regulation of morphogenesis of an epithelium [GO_1905332]
- 5672: positive regulation of motor neuron apoptotic process [GO_2000673]
- 5673: positive regulation of mRNA 3'-UTR binding [GO_1903839]
- 5674: positive regulation of mRNA binding [GO_1902416]
- 5675: positive regulation of mRNA catabolic process [GO_0061014]
- 5676: positive regulation of mRNA metabolic process [GO_1903313]
- 5677: positive regulation of mRNA modification [GO_0090366]
- 5678: positive regulation of mRNA processing [GO_0050685]
- 5679: positive regulation of mucus secretion [GO_0070257]
- 5680: positive regulation of multicellular organism growth [GO_0040018]
- 5681: positive regulation of multicellular organismal process [GO_0051240]
- 5682: positive regulation of muscle adaptation [GO_0014744]
- 5683: positive regulation of muscle cell apoptotic process [GO_0010661]
- 5684: positive regulation of muscle cell differentiation [GO_0051149]
- 5685: positive regulation of muscle contraction [GO_0045933]
- 5686: positive regulation of muscle hypertrophy [GO_0014742]
- 5687: positive regulation of muscle organ development [GO_0048636]
- 5688: positive regulation of muscle tissue development [GO_1901863]
- 5689: positive regulation of myeloid cell apoptotic process [GO_0033034]
- 5690: positive regulation of myeloid cell differentiation [GO_0045639]
- 5691: positive regulation of myeloid leukocyte differentiation [GO_0002763]
- 5692: positive regulation of myeloid leukocyte mediated immunity [GO_0002888]
- 5693: positive regulation of myeloid progenitor cell differentiation [GO_1905455]
- 5694: positive regulation of myoblast differentiation [GO_0045663]
- 5695: positive regulation of myoblast proliferation [GO_2000288]
- 5696: positive regulation of myosin light chain kinase activity [GO_0035505]
- 5697: positive regulation of myotome development [GO_2000287]
- 5698: positive regulation of myotube differentiation [GO_0010831]
- 5699: positive regulation of NAD(P)H oxidase activity [GO_0033864]
- 5700: positive regulation of NAD+ ADP-ribosyltransferase activity [GO_1901666]
- 5701: positive regulation of NAD+ kinase activity [GO_0033672]
- 5702: positive regulation of negative chemotaxis [GO_0050924]
- 5703: positive regulation of nervous system development [GO_0051962]
- 5704: positive regulation of nervous system process [GO_0031646]
- 5705: positive regulation of netrin-activated signaling pathway [GO_1902843]
- 5706: positive regulation of neural crest cell differentiation [GO_1905294]
- 5707: positive regulation of neural crest formation [GO_0090300]
- 5708: positive regulation of neural precursor cell proliferation [GO_2000179]
- 5709: positive regulation of neural retina development [GO_0061075]
- 5710: positive regulation of neuroblast proliferation [GO_0002052]
- 5711: positive regulation of neuroepithelial cell differentiation [GO_1902913]
- 5712: positive regulation of neurogenesis [GO_0050769]
- 5713: positive regulation of neuromuscular junction development [GO_1904398]
- 5714: positive regulation of neuron apoptotic process [GO_0043525]
- 5715: positive regulation of neuron death [GO_1901216]
- 5716: positive regulation of neuron differentiation [GO_0045666]
- 5717: positive regulation of neuron maturation [GO_0014042]
- 5718: positive regulation of neuron projection development [GO_0010976]
- 5719: positive regulation of neuronal action potential [GO_1904457]
- 5720: positive regulation of neurotransmitter secretion [GO_0001956]
- 5721: positive regulation of neurotransmitter transport [GO_0051590]
- 5722: positive regulation of neurotransmitter uptake [GO_0051582]
- 5723: positive regulation of nitric-oxide synthase activity [GO_0051000]
- 5724: positive regulation of nitrogen compound metabolic process [GO_0051173]
- 5725: positive regulation of NMDA glutamate receptor activity [GO_1904783]
- 5726: positive regulation of non-membrane spanning protein tyrosine kinase activity [GO_1903997]
- 5727: positive regulation of norepinephrine secretion [GO_0010701]
- 5728: positive regulation of norepinephrine uptake [GO_0051623]
- 5729: positive regulation of nuclear cell cycle DNA replication [GO_0010571]
- 5730: positive regulation of nuclear division [GO_0051785]
- 5731: positive regulation of nuclear migration along microtubule [GO_1902840]
- 5732: positive regulation of nuclease activity [GO_0032075]
- 5733: positive regulation of nucleic acid-templated transcription [GO_1903508]
- 5734: positive regulation of nucleobase-containing compound metabolic process [GO_0045935]
- 5735: positive regulation of nucleobase-containing compound transport [GO_0032241]
- 5736: positive regulation of nucleocytoplasmic transport [GO_0046824]
- 5737: positive regulation of nucleoside metabolic process [GO_0045979]
- 5738: positive regulation of nucleoside transport [GO_0032244]
- 5739: positive regulation of nucleotide biosynthetic process [GO_0030810]
- 5740: positive regulation of nucleotide catabolic process [GO_0030813]
- 5741: positive regulation of nucleotide metabolic process [GO_0045981]
- 5742: positive regulation of oligopeptide transport [GO_2000878]
- 5743: positive regulation of oocyte development [GO_0060282]
- 5744: positive regulation of oocyte maturation [GO_1900195]
- 5745: positive regulation of oogenesis [GO_1905881]
- 5746: positive regulation of organ growth [GO_0046622]
- 5747: positive regulation of organelle assembly [GO_1902117]
- 5748: positive regulation of organelle organization [GO_0010638]
- 5749: positive regulation of organic acid transport [GO_0032892]
- 5750: positive regulation of ossification [GO_0045778]
- 5751: positive regulation of oviposition [GO_1901046]
- 5752: positive regulation of oxidative phosphorylation [GO_1903862]
- 5753: positive regulation of oxidoreductase activity [GO_0051353]
- 5754: positive regulation of oxygen metabolic process [GO_2000376]
- 5755: positive regulation of P-type sodium:potassium-exchanging transporter activity [GO_1903408]
- 5756: positive regulation of pancreatic A cell differentiation [GO_2000228]
- 5757: positive regulation of peptidase activity [GO_0010952]
- 5758: positive regulation of peptide hormone secretion [GO_0090277]
- 5759: positive regulation of peptide secretion [GO_0002793]
- 5760: positive regulation of peptidyl-tyrosine phosphorylation [GO_0050731]
- 5761: positive regulation of peroxidase activity [GO_2000470]
- 5762: positive regulation of pharynx morphogenesis [GO_0110043]
- 5763: positive regulation of phosphatase activity [GO_0010922]
- 5764: positive regulation of phosphate metabolic process [GO_0045937]
- 5765: positive regulation of phosphate transmembrane transport [GO_2000187]
- 5766: positive regulation of phosphatidate phosphatase activity [GO_1903740]
- 5767: positive regulation of phosphatidylcholine biosynthetic process [GO_2001247]
- 5768: positive regulation of phosphatidylcholine metabolic process [GO_0150173]
- 5769: positive regulation of phosphatidylinositol 3-kinase activity [GO_0043552]
- 5770: positive regulation of phosphatidylinositol biosynthetic process [GO_0010513]
- 5771: positive regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO_0120139]
- 5772: positive regulation of phospholipase A2 activity [GO_0032430]
- 5773: positive regulation of phospholipase activity [GO_0010518]
- 5774: positive regulation of phospholipase C activity [GO_0010863]
- 5775: positive regulation of phospholipase D activity [GO_1904007]
- 5776: positive regulation of phospholipid biosynthetic process [GO_0071073]
- 5777: positive regulation of phospholipid metabolic process [GO_1903727]
- 5778: positive regulation of phospholipid scramblase activity [GO_1900163]
- 5779: positive regulation of phospholipid translocation [GO_0061092]
- 5780: positive regulation of phospholipid transport [GO_2001140]
- 5781: positive regulation of phosphoprotein phosphatase activity [GO_0032516]
- 5782: positive regulation of phosphorus metabolic process [GO_0010562]
- 5783: positive regulation of phosphorylation [GO_0042327]
- 5784: positive regulation of photoreceptor cell differentiation [GO_0046534]
- 5785: positive regulation of pigment cell differentiation [GO_0050942]
- 5786: positive regulation of placenta blood vessel development [GO_0110080]
- 5787: positive regulation of plasma membrane bounded cell projection assembly [GO_0120034]
- 5788: positive regulation of poly(A)-specific ribonuclease activity [GO_0106248]
- 5789: positive regulation of polyamine transmembrane transport [GO_1902269]
- 5790: positive regulation of polynucleotide 3'-phosphatase activity [GO_1901969]
- 5791: positive regulation of polynucleotide adenylyltransferase activity [GO_1904247]
- 5792: positive regulation of polysome binding [GO_1905698]
- 5793: positive regulation of positive chemotaxis [GO_0050927]
- 5794: positive regulation of post-embryonic development [GO_0048582]
- 5795: positive regulation of post-transcriptional gene silencing [GO_0060148]
- 5796: positive regulation of post-transcriptional gene silencing by RNA [GO_1900370]
- 5797: positive regulation of post-translational protein modification [GO_1901875]
- 5798: positive regulation of potassium ion transmembrane transport [GO_1901381]
- 5799: positive regulation of potassium ion transmembrane transporter activity [GO_1901018]
- 5800: positive regulation of potassium ion transport [GO_0043268]
- 5801: positive regulation of pre-miRNA processing [GO_2000633]
- 5802: positive regulation of presynapse assembly [GO_1905608]
- 5803: positive regulation of programmed cell death [GO_0043068]
- 5804: positive regulation of prostaglandin-E synthase activity [GO_2000363]
- 5805: positive regulation of proteasomal protein catabolic process [GO_1901800]
- 5806: positive regulation of protein binding [GO_0032092]
- 5807: positive regulation of protein catabolic process [GO_0045732]
- 5808: positive regulation of protein catabolic process in the vacuole [GO_1904352]
- 5809: positive regulation of protein deacetylation [GO_0090312]
- 5810: positive regulation of protein dephosphorylation [GO_0035307]
- 5811: positive regulation of protein depolymerization [GO_1901881]
- 5812: positive regulation of protein deubiquitination [GO_1903003]
- 5813: positive regulation of protein folding [GO_1903334]
- 5814: positive regulation of protein glycosylation [GO_0060050]
- 5815: positive regulation of protein homodimerization activity [GO_0090073]
- 5816: positive regulation of protein K63-linked deubiquitination [GO_1903006]
- 5817: positive regulation of protein kinase activity [GO_0045860]
- 5818: positive regulation of protein kinase C activity [GO_1900020]
- 5819: positive regulation of protein localization [GO_1903829]
- 5820: positive regulation of protein localization to cell cortex [GO_1904778]
- 5821: positive regulation of protein localization to cell leading edge [GO_1905873]
- 5822: positive regulation of protein localization to cell periphery [GO_1904377]
- 5823: positive regulation of protein localization to cell-cell junction [GO_0150107]
- 5824: positive regulation of protein localization to chromatin [GO_0120187]
- 5825: positive regulation of protein localization to ciliary membrane [GO_1903569]
- 5826: positive regulation of protein localization to cilium [GO_1903566]
- 5827: positive regulation of protein localization to membrane [GO_1905477]
- 5828: positive regulation of protein localization to nucleolus [GO_1904751]
- 5829: positive regulation of protein localization to nucleus [GO_1900182]
- 5830: positive regulation of protein localization to plasma membrane [GO_1903078]
- 5831: positive regulation of protein localization to presynapse [GO_1905386]
- 5832: positive regulation of protein localization to synapse [GO_1902474]
- 5833: positive regulation of protein maturation [GO_1903319]
- 5834: positive regulation of protein metabolic process [GO_0051247]
- 5835: positive regulation of protein modification by small protein conjugation or removal [GO_1903322]
- 5836: positive regulation of protein modification process [GO_0031401]
- 5837: positive regulation of protein O-linked glycosylation [GO_1904100]
- 5838: positive regulation of protein phosphorylation [GO_0001934]
- 5839: positive regulation of protein polymerization [GO_0032273]
- 5840: positive regulation of protein secretion [GO_0050714]
- 5841: positive regulation of protein serine/threonine kinase activity [GO_0071902]
- 5842: positive regulation of protein serine/threonine phosphatase activity [GO_1905184]
- 5843: positive regulation of protein sumoylation [GO_0033235]
- 5844: positive regulation of protein transport [GO_0051222]
- 5845: positive regulation of protein tyrosine kinase activity [GO_0061098]
- 5846: positive regulation of protein tyrosine phosphatase activity [GO_1903615]
- 5847: positive regulation of protein ubiquitination [GO_0031398]
- 5848: positive regulation of protein-containing complex assembly [GO_0031334]
- 5849: positive regulation of protein-containing complex disassembly [GO_0043243]
- 5850: positive regulation of protein-glutamine gamma-glutamyltransferase activity [GO_0150074]
- 5851: positive regulation of proteolysis [GO_0045862]
- 5852: positive regulation of proteolysis involved in protein catabolic process [GO_1903052]
- 5853: positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO_1905273]
- 5854: positive regulation of purine nucleotide biosynthetic process [GO_1900373]
- 5855: positive regulation of purine nucleotide catabolic process [GO_0033123]
- 5856: positive regulation of purine nucleotide metabolic process [GO_1900544]
- 5857: positive regulation of pyrimidine nucleotide biosynthetic process [GO_1900399]
- 5858: positive regulation of pyrroline-5-carboxylate reductase activity [GO_1903168]
- 5859: positive regulation of pyruvate dehydrogenase activity [GO_1904184]
- 5860: positive regulation of pyruvate kinase activity [GO_1903304]
- 5861: positive regulation of reactive oxygen species metabolic process [GO_2000379]
- 5862: positive regulation of receptor binding [GO_1900122]
- 5863: positive regulation of receptor-mediated endocytosis [GO_0048260]
- 5864: positive regulation of release of sequestered calcium ion into cytosol [GO_0051281]
- 5865: positive regulation of removal of superoxide radicals [GO_1904833]
- 5866: positive regulation of reproductive process [GO_2000243]
- 5867: positive regulation of respiratory gaseous exchange [GO_1903942]
- 5868: positive regulation of response to alcohol [GO_1901421]
- 5869: positive regulation of response to biotic stimulus [GO_0002833]
- 5870: positive regulation of response to calcium ion [GO_1905947]
- 5871: positive regulation of response to cytokine stimulus [GO_0060760]
- 5872: positive regulation of response to DNA damage stimulus [GO_2001022]
- 5873: positive regulation of response to drug [GO_2001025]
- 5874: positive regulation of response to external stimulus [GO_0032103]
- 5875: positive regulation of response to extracellular stimulus [GO_0032106]
- 5876: positive regulation of response to nutrient levels [GO_0032109]
- 5877: positive regulation of response to oxidative stress [GO_1902884]
- 5878: positive regulation of response to reactive oxygen species [GO_1901033]
- 5879: positive regulation of response to stimulus [GO_0048584]
- 5880: positive regulation of response to wounding [GO_1903036]
- 5881: positive regulation of retina development in camera-type eye [GO_1902868]
- 5882: positive regulation of retinal cell programmed cell death [GO_0046670]
- 5883: positive regulation of retrograde trans-synaptic signaling by neuropeptide [GO_1905434]
- 5884: positive regulation of ribonucleoside-diphosphate reductase activity [GO_1905118]
- 5885: positive regulation of ribosome biogenesis [GO_0090070]
- 5886: positive regulation of RNA binding [GO_1905216]
- 5887: positive regulation of RNA biosynthetic process [GO_1902680]
- 5888: positive regulation of RNA metabolic process [GO_0051254]
- 5889: positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO_1905636]
- 5890: positive regulation of RNA splicing [GO_0033120]
- 5891: positive regulation of rRNA processing [GO_2000234]
- 5892: positive regulation of ryanodine-sensitive calcium-release channel activity [GO_0060316]
- 5893: positive regulation of saliva secretion [GO_0046878]
- 5894: positive regulation of sarcomere organization [GO_0060298]
- 5895: positive regulation of sclerotome development [GO_0061189]
- 5896: positive regulation of secondary metabolite biosynthetic process [GO_1900378]
- 5897: positive regulation of secretion [GO_0051047]
- 5898: positive regulation of secretion by cell [GO_1903532]
- 5899: positive regulation of secretory granule organization [GO_1904411]
- 5900: positive regulation of selenocysteine insertion sequence binding [GO_1904575]
- 5901: positive regulation of semaphorin-plexin signaling pathway [GO_2001262]
- 5902: positive regulation of sensory perception of bitter taste [GO_1904662]
- 5903: positive regulation of sensory perception of pain [GO_1904058]
- 5904: positive regulation of sensory perception of sweet taste [GO_1904658]
- 5905: positive regulation of sequestering of calcium ion [GO_0051284]
- 5906: positive regulation of serine C-palmitoyltransferase activity [GO_1904222]
- 5907: positive regulation of serine-type endopeptidase activity [GO_1900005]
- 5908: positive regulation of serine-type peptidase activity [GO_1902573]
- 5909: positive regulation of serotonin biosynthetic process [GO_1905629]
- 5910: positive regulation of serotonin secretion [GO_0014064]
- 5911: positive regulation of serotonin uptake [GO_0051613]
- 5912: positive regulation of signal transduction [GO_0009967]
- 5913: positive regulation of signaling [GO_0023056]
- 5914: positive regulation of signaling receptor activity [GO_2000273]
- 5915: positive regulation of single-stranded telomeric DNA binding [GO_0060381]
- 5916: positive regulation of skeletal muscle cell differentiation [GO_2001016]
- 5917: positive regulation of skeletal muscle cell proliferation [GO_0014858]
- 5918: positive regulation of skeletal muscle fiber development [GO_0048743]
- 5919: positive regulation of skeletal muscle fiber differentiation [GO_1902811]
- 5920: positive regulation of skeletal muscle hypertrophy [GO_1904206]
- 5921: positive regulation of skeletal muscle tissue development [GO_0048643]
- 5922: positive regulation of skeletal muscle tissue growth [GO_0048633]
- 5923: positive regulation of small GTPase binding [GO_1904477]
- 5924: positive regulation of small intestine smooth muscle contraction [GO_1904349]
- 5925: positive regulation of small molecule metabolic process [GO_0062013]
- 5926: positive regulation of smooth muscle cell apoptotic process [GO_0034393]
- 5927: positive regulation of smooth muscle cell differentiation [GO_0051152]
- 5928: positive regulation of smooth muscle cell proliferation [GO_0048661]
- 5929: positive regulation of smooth muscle contraction [GO_0045987]
- 5930: positive regulation of smooth muscle hypertrophy [GO_1905149]
- 5931: positive regulation of smooth muscle tissue development [GO_1905901]
- 5932: positive regulation of sodium ion transmembrane transport [GO_1902307]
- 5933: positive regulation of sodium ion transmembrane transporter activity [GO_2000651]
- 5934: positive regulation of sodium ion transport [GO_0010765]
- 5935: positive regulation of sodium:proton antiporter activity [GO_0032417]
- 5936: positive regulation of somatic stem cell division [GO_1904677]
- 5937: positive regulation of somatostatin secretion [GO_0090274]
- 5938: positive regulation of stem cell differentiation [GO_2000738]
- 5939: positive regulation of stem cell proliferation [GO_2000648]
- 5940: positive regulation of steroid biosynthetic process [GO_0010893]
- 5941: positive regulation of steroid hormone secretion [GO_2000833]
- 5942: positive regulation of steroid metabolic process [GO_0045940]
- 5943: positive regulation of sterol transport [GO_0032373]
- 5944: positive regulation of store-operated calcium channel activity [GO_1901341]
- 5945: positive regulation of stress-activated MAPK cascade [GO_0032874]
- 5946: positive regulation of stress-activated protein kinase signaling cascade [GO_0070304]
- 5947: positive regulation of striated muscle cell apoptotic process [GO_0010663]
- 5948: positive regulation of striated muscle cell differentiation [GO_0051155]
- 5949: positive regulation of striated muscle contraction [GO_0045989]
- 5950: positive regulation of striated muscle tissue development [GO_0045844]
- 5951: positive regulation of succinate dehydrogenase activity [GO_1904231]
- 5952: positive regulation of sulfur amino acid metabolic process [GO_0031337]
- 5953: positive regulation of sulfur metabolic process [GO_0051176]
- 5954: positive regulation of SUMO transferase activity [GO_1903755]
- 5955: positive regulation of superoxide dismutase activity [GO_1901671]
- 5956: positive regulation of supramolecular fiber organization [GO_1902905]
- 5957: positive regulation of synapse assembly [GO_0051965]
- 5958: positive regulation of synapse pruning [GO_1905808]
- 5959: positive regulation of synaptic transmission [GO_0050806]
- 5960: positive regulation of synaptic transmission, cholinergic [GO_0032224]
- 5961: positive regulation of synaptic transmission, dopaminergic [GO_0032226]
- 5962: positive regulation of synaptic transmission, GABAergic [GO_0032230]
- 5963: positive regulation of synaptic transmission, glutamatergic [GO_0051968]
- 5964: positive regulation of synaptic transmission, glycinergic [GO_0060094]
- 5965: positive regulation of syncytium formation by plasma membrane fusion [GO_0060143]
- 5966: positive regulation of tau-protein kinase activity [GO_1902949]
- 5967: positive regulation of telomerase activity [GO_0051973]
- 5968: positive regulation of telomeric DNA binding [GO_1904744]
- 5969: positive regulation of termination of DNA-templated transcription [GO_0060566]
- 5970: positive regulation of tetrapyrrole biosynthetic process [GO_1901465]
- 5971: positive regulation of tetrapyrrole catabolic process [GO_1901406]
- 5972: positive regulation of tetrapyrrole metabolic process [GO_1901403]
- 5973: positive regulation of threonine-tRNA ligase activity [GO_1905023]
- 5974: positive regulation of transcription by RNA polymerase I [GO_0045943]
- 5975: positive regulation of transcription by RNA polymerase II [GO_0045944]
- 5976: positive regulation of transcription by RNA polymerase III [GO_0045945]
- 5977: positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO_1901522]
- 5978: positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation [GO_1904081]
- 5979: positive regulation of transcription regulatory region DNA binding [GO_2000679]
- 5980: positive regulation of transferase activity [GO_0051347]
- 5981: positive regulation of translation [GO_0045727]
- 5982: positive regulation of translation in response to oxidative stress [GO_0032939]
- 5983: positive regulation of translation in response to stress [GO_0032056]
- 5984: positive regulation of translational elongation [GO_0045901]
- 5985: positive regulation of translational initiation [GO_0045948]
- 5986: positive regulation of translational initiation in response to stress [GO_0032058]
- 5987: positive regulation of translational termination [GO_0045905]
- 5988: positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO_0090100]
- 5989: positive regulation of transmembrane transport [GO_0034764]
- 5990: positive regulation of transmission of nerve impulse [GO_0051971]
- 5991: positive regulation of transport [GO_0051050]
- 5992: positive regulation of transporter activity [GO_0032411]
- 5993: positive regulation of triglyceride biosynthetic process [GO_0010867]
- 5994: positive regulation of triglyceride lipase activity [GO_0061365]
- 5995: positive regulation of triglyceride metabolic process [GO_0090208]
- 5996: positive regulation of tRNA metabolic process [GO_1903328]
- 5997: positive regulation of tRNA methylation [GO_0110004]
- 5998: positive regulation of tRNA processing [GO_2000237]
- 5999: positive regulation of trophectodermal cell proliferation [GO_1904075]
- 6000: positive regulation of tumor necrosis factor-mediated signaling pathway [GO_1903265]
- 6001: positive regulation of turning behavior involved in mating [GO_0061095]
- 6002: positive regulation of type B pancreatic cell apoptotic process [GO_2000676]
- 6003: positive regulation of type B pancreatic cell development [GO_2000078]
- 6004: positive regulation of type B pancreatic cell proliferation [GO_1904692]
- 6005: positive regulation of tyrosinase activity [GO_0032773]
- 6006: positive regulation of tyrosine 3-monooxygenase activity [GO_1903178]
- 6007: positive regulation of ubiquinone biosynthetic process [GO_1904775]
- 6008: positive regulation of ubiquitin protein ligase activity [GO_1904668]
- 6009: positive regulation of ubiquitin-dependent protein catabolic process [GO_2000060]
- 6010: positive regulation of ubiquitin-protein transferase activity [GO_0051443]
- 6011: positive regulation of ubiquitin-specific protease activity [GO_2000158]
- 6012: positive regulation of vacuolar transport [GO_1903337]
- 6013: positive regulation of vacuole organization [GO_0044090]
- 6014: positive regulation of vascular associated smooth muscle cell apoptotic process [GO_1905461]
- 6015: positive regulation of vascular associated smooth muscle cell differentiation [GO_1905065]
- 6016: positive regulation of vascular associated smooth muscle cell proliferation [GO_1904707]
- 6017: positive regulation of vascular endothelial cell proliferation [GO_1905564]
- 6018: positive regulation of vasculature development [GO_1904018]
- 6019: positive regulation of vasculogenesis [GO_2001214]
- 6020: positive regulation of vesicle fusion [GO_0031340]
- 6021: positive regulation of vesicle fusion with Golgi apparatus [GO_0106216]
- 6022: positive regulation of vesicle transport along microtubule [GO_1901610]
- 6023: positive regulation of vitamin D 24-hydroxylase activity [GO_0010980]
- 6024: positive regulation of vitamin metabolic process [GO_0046136]
- 6025: positive regulation of voltage-gated calcium channel activity [GO_1901387]
- 6026: positive regulation of voltage-gated chloride channel activity [GO_1902943]
- 6027: positive regulation of voltage-gated potassium channel activity [GO_1903818]
- 6028: positive regulation of voltage-gated sodium channel activity [GO_1905152]
- 6029: positive regulation of water channel activity [GO_1902429]
- 6030: positive regulation of Wnt signaling pathway [GO_0030177]
- 6031: positive regulation of Wnt signaling pathway by BMP signaling pathway [GO_0060804]
- 6032: positive regulation of wound healing [GO_0090303]
- 6033: post-embryonic development [GO_0009791]
- 6034: post-Golgi vesicle-mediated transport [GO_0006892]
- 6035: post-transcriptional gene silencing [GO_0016441]
- 6036: post-translational protein modification [GO_0043687]
- 6037: postsynapse [GO_0098794]
- 6038: postsynapse assembly [GO_0099068]
- 6039: postsynapse of neuromuscular junction [GO_0098975]
- 6040: postsynapse organization [GO_0099173]
- 6041: postsynaptic actin cytoskeleton [GO_0098871]
- 6042: postsynaptic actin cytoskeleton organization [GO_0098974]
- 6043: postsynaptic cytoskeleton [GO_0099571]
- 6044: postsynaptic cytoskeleton organization [GO_0099188]
- 6045: postsynaptic endocytosis [GO_0140239]
- 6046: postsynaptic membrane [GO_0045211]
- 6047: postsynaptic modulation of chemical synaptic transmission [GO_0099170]
- 6048: postsynaptic neurotransmitter receptor activity [GO_0098960]
- 6049: postsynaptic signal transduction [GO_0098926]
- 6050: posttranscriptional regulation of gene expression [GO_0010608]
- 6051: potassium channel activating, G protein-coupled receptor signaling pathway [GO_0099109]
- 6052: potassium channel activator activity [GO_0099104]
- 6053: potassium channel activator activity involved in G protein-coupled receptor signaling pathway [GO_0099108]
- 6054: potassium channel inhibitor activity [GO_0019870]
- 6055: potassium channel regulator activity [GO_0015459]
- 6056: potassium ion binding [GO_0030955]
- 6057: potassium ion leak channel activity [GO_0022841]
- 6058: potassium ion transmembrane transport [GO_0071805]
- 6059: potassium ion transmembrane transporter activity [GO_0015079]
- 6060: potassium ion transport [GO_0006813]
- 6061: potassium:proton antiporter activity [GO_0015386]
- 6062: potassium:sodium symporter activity [GO_0009674]
- 6063: POZ domain binding [GO_0031208]
- 6064: PP2A dephosphorylates RAF1 [GO_0004722]
- 6065: PP2A methylation by LCMT1 [GO_0018423]
- 6066: pPR-AP:pAP cleaves the MCP:pPR-AP:pAP Complex [GO_0004176]
- 6067: PRC1 complex binding [GO_0140259]
- 6068: PRC2-EZH2 trimethylates nucleosomes associated with CDKN2A promoter [GO_0046976]
- 6069: pre-miRNA 3'-end processing [GO_0044747]
- 6070: pre-miRNA binding [GO_0070883]
- 6071: pre-miRNA processing [GO_0031054]
- 6072: pre-mRNA 3'-splice site binding [GO_0030628]
- 6073: pre-mRNA 5'-splice site binding [GO_0030627]
- 6074: pre-mRNA binding [GO_0036002]
- 6075: pre-mRNA branch point binding [GO_0045131]
- 6076: pre-mRNA intronic binding [GO_0097157]
- 6077: pre-mRNA intronic pyrimidine-rich binding [GO_0097158]
- 6078: Pre-snRNA transcript initiation, Integrator binding, LEC binding [GO_0001055]
- 6079: prechordal plate formation [GO_0021501]
- 6080: prekallikrein:kininogen:C1q binding protein tetramer -> kallikrein:kininogen:C1q binding protein tetramer [GO_0004185]
- 6081: prenyltransferase activity [GO_0004659]
- 6082: preribosome binding [GO_1990275]
- 6083: presynapse [GO_0098793]
- 6084: presynapse assembly [GO_0099054]
- 6085: presynapse organization [GO_0099172]
- 6086: presynaptic actin cytoskeleton [GO_0099143]
- 6087: presynaptic actin cytoskeleton organization [GO_0099140]
- 6088: presynaptic active zone [GO_0048786]
- 6089: presynaptic active zone organization [GO_1990709]
- 6090: presynaptic cytoskeleton [GO_0099569]
- 6091: presynaptic cytoskeleton organization [GO_0099187]
- 6092: presynaptic endocytosis [GO_0140238]
- 6093: presynaptic membrane [GO_0042734]
- 6094: presynaptic modulation of chemical synaptic transmission [GO_0099171]
- 6095: presynaptic process involved in chemical synaptic transmission [GO_0099531]
- 6096: presynaptic signal transduction [GO_0098928]
- 6097: primary active transmembrane transporter activity [GO_0015399]
- 6098: primary alcohol metabolic process [GO_0034308]
- 6099: primary amine secretion [GO_0061531]
- 6100: primary amine secretion, neurotransmission [GO_0061532]
- 6101: primary amino compound biosynthetic process [GO_1901162]
- 6102: primary amino compound catabolic process [GO_1901161]
- 6103: primary amino compound metabolic process [GO_1901160]
- 6104: primary lung bud formation [GO_0060431]
- 6105: primary metabolic process [GO_0044238]
- 6106: primary miRNA binding [GO_0070878]
- 6107: primary neural tube formation [GO_0014020]
- 6108: pristanoyl-CoA oxidase activity [GO_0016402]
- 6109: PRMT1 methylates arginine-12 of histone H2A (H2AR11) [GO_0016274]
- 6110: PRMT1 methylates ESRs [GO_0008276]
- 6111: PRMT5 methylates TP53 [GO_0035243]
- 6112: pro-RAS proteins are farnesylated [GO_0004660]
- 6113: proboscis extension reflex [GO_0007637]
- 6114: Procollagen triple helix formation [GO_0003755]
- 6115: procollagen-lysine 5-dioxygenase activity [GO_0008475]
- 6116: procollagen-proline dioxygenase activity [GO_0019798]
- 6117: proctolin receptor activity [GO_0035236]
- 6118: proctolin receptor binding [GO_0071860]
- 6119: Production of AA by iPLA2 upon FCGR activation [GO_0016787]
- 6120: proepicardium development [GO_0003342]
- 6121: programmed cell death [GO_0012501]
- 6122: programmed cell death involved in cell development [GO_0010623]
- 6123: proline + tRNA(Pro) + ATP => Pro-tRNA(Pro) + AMP + pyrophosphate [GO_0004827]
- 6124: proline dehydrogenase activity [GO_0004657]
- 6125: proline dipeptidase activity [GO_0102009]
- 6126: proline-rich region binding [GO_0070064]
- 6127: Prolyl 4-hydroxylase converts collagen prolines to 4-hydroxyprolines [GO_0004656]
- 6128: promoter-enhancer loop anchoring activity [GO_0140585]
- 6129: promoter-specific chromatin binding [GO_1990841]
- 6130: propionate-CoA ligase activity [GO_0050218]
- 6131: proprioception [GO_0019230]
- 6132: proprioception involved in equilibrioception [GO_0051355]
- 6133: Prorenin:Prorenin Receptor hydrolyzes Angiotensinogen to Angiotensin-(1-10) [GO_0004190]
- 6134: Prostaglandin E synthase isomerizes PGH2 to PGE2 [GO_0050220]
- 6135: prostaglandin-D synthase activity [GO_0004667]
- 6136: prosthetic group binding [GO_0051192]
- 6137: proteasomal protein catabolic process [GO_0010498]
- 6138: proteasome binding [GO_0070628]
- 6139: proteasome-activating activity [GO_0036402]
- 6140: protein adenylylhydrolase activity [GO_0044603]
- 6141: protein alkylation [GO_0008213]
- 6142: protein arginine phosphatase activity [GO_0098627]
- 6143: protein arginylation [GO_0016598]
- 6144: protein binding [GO_0005515]
- 6145: protein C-terminal carboxyl O-methyltransferase activity [GO_0003880]
- 6146: protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO_0004671]
- 6147: protein C-terminus binding [GO_0008022]
- 6148: protein carboxyl O-methyltransferase activity [GO_0051998]
- 6149: protein carrier chaperone [GO_0140597]
- 6150: protein catabolic process [GO_0030163]
- 6151: protein catabolic process at postsynapse [GO_0140249]
- 6152: protein catabolic process at presynapse [GO_0140247]
- 6153: protein catabolic process at synapse [GO_0140246]
- 6154: protein catabolic process in the vacuole [GO_0007039]
- 6155: protein catabolic process, modulating synaptic transmission [GO_0099546]
- 6156: protein complex involved in cell adhesion [GO_0098636]
- 6157: protein deacetylation [GO_0006476]
- 6158: protein deacylation [GO_0035601]
- 6159: protein demethylase activity [GO_0140457]
- 6160: protein dephosphorylation [GO_0006470]
- 6161: protein depolymerization [GO_0051261]
- 6162: protein desuccinylation [GO_0036048]
- 6163: protein deubiquitination [GO_0016579]
- 6164: protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO_0071947]
- 6165: protein dimerization activity [GO_0046983]
- 6166: protein domain specific binding [GO_0019904]
- 6167: protein folding [GO_0006457]
- 6168: protein folding chaperone [GO_0044183]
- 6169: protein geranylgeranyltransferase activity [GO_0004661]
- 6170: protein glycosylation [GO_0006486]
- 6171: protein heterodimerization activity [GO_0046982]
- 6172: protein histidine phosphatase activity [GO_0101006]
- 6173: protein homodimerization activity [GO_0042803]
- 6174: protein hydroxylation [GO_0018126]
- 6175: protein K48-linked deubiquitination [GO_0071108]
- 6176: protein K63-linked deubiquitination [GO_0070536]
- 6177: protein kinase A binding [GO_0051018]
- 6178: protein kinase A catalytic subunit binding [GO_0034236]
- 6179: protein kinase A regulatory subunit binding [GO_0034237]
- 6180: protein kinase activator activity [GO_0030295]
- 6181: protein kinase binding [GO_0019901]
- 6182: protein kinase C binding [GO_0005080]
- 6183: protein kinase C inhibitor activity [GO_0008426]
- 6184: protein kinase inhibitor activity [GO_0004860]
- 6185: protein kinase regulator activity [GO_0019887]
- 6186: protein localization [GO_0008104]
- 6187: protein localization to actin cytoskeleton [GO_1903119]
- 6188: protein localization to actin filament bundle [GO_1903120]
- 6189: protein localization to cell cortex [GO_0072697]
- 6190: protein localization to cell junction [GO_1902414]
- 6191: protein localization to cell leading edge [GO_1902463]
- 6192: protein localization to cell periphery [GO_1990778]
- 6193: protein localization to cell-cell junction [GO_0150105]
- 6194: protein localization to chromatin [GO_0071168]
- 6195: protein localization to chromosome [GO_0034502]
- 6196: protein localization to ciliary membrane [GO_1903441]
- 6197: protein localization to ciliary transition zone [GO_1904491]
- 6198: protein localization to cilium [GO_0061512]
- 6199: protein localization to cytoplasmic microtubule [GO_1905755]
- 6200: protein localization to cytoskeleton [GO_0044380]
- 6201: protein localization to extracellular region [GO_0071692]
- 6202: protein localization to Golgi apparatus [GO_0034067]
- 6203: protein localization to Golgi membrane [GO_1903292]
- 6204: protein localization to heterochromatin [GO_0097355]
- 6205: protein localization to membrane [GO_0072657]
- 6206: protein localization to microtubule [GO_0035372]
- 6207: protein localization to microtubule cytoskeleton [GO_0072698]
- 6208: protein localization to microvillus [GO_1904106]
- 6209: protein localization to nuclear envelope [GO_0090435]
- 6210: protein localization to nucleolus [GO_1902570]
- 6211: protein localization to nucleus [GO_0034504]
- 6212: protein localization to organelle [GO_0033365]
- 6213: protein localization to plasma membrane [GO_0072659]
- 6214: protein localization to postsynapse [GO_0062237]
- 6215: protein localization to presynapse [GO_1905383]
- 6216: protein localization to secretory granule [GO_0033366]
- 6217: protein localization to somatodendritic compartment [GO_0061938]
- 6218: protein localization to synapse [GO_0035418]
- 6219: protein localization to vacuolar membrane [GO_1903778]
- 6220: protein localization to vacuole [GO_0072665]
- 6221: protein mannosylation [GO_0035268]
- 6222: protein maturation [GO_0051604]
- 6223: protein metabolic process [GO_0019538]
- 6224: protein methylation [GO_0006479]
- 6225: protein modification by small protein conjugation [GO_0032446]
- 6226: protein modification by small protein conjugation or removal [GO_0070647]
- 6227: protein modification by small protein removal [GO_0070646]
- 6228: protein modification process [GO_0036211]
- 6229: protein N-acetylglucosaminyltransferase activity [GO_0016262]
- 6230: protein N-terminus binding [GO_0047485]
- 6231: protein O-acetylglucosaminyltransferase activity [GO_0097363]
- 6232: protein O-linked fucosylation [GO_0036066]
- 6233: protein O-linked glycosylation [GO_0006493]
- 6234: protein O-linked mannosylation [GO_0035269]
- 6235: protein phosphatase 1 binding [GO_0008157]
- 6236: protein phosphatase 2A binding [GO_0051721]
- 6237: protein phosphatase activator activity [GO_0072542]
- 6238: protein phosphatase binding [GO_0019903]
- 6239: protein phosphatase inhibitor activity [GO_0004864]
- 6240: protein phosphorylated amino acid binding [GO_0045309]
- 6241: protein phosphorylation [GO_0006468]
- 6242: protein polymerization [GO_0051258]
- 6243: protein prenyltransferase activity [GO_0008318]
- 6244: protein secretion [GO_0009306]
- 6245: protein self-association [GO_0043621]
- 6246: protein sequestering activity [GO_0140311]
- 6247: protein serine/threonine kinase activator activity [GO_0043539]
- 6248: protein serine/threonine kinase inhibitor activity [GO_0030291]
- 6249: protein serine/threonine phosphatase inhibitor activity [GO_0004865]
- 6250: protein sumoylation [GO_0016925]
- 6251: protein tag [GO_0031386]
- 6252: protein transmembrane transport [GO_0071806]
- 6253: protein transport [GO_0015031]
- 6254: protein transport along microtubule [GO_0098840]
- 6255: protein transport within lipid bilayer [GO_0032594]
- 6256: protein transport within plasma membrane [GO_0099632]
- 6257: protein tyrosine kinase activator activity [GO_0030296]
- 6258: protein tyrosine kinase binding [GO_1990782]
- 6259: protein tyrosine kinase collagen receptor activity [GO_0038062]
- 6260: protein tyrosine kinase inhibitor activity [GO_0030292]
- 6261: protein tyrosine phosphatase activator activity [GO_0008160]
- 6262: protein tyrosine phosphatase activity, metal-dependent [GO_0030946]
- 6263: protein tyrosine/threonine phosphatase activity [GO_0008330]
- 6264: protein ubiquitination [GO_0016567]
- 6265: protein xylosyltransferase activity [GO_0030158]
- 6266: protein-arginine omega-N asymmetric methyltransferase activity [GO_0035242]
- 6267: protein-arginine omega-N monomethyltransferase activity [GO_0035241]
- 6268: protein-containing complex [GO_0032991]
- 6269: protein-containing complex assembly [GO_0065003]
- 6270: protein-containing complex binding [GO_0044877]
- 6271: protein-containing complex destabilizing activity [GO_0140776]
- 6272: protein-containing complex disassembly [GO_0032984]
- 6273: protein-containing complex localization [GO_0031503]
- 6274: protein-containing complex organization [GO_0043933]
- 6275: protein-containing complex stabilizing activity [GO_0140777]
- 6276: protein-cysteine methyltransferase activity [GO_0106363]
- 6277: protein-cysteine S-acyltransferase activity [GO_0019707]
- 6278: protein-cysteine S-palmitoyltransferase activity [GO_0019706]
- 6279: protein-disulfide reductase (NAD(P)) activity [GO_0047134]
- 6280: protein-DNA complex [GO_0032993]
- 6281: protein-DNA complex assembly [GO_0065004]
- 6282: protein-DNA complex organization [GO_0071824]
- 6283: protein-glutamic acid ligase activity [GO_0070739]
- 6284: protein-glutamine N-methyltransferase activity [GO_0036009]
- 6285: protein-glutaryllysine deglutarylase activity [GO_0061697]
- 6286: protein-glycine ligase activity [GO_0070735]
- 6287: protein-glycine ligase activity, elongating [GO_0070737]
- 6288: protein-glycine ligase activity, initiating [GO_0070736]
- 6289: protein-hormone receptor activity [GO_0016500]
- 6290: protein-L-histidine N-tele-methyltransferase activity [GO_0018064]
- 6291: protein-lipid complex binding [GO_0071814]
- 6292: protein-lysine 6-oxidase activity [GO_0004720]
- 6293: protein-lysine N-methyltransferase activity [GO_0016279]
- 6294: protein-macromolecule adaptor activity [GO_0030674]
- 6295: protein-malonyllysine demalonylase activity [GO_0036054]
- 6296: protein-membrane adaptor activity [GO_0043495]
- 6297: protein-N-terminal asparagine amidohydrolase activity [GO_0008418]
- 6298: protein-N-terminal glutamine amidohydrolase activity [GO_0070773]
- 6299: protein-RNA adaptor activity [GO_0140517]
- 6300: protein-succinyllysine desuccinylase activity [GO_0036055]
- 6301: protein-tyrosine sulfotransferase activity [GO_0008476]
- 6302: proteinogenic amino acid biosynthetic process [GO_0170038]
- 6303: proteinogenic amino acid metabolic process [GO_0170039]
- 6304: proteoglycan binding [GO_0043394]
- 6305: proteolysis [GO_0006508]
- 6306: proteolysis involved in protein catabolic process [GO_0051603]
- 6307: prothoracicotrophic hormone activity [GO_0018445]
- 6308: protoheme IX farnesyltransferase activity [GO_0008495]
- 6309: proton channel activity [GO_0015252]
- 6310: proton motive force-driven ATP synthesis [GO_0015986]
- 6311: proton motive force-driven mitochondrial ATP synthesis [GO_0042776]
- 6312: proton transmembrane transport [GO_1902600]
- 6313: proton-dependent oligopeptide secondary active transmembrane transporter activity [GO_0005427]
- 6314: proton-transporting ATP synthase activity, rotational mechanism [GO_0046933]
- 6315: proton-transporting ATPase activity, rotational mechanism [GO_0046961]
- 6316: protoporphyrinogen oxidase activity [GO_0070818]
- 6317: PS is hydrolyzed to 2-acyl LPS by PLA2[10] [GO_0004623]
- 6318: pseudouridine synthase activity [GO_0009982]
- 6319: pseudouridine synthesis [GO_0001522]
- 6320: pseudouridylate synthase activity [GO_0004730]
- 6321: PTB domain binding [GO_0051425]
- 6322: PTEN cancer mutants do not dephosphorylate PIP3 [GO_0016314]
- 6323: pteridine-containing compound biosynthetic process [GO_0042559]
- 6324: pteridine-containing compound metabolic process [GO_0042558]
- 6325: PTPLs dehydrate VLC3HA-CoA to VLCTDA-CoA [GO_0080023]
- 6326: PTPMT1 dephosphorylates PGP to PG [GO_0008962]
- 6327: PTPS is phosphorylated by cGMP-dependant protein kinase II [GO_0004692]
- 6328: pulmonary artery endothelial tube morphogenesis [GO_0061155]
- 6329: pulmonary artery morphogenesis [GO_0061156]
- 6330: pulmonary vein morphogenesis [GO_0060577]
- 6331: purine deoxyribonucleoside monophosphate biosynthetic process [GO_0009171]
- 6332: purine deoxyribonucleoside monophosphate metabolic process [GO_0009170]
- 6333: purine deoxyribonucleotide biosynthetic process [GO_0009153]
- 6334: purine deoxyribonucleotide metabolic process [GO_0009151]
- 6335: purine nucleobase binding [GO_0002060]
- 6336: purine nucleobase transmembrane transport [GO_1904823]
- 6337: purine nucleobase transmembrane transporter activity [GO_0005345]
- 6338: purine nucleobase transport [GO_0006863]
- 6339: purine nucleoside binding [GO_0001883]
- 6340: purine nucleoside diphosphate catabolic process [GO_0009137]
- 6341: purine nucleoside diphosphate metabolic process [GO_0009135]
- 6342: purine nucleoside monophosphate biosynthetic process [GO_0009127]
- 6343: purine nucleoside monophosphate metabolic process [GO_0009126]
- 6344: purine nucleoside triphosphate biosynthetic process [GO_0009145]
- 6345: purine nucleoside triphosphate metabolic process [GO_0009144]
- 6346: purine nucleotide binding [GO_0017076]
- 6347: purine nucleotide biosynthetic process [GO_0006164]
- 6348: purine nucleotide catabolic process [GO_0006195]
- 6349: purine nucleotide metabolic process [GO_0006163]
- 6350: purine nucleotide transmembrane transporter activity [GO_0015216]
- 6351: purine nucleotide transport [GO_0015865]
- 6352: purine nucleotide-sugar transmembrane transport [GO_0090480]
- 6353: purine nucleotide-sugar transmembrane transporter activity [GO_0036080]
- 6354: purine ribonucleoside diphosphate catabolic process [GO_0009181]
- 6355: purine ribonucleoside diphosphate metabolic process [GO_0009179]
- 6356: purine ribonucleoside monophosphate biosynthetic process [GO_0009168]
- 6357: purine ribonucleoside monophosphate metabolic process [GO_0009167]
- 6358: purine ribonucleoside triphosphate binding [GO_0035639]
- 6359: purine ribonucleoside triphosphate biosynthetic process [GO_0009206]
- 6360: purine ribonucleoside triphosphate metabolic process [GO_0009205]
- 6361: purine ribonucleotide binding [GO_0032555]
- 6362: purine ribonucleotide biosynthetic process [GO_0009152]
- 6363: purine ribonucleotide catabolic process [GO_0009154]
- 6364: purine ribonucleotide metabolic process [GO_0009150]
- 6365: purine ribonucleotide transmembrane transporter activity [GO_0005346]
- 6366: purine ribonucleotide transport [GO_0015868]
- 6367: purine-containing compound biosynthetic process [GO_0072522]
- 6368: purine-containing compound catabolic process [GO_0072523]
- 6369: purine-containing compound metabolic process [GO_0072521]
- 6370: purine-containing compound transmembrane transport [GO_0072530]
- 6371: purine-nucleoside phosphorylase activity [GO_0004731]
- 6372: purine-rich negative regulatory element binding [GO_0032422]
- 6373: purinergic nucleotide receptor signaling pathway [GO_0035590]
- 6374: Purkinje myocyte action potential [GO_0086017]
- 6375: Purkinje myocyte development [GO_0003165]
- 6376: Purkinje myocyte differentiation [GO_0003168]
- 6377: Purkinje myocyte to ventricular cardiac muscle cell communication [GO_0086068]
- 6378: Purkinje myocyte to ventricular cardiac muscle cell signaling [GO_0086029]
- 6379: PXKLP-K305-CSAD decarboxylates 3-sulfinoalanine to hypotaurine [GO_0004782]
- 6380: PXLP-CBS tetramers condenses HCYS and L-Ser to form L-Cystathionine [GO_0004122]
- 6381: PXLP-K212-CTH cleaves L-Cystathionine [GO_0004123]
- 6382: PXLP-K314-GPT transaminates PYR to form L-Ala [GO_0004021]
- 6383: PXLP-K333-GADL1 decarboxylates CSA to HTAU [GO_0016831]
- 6384: PXLP-K357-ABAT dimer:2Fe-2S transforms GABA to SUCCSA [GO_0003867]
- 6385: PYCR1 decamer reduces (S)-1-pyrroline-5-carboxylate to L-Pro [GO_0004735]
- 6386: pyridine nucleotide catabolic process [GO_0019364]
- 6387: pyridine nucleotide metabolic process [GO_0019362]
- 6388: pyridine-containing compound biosynthetic process [GO_0072525]
- 6389: pyridine-containing compound catabolic process [GO_0072526]
- 6390: pyridine-containing compound metabolic process [GO_0072524]
- 6391: pyridoxal oxidase activity [GO_0004732]
- 6392: pyridoxal phosphate binding [GO_0030170]
- 6393: pyridoxal phosphate biosynthetic process [GO_0042823]
- 6394: pyridoxal phosphate metabolic process [GO_0042822]
- 6395: pyrimidine nucleobase binding [GO_0002061]
- 6396: pyrimidine nucleoside catabolic process [GO_0046135]
- 6397: pyrimidine nucleoside metabolic process [GO_0006213]
- 6398: pyrimidine nucleoside monophosphate biosynthetic process [GO_0009130]
- 6399: pyrimidine nucleoside monophosphate metabolic process [GO_0009129]
- 6400: pyrimidine nucleoside transmembrane transporter activity [GO_0015214]
- 6401: pyrimidine nucleoside transport [GO_0015864]
- 6402: pyrimidine nucleotide biosynthetic process [GO_0006221]
- 6403: pyrimidine nucleotide metabolic process [GO_0006220]
- 6404: pyrimidine nucleotide transmembrane transporter activity [GO_0015218]
- 6405: pyrimidine nucleotide transport [GO_0006864]
- 6406: pyrimidine nucleotide-sugar transmembrane transport [GO_0090481]
- 6407: pyrimidine nucleotide-sugar transmembrane transporter activity [GO_0015165]
- 6408: pyrimidine ribonucleoside catabolic process [GO_0046133]
- 6409: pyrimidine ribonucleoside metabolic process [GO_0046131]
- 6410: pyrimidine ribonucleoside monophosphate biosynthetic process [GO_0009174]
- 6411: pyrimidine ribonucleoside monophosphate metabolic process [GO_0009173]
- 6412: pyrimidine ribonucleotide biosynthetic process [GO_0009220]
- 6413: pyrimidine ribonucleotide metabolic process [GO_0009218]
- 6414: pyrimidine-containing compound biosynthetic process [GO_0072528]
- 6415: pyrimidine-containing compound catabolic process [GO_0072529]
- 6416: pyrimidine-containing compound metabolic process [GO_0072527]
- 6417: pyrimidine-containing compound transmembrane transport [GO_0072531]
- 6418: pyrimidine-nucleoside phosphorylase activity [GO_0016154]
- 6419: pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO_0008263]
- 6420: pyrimidodiazepine synthase activity [GO_0004734]
- 6421: pyroglutamyl-peptidase activity [GO_0016920]
- 6422: pyrokinin receptor activity [GO_0036401]
- 6423: pyrophosphatase activity [GO_0016462]
- 6424: pyrophosphate + H2O => 2 orthophosphate [cytosolic] [GO_0004427]
- 6425: pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO_0009678]
- 6426: pyruvate carboxylase activity [GO_0004736]
- 6427: pyruvate dehydrogenase (acetyl-transferring) activity [GO_0004739]
- 6428: pyruvate metabolic process [GO_0006090]
- 6429: pyruvate secondary active transmembrane transporter activity [GO_0005477]
- 6430: pyruvate transmembrane transport [GO_1901475]
- 6431: pyruvate transport [GO_0006848]
- 6432: QTRT1:QTRTD1 exchange guanine for queuosine at guanosine-34 of tRNA(Tyr) [GO_0008479]
- 6433: quaternary ammonium group binding [GO_0050997]
- 6434: quaternary ammonium group transmembrane transporter activity [GO_0015651]
- 6435: quaternary ammonium group transport [GO_0015697]
- 6436: quinone binding [GO_0048038]
- 6437: quinone biosynthetic process [GO_1901663]
- 6438: quinone metabolic process [GO_1901661]
- 6439: Rab GDP-dissociation inhibitor activity [GO_0005093]
- 6440: Rab geranylgeranyltransferase activity [GO_0004663]
- 6441: racemase activity, acting on amino acids and derivatives [GO_0036361]
- 6442: racemase and epimerase activity [GO_0016854]
- 6443: racemase and epimerase activity, acting on amino acids and derivatives [GO_0016855]
- 6444: RBKS phosphorylates ribose to R5P [GO_0004747]
- 6445: RDH11 reduces RBP2:atRAL to RBP2:atROL [GO_0016616]
- 6446: RDH5 oxidises 11cROL to 11cRAL [GO_0004745]
- 6447: rDNA binding [GO_0000182]
- 6448: reactive oxygen species metabolic process [GO_0072593]
- 6449: receptor antagonist activity [GO_0048019]
- 6450: receptor ligand activity [GO_0048018]
- 6451: receptor serine/threonine kinase binding [GO_0033612]
- 6452: receptor tyrosine kinase binding [GO_0030971]
- 6453: receptor-mediated endocytosis [GO_0006898]
- 6454: Reduction of disulphide bonds in MHC II antigens [GO_0016667]
- 6455: reflex [GO_0060004]
- 6456: regeneration [GO_0031099]
- 6457: regionalization [GO_0003002]
- 6458: regulation of 1-phosphatidylinositol 4-kinase activity [GO_0043126]
- 6459: regulation of 1-phosphatidylinositol-3-kinase activity [GO_0061901]
- 6460: regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO_0090215]
- 6461: regulation of acetylcholine secretion, neurotransmission [GO_0014056]
- 6462: regulation of acetylcholine-gated cation channel activity [GO_1903048]
- 6463: regulation of acid-sensing ion channel activity [GO_1901585]
- 6464: regulation of acinar cell proliferation [GO_1904697]
- 6465: regulation of aconitate hydratase activity [GO_1904232]
- 6466: regulation of actin binding [GO_1904616]
- 6467: regulation of actin cytoskeleton organization [GO_0032956]
- 6468: regulation of actin filament binding [GO_1904529]
- 6469: regulation of actin filament bundle assembly [GO_0032231]
- 6470: regulation of actin filament organization [GO_0110053]
- 6471: regulation of actin filament-based movement [GO_1903115]
- 6472: regulation of actin filament-based process [GO_0032970]
- 6473: regulation of action potential [GO_0098900]
- 6474: regulation of activin receptor signaling pathway [GO_0032925]
- 6475: regulation of actomyosin structure organization [GO_0110020]
- 6476: regulation of adenosine receptor signaling pathway [GO_0060167]
- 6477: regulation of adenylate cyclase activity [GO_0045761]
- 6478: regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway [GO_0010578]
- 6479: regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO_0106070]
- 6480: regulation of adipose tissue development [GO_1904177]
- 6481: regulation of aerobic respiration [GO_1903715]
- 6482: regulation of alkaline phosphatase activity [GO_0010692]
- 6483: regulation of alpha-(1->3)-fucosyltransferase activity [GO_1905619]
- 6484: regulation of amine transport [GO_0051952]
- 6485: regulation of amino acid transmembrane transport [GO_1903789]
- 6486: regulation of amino acid transport [GO_0051955]
- 6487: regulation of aminoacyl-tRNA ligase activity [GO_1903630]
- 6488: regulation of amyloid precursor protein catabolic process [GO_1902991]
- 6489: regulation of anatomical structure morphogenesis [GO_0022603]
- 6490: regulation of androgen secretion [GO_2000834]
- 6491: regulation of angiogenesis [GO_0045765]
- 6492: regulation of animal organ formation [GO_0003156]
- 6493: regulation of animal organ morphogenesis [GO_2000027]
- 6494: regulation of anion channel activity [GO_0010359]
- 6495: regulation of anion transmembrane transport [GO_1903959]
- 6496: regulation of anion transport [GO_0044070]
- 6497: regulation of aorta morphogenesis [GO_1903847]
- 6498: regulation of aortic smooth muscle cell differentiation [GO_1904829]
- 6499: regulation of apical ectodermal ridge formation [GO_1905140]
- 6500: regulation of apolipoprotein binding [GO_2000656]
- 6501: regulation of apoptosis involved in tissue homeostasis [GO_0060785]
- 6502: regulation of apoptotic process [GO_0042981]
- 6503: regulation of apoptotic process involved in development [GO_1904748]
- 6504: regulation of apoptotic process involved in morphogenesis [GO_1902337]
- 6505: regulation of apoptotic process involved in outflow tract morphogenesis [GO_1902256]
- 6506: regulation of apoptotic signaling pathway [GO_2001233]
- 6507: regulation of arginase activity [GO_0150070]
- 6508: regulation of argininosuccinate synthase activity [GO_1905752]
- 6509: regulation of artery morphogenesis [GO_1905651]
- 6510: regulation of aspartic endopeptidase activity, intramembrane cleaving [GO_0120287]
- 6511: regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902959]
- 6512: regulation of aspartic-type peptidase activity [GO_1905245]
- 6513: regulation of asymmetric cell division [GO_0009786]
- 6514: regulation of ATP biosynthetic process [GO_2001169]
- 6515: regulation of ATP citrate synthase activity [GO_2000983]
- 6516: regulation of ATP metabolic process [GO_1903578]
- 6517: regulation of ATP-dependent activity [GO_0043462]
- 6518: regulation of ATP:ADP antiporter activity [GO_0070926]
- 6519: regulation of ATPase-coupled calcium transmembrane transporter activity [GO_1901894]
- 6520: regulation of AV node cell action potential [GO_0098904]
- 6521: regulation of axo-dendritic protein transport [GO_1905126]
- 6522: regulation of axon guidance [GO_1902667]
- 6523: regulation of axonogenesis [GO_0050770]
- 6524: regulation of backward locomotion [GO_0043058]
- 6525: regulation of basement membrane organization [GO_0110011]
- 6526: regulation of behavior [GO_0050795]
- 6527: regulation of bile acid biosynthetic process [GO_0070857]
- 6528: regulation of bile acid metabolic process [GO_1904251]
- 6529: regulation of bile acid secretion [GO_0120188]
- 6530: regulation of binding [GO_0051098]
- 6531: regulation of biological process [GO_0050789]
- 6532: regulation of biological quality [GO_0065008]
- 6533: regulation of biosynthetic process [GO_0009889]
- 6534: regulation of blastocyst development [GO_0120222]
- 6535: regulation of bleb assembly [GO_1904170]
- 6536: regulation of blood circulation [GO_1903522]
- 6537: regulation of blood vessel branching [GO_1905553]
- 6538: regulation of blood vessel endothelial cell differentiation [GO_0110057]
- 6539: regulation of BMP signaling pathway [GO_0030510]
- 6540: regulation of body fluid levels [GO_0050878]
- 6541: regulation of bone development [GO_1903010]
- 6542: regulation of branching involved in lung morphogenesis [GO_0061046]
- 6543: regulation of branching morphogenesis of a nerve [GO_2000172]
- 6544: regulation of calcium ion binding [GO_1901876]
- 6545: regulation of calcium ion transmembrane transport [GO_1903169]
- 6546: regulation of calcium ion transmembrane transporter activity [GO_1901019]
- 6547: regulation of calcium ion transport [GO_0051924]
- 6548: regulation of calcium-dependent ATPase activity [GO_1903610]
- 6549: regulation of calcium-mediated signaling [GO_0050848]
- 6550: regulation of calcium:sodium antiporter activity [GO_1903279]
- 6551: regulation of cAMP-dependent protein kinase activity [GO_2000479]
- 6552: regulation of cAMP-mediated signaling [GO_0043949]
- 6553: regulation of canonical NF-kappaB signal transduction [GO_0043122]
- 6554: regulation of carbohydrate biosynthetic process [GO_0043255]
- 6555: regulation of carbohydrate catabolic process [GO_0043470]
- 6556: regulation of carbohydrate metabolic process [GO_0006109]
- 6557: regulation of carbohydrate phosphatase activity [GO_0032113]
- 6558: regulation of cardiac chamber formation [GO_1901210]
- 6559: regulation of cardiac chamber morphogenesis [GO_1901219]
- 6560: regulation of cardiac conduction [GO_1903779]
- 6561: regulation of cardiac muscle adaptation [GO_0010612]
- 6562: regulation of cardiac muscle cell action potential [GO_0098901]
- 6563: regulation of cardiac muscle cell apoptotic process [GO_0010665]
- 6564: regulation of cardiac muscle cell differentiation [GO_2000725]
- 6565: regulation of cardiac muscle cell myoblast differentiation [GO_2000690]
- 6566: regulation of cardiac muscle cell proliferation [GO_0060043]
- 6567: regulation of cardiac muscle contraction [GO_0055117]
- 6568: regulation of cardiac muscle fiber development [GO_0055018]
- 6569: regulation of cardiac muscle hypertrophy [GO_0010611]
- 6570: regulation of cardiac muscle myoblast proliferation [GO_0110022]
- 6571: regulation of cardiac muscle tissue development [GO_0055024]
- 6572: regulation of cardiac muscle tissue growth [GO_0055021]
- 6573: regulation of cardiac myofibril assembly [GO_1905304]
- 6574: regulation of cardiac ventricle development [GO_1904412]
- 6575: regulation of cardiac ventricle formation [GO_1904942]
- 6576: regulation of cardioblast differentiation [GO_0051890]
- 6577: regulation of cardiocyte differentiation [GO_1905207]
- 6578: regulation of cartilage development [GO_0061035]
- 6579: regulation of catabolic process [GO_0009894]
- 6580: regulation of catalase activity [GO_1902551]
- 6581: regulation of catalytic activity [GO_0050790]
- 6582: regulation of catecholamine metabolic process [GO_0042069]
- 6583: regulation of catecholamine secretion [GO_0050433]
- 6584: regulation of cation channel activity [GO_2001257]
- 6585: regulation of cation transmembrane transport [GO_1904062]
- 6586: regulation of CD4 production [GO_0045223]
- 6587: regulation of cell adhesion [GO_0030155]
- 6588: regulation of cell adhesion involved in heart morphogenesis [GO_0061344]
- 6589: regulation of cell communication [GO_0010646]
- 6590: regulation of cell cycle [GO_0051726]
- 6591: regulation of cell cycle process [GO_0010564]
- 6592: regulation of cell death [GO_0010941]
- 6593: regulation of cell development [GO_0060284]
- 6594: regulation of cell differentiation [GO_0045595]
- 6595: regulation of cell differentiation involved in embryonic placenta development [GO_0060800]
- 6596: regulation of cell differentiation involved in tissue homeostasis [GO_0060786]
- 6597: regulation of cell division [GO_0051302]
- 6598: regulation of cell fate commitment [GO_0010453]
- 6599: regulation of cell growth [GO_0001558]
- 6600: regulation of cell growth involved in cardiac muscle cell development [GO_0061050]
- 6601: regulation of cell junction assembly [GO_1901888]
- 6602: regulation of cell maturation [GO_1903429]
- 6603: regulation of cell migration [GO_0030334]
- 6604: regulation of cell morphogenesis [GO_0022604]
- 6605: regulation of cell morphogenesis involved in differentiation [GO_0010769]
- 6606: regulation of cell motility [GO_2000145]
- 6607: regulation of cell population proliferation [GO_0042127]
- 6608: regulation of cell projection assembly [GO_0060491]
- 6609: regulation of cell projection organization [GO_0031344]
- 6610: regulation of cell proliferation in midbrain [GO_1904933]
- 6611: regulation of cell proliferation involved in compound eye morphogenesis [GO_2000495]
- 6612: regulation of cell proliferation involved in embryonic placenta development [GO_0060723]
- 6613: regulation of cell proliferation involved in heart morphogenesis [GO_2000136]
- 6614: regulation of cell proliferation involved in outflow tract morphogenesis [GO_1901963]
- 6615: regulation of cell proliferation involved in tissue homeostasis [GO_0060784]
- 6616: regulation of cell-cell adhesion [GO_0022407]
- 6617: regulation of cellular amide metabolic process [GO_0034248]
- 6618: regulation of cellular amine catabolic process [GO_0033241]
- 6619: regulation of cellular amine metabolic process [GO_0033238]
- 6620: regulation of cellular amino acid biosynthetic process [GO_2000282]
- 6621: regulation of cellular amino acid metabolic process [GO_0006521]
- 6622: regulation of cellular biosynthetic process [GO_0031326]
- 6623: regulation of cellular carbohydrate catabolic process [GO_0043471]
- 6624: regulation of cellular carbohydrate metabolic process [GO_0010675]
- 6625: regulation of cellular catabolic process [GO_0031329]
- 6626: regulation of cellular component biogenesis [GO_0044087]
- 6627: regulation of cellular component movement [GO_0051270]
- 6628: regulation of cellular component organization [GO_0051128]
- 6629: regulation of cellular ketone metabolic process [GO_0010565]
- 6630: regulation of cellular localization [GO_0060341]
- 6631: regulation of cellular macromolecule biosynthetic process [GO_2000112]
- 6632: regulation of cellular metabolic process [GO_0031323]
- 6633: regulation of cellular process [GO_0050794]
- 6634: regulation of cellular protein metabolic process [GO_0032268]
- 6635: regulation of cellular respiration [GO_0043457]
- 6636: regulation of cellular response to alcohol [GO_1905957]
- 6637: regulation of cellular response to drug [GO_2001038]
- 6638: regulation of cellular response to growth factor stimulus [GO_0090287]
- 6639: regulation of cellular response to insulin stimulus [GO_1900076]
- 6640: regulation of cellular response to oxidative stress [GO_1900407]
- 6641: regulation of cellular response to stress [GO_0080135]
- 6642: regulation of chemokine activity [GO_1900136]
- 6643: regulation of chemorepellent activity [GO_1903667]
- 6644: regulation of chemotaxis [GO_0050920]
- 6645: regulation of chloride transport [GO_2001225]
- 6646: regulation of cholangiocyte apoptotic process [GO_1904192]
- 6647: regulation of cholangiocyte proliferation [GO_1904054]
- 6648: regulation of cholesterol transporter activity [GO_0060694]
- 6649: regulation of choline O-acetyltransferase activity [GO_1902769]
- 6650: regulation of chondrocyte development [GO_0061181]
- 6651: regulation of chondrocyte differentiation [GO_0032330]
- 6652: regulation of chondrocyte differentiation involved in endochondral bone morphogenesis [GO_1902738]
- 6653: regulation of chorionic trophoblast cell proliferation [GO_1901382]
- 6654: regulation of chromatin assembly [GO_0010847]
- 6655: regulation of chromatin assembly or disassembly [GO_0001672]
- 6656: regulation of chromatin binding [GO_0035561]
- 6657: regulation of chromatin disassembly [GO_0010848]
- 6658: regulation of chromatin organization [GO_1902275]
- 6659: regulation of chromosome condensation [GO_0060623]
- 6660: regulation of chromosome organization [GO_0033044]
- 6661: regulation of chromosome segregation [GO_0051983]
- 6662: regulation of cilium assembly [GO_1902017]
- 6663: regulation of circadian rhythm [GO_0042752]
- 6664: regulation of circadian sleep/wake cycle [GO_0042749]
- 6665: regulation of circadian sleep/wake cycle, sleep [GO_0045187]
- 6666: regulation of CoA-transferase activity [GO_1905918]
- 6667: regulation of collagen binding [GO_0033341]
- 6668: regulation of collagen biosynthetic process [GO_0032965]
- 6669: regulation of collagen catabolic process [GO_0010710]
- 6670: regulation of collagen fibril organization [GO_1904026]
- 6671: regulation of collagen metabolic process [GO_0010712]
- 6672: regulation of colon smooth muscle contraction [GO_1904341]
- 6673: regulation of compound eye photoreceptor cell differentiation [GO_0110116]
- 6674: regulation of compound eye retinal cell apoptotic process [GO_1901692]
- 6675: regulation of compound eye retinal cell programmed cell death [GO_0046669]
- 6676: regulation of copper ion transmembrane transport [GO_1902311]
- 6677: regulation of core promoter binding [GO_1904796]
- 6678: regulation of coreceptor activity [GO_0060725]
- 6679: regulation of coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060726]
- 6680: regulation of cyclase activity [GO_0031279]
- 6681: regulation of cyclic nucleotide-gated ion channel activity [GO_1902159]
- 6682: regulation of cyclic-nucleotide phosphodiesterase activity [GO_0051342]
- 6683: regulation of cyclin-dependent protein kinase activity [GO_1904029]
- 6684: regulation of cyclin-dependent protein serine/threonine kinase activity [GO_0000079]
- 6685: regulation of cystathionine beta-synthase activity [GO_1904041]
- 6686: regulation of cysteine metabolic process [GO_1901494]
- 6687: regulation of cysteine-type endopeptidase activity [GO_2000116]
- 6688: regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0043281]
- 6689: regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO_2001267]
- 6690: regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_2001270]
- 6691: regulation of cytochrome-c oxidase activity [GO_1904959]
- 6692: regulation of cytokine activity [GO_0060300]
- 6693: regulation of cytokine-mediated signaling pathway [GO_0001959]
- 6694: regulation of cytokinesis [GO_0032465]
- 6695: regulation of cytoplasmic microtubule depolymerization [GO_0010937]
- 6696: regulation of cytoskeleton organization [GO_0051493]
- 6697: regulation of D-amino-acid oxidase activity [GO_1900757]
- 6698: regulation of D-erythro-sphingosine kinase activity [GO_1900022]
- 6699: regulation of deacetylase activity [GO_0150065]
- 6700: regulation of defecation [GO_2000292]
- 6701: regulation of delayed rectifier potassium channel activity [GO_1902259]
- 6702: regulation of deoxyribonuclease activity [GO_0032070]
- 6703: regulation of dephosphorylation [GO_0035303]
- 6704: regulation of dermatome development [GO_0061183]
- 6705: regulation of detection of mechanical stimulus involved in sensory perception of touch [GO_1905787]
- 6706: regulation of development, heterochronic [GO_0040034]
- 6707: regulation of developmental growth [GO_0048638]
- 6708: regulation of developmental pigmentation [GO_0048070]
- 6709: regulation of developmental process [GO_0050793]
- 6710: regulation of diacylglycerol kinase activity [GO_1905687]
- 6711: regulation of digestive system process [GO_0044058]
- 6712: regulation of dipeptide transmembrane transport [GO_2001148]
- 6713: regulation of dipeptide transport [GO_0090089]
- 6714: regulation of DNA binding [GO_0051101]
- 6715: regulation of DNA biosynthetic process [GO_2000278]
- 6716: regulation of DNA duplex unwinding [GO_1905462]
- 6717: regulation of DNA helicase activity [GO_1905774]
- 6718: regulation of DNA ligase activity [GO_1904875]
- 6719: regulation of DNA ligation [GO_0051105]
- 6720: regulation of DNA metabolic process [GO_0051052]
- 6721: regulation of DNA methylation [GO_0044030]
- 6722: regulation of DNA N-glycosylase activity [GO_1902544]
- 6723: regulation of DNA primase activity [GO_1903932]
- 6724: regulation of DNA recombination [GO_0000018]
- 6725: regulation of DNA repair [GO_0006282]
- 6726: regulation of DNA replication [GO_0006275]
- 6727: regulation of DNA replication origin binding [GO_1902595]
- 6728: regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO_2000371]
- 6729: regulation of DNA-binding transcription factor activity [GO_0051090]
- 6730: regulation of DNA-directed DNA polymerase activity [GO_1900262]
- 6731: regulation of DNA-templated DNA replication [GO_0090329]
- 6732: regulation of DNA-templated transcription [GO_0006355]
- 6733: regulation of DNA-templated transcription initiation [GO_2000142]
- 6734: regulation of dopamine receptor signaling pathway [GO_0060159]
- 6735: regulation of dopamine secretion [GO_0014059]
- 6736: regulation of double-stranded telomeric DNA binding [GO_1905767]
- 6737: regulation of dUTP diphosphatase activity [GO_1903627]
- 6738: regulation of eclosion [GO_0007563]
- 6739: regulation of ectoderm development [GO_2000383]
- 6740: regulation of electron transfer activity [GO_1904732]
- 6741: regulation of embryonic camera-type eye development [GO_1902863]
- 6742: regulation of embryonic development [GO_0045995]
- 6743: regulation of endocrine process [GO_0044060]
- 6744: regulation of endocytosis [GO_0030100]
- 6745: regulation of endodeoxyribonuclease activity [GO_0032071]
- 6746: regulation of endodermal cell differentiation [GO_1903224]
- 6747: regulation of endopeptidase activity [GO_0052548]
- 6748: regulation of endoribonuclease activity [GO_0060699]
- 6749: regulation of endothelial cell apoptotic process [GO_2000351]
- 6750: regulation of endothelial cell development [GO_1901550]
- 6751: regulation of endothelial cell differentiation [GO_0045601]
- 6752: regulation of endothelial cell proliferation [GO_0001936]
- 6753: regulation of endothelial tube morphogenesis [GO_1901509]
- 6754: regulation of entry into reproductive diapause [GO_0061963]
- 6755: regulation of ephrin receptor signaling pathway [GO_1901187]
- 6756: regulation of epidermal cell differentiation [GO_0045604]
- 6757: regulation of epidermal cell division [GO_0010482]
- 6758: regulation of epidermal growth factor receptor signaling pathway [GO_0042058]
- 6759: regulation of epidermal growth factor-activated receptor activity [GO_0007176]
- 6760: regulation of epidermis development [GO_0045682]
- 6761: regulation of epithelial cell apoptotic process [GO_1904035]
- 6762: regulation of epithelial cell differentiation [GO_0030856]
- 6763: regulation of epithelial cell proliferation [GO_0050678]
- 6764: regulation of epithelial cell proliferation involved in lung morphogenesis [GO_2000794]
- 6765: regulation of epithelial to mesenchymal transition [GO_0010717]
- 6766: regulation of epithelial tube formation [GO_1905276]
- 6767: regulation of ERBB signaling pathway [GO_1901184]
- 6768: regulation of erythrocyte apoptotic process [GO_1902250]
- 6769: regulation of erythrocyte differentiation [GO_0045646]
- 6770: regulation of establishment of cell polarity [GO_2000114]
- 6771: regulation of establishment of planar polarity [GO_0090175]
- 6772: regulation of establishment of protein localization [GO_0070201]
- 6773: regulation of establishment of protein localization to chromosome [GO_0070202]
- 6774: regulation of establishment or maintenance of cell polarity [GO_0032878]
- 6775: regulation of euchromatin binding [GO_1904793]
- 6776: regulation of excretion [GO_0044062]
- 6777: regulation of execution phase of apoptosis [GO_1900117]
- 6778: regulation of exocytosis [GO_0017157]
- 6779: regulation of exodeoxyribonuclease activity [GO_1902392]
- 6780: regulation of exonuclease activity [GO_1905777]
- 6781: regulation of exoribonuclease activity [GO_1901917]
- 6782: regulation of exosomal secretion [GO_1903541]
- 6783: regulation of extracellular exosome assembly [GO_1903551]
- 6784: regulation of extracellular matrix assembly [GO_1901201]
- 6785: regulation of extracellular matrix disassembly [GO_0010715]
- 6786: regulation of extracellular matrix organization [GO_1903053]
- 6787: regulation of eye photoreceptor cell development [GO_0042478]
- 6788: regulation of fat cell apoptotic process [GO_1904649]
- 6789: regulation of fat cell differentiation [GO_0045598]
- 6790: regulation of fat cell proliferation [GO_0070344]
- 6791: regulation of fatty acid biosynthetic process [GO_0042304]
- 6792: regulation of fatty acid metabolic process [GO_0019217]
- 6793: regulation of fatty acid transport [GO_2000191]
- 6794: regulation of feeding behavior [GO_0060259]
- 6795: regulation of female gonad development [GO_2000194]
- 6796: regulation of female receptivity [GO_0045924]
- 6797: regulation of ferrochelatase activity [GO_0010722]
- 6798: regulation of ferrous iron binding [GO_1904432]
- 6799: regulation of fertilization [GO_0080154]
- 6800: regulation of fibroblast apoptotic process [GO_2000269]
- 6801: regulation of fibroblast growth factor receptor signaling pathway [GO_0040036]
- 6802: regulation of fibroblast proliferation [GO_0048145]
- 6803: regulation of formation of translation initiation ternary complex [GO_1901190]
- 6804: regulation of forward locomotion [GO_0043059]
- 6805: regulation of fructose 1,6-bisphosphate 1-phosphatase activity [GO_0060549]
- 6806: regulation of G protein-coupled receptor signaling pathway [GO_0008277]
- 6807: regulation of G-quadruplex DNA binding [GO_1905493]
- 6808: regulation of GABA-A receptor activity [GO_0106040]
- 6809: regulation of gamma-aminobutyric acid secretion [GO_0014052]
- 6810: regulation of gastric acid secretion [GO_0060453]
- 6811: regulation of gastric mucosal blood circulation [GO_1904344]
- 6812: regulation of gastro-intestinal system smooth muscle contraction [GO_1904304]
- 6813: regulation of gastrulation [GO_0010470]
- 6814: regulation of gene expression [GO_0010468]
- 6815: regulation of gene expression, epigenetic [GO_0040029]
- 6816: regulation of gene silencing by RNA [GO_0060966]
- 6817: regulation of generation of precursor metabolites and energy [GO_0043467]
- 6818: regulation of germ cell proliferation [GO_1905936]
- 6819: regulation of glial cell apoptotic process [GO_0034350]
- 6820: regulation of glial cell differentiation [GO_0045685]
- 6821: regulation of glial cell proliferation [GO_0060251]
- 6822: regulation of gliogenesis [GO_0014013]
- 6823: regulation of glucagon secretion [GO_0070092]
- 6824: regulation of glucan biosynthetic process [GO_0010962]
- 6825: regulation of glucokinase activity [GO_0033131]
- 6826: regulation of gluconeogenesis [GO_0006111]
- 6827: regulation of glucose metabolic process [GO_0010906]
- 6828: regulation of glucose transmembrane transport [GO_0010827]
- 6829: regulation of glucose-6-phosphatase activity [GO_0032114]
- 6830: regulation of glucosylceramidase activity [GO_1905123]
- 6831: regulation of glucuronosyltransferase activity [GO_1904223]
- 6832: regulation of glutamate receptor signaling pathway [GO_1900449]
- 6833: regulation of glutamate secretion [GO_0014048]
- 6834: regulation of glutamate secretion, neurotransmission [GO_1903294]
- 6835: regulation of glutamate-ammonia ligase activity [GO_1905478]
- 6836: regulation of glutamate-cysteine ligase activity [GO_0035227]
- 6837: regulation of glutathione biosynthetic process [GO_1903786]
- 6838: regulation of glutathione peroxidase activity [GO_1903282]
- 6839: regulation of glycine secretion, neurotransmission [GO_1904624]
- 6840: regulation of glycogen (starch) synthase activity [GO_2000465]
- 6841: regulation of glycogen biosynthetic process [GO_0005979]
- 6842: regulation of glycogen catabolic process [GO_0005981]
- 6843: regulation of glycogen metabolic process [GO_0070873]
- 6844: regulation of glycolytic process [GO_0006110]
- 6845: regulation of glycolytic process through fructose-6-phosphate [GO_1904538]
- 6846: regulation of glycoprotein biosynthetic process [GO_0010559]
- 6847: regulation of glycoprotein metabolic process [GO_1903018]
- 6848: regulation of Golgi inheritance [GO_0090170]
- 6849: regulation of Golgi organization [GO_1903358]
- 6850: regulation of Golgi to plasma membrane protein transport [GO_0042996]
- 6851: regulation of gonad development [GO_1905939]
- 6852: regulation of grooming behavior [GO_2000821]
- 6853: regulation of growth [GO_0040008]
- 6854: regulation of GTP binding [GO_1904424]
- 6855: regulation of GTP cyclohydrolase I activity [GO_0043095]
- 6856: regulation of GTPase activity [GO_0043087]
- 6857: regulation of guanyl-nucleotide exchange factor activity [GO_1905097]
- 6858: regulation of guanylate cyclase activity [GO_0031282]
- 6859: regulation of heart contraction [GO_0008016]
- 6860: regulation of heart growth [GO_0060420]
- 6861: regulation of heart morphogenesis [GO_2000826]
- 6862: regulation of heart rate [GO_0002027]
- 6863: regulation of helicase activity [GO_0051095]
- 6864: regulation of hematopoietic progenitor cell differentiation [GO_1901532]
- 6865: regulation of hematopoietic stem cell differentiation [GO_1902036]
- 6866: regulation of hematopoietic stem cell proliferation [GO_1902033]
- 6867: regulation of heme oxygenase activity [GO_0061960]
- 6868: regulation of hemopoiesis [GO_1903706]
- 6869: regulation of heparan sulfate proteoglycan binding [GO_1905858]
- 6870: regulation of hepatocyte apoptotic process [GO_1903943]
- 6871: regulation of hepatocyte differentiation [GO_0070366]
- 6872: regulation of heterochromatin assembly [GO_0031445]
- 6873: regulation of heterochromatin organization [GO_0120261]
- 6874: regulation of hexokinase activity [GO_1903299]
- 6875: regulation of high voltage-gated calcium channel activity [GO_1901841]
- 6876: regulation of hindgut contraction [GO_0043134]
- 6877: regulation of histone deacetylase activity [GO_1901725]
- 6878: regulation of histone deacetylation [GO_0031063]
- 6879: regulation of histone demethylase activity (H3-K4 specific) [GO_1904173]
- 6880: regulation of histone modification [GO_0031056]
- 6881: regulation of hormone levels [GO_0010817]
- 6882: regulation of hormone metabolic process [GO_0032350]
- 6883: regulation of hormone secretion [GO_0046883]
- 6884: regulation of hyaluronan biosynthetic process [GO_1900125]
- 6885: regulation of hydrolase activity [GO_0051336]
- 6886: regulation of I-kappaB phosphorylation [GO_1903719]
- 6887: regulation of immune effector process [GO_0002697]
- 6888: regulation of immune response [GO_0050776]
- 6889: regulation of immune system process [GO_0002682]
- 6890: regulation of inorganic anion transmembrane transport [GO_1903795]
- 6891: regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0031585]
- 6892: regulation of inositol-polyphosphate 5-phosphatase activity [GO_0010924]
- 6893: regulation of insulin receptor signaling pathway [GO_0046626]
- 6894: regulation of insulin secretion [GO_0050796]
- 6895: regulation of intestinal absorption [GO_1904478]
- 6896: regulation of intestinal epithelial cell development [GO_1905298]
- 6897: regulation of intracellular calcium activated chloride channel activity [GO_1902938]
- 6898: regulation of intracellular lipid transport [GO_0032377]
- 6899: regulation of intracellular protein transport [GO_0033157]
- 6900: regulation of intracellular signal transduction [GO_1902531]
- 6901: regulation of intracellular sterol transport [GO_0032380]
- 6902: regulation of intracellular transport [GO_0032386]
- 6903: regulation of inward rectifier potassium channel activity [GO_1901979]
- 6904: regulation of ion transmembrane transport [GO_0034765]
- 6905: regulation of ion transmembrane transporter activity [GO_0032412]
- 6906: regulation of ion transport [GO_0043269]
- 6907: regulation of iron ion transmembrane transport [GO_0034759]
- 6908: regulation of iron ion transmembrane transporter activity [GO_1904254]
- 6909: regulation of iron ion transport [GO_0034756]
- 6910: regulation of isoleucine-tRNA ligase activity [GO_1905015]
- 6911: regulation of isomerase activity [GO_0010911]
- 6912: regulation of isoprenoid metabolic process [GO_0019747]
- 6913: regulation of JNK cascade [GO_0046328]
- 6914: regulation of JUN kinase activity [GO_0043506]
- 6915: regulation of kainate selective glutamate receptor activity [GO_2000312]
- 6916: regulation of karyogamy [GO_0032871]
- 6917: regulation of ketone biosynthetic process [GO_0010566]
- 6918: regulation of ketone catabolic process [GO_0010567]
- 6919: regulation of kinase activity [GO_0043549]
- 6920: regulation of L-dopa decarboxylase activity [GO_1903198]
- 6921: regulation of large conductance calcium-activated potassium channel activity [GO_1902606]
- 6922: regulation of leucine-tRNA ligase activity [GO_1903633]
- 6923: regulation of leukocyte apoptotic process [GO_2000106]
- 6924: regulation of leukocyte differentiation [GO_1902105]
- 6925: regulation of leukocyte mediated immunity [GO_0002703]
- 6926: regulation of leukocyte proliferation [GO_0070663]
- 6927: regulation of ligase activity [GO_0051340]
- 6928: regulation of light-activated channel activity [GO_0016061]
- 6929: regulation of lipase activity [GO_0060191]
- 6930: regulation of lipid binding [GO_1900130]
- 6931: regulation of lipid biosynthetic process [GO_0046890]
- 6932: regulation of lipid catabolic process [GO_0050994]
- 6933: regulation of lipid kinase activity [GO_0043550]
- 6934: regulation of lipid localization [GO_1905952]
- 6935: regulation of lipid metabolic process [GO_0019216]
- 6936: regulation of lipid storage [GO_0010883]
- 6937: regulation of lipid transport [GO_0032368]
- 6938: regulation of lipid transporter activity [GO_0110112]
- 6939: regulation of lipopolysaccharide-mediated signaling pathway [GO_0031664]
- 6940: regulation of lipoprotein lipase activity [GO_0051004]
- 6941: regulation of localization [GO_0032879]
- 6942: regulation of locomotion [GO_0040012]
- 6943: regulation of locomotion involved in locomotory behavior [GO_0090325]
- 6944: regulation of locomotor rhythm [GO_1904059]
- 6945: regulation of low-density lipoprotein particle receptor binding [GO_1905595]
- 6946: regulation of lung ciliated cell differentiation [GO_1901246]
- 6947: regulation of lyase activity [GO_0051339]
- 6948: regulation of lysozyme activity [GO_1903590]
- 6949: regulation of m7G(5')pppN diphosphatase activity [GO_1903398]
- 6950: regulation of macromolecule biosynthetic process [GO_0010556]
- 6951: regulation of macromolecule metabolic process [GO_0060255]
- 6952: regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO_1903218]
- 6953: regulation of male mating behavior [GO_1902435]
- 6954: regulation of MAP kinase activity [GO_0043405]
- 6955: regulation of MAPK cascade [GO_0043408]
- 6956: regulation of megakaryocyte differentiation [GO_0045652]
- 6957: regulation of meiotic cell cycle [GO_0051445]
- 6958: regulation of meiotic cell cycle process involved in oocyte maturation [GO_1903538]
- 6959: regulation of meiotic nuclear division [GO_0040020]
- 6960: regulation of membrane disassembly [GO_0010549]
- 6961: regulation of membrane invagination [GO_1905153]
- 6962: regulation of membrane lipid distribution [GO_0097035]
- 6963: regulation of membrane potential [GO_0042391]
- 6964: regulation of membrane potential in photoreceptor cell [GO_0016057]
- 6965: regulation of mesenchymal cell apoptotic process [GO_2001053]
- 6966: regulation of mesenchymal cell proliferation [GO_0010464]
- 6967: regulation of mesenchymal cell proliferation involved in lung development [GO_2000790]
- 6968: regulation of mesoderm development [GO_2000380]
- 6969: regulation of mesoderm formation [GO_1905902]
- 6970: regulation of mesodermal cell differentiation [GO_1905770]
- 6971: regulation of metabolic process [GO_0019222]
- 6972: regulation of metal ion transport [GO_0010959]
- 6973: regulation of metalloendopeptidase activity [GO_1904683]
- 6974: regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902962]
- 6975: regulation of metallopeptidase activity [GO_1905048]
- 6976: regulation of methionine-tRNA ligase activity [GO_1905018]
- 6977: regulation of methylenetetrahydrofolate reductase (NAD(P)H) activity [GO_1903868]
- 6978: regulation of microtubule binding [GO_1904526]
- 6979: regulation of microtubule cytoskeleton organization [GO_0070507]
- 6980: regulation of microtubule depolymerization [GO_0031114]
- 6981: regulation of microtubule minus-end binding [GO_1902619]
- 6982: regulation of microtubule nucleation [GO_0010968]
- 6983: regulation of microtubule plus-end binding [GO_1903031]
- 6984: regulation of microtubule polymerization [GO_0031113]
- 6985: regulation of microtubule polymerization or depolymerization [GO_0031110]
- 6986: regulation of microtubule-based movement [GO_0060632]
- 6987: regulation of microtubule-based process [GO_0032886]
- 6988: regulation of microvillus assembly [GO_0032534]
- 6989: regulation of microvillus organization [GO_0032530]
- 6990: regulation of miRNA processing [GO_1903798]
- 6991: regulation of miRNA-mediated gene silencing [GO_0060964]
- 6992: regulation of mitochondrial ATP synthesis coupled proton transport [GO_1905706]
- 6993: regulation of mitochondrial DNA metabolic process [GO_1901858]
- 6994: regulation of mitochondrial DNA replication [GO_0090296]
- 6995: regulation of mitochondrial gene expression [GO_0062125]
- 6996: regulation of mitochondrial mRNA catabolic process [GO_1905637]
- 6997: regulation of mitochondrial RNA catabolic process [GO_0000960]
- 6998: regulation of mitochondrial transcription [GO_1903108]
- 6999: regulation of mitochondrial translation [GO_0070129]
- 7000: regulation of mitochondrial translational elongation [GO_1905082]
- 7001: regulation of mitochondrial translational initiation [GO_0070132]
- 7002: regulation of mitochondrion organization [GO_0010821]
- 7003: regulation of mitotic cell cycle [GO_0007346]
- 7004: regulation of mitotic cell cycle DNA replication [GO_1903463]
- 7005: regulation of mitotic cell cycle, embryonic [GO_0009794]
- 7006: regulation of mitotic chromosome condensation [GO_1903379]
- 7007: regulation of mitotic nuclear division [GO_0007088]
- 7008: regulation of mitotic nuclear envelope disassembly [GO_1905557]
- 7009: regulation of mitotic sister chromatid segregation [GO_0033047]
- 7010: regulation of molecular function [GO_0065009]
- 7011: regulation of mononuclear cell proliferation [GO_0032944]
- 7012: regulation of monooxygenase activity [GO_0032768]
- 7013: regulation of morphogenesis of a branching structure [GO_0060688]
- 7014: regulation of morphogenesis of an epithelium [GO_1905330]
- 7015: regulation of motor neuron apoptotic process [GO_2000671]
- 7016: regulation of mRNA 3'-UTR binding [GO_1903837]
- 7017: regulation of mRNA binding [GO_1902415]
- 7018: regulation of mRNA catabolic process [GO_0061013]
- 7019: regulation of mRNA metabolic process [GO_1903311]
- 7020: regulation of mRNA modification [GO_0090365]
- 7021: regulation of mRNA processing [GO_0050684]
- 7022: regulation of mRNA stability [GO_0043488]
- 7023: regulation of mRNA stability involved in response to oxidative stress [GO_2000815]
- 7024: regulation of mRNA stability involved in response to stress [GO_0010610]
- 7025: regulation of mucus secretion [GO_0070255]
- 7026: regulation of multi-organism process [GO_0043900]
- 7027: regulation of multicellular organism growth [GO_0040014]
- 7028: regulation of multicellular organismal development [GO_2000026]
- 7029: regulation of multicellular organismal process [GO_0051239]
- 7030: regulation of muscle adaptation [GO_0043502]
- 7031: regulation of muscle cell apoptotic process [GO_0010660]
- 7032: regulation of muscle cell differentiation [GO_0051147]
- 7033: regulation of muscle contraction [GO_0006937]
- 7034: regulation of muscle hypertrophy [GO_0014743]
- 7035: regulation of muscle organ development [GO_0048634]
- 7036: regulation of muscle system process [GO_0090257]
- 7037: regulation of muscle tissue development [GO_1901861]
- 7038: regulation of myeloid cell apoptotic process [GO_0033032]
- 7039: regulation of myeloid cell differentiation [GO_0045637]
- 7040: regulation of myeloid leukocyte differentiation [GO_0002761]
- 7041: regulation of myeloid leukocyte mediated immunity [GO_0002886]
- 7042: regulation of myeloid progenitor cell differentiation [GO_1905453]
- 7043: regulation of myoblast differentiation [GO_0045661]
- 7044: regulation of myoblast proliferation [GO_2000291]
- 7045: regulation of myosin light chain kinase activity [GO_0035504]
- 7046: regulation of myotome development [GO_2000290]
- 7047: regulation of myotube differentiation [GO_0010830]
- 7048: regulation of NAD(P)H oxidase activity [GO_0033860]
- 7049: regulation of NAD+ ADP-ribosyltransferase activity [GO_1901664]
- 7050: regulation of NAD+ kinase activity [GO_0033670]
- 7051: regulation of negative chemotaxis [GO_0050923]
- 7052: regulation of nervous system development [GO_0051960]
- 7053: regulation of nervous system process [GO_0031644]
- 7054: regulation of netrin-activated signaling pathway [GO_1902841]
- 7055: regulation of neural crest cell differentiation [GO_1905292]
- 7056: regulation of neural crest formation [GO_0090299]
- 7057: regulation of neural precursor cell proliferation [GO_2000177]
- 7058: regulation of neural retina development [GO_0061074]
- 7059: regulation of neuroblast proliferation [GO_1902692]
- 7060: regulation of neurogenesis [GO_0050767]
- 7061: regulation of neuromuscular junction development [GO_1904396]
- 7062: regulation of neuron apoptotic process [GO_0043523]
- 7063: regulation of neuron death [GO_1901214]
- 7064: regulation of neuron differentiation [GO_0045664]
- 7065: regulation of neuron maturation [GO_0014041]
- 7066: regulation of neuron projection development [GO_0010975]
- 7067: regulation of neuronal action potential [GO_0098908]
- 7068: regulation of neurotransmitter levels [GO_0001505]
- 7069: regulation of neurotransmitter receptor activity [GO_0099601]
- 7070: regulation of neurotransmitter secretion [GO_0046928]
- 7071: regulation of neurotransmitter transport [GO_0051588]
- 7072: regulation of neurotransmitter uptake [GO_0051580]
- 7073: regulation of nitric-oxide synthase activity [GO_0050999]
- 7074: regulation of nitrogen compound metabolic process [GO_0051171]
- 7075: regulation of NMDA receptor activity [GO_2000310]
- 7076: regulation of non-membrane spanning protein tyrosine kinase activity [GO_1903995]
- 7077: regulation of norepinephrine secretion [GO_0014061]
- 7078: regulation of norepinephrine uptake [GO_0051621]
- 7079: regulation of nuclear cell cycle DNA replication [GO_0033262]
- 7080: regulation of nuclear division [GO_0051783]
- 7081: regulation of nuclear migration along microtubule [GO_1902838]
- 7082: regulation of nuclease activity [GO_0032069]
- 7083: regulation of nucleic acid-templated transcription [GO_1903506]
- 7084: regulation of nucleobase-containing compound metabolic process [GO_0019219]
- 7085: regulation of nucleobase-containing compound transport [GO_0032239]
- 7086: regulation of nucleocytoplasmic transport [GO_0046822]
- 7087: regulation of nucleoside metabolic process [GO_0009118]
- 7088: regulation of nucleoside transport [GO_0032242]
- 7089: regulation of nucleotide biosynthetic process [GO_0030808]
- 7090: regulation of nucleotide catabolic process [GO_0030811]
- 7091: regulation of nucleotide metabolic process [GO_0006140]
- 7092: regulation of nucleus organization [GO_1903353]
- 7093: regulation of olfactory learning [GO_0090328]
- 7094: regulation of oligopeptide transport [GO_0090088]
- 7095: regulation of oocyte development [GO_0060281]
- 7096: regulation of oocyte maturation [GO_1900193]
- 7097: regulation of oogenesis [GO_1905879]
- 7098: regulation of organ growth [GO_0046620]
- 7099: regulation of organelle assembly [GO_1902115]
- 7100: regulation of organelle organization [GO_0033043]
- 7101: regulation of organelle transport along microtubule [GO_1902513]
- 7102: regulation of organic acid transport [GO_0032890]
- 7103: regulation of ossification [GO_0030278]
- 7104: regulation of oviposition [GO_0046662]
- 7105: regulation of oxidative phosphorylation [GO_0002082]
- 7106: regulation of oxidoreductase activity [GO_0051341]
- 7107: regulation of oxygen metabolic process [GO_2000374]
- 7108: regulation of P-type sodium:potassium-exchanging transporter activity [GO_1903406]
- 7109: regulation of pancreatic A cell differentiation [GO_2000226]
- 7110: regulation of peptidase activity [GO_0052547]
- 7111: regulation of peptide hormone secretion [GO_0090276]
- 7112: regulation of peptide secretion [GO_0002791]
- 7113: regulation of peptide transport [GO_0090087]
- 7114: regulation of peptidyl-tyrosine phosphorylation [GO_0050730]
- 7115: regulation of peroxidase activity [GO_2000468]
- 7116: regulation of pharynx morphogenesis [GO_0110041]
- 7117: regulation of phosphatase activity [GO_0010921]
- 7118: regulation of phosphate metabolic process [GO_0019220]
- 7119: regulation of phosphate transmembrane transport [GO_2000185]
- 7120: regulation of phosphate transport [GO_0010966]
- 7121: regulation of phosphatidate phosphatase activity [GO_1903730]
- 7122: regulation of phosphatidylcholine biosynthetic process [GO_2001245]
- 7123: regulation of phosphatidylcholine metabolic process [GO_0150172]
- 7124: regulation of phosphatidylinositol 3-kinase activity [GO_0043551]
- 7125: regulation of phosphatidylinositol biosynthetic process [GO_0010511]
- 7126: regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO_0120138]
- 7127: regulation of phospholipase A2 activity [GO_0032429]
- 7128: regulation of phospholipase activity [GO_0010517]
- 7129: regulation of phospholipase C activity [GO_1900274]
- 7130: regulation of phospholipase D activity [GO_1904005]
- 7131: regulation of phospholipid biosynthetic process [GO_0071071]
- 7132: regulation of phospholipid metabolic process [GO_1903725]
- 7133: regulation of phospholipid scramblase activity [GO_1900161]
- 7134: regulation of phospholipid translocation [GO_0061091]
- 7135: regulation of phospholipid transport [GO_2001138]
- 7136: regulation of phosphoprotein phosphatase activity [GO_0043666]
- 7137: regulation of phosphorus metabolic process [GO_0051174]
- 7138: regulation of phosphorylation [GO_0042325]
- 7139: regulation of photoreceptor cell differentiation [GO_0046532]
- 7140: regulation of pigment cell differentiation [GO_0050932]
- 7141: regulation of pigmentation [GO_0120305]
- 7142: regulation of placenta blood vessel development [GO_0110079]
- 7143: regulation of plasma membrane bounded cell projection assembly [GO_0120032]
- 7144: regulation of plasma membrane bounded cell projection organization [GO_0120035]
- 7145: regulation of plasma membrane organization [GO_1903729]
- 7146: regulation of poly(A)-specific ribonuclease activity [GO_0106246]
- 7147: regulation of polyamine transmembrane transport [GO_1902267]
- 7148: regulation of polynucleotide 3'-phosphatase activity [GO_1901968]
- 7149: regulation of polynucleotide adenylyltransferase activity [GO_1904245]
- 7150: regulation of polysaccharide biosynthetic process [GO_0032885]
- 7151: regulation of polysaccharide metabolic process [GO_0032881]
- 7152: regulation of polysome binding [GO_1905696]
- 7153: regulation of positive chemotaxis [GO_0050926]
- 7154: regulation of post-embryonic development [GO_0048580]
- 7155: regulation of post-transcriptional gene silencing [GO_0060147]
- 7156: regulation of post-transcriptional gene silencing by RNA [GO_1900368]
- 7157: regulation of post-translational protein modification [GO_1901873]
- 7158: regulation of postsynapse assembly [GO_0150052]
- 7159: regulation of postsynapse organization [GO_0099175]
- 7160: regulation of postsynaptic membrane potential [GO_0060078]
- 7161: regulation of postsynaptic neurotransmitter receptor activity [GO_0098962]
- 7162: regulation of potassium ion transmembrane transport [GO_1901379]
- 7163: regulation of potassium ion transmembrane transporter activity [GO_1901016]
- 7164: regulation of potassium ion transport [GO_0043266]
- 7165: regulation of pre-miRNA processing [GO_2000631]
- 7166: regulation of presynapse assembly [GO_1905606]
- 7167: regulation of presynapse organization [GO_0099174]
- 7168: regulation of primary metabolic process [GO_0080090]
- 7169: regulation of programmed cell death [GO_0043067]
- 7170: regulation of prostaglandin-E synthase activity [GO_2000361]
- 7171: regulation of proteasomal protein catabolic process [GO_0061136]
- 7172: regulation of protein ADP-ribosylation [GO_0010835]
- 7173: regulation of protein binding [GO_0043393]
- 7174: regulation of protein catabolic process [GO_0042176]
- 7175: regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO_0099576]
- 7176: regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO_0099575]
- 7177: regulation of protein catabolic process at synapse, modulating synaptic transmission [GO_0099574]
- 7178: regulation of protein catabolic process in the vacuole [GO_1904350]
- 7179: regulation of protein deacetylation [GO_0090311]
- 7180: regulation of protein dephosphorylation [GO_0035304]
- 7181: regulation of protein depolymerization [GO_1901879]
- 7182: regulation of protein deubiquitination [GO_0090085]
- 7183: regulation of protein folding [GO_1903332]
- 7184: regulation of protein glycosylation [GO_0060049]
- 7185: regulation of protein heterodimerization activity [GO_0043497]
- 7186: regulation of protein homodimerization activity [GO_0043496]
- 7187: regulation of protein K48-linked deubiquitination [GO_1903093]
- 7188: regulation of protein K63-linked deubiquitination [GO_1903004]
- 7189: regulation of protein kinase activity [GO_0045859]
- 7190: regulation of protein kinase C activity [GO_1900019]
- 7191: regulation of protein localization [GO_0032880]
- 7192: regulation of protein localization to cell cortex [GO_1904776]
- 7193: regulation of protein localization to cell leading edge [GO_1905871]
- 7194: regulation of protein localization to cell periphery [GO_1904375]
- 7195: regulation of protein localization to cell-cell junction [GO_0150106]
- 7196: regulation of protein localization to chromatin [GO_1905634]
- 7197: regulation of protein localization to ciliary membrane [GO_1903567]
- 7198: regulation of protein localization to cilium [GO_1903564]
- 7199: regulation of protein localization to membrane [GO_1905475]
- 7200: regulation of protein localization to microtubule [GO_1902816]
- 7201: regulation of protein localization to nucleolus [GO_1904749]
- 7202: regulation of protein localization to nucleus [GO_1900180]
- 7203: regulation of protein localization to plasma membrane [GO_1903076]
- 7204: regulation of protein localization to presynapse [GO_1905384]
- 7205: regulation of protein localization to synapse [GO_1902473]
- 7206: regulation of protein maturation [GO_1903317]
- 7207: regulation of protein metabolic process [GO_0051246]
- 7208: regulation of protein modification by small protein conjugation or removal [GO_1903320]
- 7209: regulation of protein modification process [GO_0031399]
- 7210: regulation of protein O-linked glycosylation [GO_1904098]
- 7211: regulation of protein phosphorylation [GO_0001932]
- 7212: regulation of protein polymerization [GO_0032271]
- 7213: regulation of protein secretion [GO_0050708]
- 7214: regulation of protein serine/threonine kinase activity [GO_0071900]
- 7215: regulation of protein sumoylation [GO_0033233]
- 7216: regulation of protein transport [GO_0051223]
- 7217: regulation of protein tyrosine kinase activity [GO_0061097]
- 7218: regulation of protein tyrosine phosphatase activity [GO_1903613]
- 7219: regulation of protein ubiquitination [GO_0031396]
- 7220: regulation of protein-containing complex assembly [GO_0043254]
- 7221: regulation of protein-containing complex disassembly [GO_0043244]
- 7222: regulation of protein-glutamine gamma-glutamyltransferase activity [GO_0150073]
- 7223: regulation of proteolysis [GO_0030162]
- 7224: regulation of proteolysis involved in protein catabolic process [GO_1903050]
- 7225: regulation of proton transport [GO_0010155]
- 7226: regulation of proton-transporting ATP synthase activity, rotational mechanism [GO_1905271]
- 7227: regulation of proton-transporting ATPase activity, rotational mechanism [GO_0010849]
- 7228: regulation of purine nucleotide biosynthetic process [GO_1900371]
- 7229: regulation of purine nucleotide catabolic process [GO_0033121]
- 7230: regulation of purine nucleotide metabolic process [GO_1900542]
- 7231: regulation of Purkinje myocyte action potential [GO_0098906]
- 7232: regulation of pyrimidine nucleoside transport [GO_0032246]
- 7233: regulation of pyrimidine nucleotide biosynthetic process [GO_1900397]
- 7234: regulation of pyrroline-5-carboxylate reductase activity [GO_1903167]
- 7235: regulation of pyruvate dehydrogenase activity [GO_1904182]
- 7236: regulation of pyruvate kinase activity [GO_1903302]
- 7237: regulation of reactive oxygen species metabolic process [GO_2000377]
- 7238: regulation of receptor binding [GO_1900120]
- 7239: regulation of receptor-mediated endocytosis [GO_0048259]
- 7240: regulation of regulatory ncRNA processing [GO_0070920]
- 7241: regulation of release of sequestered calcium ion into cytosol [GO_0051279]
- 7242: regulation of removal of superoxide radicals [GO_2000121]
- 7243: regulation of renal system process [GO_0098801]
- 7244: regulation of reproductive process [GO_2000241]
- 7245: regulation of respiratory gaseous exchange [GO_0043576]
- 7246: regulation of respiratory gaseous exchange by nervous system process [GO_0002087]
- 7247: regulation of respiratory system process [GO_0044065]
- 7248: regulation of response to alcohol [GO_1901419]
- 7249: regulation of response to biotic stimulus [GO_0002831]
- 7250: regulation of response to calcium ion [GO_1905945]
- 7251: regulation of response to cytokine stimulus [GO_0060759]
- 7252: regulation of response to DNA damage stimulus [GO_2001020]
- 7253: regulation of response to drug [GO_2001023]
- 7254: regulation of response to external stimulus [GO_0032101]
- 7255: regulation of response to extracellular stimulus [GO_0032104]
- 7256: regulation of response to nutrient levels [GO_0032107]
- 7257: regulation of response to osmotic stress [GO_0047484]
- 7258: regulation of response to oxidative stress [GO_1902882]
- 7259: regulation of response to reactive oxygen species [GO_1901031]
- 7260: regulation of response to stimulus [GO_0048583]
- 7261: regulation of response to stress [GO_0080134]
- 7262: regulation of response to wounding [GO_1903034]
- 7263: regulation of retina development in camera-type eye [GO_1902866]
- 7264: regulation of retinal cell programmed cell death [GO_0046668]
- 7265: regulation of retrograde trans-synaptic signaling by neuropeptide [GO_1905432]
- 7266: regulation of Rho-dependent protein serine/threonine kinase activity [GO_2000298]
- 7267: regulation of rhodopsin mediated signaling pathway [GO_0022400]
- 7268: regulation of ribonuclease activity [GO_0060700]
- 7269: regulation of ribonucleoside-diphosphate reductase activity [GO_1905117]
- 7270: regulation of ribosome biogenesis [GO_0090069]
- 7271: regulation of RNA binding [GO_1905214]
- 7272: regulation of RNA biosynthetic process [GO_2001141]
- 7273: regulation of RNA helicase activity [GO_1902280]
- 7274: regulation of RNA metabolic process [GO_0051252]
- 7275: regulation of RNA polymerase I regulatory region sequence-specific DNA binding [GO_1901839]
- 7276: regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO_1903025]
- 7277: regulation of RNA polymerase III activity [GO_1903622]
- 7278: regulation of RNA splicing [GO_0043484]
- 7279: regulation of RNA stability [GO_0043487]
- 7280: regulation of rRNA processing [GO_2000232]
- 7281: regulation of ryanodine-sensitive calcium-release channel activity [GO_0060314]
- 7282: regulation of SA node cell action potential [GO_0098907]
- 7283: regulation of saliva secretion [GO_0046877]
- 7284: regulation of sarcomere organization [GO_0060297]
- 7285: regulation of sclerotome development [GO_0061190]
- 7286: regulation of secondary metabolic process [GO_0043455]
- 7287: regulation of secondary metabolite biosynthetic process [GO_1900376]
- 7288: regulation of secretion [GO_0051046]
- 7289: regulation of secretion by cell [GO_1903530]
- 7290: regulation of secretory granule organization [GO_1904409]
- 7291: regulation of selenocysteine insertion sequence binding [GO_1904573]
- 7292: regulation of semaphorin-plexin signaling pathway [GO_2001260]
- 7293: regulation of sensory perception [GO_0051931]
- 7294: regulation of sensory perception of bitter taste [GO_1904660]
- 7295: regulation of sensory perception of pain [GO_0051930]
- 7296: regulation of sensory perception of sweet taste [GO_1904656]
- 7297: regulation of sequestering of calcium ion [GO_0051282]
- 7298: regulation of serine C-palmitoyltransferase activity [GO_1904220]
- 7299: regulation of serine-type endopeptidase activity [GO_1900003]
- 7300: regulation of serine-type peptidase activity [GO_1902571]
- 7301: regulation of serotonin biosynthetic process [GO_1905627]
- 7302: regulation of serotonin secretion [GO_0014062]
- 7303: regulation of serotonin uptake [GO_0051611]
- 7304: regulation of signal transduction [GO_0009966]
- 7305: regulation of signaling [GO_0023051]
- 7306: regulation of signaling receptor activity [GO_0010469]
- 7307: regulation of single-stranded telomeric DNA binding [GO_0060380]
- 7308: regulation of sister chromatid segregation [GO_0033045]
- 7309: regulation of skeletal muscle adaptation [GO_0014733]
- 7310: regulation of skeletal muscle cell differentiation [GO_2001014]
- 7311: regulation of skeletal muscle cell proliferation [GO_0014857]
- 7312: regulation of skeletal muscle contraction [GO_0014819]
- 7313: